CZ303675B6 - Izolovaný polynukleotid, vektor, hostitelská bunka, zpusob produkce, izolovaný polypeptid, chimérový polypeptid, vakcinacní prostredek a pouzití - Google Patents
Izolovaný polynukleotid, vektor, hostitelská bunka, zpusob produkce, izolovaný polypeptid, chimérový polypeptid, vakcinacní prostredek a pouzití Download PDFInfo
- Publication number
- CZ303675B6 CZ303675B6 CZ20012161A CZ20012161A CZ303675B6 CZ 303675 B6 CZ303675 B6 CZ 303675B6 CZ 20012161 A CZ20012161 A CZ 20012161A CZ 20012161 A CZ20012161 A CZ 20012161A CZ 303675 B6 CZ303675 B6 CZ 303675B6
- Authority
- CZ
- Czechia
- Prior art keywords
- seq
- polypeptide
- bvh
- amino acid
- acid sequence
- Prior art date
Links
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 69
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 69
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 69
- 229960005486 vaccine Drugs 0.000 title claims abstract description 25
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 282
- 102000004196 processed proteins & peptides Human genes 0.000 title claims description 280
- 229920001184 polypeptide Polymers 0.000 title claims description 278
- 239000013598 vector Substances 0.000 title claims description 25
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 239000000203 mixture Substances 0.000 title description 12
- 241000194017 Streptococcus Species 0.000 claims abstract description 18
- 238000011321 prophylaxis Methods 0.000 claims abstract description 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 98
- 239000002773 nucleotide Substances 0.000 claims description 31
- 125000003729 nucleotide group Chemical group 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 20
- 239000002671 adjuvant Substances 0.000 claims description 19
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims description 17
- 206010061372 Streptococcal infection Diseases 0.000 claims description 16
- 230000014509 gene expression Effects 0.000 claims description 14
- 230000028993 immune response Effects 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 5
- 241000282414 Homo sapiens Species 0.000 claims description 5
- 206010035664 Pneumonia Diseases 0.000 claims description 5
- 241000193998 Streptococcus pneumoniae Species 0.000 claims description 5
- 230000003248 secreting effect Effects 0.000 claims description 5
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 201000009906 Meningitis Diseases 0.000 claims description 4
- 206010033078 Otitis media Diseases 0.000 claims description 4
- 241000193996 Streptococcus pyogenes Species 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 241000193985 Streptococcus agalactiae Species 0.000 claims description 3
- 241000194042 Streptococcus dysgalactiae Species 0.000 claims description 3
- 241000194054 Streptococcus uberis Species 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 2
- 229940030998 streptococcus agalactiae Drugs 0.000 claims 2
- 229940115920 streptococcus dysgalactiae Drugs 0.000 claims 2
- 229940115922 streptococcus uberis Drugs 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 194
- 102000004169 proteins and genes Human genes 0.000 abstract description 124
- 108091007433 antigens Proteins 0.000 abstract description 22
- 102000036639 antigens Human genes 0.000 abstract description 22
- 230000000890 antigenic effect Effects 0.000 abstract description 8
- 208000015181 infectious disease Diseases 0.000 abstract description 8
- 238000003556 assay Methods 0.000 abstract description 5
- 238000002560 therapeutic procedure Methods 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000010188 recombinant method Methods 0.000 abstract description 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 description 135
- 241000282326 Felis catus Species 0.000 description 97
- 108020004414 DNA Proteins 0.000 description 74
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 72
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 66
- 238000003752 polymerase chain reaction Methods 0.000 description 61
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 54
- 241001122767 Theaceae Species 0.000 description 53
- 241000699670 Mus sp. Species 0.000 description 52
- 150000001413 amino acids Chemical class 0.000 description 52
- 244000005700 microbiome Species 0.000 description 49
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 45
- 108091034117 Oligonucleotide Proteins 0.000 description 43
- QTMKFZAYZKBFRC-BZSNNMDCSA-N His-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N)O QTMKFZAYZKBFRC-BZSNNMDCSA-N 0.000 description 39
- 108010005233 alanylglutamic acid Proteins 0.000 description 39
- 239000013615 primer Substances 0.000 description 39
- 108010049041 glutamylalanine Proteins 0.000 description 36
- 239000000047 product Substances 0.000 description 35
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 34
- 108010050848 glycylleucine Proteins 0.000 description 33
- 108010047857 aspartylglycine Proteins 0.000 description 31
- 108010087823 glycyltyrosine Proteins 0.000 description 31
- 108010003700 lysyl aspartic acid Proteins 0.000 description 29
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 28
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 28
- 108010092114 histidylphenylalanine Proteins 0.000 description 28
- 108010038633 aspartylglutamate Proteins 0.000 description 27
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 26
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 25
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 25
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 25
- 108010034529 leucyl-lysine Proteins 0.000 description 25
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 25
- PGUYEUCYVNZGGV-QWRGUYRKSA-N Asp-Gly-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PGUYEUCYVNZGGV-QWRGUYRKSA-N 0.000 description 24
- 108010070783 alanyltyrosine Proteins 0.000 description 24
- 108010092854 aspartyllysine Proteins 0.000 description 24
- LTFSLKWFMWZEBD-IMJSIDKUSA-N Ser-Asn Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O LTFSLKWFMWZEBD-IMJSIDKUSA-N 0.000 description 23
- UOLGINIHBRIECN-FXQIFTODSA-N Ser-Glu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UOLGINIHBRIECN-FXQIFTODSA-N 0.000 description 23
- 239000013612 plasmid Substances 0.000 description 22
- HKTRDWYCAUTRRL-YUMQZZPRSA-N Glu-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 HKTRDWYCAUTRRL-YUMQZZPRSA-N 0.000 description 21
- ATIPDCIQTUXABX-UWVGGRQHSA-N Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ATIPDCIQTUXABX-UWVGGRQHSA-N 0.000 description 21
- 108010064235 lysylglycine Proteins 0.000 description 21
- MRWYPDWDZSLWJM-ACZMJKKPSA-N Glu-Ser-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O MRWYPDWDZSLWJM-ACZMJKKPSA-N 0.000 description 20
- IDAHFEPYTJJZFD-PEFMBERDSA-N Ile-Asp-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N IDAHFEPYTJJZFD-PEFMBERDSA-N 0.000 description 20
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 20
- 108010048818 seryl-histidine Proteins 0.000 description 20
- FPQMQEOVSKMVMA-ACRUOGEOSA-N Lys-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCCCN)N)O FPQMQEOVSKMVMA-ACRUOGEOSA-N 0.000 description 19
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 19
- 108010047495 alanylglycine Proteins 0.000 description 19
- 108010015792 glycyllysine Proteins 0.000 description 19
- UHVIQGKBMXEVGN-WDSKDSINSA-N Glu-Gly-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UHVIQGKBMXEVGN-WDSKDSINSA-N 0.000 description 18
- OEROYDLRVAYIMQ-YUMQZZPRSA-N His-Gly-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O OEROYDLRVAYIMQ-YUMQZZPRSA-N 0.000 description 18
- 108700026244 Open Reading Frames Proteins 0.000 description 18
- 239000000427 antigen Substances 0.000 description 18
- 102000037865 fusion proteins Human genes 0.000 description 18
- 108020001507 fusion proteins Proteins 0.000 description 18
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 18
- PZXPWHFYZXTFBI-YUMQZZPRSA-N Asp-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PZXPWHFYZXTFBI-YUMQZZPRSA-N 0.000 description 17
- 108010070944 alanylhistidine Proteins 0.000 description 17
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 16
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 16
- GLWFAWNYGWBMOC-SRVKXCTJSA-N Asn-Leu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GLWFAWNYGWBMOC-SRVKXCTJSA-N 0.000 description 16
- FYRVDDJMNISIKJ-UWVGGRQHSA-N Asn-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FYRVDDJMNISIKJ-UWVGGRQHSA-N 0.000 description 16
- 241000588724 Escherichia coli Species 0.000 description 16
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 16
- LLXVQPKEQQCISF-YUMQZZPRSA-N Gly-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN LLXVQPKEQQCISF-YUMQZZPRSA-N 0.000 description 16
- ZURHXHNAEJJRNU-CIUDSAMLSA-N Leu-Asp-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZURHXHNAEJJRNU-CIUDSAMLSA-N 0.000 description 16
- RZXLZBIUTDQHJQ-SRVKXCTJSA-N Leu-Lys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O RZXLZBIUTDQHJQ-SRVKXCTJSA-N 0.000 description 16
- XGDCYUQSFDQISZ-BQBZGAKWSA-N Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O XGDCYUQSFDQISZ-BQBZGAKWSA-N 0.000 description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 description 16
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 16
- PRONOHBTMLNXCZ-BZSNNMDCSA-N Tyr-Leu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PRONOHBTMLNXCZ-BZSNNMDCSA-N 0.000 description 16
- 108010009298 lysylglutamic acid Proteins 0.000 description 16
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 16
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 15
- IIFDPDVJAHQFSR-WHFBIAKZSA-N Asn-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O IIFDPDVJAHQFSR-WHFBIAKZSA-N 0.000 description 15
- OLVIPTLKNSAYRJ-YUMQZZPRSA-N Asn-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N OLVIPTLKNSAYRJ-YUMQZZPRSA-N 0.000 description 15
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 description 15
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 15
- VBOFRJNDIOPNDO-YUMQZZPRSA-N His-Gly-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N VBOFRJNDIOPNDO-YUMQZZPRSA-N 0.000 description 15
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 15
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 15
- NFDYGNFETJVMSE-BQBZGAKWSA-N Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CO NFDYGNFETJVMSE-BQBZGAKWSA-N 0.000 description 15
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 15
- BCYUHPXBHCUYBA-CUJWVEQBSA-N Thr-Ser-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O BCYUHPXBHCUYBA-CUJWVEQBSA-N 0.000 description 15
- 108010013835 arginine glutamate Proteins 0.000 description 15
- 108010062796 arginyllysine Proteins 0.000 description 15
- 238000010367 cloning Methods 0.000 description 15
- 108010018006 histidylserine Proteins 0.000 description 15
- 108091008146 restriction endonucleases Proteins 0.000 description 15
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 14
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 14
- ZBYLEBZCVKLPCY-FXQIFTODSA-N Asp-Ser-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZBYLEBZCVKLPCY-FXQIFTODSA-N 0.000 description 14
- RDDSZZJOKDVPAE-ACZMJKKPSA-N Glu-Asn-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDDSZZJOKDVPAE-ACZMJKKPSA-N 0.000 description 14
- LGYZYFFDELZWRS-DCAQKATOSA-N Glu-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O LGYZYFFDELZWRS-DCAQKATOSA-N 0.000 description 14
- XBGGUPMXALFZOT-VIFPVBQESA-N Gly-Tyr Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-VIFPVBQESA-N 0.000 description 14
- RMOKGALPSPOYKE-KATARQTJSA-N Lys-Thr-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O RMOKGALPSPOYKE-KATARQTJSA-N 0.000 description 14
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 14
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 14
- 230000003053 immunization Effects 0.000 description 14
- 238000002649 immunization Methods 0.000 description 14
- 108010063431 methionyl-aspartyl-glycine Proteins 0.000 description 14
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 13
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 13
- DGLAHESNTJWGDO-SRVKXCTJSA-N His-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N DGLAHESNTJWGDO-SRVKXCTJSA-N 0.000 description 13
- FFAUOCITXBMRBT-YTFOTSKYSA-N Ile-Lys-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FFAUOCITXBMRBT-YTFOTSKYSA-N 0.000 description 13
- IBSGMIPRBMPMHE-IHRRRGAJSA-N Leu-Met-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O IBSGMIPRBMPMHE-IHRRRGAJSA-N 0.000 description 13
- GJJQCBVRWDGLMQ-GUBZILKMSA-N Lys-Glu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O GJJQCBVRWDGLMQ-GUBZILKMSA-N 0.000 description 13
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 13
- XZKQVQKUZMAADP-IMJSIDKUSA-N Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(O)=O XZKQVQKUZMAADP-IMJSIDKUSA-N 0.000 description 13
- LDEBVRIURYMKQS-WISUUJSJSA-N Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO LDEBVRIURYMKQS-WISUUJSJSA-N 0.000 description 13
- YOSLMIPKOUAHKI-OLHMAJIHSA-N Thr-Asp-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O YOSLMIPKOUAHKI-OLHMAJIHSA-N 0.000 description 13
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 13
- PDSLRCZINIDLMU-QWRGUYRKSA-N Tyr-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PDSLRCZINIDLMU-QWRGUYRKSA-N 0.000 description 13
- OSXNCKRGMSHWSQ-ACRUOGEOSA-N Tyr-His-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OSXNCKRGMSHWSQ-ACRUOGEOSA-N 0.000 description 13
- 230000004927 fusion Effects 0.000 description 13
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 13
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 13
- 108010054155 lysyllysine Proteins 0.000 description 13
- 108010003137 tyrosyltyrosine Proteins 0.000 description 13
- AENHOIXXHKNIQL-AUTRQRHGSA-N Ala-Tyr-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]([NH3+])C)CC1=CC=C(O)C=C1 AENHOIXXHKNIQL-AUTRQRHGSA-N 0.000 description 12
- SJUXYGVRSGTPMC-IMJSIDKUSA-N Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O SJUXYGVRSGTPMC-IMJSIDKUSA-N 0.000 description 12
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 12
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 12
- UQBGYPFHWFZMCD-ZLUOBGJFSA-N Asp-Asn-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O UQBGYPFHWFZMCD-ZLUOBGJFSA-N 0.000 description 12
- TVVYVAUGRHNTGT-UGYAYLCHSA-N Asp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O TVVYVAUGRHNTGT-UGYAYLCHSA-N 0.000 description 12
- SWTQDYFZVOJVLL-KKUMJFAQSA-N Asp-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N)O SWTQDYFZVOJVLL-KKUMJFAQSA-N 0.000 description 12
- VNXQRBXEQXLERQ-CIUDSAMLSA-N Asp-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N VNXQRBXEQXLERQ-CIUDSAMLSA-N 0.000 description 12
- UWBDLNOCIDGPQE-GUBZILKMSA-N Ile-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN UWBDLNOCIDGPQE-GUBZILKMSA-N 0.000 description 12
- YKNBJXOJTURHCU-DCAQKATOSA-N Leu-Asp-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKNBJXOJTURHCU-DCAQKATOSA-N 0.000 description 12
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 12
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 12
- HWMGTNOVUDIKRE-UWVGGRQHSA-N Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 HWMGTNOVUDIKRE-UWVGGRQHSA-N 0.000 description 12
- LALNXSXEYFUUDD-GUBZILKMSA-N Ser-Glu-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LALNXSXEYFUUDD-GUBZILKMSA-N 0.000 description 12
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 12
- AAZOYLQUEQRUMZ-GSSVUCPTSA-N Thr-Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O AAZOYLQUEQRUMZ-GSSVUCPTSA-N 0.000 description 12
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 12
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 12
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 11
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 11
- SKTGPBFTMNLIHQ-KKUMJFAQSA-N Arg-Glu-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SKTGPBFTMNLIHQ-KKUMJFAQSA-N 0.000 description 11
- QMQZYILAWUOLPV-JYJNAYRXSA-N Arg-Tyr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CC1=CC=C(O)C=C1 QMQZYILAWUOLPV-JYJNAYRXSA-N 0.000 description 11
- NPDLYUOYAGBHFB-WDSKDSINSA-N Asn-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NPDLYUOYAGBHFB-WDSKDSINSA-N 0.000 description 11
- PPMTUXJSQDNUDE-CIUDSAMLSA-N Asn-Glu-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PPMTUXJSQDNUDE-CIUDSAMLSA-N 0.000 description 11
- QYRMBFWDSFGSFC-OLHMAJIHSA-N Asn-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QYRMBFWDSFGSFC-OLHMAJIHSA-N 0.000 description 11
- GWIJZUVQVDJHDI-AVGNSLFASA-N Asp-Phe-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GWIJZUVQVDJHDI-AVGNSLFASA-N 0.000 description 11
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 11
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 11
- LPBWRHRHEIYAIP-KKUMJFAQSA-N His-Tyr-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LPBWRHRHEIYAIP-KKUMJFAQSA-N 0.000 description 11
- HZYHBDVRCBDJJV-HAFWLYHUSA-N Ile-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O HZYHBDVRCBDJJV-HAFWLYHUSA-N 0.000 description 11
- WCNWGAUZWWSYDG-SVSWQMSJSA-N Ile-Thr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O)N WCNWGAUZWWSYDG-SVSWQMSJSA-N 0.000 description 11
- DGTOKVBDZXJHNZ-WZLNRYEVSA-N Ile-Thr-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N DGTOKVBDZXJHNZ-WZLNRYEVSA-N 0.000 description 11
- JIHDFWWRYHSAQB-GUBZILKMSA-N Leu-Ser-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JIHDFWWRYHSAQB-GUBZILKMSA-N 0.000 description 11
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 11
- KPJJOZUXFOLGMQ-CIUDSAMLSA-N Lys-Asp-Asn Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N KPJJOZUXFOLGMQ-CIUDSAMLSA-N 0.000 description 11
- GHKXHCMRAUYLBS-CIUDSAMLSA-N Lys-Ser-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O GHKXHCMRAUYLBS-CIUDSAMLSA-N 0.000 description 11
- RMLLCGYYVZKKRT-CIUDSAMLSA-N Met-Ser-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O RMLLCGYYVZKKRT-CIUDSAMLSA-N 0.000 description 11
- 241001644525 Nastus productus Species 0.000 description 11
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 11
- KYYMILWEGJYPQZ-IHRRRGAJSA-N Phe-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KYYMILWEGJYPQZ-IHRRRGAJSA-N 0.000 description 11
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 11
- MFEVVAXTBZELLL-GGVZMXCHSA-N Tyr-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MFEVVAXTBZELLL-GGVZMXCHSA-N 0.000 description 11
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 11
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 11
- 108010089804 glycyl-threonine Proteins 0.000 description 11
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 10
- MAISCYVJLBBRNU-DCAQKATOSA-N Arg-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N MAISCYVJLBBRNU-DCAQKATOSA-N 0.000 description 10
- BNODVYXZAAXSHW-IUCAKERBSA-N Arg-His Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 BNODVYXZAAXSHW-IUCAKERBSA-N 0.000 description 10
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 10
- REQUGIWGOGSOEZ-ZLUOBGJFSA-N Asn-Ser-Asn Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)C(=O)N REQUGIWGOGSOEZ-ZLUOBGJFSA-N 0.000 description 10
- ZUFPUBYQYWCMDB-NUMRIWBASA-N Asn-Thr-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZUFPUBYQYWCMDB-NUMRIWBASA-N 0.000 description 10
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 10
- BLQBMRNMBAYREH-UWJYBYFXSA-N Asp-Ala-Tyr Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O BLQBMRNMBAYREH-UWJYBYFXSA-N 0.000 description 10
- KGHLGJAXYSVNJP-WHFBIAKZSA-N Asp-Ser-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O KGHLGJAXYSVNJP-WHFBIAKZSA-N 0.000 description 10
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 10
- XUORRGAFUQIMLC-STQMWFEESA-N Gly-Arg-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O XUORRGAFUQIMLC-STQMWFEESA-N 0.000 description 10
- UXJHNZODTMHWRD-WHFBIAKZSA-N Gly-Asn-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O UXJHNZODTMHWRD-WHFBIAKZSA-N 0.000 description 10
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 10
- STGQSBKUYSPPIG-CIUDSAMLSA-N His-Ser-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 STGQSBKUYSPPIG-CIUDSAMLSA-N 0.000 description 10
- KWTVLKBOQATPHJ-SRVKXCTJSA-N Leu-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N KWTVLKBOQATPHJ-SRVKXCTJSA-N 0.000 description 10
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 10
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 10
- HQVDJTYKCMIWJP-YUMQZZPRSA-N Lys-Asn-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HQVDJTYKCMIWJP-YUMQZZPRSA-N 0.000 description 10
- IWWMPCPLFXFBAF-SRVKXCTJSA-N Lys-Asp-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O IWWMPCPLFXFBAF-SRVKXCTJSA-N 0.000 description 10
- NNKLKUUGESXCBS-KBPBESRZSA-N Lys-Gly-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NNKLKUUGESXCBS-KBPBESRZSA-N 0.000 description 10
- MGKFCQFVPKOWOL-CIUDSAMLSA-N Lys-Ser-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N MGKFCQFVPKOWOL-CIUDSAMLSA-N 0.000 description 10
- BXNGIHFNNNSEOS-UWVGGRQHSA-N Phe-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 BXNGIHFNNNSEOS-UWVGGRQHSA-N 0.000 description 10
- WXUBSIDKNMFAGS-IHRRRGAJSA-N Ser-Arg-Tyr Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WXUBSIDKNMFAGS-IHRRRGAJSA-N 0.000 description 10
- WXWDPFVKQRVJBJ-CIUDSAMLSA-N Ser-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N WXWDPFVKQRVJBJ-CIUDSAMLSA-N 0.000 description 10
- XFTYVCHLARBHBQ-FOHZUACHSA-N Thr-Gly-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XFTYVCHLARBHBQ-FOHZUACHSA-N 0.000 description 10
- GAYLGYUVTDMLKC-UWJYBYFXSA-N Tyr-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GAYLGYUVTDMLKC-UWJYBYFXSA-N 0.000 description 10
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 108010081551 glycylphenylalanine Proteins 0.000 description 10
- 108010061238 threonyl-glycine Proteins 0.000 description 10
- SHYYAQLDNVHPFT-DLOVCJGASA-N Ala-Asn-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SHYYAQLDNVHPFT-DLOVCJGASA-N 0.000 description 9
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 9
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 9
- UBCPNBUIQNMDNH-NAKRPEOUSA-N Arg-Ile-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O UBCPNBUIQNMDNH-NAKRPEOUSA-N 0.000 description 9
- AKEBUSZTMQLNIX-UWJYBYFXSA-N Asn-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N AKEBUSZTMQLNIX-UWJYBYFXSA-N 0.000 description 9
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 description 9
- RJONUNZIMUXUOI-GUBZILKMSA-N Glu-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N RJONUNZIMUXUOI-GUBZILKMSA-N 0.000 description 9
- IQACOVZVOMVILH-FXQIFTODSA-N Glu-Glu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O IQACOVZVOMVILH-FXQIFTODSA-N 0.000 description 9
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 9
- SUIAHERNFYRBDZ-GVXVVHGQSA-N Glu-Lys-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O SUIAHERNFYRBDZ-GVXVVHGQSA-N 0.000 description 9
- IDEODOAVGCMUQV-GUBZILKMSA-N Glu-Ser-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IDEODOAVGCMUQV-GUBZILKMSA-N 0.000 description 9
- HZISRJBYZAODRV-XQXXSGGOSA-N Glu-Thr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O HZISRJBYZAODRV-XQXXSGGOSA-N 0.000 description 9
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 9
- KOYUSMBPJOVSOO-XEGUGMAKSA-N Gly-Tyr-Ile Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KOYUSMBPJOVSOO-XEGUGMAKSA-N 0.000 description 9
- ZPVJJPAIUZLSNE-DCAQKATOSA-N His-Arg-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O ZPVJJPAIUZLSNE-DCAQKATOSA-N 0.000 description 9
- HIJIJPFILYPTFR-ACRUOGEOSA-N His-Tyr-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HIJIJPFILYPTFR-ACRUOGEOSA-N 0.000 description 9
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 9
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 9
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 9
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 9
- BTEMNFBEAAOGBR-BZSNNMDCSA-N Leu-Tyr-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BTEMNFBEAAOGBR-BZSNNMDCSA-N 0.000 description 9
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 9
- GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 9
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 9
- NJNRBRKHOWSGMN-SRVKXCTJSA-N Lys-Leu-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O NJNRBRKHOWSGMN-SRVKXCTJSA-N 0.000 description 9
- PLDJDCJLRCYPJB-VOAKCMCISA-N Lys-Lys-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PLDJDCJLRCYPJB-VOAKCMCISA-N 0.000 description 9
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 9
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 9
- 101100460200 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) NEW1 gene Proteins 0.000 description 9
- 101100273916 Schizosaccharomyces pombe (strain 972 / ATCC 24843) wip1 gene Proteins 0.000 description 9
- LAFKUZYWNCHOHT-WHFBIAKZSA-N Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O LAFKUZYWNCHOHT-WHFBIAKZSA-N 0.000 description 9
- SQBLRDDJTUJDMV-ACZMJKKPSA-N Ser-Glu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQBLRDDJTUJDMV-ACZMJKKPSA-N 0.000 description 9
- CLKKNZQUQMZDGD-SRVKXCTJSA-N Ser-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CN=CN1 CLKKNZQUQMZDGD-SRVKXCTJSA-N 0.000 description 9
- MQUZANJDFOQOBX-SRVKXCTJSA-N Ser-Phe-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O MQUZANJDFOQOBX-SRVKXCTJSA-N 0.000 description 9
- IOWJRKAVLALBQB-IWGUZYHVSA-N Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O IOWJRKAVLALBQB-IWGUZYHVSA-N 0.000 description 9
- VGYVVSQFSSKZRJ-OEAJRASXSA-N Thr-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=CC=C1 VGYVVSQFSSKZRJ-OEAJRASXSA-N 0.000 description 9
- KLQPIEVIKOQRAW-IZPVPAKOSA-N Tyr-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O KLQPIEVIKOQRAW-IZPVPAKOSA-N 0.000 description 9
- 108010068265 aspartyltyrosine Proteins 0.000 description 9
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 9
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 9
- 108010040030 histidinoalanine Proteins 0.000 description 9
- 108010038320 lysylphenylalanine Proteins 0.000 description 9
- 108010012581 phenylalanylglutamate Proteins 0.000 description 9
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 9
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 9
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 8
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 8
- PUBLUECXJRHTBK-ACZMJKKPSA-N Ala-Glu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O PUBLUECXJRHTBK-ACZMJKKPSA-N 0.000 description 8
- AJBVYEYZVYPFCF-CIUDSAMLSA-N Ala-Lys-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O AJBVYEYZVYPFCF-CIUDSAMLSA-N 0.000 description 8
- XHNLCGXYBXNRIS-BJDJZHNGSA-N Ala-Lys-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XHNLCGXYBXNRIS-BJDJZHNGSA-N 0.000 description 8
- XAXMJQUMRJAFCH-CQDKDKBSSA-N Ala-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 XAXMJQUMRJAFCH-CQDKDKBSSA-N 0.000 description 8
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 8
- HAJWYALLJIATCX-FXQIFTODSA-N Asn-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N HAJWYALLJIATCX-FXQIFTODSA-N 0.000 description 8
- MSBDSTRUMZFSEU-PEFMBERDSA-N Asn-Glu-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MSBDSTRUMZFSEU-PEFMBERDSA-N 0.000 description 8
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 8
- FBODFHMLALOPHP-GUBZILKMSA-N Asn-Lys-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O FBODFHMLALOPHP-GUBZILKMSA-N 0.000 description 8
- VFUXXFVCYZPOQG-WDSKDSINSA-N Asp-Glu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VFUXXFVCYZPOQG-WDSKDSINSA-N 0.000 description 8
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 8
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 8
- NALWOULWGHTVDA-UWVGGRQHSA-N Asp-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NALWOULWGHTVDA-UWVGGRQHSA-N 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 8
- 239000003298 DNA probe Substances 0.000 description 8
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 8
- CXRWMMRLEMVSEH-PEFMBERDSA-N Glu-Ile-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CXRWMMRLEMVSEH-PEFMBERDSA-N 0.000 description 8
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 8
- UQHGAYSULGRWRG-WHFBIAKZSA-N Glu-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UQHGAYSULGRWRG-WHFBIAKZSA-N 0.000 description 8
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 8
- FDQYIRHBVVUTJF-ZETCQYMHSA-N His-Gly-Gly Chemical compound [O-]C(=O)CNC(=O)CNC(=O)[C@@H]([NH3+])CC1=CN=CN1 FDQYIRHBVVUTJF-ZETCQYMHSA-N 0.000 description 8
- WSEITRHJRVDTRX-QTKMDUPCSA-N His-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CN=CN1)N)O WSEITRHJRVDTRX-QTKMDUPCSA-N 0.000 description 8
- LVQDUPQUJZWKSU-PYJNHQTQSA-N Ile-Arg-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LVQDUPQUJZWKSU-PYJNHQTQSA-N 0.000 description 8
- UIEZQYNXCYHMQS-BJDJZHNGSA-N Ile-Lys-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)N UIEZQYNXCYHMQS-BJDJZHNGSA-N 0.000 description 8
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 8
- JGAMUXDWYSXYLM-SRVKXCTJSA-N Lys-Arg-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O JGAMUXDWYSXYLM-SRVKXCTJSA-N 0.000 description 8
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 8
- WVJNGSFKBKOKRV-AJNGGQMLSA-N Lys-Leu-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVJNGSFKBKOKRV-AJNGGQMLSA-N 0.000 description 8
- FJVJLMZUIGMFFU-BQBZGAKWSA-N Met-Asp-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FJVJLMZUIGMFFU-BQBZGAKWSA-N 0.000 description 8
- LHXFNWBNRBWMNV-DCAQKATOSA-N Met-Ser-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LHXFNWBNRBWMNV-DCAQKATOSA-N 0.000 description 8
- NSTPXGARCQOSAU-VIFPVBQESA-N N-formyl-L-phenylalanine Chemical compound O=CN[C@H](C(=O)O)CC1=CC=CC=C1 NSTPXGARCQOSAU-VIFPVBQESA-N 0.000 description 8
- 101100205189 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-5 gene Proteins 0.000 description 8
- 101100228799 Schizosaccharomyces pombe (strain 972 / ATCC 24843) gem6 gene Proteins 0.000 description 8
- SSJMZMUVNKEENT-IMJSIDKUSA-N Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CO SSJMZMUVNKEENT-IMJSIDKUSA-N 0.000 description 8
- ICHZYBVODUVUKN-SRVKXCTJSA-N Ser-Asn-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ICHZYBVODUVUKN-SRVKXCTJSA-N 0.000 description 8
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 8
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 8
- UBTNVMGPMYDYIU-HJPIBITLSA-N Ser-Tyr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UBTNVMGPMYDYIU-HJPIBITLSA-N 0.000 description 8
- UYTYTDMCDBPDSC-URLPEUOOSA-N Thr-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N UYTYTDMCDBPDSC-URLPEUOOSA-N 0.000 description 8
- BQBCIBCLXBKYHW-CSMHCCOUSA-N Thr-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O BQBCIBCLXBKYHW-CSMHCCOUSA-N 0.000 description 8
- AYHSJESDFKREAR-KKUMJFAQSA-N Tyr-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AYHSJESDFKREAR-KKUMJFAQSA-N 0.000 description 8
- HPYDSVWYXXKHRD-VIFPVBQESA-N Tyr-Gly Chemical compound [O-]C(=O)CNC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 HPYDSVWYXXKHRD-VIFPVBQESA-N 0.000 description 8
- OLWFDNLLBWQWCP-STQMWFEESA-N Tyr-Gly-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OLWFDNLLBWQWCP-STQMWFEESA-N 0.000 description 8
- AZZLDIDWPZLCCW-ZEWNOJEFSA-N Tyr-Ile-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O AZZLDIDWPZLCCW-ZEWNOJEFSA-N 0.000 description 8
- NZBSVMQZQMEUHI-WZLNRYEVSA-N Tyr-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NZBSVMQZQMEUHI-WZLNRYEVSA-N 0.000 description 8
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 8
- 108010020688 glycylhistidine Proteins 0.000 description 8
- 230000004083 survival effect Effects 0.000 description 8
- GCTANJIJJROSLH-GVARAGBVSA-N Ala-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C)N GCTANJIJJROSLH-GVARAGBVSA-N 0.000 description 7
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 7
- MSILNNHVVMMTHZ-UWVGGRQHSA-N Arg-His-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 MSILNNHVVMMTHZ-UWVGGRQHSA-N 0.000 description 7
- ASQKVGRCKOFKIU-KZVJFYERSA-N Arg-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ASQKVGRCKOFKIU-KZVJFYERSA-N 0.000 description 7
- DDBMKOCQWNFDBH-RHYQMDGZSA-N Arg-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O DDBMKOCQWNFDBH-RHYQMDGZSA-N 0.000 description 7
- QHUOOCKNNURZSL-IHRRRGAJSA-N Arg-Tyr-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O QHUOOCKNNURZSL-IHRRRGAJSA-N 0.000 description 7
- XWGJDUSDTRPQRK-ZLUOBGJFSA-N Asn-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O XWGJDUSDTRPQRK-ZLUOBGJFSA-N 0.000 description 7
- ACKNRKFVYUVWAC-ZPFDUUQYSA-N Asn-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ACKNRKFVYUVWAC-ZPFDUUQYSA-N 0.000 description 7
- VGRHZPNRCLAHQA-IMJSIDKUSA-N Asp-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O VGRHZPNRCLAHQA-IMJSIDKUSA-N 0.000 description 7
- RWHHSFSWKFBTCF-KKUMJFAQSA-N Asp-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N RWHHSFSWKFBTCF-KKUMJFAQSA-N 0.000 description 7
- BSWHERGFUNMWGS-UHFFFAOYSA-N Asp-Ile Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CC(O)=O BSWHERGFUNMWGS-UHFFFAOYSA-N 0.000 description 7
- DWBZEJHQQIURML-IMJSIDKUSA-N Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O DWBZEJHQQIURML-IMJSIDKUSA-N 0.000 description 7
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 7
- JDDYEZGPYBBPBN-JRQIVUDYSA-N Asp-Thr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JDDYEZGPYBBPBN-JRQIVUDYSA-N 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 7
- JZDHUJAFXGNDSB-WHFBIAKZSA-N Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O JZDHUJAFXGNDSB-WHFBIAKZSA-N 0.000 description 7
- TUTIHHSZKFBMHM-WHFBIAKZSA-N Glu-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O TUTIHHSZKFBMHM-WHFBIAKZSA-N 0.000 description 7
- SVZIKUHLRKVZIF-GUBZILKMSA-N Glu-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N SVZIKUHLRKVZIF-GUBZILKMSA-N 0.000 description 7
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 7
- PHONAZGUEGIOEM-GLLZPBPUSA-N Glu-Glu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PHONAZGUEGIOEM-GLLZPBPUSA-N 0.000 description 7
- LSPKYLAFTPBWIL-BYPYZUCNSA-N Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(O)=O LSPKYLAFTPBWIL-BYPYZUCNSA-N 0.000 description 7
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 7
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 7
- IKAIKUBBJHFNBZ-LURJTMIESA-N Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CN IKAIKUBBJHFNBZ-LURJTMIESA-N 0.000 description 7
- FFALDIDGPLUDKV-ZDLURKLDSA-N Gly-Thr-Ser Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O FFALDIDGPLUDKV-ZDLURKLDSA-N 0.000 description 7
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 7
- UWNUQPZUSRFIIN-JUKXBJQTSA-N His-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CN=CN2)N UWNUQPZUSRFIIN-JUKXBJQTSA-N 0.000 description 7
- DCQMJRSOGCYKTR-GHCJXIJMSA-N Ile-Asp-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O DCQMJRSOGCYKTR-GHCJXIJMSA-N 0.000 description 7
- KIMHKBDJQQYLHU-PEFMBERDSA-N Ile-Glu-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KIMHKBDJQQYLHU-PEFMBERDSA-N 0.000 description 7
- SJLVSMMIFYTSGY-GRLWGSQLSA-N Ile-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SJLVSMMIFYTSGY-GRLWGSQLSA-N 0.000 description 7
- OTSVBELRDMSPKY-PCBIJLKTSA-N Ile-Phe-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OTSVBELRDMSPKY-PCBIJLKTSA-N 0.000 description 7
- IIWQTXMUALXGOV-PCBIJLKTSA-N Ile-Phe-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IIWQTXMUALXGOV-PCBIJLKTSA-N 0.000 description 7
- CZCSUZMIRKFFFA-CIUDSAMLSA-N Leu-Ala-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O CZCSUZMIRKFFFA-CIUDSAMLSA-N 0.000 description 7
- HASRFYOMVPJRPU-SRVKXCTJSA-N Leu-Arg-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HASRFYOMVPJRPU-SRVKXCTJSA-N 0.000 description 7
- YVKSMSDXKMSIRX-GUBZILKMSA-N Leu-Glu-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O YVKSMSDXKMSIRX-GUBZILKMSA-N 0.000 description 7
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 7
- QYOXSYXPHUHOJR-GUBZILKMSA-N Lys-Asn-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QYOXSYXPHUHOJR-GUBZILKMSA-N 0.000 description 7
- NRQRKMYZONPCTM-CIUDSAMLSA-N Lys-Asp-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NRQRKMYZONPCTM-CIUDSAMLSA-N 0.000 description 7
- ZXEUFAVXODIPHC-GUBZILKMSA-N Lys-Glu-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZXEUFAVXODIPHC-GUBZILKMSA-N 0.000 description 7
- VQXAVLQBQJMENB-SRVKXCTJSA-N Lys-Glu-Met Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O VQXAVLQBQJMENB-SRVKXCTJSA-N 0.000 description 7
- CANPXOLVTMKURR-WEDXCCLWSA-N Lys-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN CANPXOLVTMKURR-WEDXCCLWSA-N 0.000 description 7
- HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 7
- JMNRXRPBHFGXQX-GUBZILKMSA-N Lys-Ser-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JMNRXRPBHFGXQX-GUBZILKMSA-N 0.000 description 7
- MIDZLCFIAINOQN-WPRPVWTQSA-N Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 MIDZLCFIAINOQN-WPRPVWTQSA-N 0.000 description 7
- ZZVUXQCQPXSUFH-JBACZVJFSA-N Phe-Glu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 ZZVUXQCQPXSUFH-JBACZVJFSA-N 0.000 description 7
- BXLYSRPHVMCOPS-ACZMJKKPSA-N Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO BXLYSRPHVMCOPS-ACZMJKKPSA-N 0.000 description 7
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 7
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 7
- CQNFRKAKGDSJFR-NUMRIWBASA-N Thr-Glu-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O CQNFRKAKGDSJFR-NUMRIWBASA-N 0.000 description 7
- XTCNBOBTROGWMW-RWRJDSDZSA-N Thr-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XTCNBOBTROGWMW-RWRJDSDZSA-N 0.000 description 7
- VTVVYQOXJCZVEB-WDCWCFNPSA-N Thr-Leu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VTVVYQOXJCZVEB-WDCWCFNPSA-N 0.000 description 7
- ZSPQUTWLWGWTPS-HJGDQZAQSA-N Thr-Lys-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZSPQUTWLWGWTPS-HJGDQZAQSA-N 0.000 description 7
- KZURUCDWKDEAFZ-XVSYOHENSA-N Thr-Phe-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O KZURUCDWKDEAFZ-XVSYOHENSA-N 0.000 description 7
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 7
- RCLOWEZASFJFEX-KKUMJFAQSA-N Tyr-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RCLOWEZASFJFEX-KKUMJFAQSA-N 0.000 description 7
- ZZDYJFVIKVSUFA-WLTAIBSBSA-N Tyr-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ZZDYJFVIKVSUFA-WLTAIBSBSA-N 0.000 description 7
- 239000011543 agarose gel Substances 0.000 description 7
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 7
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 7
- 230000001404 mediated effect Effects 0.000 description 7
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 7
- 108010024607 phenylalanylalanine Proteins 0.000 description 7
- 239000013600 plasmid vector Substances 0.000 description 7
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 6
- XQGIRPGAVLFKBJ-CIUDSAMLSA-N Ala-Asn-Lys Chemical compound N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O XQGIRPGAVLFKBJ-CIUDSAMLSA-N 0.000 description 6
- GSCLWXDNIMNIJE-ZLUOBGJFSA-N Ala-Asp-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GSCLWXDNIMNIJE-ZLUOBGJFSA-N 0.000 description 6
- BTYTYHBSJKQBQA-GCJQMDKQSA-N Ala-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)O BTYTYHBSJKQBQA-GCJQMDKQSA-N 0.000 description 6
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 6
- BLIMFWGRQKRCGT-YUMQZZPRSA-N Ala-Gly-Lys Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN BLIMFWGRQKRCGT-YUMQZZPRSA-N 0.000 description 6
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 6
- BLTRAARCJYVJKV-QEJZJMRPSA-N Ala-Lys-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O BLTRAARCJYVJKV-QEJZJMRPSA-N 0.000 description 6
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 6
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 6
- BUQICHWNXBIBOG-LMVFSUKVSA-N Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)N BUQICHWNXBIBOG-LMVFSUKVSA-N 0.000 description 6
- UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 6
- SYFHFLGAROUHNT-VEVYYDQMSA-N Arg-Thr-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SYFHFLGAROUHNT-VEVYYDQMSA-N 0.000 description 6
- LEFKSBYHUGUWLP-ACZMJKKPSA-N Asn-Ala-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LEFKSBYHUGUWLP-ACZMJKKPSA-N 0.000 description 6
- WQLJRNRLHWJIRW-KKUMJFAQSA-N Asn-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N)O WQLJRNRLHWJIRW-KKUMJFAQSA-N 0.000 description 6
- DJIMLSXHXKWADV-CIUDSAMLSA-N Asn-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O DJIMLSXHXKWADV-CIUDSAMLSA-N 0.000 description 6
- BKFXFUPYETWGGA-XVSYOHENSA-N Asn-Phe-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BKFXFUPYETWGGA-XVSYOHENSA-N 0.000 description 6
- VWADICJNCPFKJS-ZLUOBGJFSA-N Asn-Ser-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O VWADICJNCPFKJS-ZLUOBGJFSA-N 0.000 description 6
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 6
- JHFNSBBHKSZXKB-VKHMYHEASA-N Asp-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(O)=O JHFNSBBHKSZXKB-VKHMYHEASA-N 0.000 description 6
- SVABRQFIHCSNCI-FOHZUACHSA-N Asp-Gly-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SVABRQFIHCSNCI-FOHZUACHSA-N 0.000 description 6
- 102100021277 Beta-secretase 2 Human genes 0.000 description 6
- 101710150190 Beta-secretase 2 Proteins 0.000 description 6
- 101100289888 Caenorhabditis elegans lys-5 gene Proteins 0.000 description 6
- KKZHXOOZHFABQQ-UWJYBYFXSA-N Cys-Ala-Tyr Chemical compound SC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KKZHXOOZHFABQQ-UWJYBYFXSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- SJPMNHCEWPTRBR-BQBZGAKWSA-N Glu-Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SJPMNHCEWPTRBR-BQBZGAKWSA-N 0.000 description 6
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 6
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 6
- QCMVGXDELYMZET-GLLZPBPUSA-N Glu-Thr-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QCMVGXDELYMZET-GLLZPBPUSA-N 0.000 description 6
- HDNXXTBKOJKWNN-WDSKDSINSA-N Gly-Glu-Asn Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O HDNXXTBKOJKWNN-WDSKDSINSA-N 0.000 description 6
- STVHDEHTKFXBJQ-LAEOZQHASA-N Gly-Glu-Ile Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O STVHDEHTKFXBJQ-LAEOZQHASA-N 0.000 description 6
- LRQXRHGQEVWGPV-NHCYSSNCSA-N Gly-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN LRQXRHGQEVWGPV-NHCYSSNCSA-N 0.000 description 6
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 6
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 6
- OLIFSFOFKGKIRH-WUJLRWPWSA-N Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CN OLIFSFOFKGKIRH-WUJLRWPWSA-N 0.000 description 6
- DCRODRAURLJOFY-XPUUQOCRSA-N His-Ala-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)NCC(O)=O DCRODRAURLJOFY-XPUUQOCRSA-N 0.000 description 6
- NOQPTNXSGNPJNS-YUMQZZPRSA-N His-Asn-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O NOQPTNXSGNPJNS-YUMQZZPRSA-N 0.000 description 6
- AQCUAZTZSPQJFF-ZKWXMUAHSA-N Ile-Ala-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AQCUAZTZSPQJFF-ZKWXMUAHSA-N 0.000 description 6
- KBAPKNDWAGVGTH-IGISWZIWSA-N Ile-Ile-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KBAPKNDWAGVGTH-IGISWZIWSA-N 0.000 description 6
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 6
- ZUPJCJINYQISSN-XUXIUFHCSA-N Ile-Met-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N ZUPJCJINYQISSN-XUXIUFHCSA-N 0.000 description 6
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 6
- BIZNDKMFQHDOIE-KKUMJFAQSA-N Leu-Phe-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 BIZNDKMFQHDOIE-KKUMJFAQSA-N 0.000 description 6
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 6
- DGAAQRAUOFHBFJ-CIUDSAMLSA-N Lys-Asn-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O DGAAQRAUOFHBFJ-CIUDSAMLSA-N 0.000 description 6
- HGZHSNBZDOLMLH-DCAQKATOSA-N Lys-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N HGZHSNBZDOLMLH-DCAQKATOSA-N 0.000 description 6
- DGWXCIORNLWGGG-CIUDSAMLSA-N Lys-Asn-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O DGWXCIORNLWGGG-CIUDSAMLSA-N 0.000 description 6
- RIJCHEVHFWMDKD-SRVKXCTJSA-N Lys-Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RIJCHEVHFWMDKD-SRVKXCTJSA-N 0.000 description 6
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 6
- ZLGQEBCCANLYRA-RYUDHWBXSA-N Phe-Gly-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O ZLGQEBCCANLYRA-RYUDHWBXSA-N 0.000 description 6
- SFKOEHXABNPLRT-KBPBESRZSA-N Phe-His-Gly Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(O)=O SFKOEHXABNPLRT-KBPBESRZSA-N 0.000 description 6
- DMEYUTSDVRCWRS-ULQDDVLXSA-N Phe-Lys-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 DMEYUTSDVRCWRS-ULQDDVLXSA-N 0.000 description 6
- QKQDTEYDEIJPNK-GUBZILKMSA-N Ser-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO QKQDTEYDEIJPNK-GUBZILKMSA-N 0.000 description 6
- WSTIOCFMWXNOCX-YUMQZZPRSA-N Ser-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N WSTIOCFMWXNOCX-YUMQZZPRSA-N 0.000 description 6
- SQHKXWODKJDZRC-LKXGYXEUSA-N Ser-Thr-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQHKXWODKJDZRC-LKXGYXEUSA-N 0.000 description 6
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 6
- SCSVNSNWUTYSFO-WDCWCFNPSA-N Thr-Lys-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O SCSVNSNWUTYSFO-WDCWCFNPSA-N 0.000 description 6
- BDYBHQWMHYDRKJ-UNQGMJICSA-N Thr-Phe-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)O)N)O BDYBHQWMHYDRKJ-UNQGMJICSA-N 0.000 description 6
- IVDFVBVIVLJJHR-LKXGYXEUSA-N Thr-Ser-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IVDFVBVIVLJJHR-LKXGYXEUSA-N 0.000 description 6
- ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 6
- AYPAIRCDLARHLM-KKUMJFAQSA-N Tyr-Asn-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O AYPAIRCDLARHLM-KKUMJFAQSA-N 0.000 description 6
- HHFMNAVFGBYSAT-IGISWZIWSA-N Tyr-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N HHFMNAVFGBYSAT-IGISWZIWSA-N 0.000 description 6
- NHOVZGFNTGMYMI-KKUMJFAQSA-N Tyr-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NHOVZGFNTGMYMI-KKUMJFAQSA-N 0.000 description 6
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 6
- 125000000539 amino acid group Chemical group 0.000 description 6
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 6
- 239000012472 biological sample Substances 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002163 immunogen Effects 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 108010051110 tyrosyl-lysine Proteins 0.000 description 6
- YAXNATKKPOWVCP-ZLUOBGJFSA-N Ala-Asn-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O YAXNATKKPOWVCP-ZLUOBGJFSA-N 0.000 description 5
- CFPQUJZTLUQUTJ-HTFCKZLJSA-N Ala-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C)N CFPQUJZTLUQUTJ-HTFCKZLJSA-N 0.000 description 5
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 5
- FFEUXEAKYRCACT-PEDHHIEDSA-N Arg-Ile-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(O)=O FFEUXEAKYRCACT-PEDHHIEDSA-N 0.000 description 5
- SSZGOKWBHLOCHK-DCAQKATOSA-N Arg-Lys-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N SSZGOKWBHLOCHK-DCAQKATOSA-N 0.000 description 5
- ORXCYAFUCSTQGY-FXQIFTODSA-N Asn-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N ORXCYAFUCSTQGY-FXQIFTODSA-N 0.000 description 5
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 5
- JWKDQOORUCYUIW-ZPFDUUQYSA-N Asn-Lys-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JWKDQOORUCYUIW-ZPFDUUQYSA-N 0.000 description 5
- JDHOJQJMWBKHDB-CIUDSAMLSA-N Asp-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N JDHOJQJMWBKHDB-CIUDSAMLSA-N 0.000 description 5
- NVFSJIXJZCDICF-SRVKXCTJSA-N Asp-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N NVFSJIXJZCDICF-SRVKXCTJSA-N 0.000 description 5
- YBAFDPFAUTYYRW-YUMQZZPRSA-N Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O YBAFDPFAUTYYRW-YUMQZZPRSA-N 0.000 description 5
- WNRZUESNGGDCJX-JYJNAYRXSA-N Glu-Leu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WNRZUESNGGDCJX-JYJNAYRXSA-N 0.000 description 5
- JSIQVRIXMINMTA-ZDLURKLDSA-N Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O JSIQVRIXMINMTA-ZDLURKLDSA-N 0.000 description 5
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 5
- DGKBSGNCMCLDSL-BYULHYEWSA-N Gly-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN DGKBSGNCMCLDSL-BYULHYEWSA-N 0.000 description 5
- CVFOYJJOZYYEPE-KBPBESRZSA-N Gly-Lys-Tyr Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CVFOYJJOZYYEPE-KBPBESRZSA-N 0.000 description 5
- LLWQVJNHMYBLLK-CDMKHQONSA-N Gly-Thr-Phe Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLWQVJNHMYBLLK-CDMKHQONSA-N 0.000 description 5
- JCOSMKPAOYDKRO-AVGNSLFASA-N His-Glu-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N JCOSMKPAOYDKRO-AVGNSLFASA-N 0.000 description 5
- LYCVKHSJGDMDLM-LURJTMIESA-N His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1 LYCVKHSJGDMDLM-LURJTMIESA-N 0.000 description 5
- STOOMQFEJUVAKR-KKUMJFAQSA-N His-His-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CNC=N1 STOOMQFEJUVAKR-KKUMJFAQSA-N 0.000 description 5
- UCGDDTHMMVWVMV-FSPLSTOPSA-N Ile-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(O)=O UCGDDTHMMVWVMV-FSPLSTOPSA-N 0.000 description 5
- BCVIOZZGJNOEQS-XKNYDFJKSA-N Ile-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)[C@@H](C)CC BCVIOZZGJNOEQS-XKNYDFJKSA-N 0.000 description 5
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 5
- 108010065920 Insulin Lispro Proteins 0.000 description 5
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 5
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 5
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 5
- SQUFDMCWMFOEBA-KKUMJFAQSA-N Leu-Ser-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SQUFDMCWMFOEBA-KKUMJFAQSA-N 0.000 description 5
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 5
- CIOWSLJGLSUOME-BQBZGAKWSA-N Lys-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O CIOWSLJGLSUOME-BQBZGAKWSA-N 0.000 description 5
- WGCKDDHUFPQSMZ-ZPFDUUQYSA-N Lys-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCCN WGCKDDHUFPQSMZ-ZPFDUUQYSA-N 0.000 description 5
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N Lys-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UGTZHPSKYRIGRJ-YUMQZZPRSA-N 0.000 description 5
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 5
- OWRUUFUVXFREBD-KKUMJFAQSA-N Lys-His-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O OWRUUFUVXFREBD-KKUMJFAQSA-N 0.000 description 5
- SLQJJFAVWSZLBL-BJDJZHNGSA-N Lys-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN SLQJJFAVWSZLBL-BJDJZHNGSA-N 0.000 description 5
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 5
- ZJSZPXISKMDJKQ-JYJNAYRXSA-N Lys-Phe-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=CC=C1 ZJSZPXISKMDJKQ-JYJNAYRXSA-N 0.000 description 5
- QVTDVTONTRSQMF-WDCWCFNPSA-N Lys-Thr-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CCCCN QVTDVTONTRSQMF-WDCWCFNPSA-N 0.000 description 5
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 5
- UROWNMBTQGGTHB-DCAQKATOSA-N Met-Leu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UROWNMBTQGGTHB-DCAQKATOSA-N 0.000 description 5
- YYEIFXZOBZVDPH-DCAQKATOSA-N Met-Lys-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O YYEIFXZOBZVDPH-DCAQKATOSA-N 0.000 description 5
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 5
- 208000035109 Pneumococcal Infections Diseases 0.000 description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 description 5
- 238000012300 Sequence Analysis Methods 0.000 description 5
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 5
- UBRXAVQWXOWRSJ-ZLUOBGJFSA-N Ser-Asn-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)C(=O)N UBRXAVQWXOWRSJ-ZLUOBGJFSA-N 0.000 description 5
- FTVRVZNYIYWJGB-ACZMJKKPSA-N Ser-Asp-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FTVRVZNYIYWJGB-ACZMJKKPSA-N 0.000 description 5
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 5
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 5
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 5
- MFEBUIFJVPNZLO-OLHMAJIHSA-N Thr-Asp-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O MFEBUIFJVPNZLO-OLHMAJIHSA-N 0.000 description 5
- GNHRVXYZKWSJTF-HJGDQZAQSA-N Thr-Asp-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GNHRVXYZKWSJTF-HJGDQZAQSA-N 0.000 description 5
- DJDSEDOKJTZBAR-ZDLURKLDSA-N Thr-Gly-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O DJDSEDOKJTZBAR-ZDLURKLDSA-N 0.000 description 5
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 5
- YRJOLUDFVAUXLI-GSSVUCPTSA-N Thr-Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O YRJOLUDFVAUXLI-GSSVUCPTSA-N 0.000 description 5
- GFHYISDTIWZUSU-QWRGUYRKSA-N Tyr-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GFHYISDTIWZUSU-QWRGUYRKSA-N 0.000 description 5
- 108010028939 alanyl-alanyl-lysyl-alanine Proteins 0.000 description 5
- 108010041407 alanylaspartic acid Proteins 0.000 description 5
- 230000027455 binding Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000001332 colony forming effect Effects 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 5
- 108010036413 histidylglycine Proteins 0.000 description 5
- 101150066555 lacZ gene Proteins 0.000 description 5
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 5
- 108010012058 leucyltyrosine Proteins 0.000 description 5
- 108010056582 methionylglutamic acid Proteins 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 230000009257 reactivity Effects 0.000 description 5
- 238000002255 vaccination Methods 0.000 description 5
- 108010073969 valyllysine Proteins 0.000 description 5
- RVLOMLVNNBWRSR-KNIFDHDWSA-N (2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O RVLOMLVNNBWRSR-KNIFDHDWSA-N 0.000 description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- 108010036211 5-HT-moduline Proteins 0.000 description 4
- SKHCUBQVZJHOFM-NAKRPEOUSA-N Ala-Arg-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SKHCUBQVZJHOFM-NAKRPEOUSA-N 0.000 description 4
- FSBCNCKIQZZASN-GUBZILKMSA-N Ala-Arg-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O FSBCNCKIQZZASN-GUBZILKMSA-N 0.000 description 4
- KXEVYGKATAMXJJ-ACZMJKKPSA-N Ala-Glu-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KXEVYGKATAMXJJ-ACZMJKKPSA-N 0.000 description 4
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 4
- QUIGLPSHIFPEOV-CIUDSAMLSA-N Ala-Lys-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O QUIGLPSHIFPEOV-CIUDSAMLSA-N 0.000 description 4
- SDZRIBWEVVRDQI-CIUDSAMLSA-N Ala-Lys-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O SDZRIBWEVVRDQI-CIUDSAMLSA-N 0.000 description 4
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 4
- ZJLORAAXDAJLDC-CQDKDKBSSA-N Ala-Tyr-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O ZJLORAAXDAJLDC-CQDKDKBSSA-N 0.000 description 4
- COXMUHNBYCVVRG-DCAQKATOSA-N Arg-Leu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O COXMUHNBYCVVRG-DCAQKATOSA-N 0.000 description 4
- IJYZHIOOBGIINM-WDSKDSINSA-N Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N IJYZHIOOBGIINM-WDSKDSINSA-N 0.000 description 4
- DAPLJWATMAXPPZ-CIUDSAMLSA-N Asn-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O DAPLJWATMAXPPZ-CIUDSAMLSA-N 0.000 description 4
- VKCOHFFSTKCXEQ-OLHMAJIHSA-N Asn-Asn-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VKCOHFFSTKCXEQ-OLHMAJIHSA-N 0.000 description 4
- HXWUJJADFMXNKA-BQBZGAKWSA-N Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O HXWUJJADFMXNKA-BQBZGAKWSA-N 0.000 description 4
- FTSAJSADJCMDHH-CIUDSAMLSA-N Asn-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FTSAJSADJCMDHH-CIUDSAMLSA-N 0.000 description 4
- NYGILGUOUOXGMJ-YUMQZZPRSA-N Asn-Lys-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O NYGILGUOUOXGMJ-YUMQZZPRSA-N 0.000 description 4
- QDXQWFBLUVTOFL-FXQIFTODSA-N Asn-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)N)N QDXQWFBLUVTOFL-FXQIFTODSA-N 0.000 description 4
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 4
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 4
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 4
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 4
- XAJRHVUUVUPFQL-ACZMJKKPSA-N Asp-Glu-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O XAJRHVUUVUPFQL-ACZMJKKPSA-N 0.000 description 4
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 4
- USNJAPJZSGTTPX-XVSYOHENSA-N Asp-Phe-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O USNJAPJZSGTTPX-XVSYOHENSA-N 0.000 description 4
- NTQDELBZOMWXRS-IWGUZYHVSA-N Asp-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O NTQDELBZOMWXRS-IWGUZYHVSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 4
- NKLRYVLERDYDBI-FXQIFTODSA-N Glu-Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKLRYVLERDYDBI-FXQIFTODSA-N 0.000 description 4
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 4
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 4
- WVTIBGWZUMJBFY-GUBZILKMSA-N Glu-His-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O WVTIBGWZUMJBFY-GUBZILKMSA-N 0.000 description 4
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 4
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 4
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 4
- FMBWLLMUPXTXFC-SDDRHHMPSA-N Glu-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)N)C(=O)O FMBWLLMUPXTXFC-SDDRHHMPSA-N 0.000 description 4
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 4
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 4
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 4
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 4
- AFWYPMDMDYCKMD-KBPBESRZSA-N Gly-Leu-Tyr Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 AFWYPMDMDYCKMD-KBPBESRZSA-N 0.000 description 4
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 4
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 4
- HQSKKSLNLSTONK-JTQLQIEISA-N Gly-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 HQSKKSLNLSTONK-JTQLQIEISA-N 0.000 description 4
- VHOLZZKNEBBHTH-YUMQZZPRSA-N His-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 VHOLZZKNEBBHTH-YUMQZZPRSA-N 0.000 description 4
- VYUXYMRNGALHEA-DLOVCJGASA-N His-Leu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O VYUXYMRNGALHEA-DLOVCJGASA-N 0.000 description 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
- XIRYQRLFHWWWTC-QEJZJMRPSA-N Leu-Ala-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XIRYQRLFHWWWTC-QEJZJMRPSA-N 0.000 description 4
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 4
- WXUOJXIGOPMDJM-SRVKXCTJSA-N Leu-Lys-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O WXUOJXIGOPMDJM-SRVKXCTJSA-N 0.000 description 4
- RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 4
- VJGQRELPQWNURN-JYJNAYRXSA-N Leu-Tyr-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJGQRELPQWNURN-JYJNAYRXSA-N 0.000 description 4
- JGKHAFUAPZCCDU-BZSNNMDCSA-N Leu-Tyr-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=C(O)C=C1 JGKHAFUAPZCCDU-BZSNNMDCSA-N 0.000 description 4
- VHXMZJGOKIMETG-CQDKDKBSSA-N Lys-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCCCN)N VHXMZJGOKIMETG-CQDKDKBSSA-N 0.000 description 4
- FACUGMGEFUEBTI-SRVKXCTJSA-N Lys-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN FACUGMGEFUEBTI-SRVKXCTJSA-N 0.000 description 4
- KZOHPCYVORJBLG-AVGNSLFASA-N Lys-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N KZOHPCYVORJBLG-AVGNSLFASA-N 0.000 description 4
- HGNRJCINZYHNOU-LURJTMIESA-N Lys-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(O)=O HGNRJCINZYHNOU-LURJTMIESA-N 0.000 description 4
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 4
- LUAJJLPHUXPQLH-KKUMJFAQSA-N Lys-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N LUAJJLPHUXPQLH-KKUMJFAQSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- LNIIRLODKOWQIY-IHRRRGAJSA-N Phe-Asn-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O LNIIRLODKOWQIY-IHRRRGAJSA-N 0.000 description 4
- WPTYDQPGBMDUBI-QWRGUYRKSA-N Phe-Gly-Asn Chemical compound N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O WPTYDQPGBMDUBI-QWRGUYRKSA-N 0.000 description 4
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 4
- JWBLQDDHSDGEGR-DRZSPHRISA-N Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JWBLQDDHSDGEGR-DRZSPHRISA-N 0.000 description 4
- OBVCYFIHIIYIQF-CIUDSAMLSA-N Pro-Asn-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OBVCYFIHIIYIQF-CIUDSAMLSA-N 0.000 description 4
- 101100460204 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new4 gene Proteins 0.000 description 4
- 101100460205 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new9 gene Proteins 0.000 description 4
- XVAUJOAYHWWNQF-ZLUOBGJFSA-N Ser-Asn-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O XVAUJOAYHWWNQF-ZLUOBGJFSA-N 0.000 description 4
- OHKLFYXEOGGGCK-ZLUOBGJFSA-N Ser-Asp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OHKLFYXEOGGGCK-ZLUOBGJFSA-N 0.000 description 4
- SFZKGGOGCNQPJY-CIUDSAMLSA-N Ser-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N SFZKGGOGCNQPJY-CIUDSAMLSA-N 0.000 description 4
- HMRAQFJFTOLDKW-GUBZILKMSA-N Ser-His-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O HMRAQFJFTOLDKW-GUBZILKMSA-N 0.000 description 4
- QGAHMVHBORDHDC-YUMQZZPRSA-N Ser-His-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 QGAHMVHBORDHDC-YUMQZZPRSA-N 0.000 description 4
- YIUWWXVTYLANCJ-NAKRPEOUSA-N Ser-Ile-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YIUWWXVTYLANCJ-NAKRPEOUSA-N 0.000 description 4
- RIAKPZVSNBBNRE-BJDJZHNGSA-N Ser-Ile-Leu Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O RIAKPZVSNBBNRE-BJDJZHNGSA-N 0.000 description 4
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 4
- GSCVDSBEYVGMJQ-SRVKXCTJSA-N Ser-Tyr-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)O GSCVDSBEYVGMJQ-SRVKXCTJSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- LGNBRHZANHMZHK-NUMRIWBASA-N Thr-Glu-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O LGNBRHZANHMZHK-NUMRIWBASA-N 0.000 description 4
- QYDKSNXSBXZPFK-ZJDVBMNYSA-N Thr-Thr-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYDKSNXSBXZPFK-ZJDVBMNYSA-N 0.000 description 4
- VBMOVTMNHWPZJR-SUSMZKCASA-N Thr-Thr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VBMOVTMNHWPZJR-SUSMZKCASA-N 0.000 description 4
- GQEXFCQNAJHJTI-IHPCNDPISA-N Trp-Phe-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N GQEXFCQNAJHJTI-IHPCNDPISA-N 0.000 description 4
- TVOGEPLDNYTAHD-CQDKDKBSSA-N Tyr-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TVOGEPLDNYTAHD-CQDKDKBSSA-N 0.000 description 4
- WTXQBCCKXIKKHB-JYJNAYRXSA-N Tyr-Arg-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WTXQBCCKXIKKHB-JYJNAYRXSA-N 0.000 description 4
- NQJDICVXXIMMMB-XDTLVQLUSA-N Tyr-Glu-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O NQJDICVXXIMMMB-XDTLVQLUSA-N 0.000 description 4
- BSCBBPKDVOZICB-KKUMJFAQSA-N Tyr-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BSCBBPKDVOZICB-KKUMJFAQSA-N 0.000 description 4
- UMSZZGTXGKHTFJ-SRVKXCTJSA-N Tyr-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UMSZZGTXGKHTFJ-SRVKXCTJSA-N 0.000 description 4
- SDUBQHUJJWQTEU-XUXIUFHCSA-N Val-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)N SDUBQHUJJWQTEU-XUXIUFHCSA-N 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000004408 hybridoma Anatomy 0.000 description 4
- 108010057821 leucylproline Proteins 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- -1 synthetic multimers) Polymers 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- ALBODLTZUXKBGZ-JUUVMNCLSA-N (2s)-2-amino-3-phenylpropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 ALBODLTZUXKBGZ-JUUVMNCLSA-N 0.000 description 3
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 3
- XEXJJJRVTFGWIC-FXQIFTODSA-N Ala-Asn-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XEXJJJRVTFGWIC-FXQIFTODSA-N 0.000 description 3
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 3
- HHRAXZAYZFFRAM-CIUDSAMLSA-N Ala-Leu-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O HHRAXZAYZFFRAM-CIUDSAMLSA-N 0.000 description 3
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 3
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 3
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 3
- XRUJOVRWNMBAAA-NHCYSSNCSA-N Ala-Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 XRUJOVRWNMBAAA-NHCYSSNCSA-N 0.000 description 3
- ALZVPLKYDKJKQU-XVKPBYJWSA-N Ala-Tyr Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ALZVPLKYDKJKQU-XVKPBYJWSA-N 0.000 description 3
- YCTIYBUTCKNOTI-UWJYBYFXSA-N Ala-Tyr-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCTIYBUTCKNOTI-UWJYBYFXSA-N 0.000 description 3
- OOBVTWHLKYJFJH-FXQIFTODSA-N Arg-Ala-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O OOBVTWHLKYJFJH-FXQIFTODSA-N 0.000 description 3
- AMIQZQAAYGYKOP-FXQIFTODSA-N Arg-Ser-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O AMIQZQAAYGYKOP-FXQIFTODSA-N 0.000 description 3
- MEFGKQUUYZOLHM-GMOBBJLQSA-N Asn-Arg-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MEFGKQUUYZOLHM-GMOBBJLQSA-N 0.000 description 3
- XSGBIBGAMKTHMY-WHFBIAKZSA-N Asn-Asp-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O XSGBIBGAMKTHMY-WHFBIAKZSA-N 0.000 description 3
- OWUCNXMFJRFOFI-BQBZGAKWSA-N Asn-Gly-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OWUCNXMFJRFOFI-BQBZGAKWSA-N 0.000 description 3
- JQSWHKKUZMTOIH-QWRGUYRKSA-N Asn-Gly-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N JQSWHKKUZMTOIH-QWRGUYRKSA-N 0.000 description 3
- MDDXKBHIMYYJLW-FXQIFTODSA-N Asn-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N MDDXKBHIMYYJLW-FXQIFTODSA-N 0.000 description 3
- AEZCCDMZZJOGII-DCAQKATOSA-N Asn-Met-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O AEZCCDMZZJOGII-DCAQKATOSA-N 0.000 description 3
- KDFQZBWWPYQBEN-ZLUOBGJFSA-N Asp-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N KDFQZBWWPYQBEN-ZLUOBGJFSA-N 0.000 description 3
- VILLWIDTHYPSLC-PEFMBERDSA-N Asp-Glu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VILLWIDTHYPSLC-PEFMBERDSA-N 0.000 description 3
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 3
- WYOSXGYAKZQPGF-SRVKXCTJSA-N Asp-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC(=O)O)N WYOSXGYAKZQPGF-SRVKXCTJSA-N 0.000 description 3
- ORRJQLIATJDMQM-HJGDQZAQSA-N Asp-Leu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O ORRJQLIATJDMQM-HJGDQZAQSA-N 0.000 description 3
- 208000031729 Bacteremia Diseases 0.000 description 3
- IXPSSIBVVKSOIE-SRVKXCTJSA-N Cys-Ser-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N)O IXPSSIBVVKSOIE-SRVKXCTJSA-N 0.000 description 3
- 108020003215 DNA Probes Proteins 0.000 description 3
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 3
- SSHIXEILTLPAQT-WHFBIAKZSA-N Gln-Asp Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O SSHIXEILTLPAQT-WHFBIAKZSA-N 0.000 description 3
- RLZBLVSJDFHDBL-KBIXCLLPSA-N Glu-Ala-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RLZBLVSJDFHDBL-KBIXCLLPSA-N 0.000 description 3
- AFODTOLGSZQDSL-PEFMBERDSA-N Glu-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N AFODTOLGSZQDSL-PEFMBERDSA-N 0.000 description 3
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 3
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 3
- OAGVHWYIBZMWLA-YFKPBYRVSA-N Glu-Gly-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)NCC(O)=O OAGVHWYIBZMWLA-YFKPBYRVSA-N 0.000 description 3
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 3
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 3
- IOUQWHIEQYQVFD-JYJNAYRXSA-N Glu-Leu-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IOUQWHIEQYQVFD-JYJNAYRXSA-N 0.000 description 3
- OCJRHJZKGGSPRW-IUCAKERBSA-N Glu-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O OCJRHJZKGGSPRW-IUCAKERBSA-N 0.000 description 3
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 3
- MIIGESVJEBDJMP-FHWLQOOXSA-N Glu-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 MIIGESVJEBDJMP-FHWLQOOXSA-N 0.000 description 3
- QOXDAWODGSIDDI-GUBZILKMSA-N Glu-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N QOXDAWODGSIDDI-GUBZILKMSA-N 0.000 description 3
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 3
- OGCIHJPYKVSMTE-YUMQZZPRSA-N Gly-Arg-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O OGCIHJPYKVSMTE-YUMQZZPRSA-N 0.000 description 3
- FUESBOMYALLFNI-VKHMYHEASA-N Gly-Asn Chemical compound NCC(=O)N[C@H](C(O)=O)CC(N)=O FUESBOMYALLFNI-VKHMYHEASA-N 0.000 description 3
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 3
- YTSVAIMKVLZUDU-YUMQZZPRSA-N Gly-Leu-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YTSVAIMKVLZUDU-YUMQZZPRSA-N 0.000 description 3
- LIXWIUAORXJNBH-QWRGUYRKSA-N Gly-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN LIXWIUAORXJNBH-QWRGUYRKSA-N 0.000 description 3
- YHYDTTUSJXGTQK-UWVGGRQHSA-N Gly-Met-Leu Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(O)=O YHYDTTUSJXGTQK-UWVGGRQHSA-N 0.000 description 3
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 3
- IRJWAYCXIYUHQE-WHFBIAKZSA-N Gly-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CN IRJWAYCXIYUHQE-WHFBIAKZSA-N 0.000 description 3
- HUFUVTYGPOUCBN-MBLNEYKQSA-N Gly-Thr-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HUFUVTYGPOUCBN-MBLNEYKQSA-N 0.000 description 3
- NIKBMHGRNAPJFW-IUCAKERBSA-N His-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 NIKBMHGRNAPJFW-IUCAKERBSA-N 0.000 description 3
- 102000002265 Human Growth Hormone Human genes 0.000 description 3
- 108010000521 Human Growth Hormone Proteins 0.000 description 3
- 239000000854 Human Growth Hormone Substances 0.000 description 3
- JRHFQUPIZOYKQP-KBIXCLLPSA-N Ile-Ala-Glu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O JRHFQUPIZOYKQP-KBIXCLLPSA-N 0.000 description 3
- LPXHYGGZJOCAFR-MNXVOIDGSA-N Ile-Glu-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N LPXHYGGZJOCAFR-MNXVOIDGSA-N 0.000 description 3
- WIZPFZKOFZXDQG-HTFCKZLJSA-N Ile-Ile-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O WIZPFZKOFZXDQG-HTFCKZLJSA-N 0.000 description 3
- CSQNHSGHAPRGPQ-YTFOTSKYSA-N Ile-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O)N CSQNHSGHAPRGPQ-YTFOTSKYSA-N 0.000 description 3
- FXJLRZFMKGHYJP-CFMVVWHZSA-N Ile-Tyr-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N FXJLRZFMKGHYJP-CFMVVWHZSA-N 0.000 description 3
- XBBKIIGCUMBKCO-JXUBOQSCSA-N Leu-Ala-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XBBKIIGCUMBKCO-JXUBOQSCSA-N 0.000 description 3
- MLTRLIITQPXHBJ-BQBZGAKWSA-N Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O MLTRLIITQPXHBJ-BQBZGAKWSA-N 0.000 description 3
- IIKJNQWOQIWWMR-CIUDSAMLSA-N Leu-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)N IIKJNQWOQIWWMR-CIUDSAMLSA-N 0.000 description 3
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 3
- OTXBNHIUIHNGAO-UWVGGRQHSA-N Leu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN OTXBNHIUIHNGAO-UWVGGRQHSA-N 0.000 description 3
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 3
- PJWOOBTYQNNRBF-BZSNNMDCSA-N Leu-Phe-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)O)N PJWOOBTYQNNRBF-BZSNNMDCSA-N 0.000 description 3
- VTJUNIYRYIAIHF-IUCAKERBSA-N Leu-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O VTJUNIYRYIAIHF-IUCAKERBSA-N 0.000 description 3
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 3
- MPGHETGWWWUHPY-CIUDSAMLSA-N Lys-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN MPGHETGWWWUHPY-CIUDSAMLSA-N 0.000 description 3
- JPNRPAJITHRXRH-BQBZGAKWSA-N Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O JPNRPAJITHRXRH-BQBZGAKWSA-N 0.000 description 3
- ITWQLSZTLBKWJM-YUMQZZPRSA-N Lys-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCCN ITWQLSZTLBKWJM-YUMQZZPRSA-N 0.000 description 3
- IGRMTQMIDNDFAA-UWVGGRQHSA-N Lys-His Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IGRMTQMIDNDFAA-UWVGGRQHSA-N 0.000 description 3
- KKFVKBWCXXLKIK-AVGNSLFASA-N Lys-His-Glu Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)N KKFVKBWCXXLKIK-AVGNSLFASA-N 0.000 description 3
- OVAOHZIOUBEQCJ-IHRRRGAJSA-N Lys-Leu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OVAOHZIOUBEQCJ-IHRRRGAJSA-N 0.000 description 3
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 3
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 3
- GAHJXEMYXKLZRQ-AJNGGQMLSA-N Lys-Lys-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GAHJXEMYXKLZRQ-AJNGGQMLSA-N 0.000 description 3
- CNGOEHJCLVCJHN-SRVKXCTJSA-N Lys-Pro-Glu Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O CNGOEHJCLVCJHN-SRVKXCTJSA-N 0.000 description 3
- ZOKVLMBYDSIDKG-CSMHCCOUSA-N Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ZOKVLMBYDSIDKG-CSMHCCOUSA-N 0.000 description 3
- GIKFNMZSGYAPEJ-HJGDQZAQSA-N Lys-Thr-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O GIKFNMZSGYAPEJ-HJGDQZAQSA-N 0.000 description 3
- MYTOTTSMVMWVJN-STQMWFEESA-N Lys-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 MYTOTTSMVMWVJN-STQMWFEESA-N 0.000 description 3
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 3
- 102100027343 Napsin-A Human genes 0.000 description 3
- LDSOBEJVGGVWGD-DLOVCJGASA-N Phe-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 LDSOBEJVGGVWGD-DLOVCJGASA-N 0.000 description 3
- MGBRZXXGQBAULP-DRZSPHRISA-N Phe-Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGBRZXXGQBAULP-DRZSPHRISA-N 0.000 description 3
- GLUBLISJVJFHQS-VIFPVBQESA-N Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 GLUBLISJVJFHQS-VIFPVBQESA-N 0.000 description 3
- YCCUXNNKXDGMAM-KKUMJFAQSA-N Phe-Leu-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YCCUXNNKXDGMAM-KKUMJFAQSA-N 0.000 description 3
- PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 3
- BONHGTUEEPIMPM-AVGNSLFASA-N Phe-Ser-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O BONHGTUEEPIMPM-AVGNSLFASA-N 0.000 description 3
- GMWNQSGWWGKTSF-LFSVMHDDSA-N Phe-Thr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMWNQSGWWGKTSF-LFSVMHDDSA-N 0.000 description 3
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 3
- 108010066124 Protein S Proteins 0.000 description 3
- 102000029301 Protein S Human genes 0.000 description 3
- 229940096437 Protein S Drugs 0.000 description 3
- 101100172625 Schizosaccharomyces pombe (strain 972 / ATCC 24843) erh1 gene Proteins 0.000 description 3
- 101100460198 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new14 gene Proteins 0.000 description 3
- 101100322386 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new8 gene Proteins 0.000 description 3
- 101100255212 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rsa3 gene Proteins 0.000 description 3
- 101100210181 Schizosaccharomyces pombe (strain 972 / ATCC 24843) vts1 gene Proteins 0.000 description 3
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 3
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 3
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 3
- ZIFYDQAFEMIZII-GUBZILKMSA-N Ser-Leu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZIFYDQAFEMIZII-GUBZILKMSA-N 0.000 description 3
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 3
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 3
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 3
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 3
- 241000680505 Streptococcus pneumoniae WU2 Species 0.000 description 3
- UQTNIFUCMBFWEJ-IWGUZYHVSA-N Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O UQTNIFUCMBFWEJ-IWGUZYHVSA-N 0.000 description 3
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 3
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 3
- WXVIGTAUZBUDPZ-DTLFHODZSA-N Thr-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 WXVIGTAUZBUDPZ-DTLFHODZSA-N 0.000 description 3
- KRGDDWVBBDLPSJ-CUJWVEQBSA-N Thr-His-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O KRGDDWVBBDLPSJ-CUJWVEQBSA-N 0.000 description 3
- LCCSEJSPBWKBNT-OSUNSFLBSA-N Thr-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N LCCSEJSPBWKBNT-OSUNSFLBSA-N 0.000 description 3
- GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 description 3
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 3
- ABCLYRRGTZNIFU-BWAGICSOSA-N Thr-Tyr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O ABCLYRRGTZNIFU-BWAGICSOSA-N 0.000 description 3
- ZWZOCUWOXSDYFZ-CQDKDKBSSA-N Tyr-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ZWZOCUWOXSDYFZ-CQDKDKBSSA-N 0.000 description 3
- ONWMQORSVZYVNH-UWVGGRQHSA-N Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ONWMQORSVZYVNH-UWVGGRQHSA-N 0.000 description 3
- CKKFTIQYURNSEI-IHRRRGAJSA-N Tyr-Asn-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CKKFTIQYURNSEI-IHRRRGAJSA-N 0.000 description 3
- VFJIWSJKZJTQII-SRVKXCTJSA-N Tyr-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VFJIWSJKZJTQII-SRVKXCTJSA-N 0.000 description 3
- KCPFDGNYAMKZQP-KBPBESRZSA-N Tyr-Gly-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O KCPFDGNYAMKZQP-KBPBESRZSA-N 0.000 description 3
- NOOMDULIORCDNF-IRXDYDNUSA-N Tyr-Gly-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NOOMDULIORCDNF-IRXDYDNUSA-N 0.000 description 3
- YIKDYZDNRCNFQB-KKUMJFAQSA-N Tyr-His-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O YIKDYZDNRCNFQB-KKUMJFAQSA-N 0.000 description 3
- KSCVLGXNQXKUAR-JYJNAYRXSA-N Tyr-Leu-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KSCVLGXNQXKUAR-JYJNAYRXSA-N 0.000 description 3
- AOLHUMAVONBBEZ-STQMWFEESA-N Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AOLHUMAVONBBEZ-STQMWFEESA-N 0.000 description 3
- PWKMJDQXKCENMF-MEYUZBJRSA-N Tyr-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O PWKMJDQXKCENMF-MEYUZBJRSA-N 0.000 description 3
- YDPFWRVQHFWBKI-GVXVVHGQSA-N Val-Glu-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N YDPFWRVQHFWBKI-GVXVVHGQSA-N 0.000 description 3
- 108010011559 alanylphenylalanine Proteins 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 3
- 108010093581 aspartyl-proline Proteins 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 239000007330 chocolate agar Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000004186 co-expression Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 3
- 108010078144 glutaminyl-glycine Proteins 0.000 description 3
- 101150089730 gly-10 gene Proteins 0.000 description 3
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 3
- 108010010147 glycylglutamine Proteins 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 108010017391 lysylvaline Proteins 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229940124733 pneumococcal vaccine Drugs 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012134 supernatant fraction Substances 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- AUXMWYRZQPIXCC-KNIFDHDWSA-N (2s)-2-amino-4-methylpentanoic acid;(2s)-2-aminopropanoic acid Chemical compound C[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O AUXMWYRZQPIXCC-KNIFDHDWSA-N 0.000 description 2
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 2
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 2
- WQVFQXXBNHHPLX-ZKWXMUAHSA-N Ala-Ala-His Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O WQVFQXXBNHHPLX-ZKWXMUAHSA-N 0.000 description 2
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 2
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 2
- GFBLJMHGHAXGNY-ZLUOBGJFSA-N Ala-Asn-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GFBLJMHGHAXGNY-ZLUOBGJFSA-N 0.000 description 2
- CVGNCMIULZNYES-WHFBIAKZSA-N Ala-Asn-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CVGNCMIULZNYES-WHFBIAKZSA-N 0.000 description 2
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 2
- WXERCAHAIKMTKX-ZLUOBGJFSA-N Ala-Asp-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O WXERCAHAIKMTKX-ZLUOBGJFSA-N 0.000 description 2
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 2
- HMRWQTHUDVXMGH-GUBZILKMSA-N Ala-Glu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HMRWQTHUDVXMGH-GUBZILKMSA-N 0.000 description 2
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 2
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 2
- JDIQCVUDDFENPU-ZKWXMUAHSA-N Ala-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CNC=N1 JDIQCVUDDFENPU-ZKWXMUAHSA-N 0.000 description 2
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 2
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 2
- XQNRANMFRPCFFW-GCJQMDKQSA-N Ala-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)N)O XQNRANMFRPCFFW-GCJQMDKQSA-N 0.000 description 2
- DEAGTWNKODHUIY-MRFFXTKBSA-N Ala-Tyr-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O DEAGTWNKODHUIY-MRFFXTKBSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- HPKSHFSEXICTLI-CIUDSAMLSA-N Arg-Glu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HPKSHFSEXICTLI-CIUDSAMLSA-N 0.000 description 2
- XUUXCWCKKCZEAW-YFKPBYRVSA-N Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N XUUXCWCKKCZEAW-YFKPBYRVSA-N 0.000 description 2
- AUFHLLPVPSMEOG-YUMQZZPRSA-N Arg-Gly-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AUFHLLPVPSMEOG-YUMQZZPRSA-N 0.000 description 2
- FLYANDHDFRGGTM-PYJNHQTQSA-N Arg-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N FLYANDHDFRGGTM-PYJNHQTQSA-N 0.000 description 2
- FSNVAJOPUDVQAR-AVGNSLFASA-N Arg-Lys-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FSNVAJOPUDVQAR-AVGNSLFASA-N 0.000 description 2
- QJWLLRZTJFPCHA-STECZYCISA-N Arg-Tyr-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QJWLLRZTJFPCHA-STECZYCISA-N 0.000 description 2
- SWLOHUMCUDRTCL-ZLUOBGJFSA-N Asn-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N SWLOHUMCUDRTCL-ZLUOBGJFSA-N 0.000 description 2
- CMLGVVWQQHUXOZ-GHCJXIJMSA-N Asn-Ala-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CMLGVVWQQHUXOZ-GHCJXIJMSA-N 0.000 description 2
- SLKLLQWZQHXYSV-CIUDSAMLSA-N Asn-Ala-Lys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O SLKLLQWZQHXYSV-CIUDSAMLSA-N 0.000 description 2
- AYKKKGFJXIDYLX-ACZMJKKPSA-N Asn-Gln-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O AYKKKGFJXIDYLX-ACZMJKKPSA-N 0.000 description 2
- OPEPUCYIGFEGSW-WDSKDSINSA-N Asn-Gly-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OPEPUCYIGFEGSW-WDSKDSINSA-N 0.000 description 2
- HYQYLOSCICEYTR-YUMQZZPRSA-N Asn-Gly-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O HYQYLOSCICEYTR-YUMQZZPRSA-N 0.000 description 2
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 2
- NLRJGXZWTKXRHP-DCAQKATOSA-N Asn-Leu-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NLRJGXZWTKXRHP-DCAQKATOSA-N 0.000 description 2
- QJMCHPGWFZZRID-BQBZGAKWSA-N Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O QJMCHPGWFZZRID-BQBZGAKWSA-N 0.000 description 2
- ZYPWIUFLYMQZBS-SRVKXCTJSA-N Asn-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ZYPWIUFLYMQZBS-SRVKXCTJSA-N 0.000 description 2
- PUUPMDXIHCOPJU-HJGDQZAQSA-N Asn-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O PUUPMDXIHCOPJU-HJGDQZAQSA-N 0.000 description 2
- CBHVAFXKOYAHOY-NHCYSSNCSA-N Asn-Val-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O CBHVAFXKOYAHOY-NHCYSSNCSA-N 0.000 description 2
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 2
- BUVNWKQBMZLCDW-UGYAYLCHSA-N Asp-Asn-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BUVNWKQBMZLCDW-UGYAYLCHSA-N 0.000 description 2
- KNMRXHIAVXHCLW-ZLUOBGJFSA-N Asp-Asn-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N)C(=O)O KNMRXHIAVXHCLW-ZLUOBGJFSA-N 0.000 description 2
- FRYULLIZUDQONW-IMJSIDKUSA-N Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FRYULLIZUDQONW-IMJSIDKUSA-N 0.000 description 2
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 2
- YDJVIBMKAMQPPP-LAEOZQHASA-N Asp-Glu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O YDJVIBMKAMQPPP-LAEOZQHASA-N 0.000 description 2
- CYCKJEFVFNRWEZ-UGYAYLCHSA-N Asp-Ile-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CYCKJEFVFNRWEZ-UGYAYLCHSA-N 0.000 description 2
- TZOZNVLBTAFJRW-UGYAYLCHSA-N Asp-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N TZOZNVLBTAFJRW-UGYAYLCHSA-N 0.000 description 2
- SPWXXPFDTMYTRI-IUKAMOBKSA-N Asp-Ile-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SPWXXPFDTMYTRI-IUKAMOBKSA-N 0.000 description 2
- NAAAPCLFJPURAM-HJGDQZAQSA-N Asp-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O NAAAPCLFJPURAM-HJGDQZAQSA-N 0.000 description 2
- RSMZEHCMIOKNMW-GSSVUCPTSA-N Asp-Thr-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RSMZEHCMIOKNMW-GSSVUCPTSA-N 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 101100338242 Drosophila virilis His1.1 gene Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000672609 Escherichia coli BL21 Species 0.000 description 2
- IKFZXRLDMYWNBU-YUMQZZPRSA-N Gln-Gly-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N IKFZXRLDMYWNBU-YUMQZZPRSA-N 0.000 description 2
- JXFLPKSDLDEOQK-JHEQGTHGSA-N Gln-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O JXFLPKSDLDEOQK-JHEQGTHGSA-N 0.000 description 2
- XITLYYAIPBBHPX-ZKWXMUAHSA-N Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(N)=O XITLYYAIPBBHPX-ZKWXMUAHSA-N 0.000 description 2
- DUGYCMAIAKAQPB-GLLZPBPUSA-N Gln-Thr-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DUGYCMAIAKAQPB-GLLZPBPUSA-N 0.000 description 2
- SGVGIVDZLSHSEN-RYUDHWBXSA-N Gln-Tyr-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O SGVGIVDZLSHSEN-RYUDHWBXSA-N 0.000 description 2
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 2
- IRDASPPCLZIERZ-XHNCKOQMSA-N Glu-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N IRDASPPCLZIERZ-XHNCKOQMSA-N 0.000 description 2
- AVZHGSCDKIQZPQ-CIUDSAMLSA-N Glu-Arg-Ala Chemical compound C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AVZHGSCDKIQZPQ-CIUDSAMLSA-N 0.000 description 2
- CKRUHITYRFNUKW-WDSKDSINSA-N Glu-Asn-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CKRUHITYRFNUKW-WDSKDSINSA-N 0.000 description 2
- SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 description 2
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 2
- QQLBPVKLJBAXBS-FXQIFTODSA-N Glu-Glu-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QQLBPVKLJBAXBS-FXQIFTODSA-N 0.000 description 2
- AUTNXSQEVVHSJK-YVNDNENWSA-N Glu-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 2
- KUTPGXNAAOQSPD-LPEHRKFASA-N Glu-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O KUTPGXNAAOQSPD-LPEHRKFASA-N 0.000 description 2
- RAUDKMVXNOWDLS-WDSKDSINSA-N Glu-Gly-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O RAUDKMVXNOWDLS-WDSKDSINSA-N 0.000 description 2
- LGYCLOCORAEQSZ-PEFMBERDSA-N Glu-Ile-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O LGYCLOCORAEQSZ-PEFMBERDSA-N 0.000 description 2
- VGUYMZGLJUJRBV-YVNDNENWSA-N Glu-Ile-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O VGUYMZGLJUJRBV-YVNDNENWSA-N 0.000 description 2
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 2
- NJCALAAIGREHDR-WDCWCFNPSA-N Glu-Leu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NJCALAAIGREHDR-WDCWCFNPSA-N 0.000 description 2
- SWRVAQHFBRZVNX-GUBZILKMSA-N Glu-Lys-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SWRVAQHFBRZVNX-GUBZILKMSA-N 0.000 description 2
- HRBYTAIBKPNZKQ-AVGNSLFASA-N Glu-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O HRBYTAIBKPNZKQ-AVGNSLFASA-N 0.000 description 2
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 2
- FGGKGJHCVMYGCD-UKJIMTQDSA-N Glu-Val-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGGKGJHCVMYGCD-UKJIMTQDSA-N 0.000 description 2
- JLXVRFDTDUGQEE-YFKPBYRVSA-N Gly-Arg Chemical compound NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N JLXVRFDTDUGQEE-YFKPBYRVSA-N 0.000 description 2
- OCDLPQDYTJPWNG-YUMQZZPRSA-N Gly-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN OCDLPQDYTJPWNG-YUMQZZPRSA-N 0.000 description 2
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 2
- SCCPDJAQCXWPTF-VKHMYHEASA-N Gly-Asp Chemical compound NCC(=O)N[C@H](C(O)=O)CC(O)=O SCCPDJAQCXWPTF-VKHMYHEASA-N 0.000 description 2
- PNMUAGGSDZXTHX-BYPYZUCNSA-N Gly-Gln Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(N)=O PNMUAGGSDZXTHX-BYPYZUCNSA-N 0.000 description 2
- IEFJWDNGDZAYNZ-BYPYZUCNSA-N Gly-Glu Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(O)=O IEFJWDNGDZAYNZ-BYPYZUCNSA-N 0.000 description 2
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 2
- KGVHCTWYMPWEGN-FSPLSTOPSA-N Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CN KGVHCTWYMPWEGN-FSPLSTOPSA-N 0.000 description 2
- UTYGDAHJBBDPBA-BYULHYEWSA-N Gly-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN UTYGDAHJBBDPBA-BYULHYEWSA-N 0.000 description 2
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 2
- GAFKBWKVXNERFA-QWRGUYRKSA-N Gly-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 GAFKBWKVXNERFA-QWRGUYRKSA-N 0.000 description 2
- YOBGUCWZPXJHTN-BQBZGAKWSA-N Gly-Ser-Arg Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YOBGUCWZPXJHTN-BQBZGAKWSA-N 0.000 description 2
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 2
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 2
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 2
- DUAWRXXTOQOECJ-JSGCOSHPSA-N Gly-Tyr-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O DUAWRXXTOQOECJ-JSGCOSHPSA-N 0.000 description 2
- HRGGKHFHRSFSDE-CIUDSAMLSA-N His-Asn-Ser Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N HRGGKHFHRSFSDE-CIUDSAMLSA-N 0.000 description 2
- IMCHNUANCIGUKS-SRVKXCTJSA-N His-Glu-Arg Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IMCHNUANCIGUKS-SRVKXCTJSA-N 0.000 description 2
- TXLQHACKRLWYCM-DCAQKATOSA-N His-Glu-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O TXLQHACKRLWYCM-DCAQKATOSA-N 0.000 description 2
- PMWSGVRIMIFXQH-KKUMJFAQSA-N His-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CN=CN1 PMWSGVRIMIFXQH-KKUMJFAQSA-N 0.000 description 2
- UXSATKFPUVZVDK-KKUMJFAQSA-N His-Lys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CN=CN1)N UXSATKFPUVZVDK-KKUMJFAQSA-N 0.000 description 2
- YXXKBPJEIYFGOD-MGHWNKPDSA-N His-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CN=CN2)N YXXKBPJEIYFGOD-MGHWNKPDSA-N 0.000 description 2
- KRBMQYPTDYSENE-BQBZGAKWSA-N His-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 KRBMQYPTDYSENE-BQBZGAKWSA-N 0.000 description 2
- FBTYOQIYBULKEH-ZFWWWQNUSA-N His-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CNC=N1 FBTYOQIYBULKEH-ZFWWWQNUSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000581940 Homo sapiens Napsin-A Proteins 0.000 description 2
- QADCTXFNLZBZAB-GHCJXIJMSA-N Ile-Asn-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N QADCTXFNLZBZAB-GHCJXIJMSA-N 0.000 description 2
- IDMNOFVUXYYZPF-DKIMLUQUSA-N Ile-Lys-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N IDMNOFVUXYYZPF-DKIMLUQUSA-N 0.000 description 2
- NLZVTPYXYXMCIP-XUXIUFHCSA-N Ile-Pro-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O NLZVTPYXYXMCIP-XUXIUFHCSA-N 0.000 description 2
- TWVKGYNQQAUNRN-ACZMJKKPSA-N Ile-Ser Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O TWVKGYNQQAUNRN-ACZMJKKPSA-N 0.000 description 2
- DRCKHKZYDLJYFQ-YWIQKCBGSA-N Ile-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DRCKHKZYDLJYFQ-YWIQKCBGSA-N 0.000 description 2
- YWCJXQKATPNPOE-UKJIMTQDSA-N Ile-Val-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N YWCJXQKATPNPOE-UKJIMTQDSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 2
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 description 2
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 2
- WGNOPSQMIQERPK-GARJFASQSA-N Leu-Asn-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N WGNOPSQMIQERPK-GARJFASQSA-N 0.000 description 2
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 2
- CCQLQKZTXZBXTN-NHCYSSNCSA-N Leu-Gly-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CCQLQKZTXZBXTN-NHCYSSNCSA-N 0.000 description 2
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 2
- HNDWYLYAYNBWMP-AJNGGQMLSA-N Leu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N HNDWYLYAYNBWMP-AJNGGQMLSA-N 0.000 description 2
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 2
- INCJJHQRZGQLFC-KBPBESRZSA-N Leu-Phe-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O INCJJHQRZGQLFC-KBPBESRZSA-N 0.000 description 2
- LRKCBIUDWAXNEG-CSMHCCOUSA-N Leu-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRKCBIUDWAXNEG-CSMHCCOUSA-N 0.000 description 2
- AEDWWMMHUGYIFD-HJGDQZAQSA-N Leu-Thr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O AEDWWMMHUGYIFD-HJGDQZAQSA-N 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 2
- VHNOAIFVYUQOOY-XUXIUFHCSA-N Lys-Arg-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VHNOAIFVYUQOOY-XUXIUFHCSA-N 0.000 description 2
- CKSXSQUVEYCDIW-AVGNSLFASA-N Lys-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N CKSXSQUVEYCDIW-AVGNSLFASA-N 0.000 description 2
- LMVOVCYVZBBWQB-SRVKXCTJSA-N Lys-Asp-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LMVOVCYVZBBWQB-SRVKXCTJSA-N 0.000 description 2
- NTBFKPBULZGXQL-KKUMJFAQSA-N Lys-Asp-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTBFKPBULZGXQL-KKUMJFAQSA-N 0.000 description 2
- HWMZUBUEOYAQSC-DCAQKATOSA-N Lys-Gln-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O HWMZUBUEOYAQSC-DCAQKATOSA-N 0.000 description 2
- VEGLGAOVLFODGC-GUBZILKMSA-N Lys-Glu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VEGLGAOVLFODGC-GUBZILKMSA-N 0.000 description 2
- WGLAORUKDGRINI-WDCWCFNPSA-N Lys-Glu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGLAORUKDGRINI-WDCWCFNPSA-N 0.000 description 2
- FMIIKPHLJKUXGE-GUBZILKMSA-N Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN FMIIKPHLJKUXGE-GUBZILKMSA-N 0.000 description 2
- NCZIQZYZPUPMKY-PPCPHDFISA-N Lys-Ile-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NCZIQZYZPUPMKY-PPCPHDFISA-N 0.000 description 2
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 2
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 2
- UQRZFMQQXXJTTF-AVGNSLFASA-N Lys-Lys-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O UQRZFMQQXXJTTF-AVGNSLFASA-N 0.000 description 2
- YUAXTFMFMOIMAM-QWRGUYRKSA-N Lys-Lys-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O YUAXTFMFMOIMAM-QWRGUYRKSA-N 0.000 description 2
- UDXSLGLHFUBRRM-OEAJRASXSA-N Lys-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N)O UDXSLGLHFUBRRM-OEAJRASXSA-N 0.000 description 2
- YSZNURNVYFUEHC-BQBZGAKWSA-N Lys-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YSZNURNVYFUEHC-BQBZGAKWSA-N 0.000 description 2
- IMDJSVBFQKDDEQ-MGHWNKPDSA-N Lys-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)N IMDJSVBFQKDDEQ-MGHWNKPDSA-N 0.000 description 2
- PPNCMJARTHYNEC-MEYUZBJRSA-N Lys-Tyr-Thr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)CC1=CC=C(O)C=C1 PPNCMJARTHYNEC-MEYUZBJRSA-N 0.000 description 2
- VKCPHIOZDWUFSW-ONGXEEELSA-N Lys-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN VKCPHIOZDWUFSW-ONGXEEELSA-N 0.000 description 2
- VHGIWFGJIHTASW-FXQIFTODSA-N Met-Ala-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O VHGIWFGJIHTASW-FXQIFTODSA-N 0.000 description 2
- ONGCSGVHCSAATF-CIUDSAMLSA-N Met-Ala-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O ONGCSGVHCSAATF-CIUDSAMLSA-N 0.000 description 2
- UZVWDRPUTHXQAM-FXQIFTODSA-N Met-Asp-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O UZVWDRPUTHXQAM-FXQIFTODSA-N 0.000 description 2
- LRALLISKBZNSKN-BQBZGAKWSA-N Met-Gly-Ser Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LRALLISKBZNSKN-BQBZGAKWSA-N 0.000 description 2
- QZPXMHVKPHJNTR-DCAQKATOSA-N Met-Leu-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O QZPXMHVKPHJNTR-DCAQKATOSA-N 0.000 description 2
- IMTUWVJPCQPJEE-IUCAKERBSA-N Met-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN IMTUWVJPCQPJEE-IUCAKERBSA-N 0.000 description 2
- CGUYGMFQZCYJSG-DCAQKATOSA-N Met-Lys-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O CGUYGMFQZCYJSG-DCAQKATOSA-N 0.000 description 2
- WEDDFMCSUNNZJR-WDSKDSINSA-N Met-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O WEDDFMCSUNNZJR-WDSKDSINSA-N 0.000 description 2
- KAKJTZWHIUWTTD-VQVTYTSYSA-N Met-Thr Chemical compound CSCC[C@H]([NH3+])C(=O)N[C@@H]([C@@H](C)O)C([O-])=O KAKJTZWHIUWTTD-VQVTYTSYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 2
- LSXGADJXBDFXQU-DLOVCJGASA-N Phe-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 LSXGADJXBDFXQU-DLOVCJGASA-N 0.000 description 2
- SEPNOAFMZLLCEW-UBHSHLNASA-N Phe-Ala-Val Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O SEPNOAFMZLLCEW-UBHSHLNASA-N 0.000 description 2
- QCHNRQQVLJYDSI-DLOVCJGASA-N Phe-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 QCHNRQQVLJYDSI-DLOVCJGASA-N 0.000 description 2
- VZFPYFRVHMSSNA-JURCDPSOSA-N Phe-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=CC=C1 VZFPYFRVHMSSNA-JURCDPSOSA-N 0.000 description 2
- SZYBZVANEAOIPE-UBHSHLNASA-N Phe-Met-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O SZYBZVANEAOIPE-UBHSHLNASA-N 0.000 description 2
- RBRNEFJTEHPDSL-ACRUOGEOSA-N Phe-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RBRNEFJTEHPDSL-ACRUOGEOSA-N 0.000 description 2
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- KIPIKSXPPLABPN-CIUDSAMLSA-N Pro-Glu-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 KIPIKSXPPLABPN-CIUDSAMLSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 101100167780 Schizosaccharomyces pombe (strain 972 / ATCC 24843) coa2 gene Proteins 0.000 description 2
- 101100390985 Schizosaccharomyces pombe (strain 972 / ATCC 24843) fmc1 gene Proteins 0.000 description 2
- SRTCFKGBYBZRHA-ACZMJKKPSA-N Ser-Ala-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SRTCFKGBYBZRHA-ACZMJKKPSA-N 0.000 description 2
- OBXVZEAMXFSGPU-FXQIFTODSA-N Ser-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)CN=C(N)N OBXVZEAMXFSGPU-FXQIFTODSA-N 0.000 description 2
- FIDMVVBUOCMMJG-CIUDSAMLSA-N Ser-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO FIDMVVBUOCMMJG-CIUDSAMLSA-N 0.000 description 2
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 2
- VBKBDLMWICBSCY-IMJSIDKUSA-N Ser-Asp Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O VBKBDLMWICBSCY-IMJSIDKUSA-N 0.000 description 2
- BNFVPSRLHHPQKS-WHFBIAKZSA-N Ser-Asp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O BNFVPSRLHHPQKS-WHFBIAKZSA-N 0.000 description 2
- OLIJLNWFEQEFDM-SRVKXCTJSA-N Ser-Asp-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLIJLNWFEQEFDM-SRVKXCTJSA-N 0.000 description 2
- SMIDBHKWSYUBRZ-ACZMJKKPSA-N Ser-Glu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O SMIDBHKWSYUBRZ-ACZMJKKPSA-N 0.000 description 2
- GZBKRJVCRMZAST-XKBZYTNZSA-N Ser-Glu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZBKRJVCRMZAST-XKBZYTNZSA-N 0.000 description 2
- WBINSDOPZHQPPM-AVGNSLFASA-N Ser-Glu-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N)O WBINSDOPZHQPPM-AVGNSLFASA-N 0.000 description 2
- AEGUWTFAQQWVLC-BQBZGAKWSA-N Ser-Gly-Arg Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEGUWTFAQQWVLC-BQBZGAKWSA-N 0.000 description 2
- BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 2
- NBUKGEFVZJMSIS-XIRDDKMYSA-N Ser-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CO)N NBUKGEFVZJMSIS-XIRDDKMYSA-N 0.000 description 2
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 2
- VZQRNAYURWAEFE-KKUMJFAQSA-N Ser-Leu-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VZQRNAYURWAEFE-KKUMJFAQSA-N 0.000 description 2
- WGDYNRCOQRERLZ-KKUMJFAQSA-N Ser-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N WGDYNRCOQRERLZ-KKUMJFAQSA-N 0.000 description 2
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 2
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 2
- MQCPGOZXFSYJPS-KZVJFYERSA-N Thr-Ala-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MQCPGOZXFSYJPS-KZVJFYERSA-N 0.000 description 2
- DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 description 2
- WFUAUEQXPVNAEF-ZJDVBMNYSA-N Thr-Arg-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CCCN=C(N)N WFUAUEQXPVNAEF-ZJDVBMNYSA-N 0.000 description 2
- DCCGCVLVVSAJFK-NUMRIWBASA-N Thr-Asp-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O DCCGCVLVVSAJFK-NUMRIWBASA-N 0.000 description 2
- NOWXWJLVGTVJKM-PBCZWWQYSA-N Thr-Asp-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O NOWXWJLVGTVJKM-PBCZWWQYSA-N 0.000 description 2
- NLSNVZAREYQMGR-HJGDQZAQSA-N Thr-Asp-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NLSNVZAREYQMGR-HJGDQZAQSA-N 0.000 description 2
- VGYBYGQXZJDZJU-XQXXSGGOSA-N Thr-Glu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VGYBYGQXZJDZJU-XQXXSGGOSA-N 0.000 description 2
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 2
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 2
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 2
- QNCFWHZVRNXAKW-OEAJRASXSA-N Thr-Lys-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QNCFWHZVRNXAKW-OEAJRASXSA-N 0.000 description 2
- DSGIVWSDDRDJIO-ZXXMMSQZSA-N Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DSGIVWSDDRDJIO-ZXXMMSQZSA-N 0.000 description 2
- WCRFXRIWBFRZBR-GGVZMXCHSA-N Thr-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WCRFXRIWBFRZBR-GGVZMXCHSA-N 0.000 description 2
- JAWUQFCGNVEDRN-MEYUZBJRSA-N Thr-Tyr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N)O JAWUQFCGNVEDRN-MEYUZBJRSA-N 0.000 description 2
- LVRFMARKDGGZMX-IZPVPAKOSA-N Thr-Tyr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=C(O)C=C1 LVRFMARKDGGZMX-IZPVPAKOSA-N 0.000 description 2
- KPMIQCXJDVKWKO-IFFSRLJSSA-N Thr-Val-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPMIQCXJDVKWKO-IFFSRLJSSA-N 0.000 description 2
- ILDJYIDXESUBOE-HSCHXYMDSA-N Trp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N ILDJYIDXESUBOE-HSCHXYMDSA-N 0.000 description 2
- DKKHULUSOSWGHS-UWJYBYFXSA-N Tyr-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N DKKHULUSOSWGHS-UWJYBYFXSA-N 0.000 description 2
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 2
- QNJYPWZACBACER-KKUMJFAQSA-N Tyr-Asp-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O QNJYPWZACBACER-KKUMJFAQSA-N 0.000 description 2
- ARJASMXQBRNAGI-YESZJQIVSA-N Tyr-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N ARJASMXQBRNAGI-YESZJQIVSA-N 0.000 description 2
- GZOCMHSZGGJBCX-ULQDDVLXSA-N Tyr-Lys-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O GZOCMHSZGGJBCX-ULQDDVLXSA-N 0.000 description 2
- RCMWNNJFKNDKQR-UFYCRDLUSA-N Tyr-Pro-Phe Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 RCMWNNJFKNDKQR-UFYCRDLUSA-N 0.000 description 2
- ZSXJENBJGRHKIG-UWVGGRQHSA-N Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ZSXJENBJGRHKIG-UWVGGRQHSA-N 0.000 description 2
- YMZYSCDRTXEOKD-IHPCNDPISA-N Tyr-Trp-Asn Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N YMZYSCDRTXEOKD-IHPCNDPISA-N 0.000 description 2
- DDNIHOWRDOXXPF-NGZCFLSTSA-N Val-Asp-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DDNIHOWRDOXXPF-NGZCFLSTSA-N 0.000 description 2
- CVIXTAITYJQMPE-LAEOZQHASA-N Val-Glu-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CVIXTAITYJQMPE-LAEOZQHASA-N 0.000 description 2
- XWYUBUYQMOUFRQ-IFFSRLJSSA-N Val-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N)O XWYUBUYQMOUFRQ-IFFSRLJSSA-N 0.000 description 2
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 2
- GVRKWABULJAONN-VQVTYTSYSA-N Val-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GVRKWABULJAONN-VQVTYTSYSA-N 0.000 description 2
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 108010057952 lysyl-phenylalanyl-lysine Proteins 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000007479 molecular analysis Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 210000004897 n-terminal region Anatomy 0.000 description 2
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 108010015796 prolylisoleucine Proteins 0.000 description 2
- 229940023143 protein vaccine Drugs 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 2
- 108010078580 tyrosylleucine Proteins 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 229940125575 vaccine candidate Drugs 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 description 1
- SITWEMZOJNKJCH-WDSKDSINSA-N Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SITWEMZOJNKJCH-WDSKDSINSA-N 0.000 description 1
- CCUAQNUWXLYFRA-IMJSIDKUSA-N Ala-Asn Chemical compound C[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC(N)=O CCUAQNUWXLYFRA-IMJSIDKUSA-N 0.000 description 1
- DECCMEWNXSNSDO-ZLUOBGJFSA-N Ala-Cys-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O DECCMEWNXSNSDO-ZLUOBGJFSA-N 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- ZODMADSIQZZBSQ-FXQIFTODSA-N Ala-Gln-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZODMADSIQZZBSQ-FXQIFTODSA-N 0.000 description 1
- MVBWLRJESQOQTM-ACZMJKKPSA-N Ala-Gln-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O MVBWLRJESQOQTM-ACZMJKKPSA-N 0.000 description 1
- SFNFGFDRYJKZKN-XQXXSGGOSA-N Ala-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)N)O SFNFGFDRYJKZKN-XQXXSGGOSA-N 0.000 description 1
- NJPMYXWVWQWCSR-ACZMJKKPSA-N Ala-Glu-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NJPMYXWVWQWCSR-ACZMJKKPSA-N 0.000 description 1
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 1
- OMMDTNGURYRDAC-NRPADANISA-N Ala-Glu-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OMMDTNGURYRDAC-NRPADANISA-N 0.000 description 1
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 1
- NIZKGBJVCMRDKO-KWQFWETISA-N Ala-Gly-Tyr Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 1
- NYDBKUNVSALYPX-NAKRPEOUSA-N Ala-Ile-Arg Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NYDBKUNVSALYPX-NAKRPEOUSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- GKAZXNDATBWNBI-DCAQKATOSA-N Ala-Met-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N GKAZXNDATBWNBI-DCAQKATOSA-N 0.000 description 1
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 1
- VQAVBBCZFQAAED-FXQIFTODSA-N Ala-Pro-Asn Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N VQAVBBCZFQAAED-FXQIFTODSA-N 0.000 description 1
- YYAVDNKUWLAFCV-ACZMJKKPSA-N Ala-Ser-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYAVDNKUWLAFCV-ACZMJKKPSA-N 0.000 description 1
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 1
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 1
- IETUUAHKCHOQHP-KZVJFYERSA-N Ala-Thr-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(O)=O IETUUAHKCHOQHP-KZVJFYERSA-N 0.000 description 1
- BGGAIXWIZCIFSG-XDTLVQLUSA-N Ala-Tyr-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O BGGAIXWIZCIFSG-XDTLVQLUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- NUBPTCMEOCKWDO-DCAQKATOSA-N Arg-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N NUBPTCMEOCKWDO-DCAQKATOSA-N 0.000 description 1
- RWCLSUOSKWTXLA-FXQIFTODSA-N Arg-Asp-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O RWCLSUOSKWTXLA-FXQIFTODSA-N 0.000 description 1
- OBFTYSPXDRROQO-SRVKXCTJSA-N Arg-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCN=C(N)N OBFTYSPXDRROQO-SRVKXCTJSA-N 0.000 description 1
- NKBQZKVMKJJDLX-SRVKXCTJSA-N Arg-Glu-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NKBQZKVMKJJDLX-SRVKXCTJSA-N 0.000 description 1
- UFBURHXMKFQVLM-CIUDSAMLSA-N Arg-Glu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UFBURHXMKFQVLM-CIUDSAMLSA-N 0.000 description 1
- PNIGSVZJNVUVJA-BQBZGAKWSA-N Arg-Gly-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O PNIGSVZJNVUVJA-BQBZGAKWSA-N 0.000 description 1
- HJDNZFIYILEIKR-OSUNSFLBSA-N Arg-Ile-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HJDNZFIYILEIKR-OSUNSFLBSA-N 0.000 description 1
- NMRHDSAOIURTNT-RWMBFGLXSA-N Arg-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NMRHDSAOIURTNT-RWMBFGLXSA-N 0.000 description 1
- XUGATJVGQUGQKY-ULQDDVLXSA-N Arg-Lys-Phe Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XUGATJVGQUGQKY-ULQDDVLXSA-N 0.000 description 1
- OMKZPCPZEFMBIT-SRVKXCTJSA-N Arg-Met-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OMKZPCPZEFMBIT-SRVKXCTJSA-N 0.000 description 1
- LCBSSOCDWUTQQV-SDDRHHMPSA-N Arg-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LCBSSOCDWUTQQV-SDDRHHMPSA-N 0.000 description 1
- STHNZYKCJHWULY-AVGNSLFASA-N Arg-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O STHNZYKCJHWULY-AVGNSLFASA-N 0.000 description 1
- ZPWMEWYQBWSGAO-ZJDVBMNYSA-N Arg-Thr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZPWMEWYQBWSGAO-ZJDVBMNYSA-N 0.000 description 1
- CGWVCWFQGXOUSJ-ULQDDVLXSA-N Arg-Tyr-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O CGWVCWFQGXOUSJ-ULQDDVLXSA-N 0.000 description 1
- IZSMEUDYADKZTJ-KJEVXHAQSA-N Arg-Tyr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IZSMEUDYADKZTJ-KJEVXHAQSA-N 0.000 description 1
- PSUXEQYPYZLNER-QXEWZRGKSA-N Arg-Val-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PSUXEQYPYZLNER-QXEWZRGKSA-N 0.000 description 1
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 1
- FXGMURPOWCKNAZ-JYJNAYRXSA-N Arg-Val-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FXGMURPOWCKNAZ-JYJNAYRXSA-N 0.000 description 1
- CPTXATAOUQJQRO-GUBZILKMSA-N Arg-Val-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O CPTXATAOUQJQRO-GUBZILKMSA-N 0.000 description 1
- CIBWFJFMOBIFTE-CIUDSAMLSA-N Asn-Arg-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N CIBWFJFMOBIFTE-CIUDSAMLSA-N 0.000 description 1
- GXMSVVBIAMWMKO-BQBZGAKWSA-N Asn-Arg-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CCCN=C(N)N GXMSVVBIAMWMKO-BQBZGAKWSA-N 0.000 description 1
- JEPNYDRDYNSFIU-QXEWZRGKSA-N Asn-Arg-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(N)=O)C(O)=O JEPNYDRDYNSFIU-QXEWZRGKSA-N 0.000 description 1
- RJUHZPRQRQLCFL-IMJSIDKUSA-N Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O RJUHZPRQRQLCFL-IMJSIDKUSA-N 0.000 description 1
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 1
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 1
- KUYKVGODHGHFDI-ACZMJKKPSA-N Asn-Gln-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O KUYKVGODHGHFDI-ACZMJKKPSA-N 0.000 description 1
- OKZOABJQOMAYEC-NUMRIWBASA-N Asn-Gln-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OKZOABJQOMAYEC-NUMRIWBASA-N 0.000 description 1
- FFMIYIMKQIMDPK-BQBZGAKWSA-N Asn-His Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 FFMIYIMKQIMDPK-BQBZGAKWSA-N 0.000 description 1
- RAKKBBHMTJSXOY-XVYDVKMFSA-N Asn-His-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O RAKKBBHMTJSXOY-XVYDVKMFSA-N 0.000 description 1
- NKLRWRRVYGQNIH-GHCJXIJMSA-N Asn-Ile-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O NKLRWRRVYGQNIH-GHCJXIJMSA-N 0.000 description 1
- OLISTMZJGQUOGS-GMOBBJLQSA-N Asn-Ile-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N OLISTMZJGQUOGS-GMOBBJLQSA-N 0.000 description 1
- PNHQRQTVBRDIEF-CIUDSAMLSA-N Asn-Leu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)N PNHQRQTVBRDIEF-CIUDSAMLSA-N 0.000 description 1
- TZFQICWZWFNIKU-KKUMJFAQSA-N Asn-Leu-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 TZFQICWZWFNIKU-KKUMJFAQSA-N 0.000 description 1
- ORJQQZIXTOYGGH-SRVKXCTJSA-N Asn-Lys-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ORJQQZIXTOYGGH-SRVKXCTJSA-N 0.000 description 1
- GIQCDTKOIPUDSG-GARJFASQSA-N Asn-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N)C(=O)O GIQCDTKOIPUDSG-GARJFASQSA-N 0.000 description 1
- COWITDLVHMZSIW-CIUDSAMLSA-N Asn-Lys-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O COWITDLVHMZSIW-CIUDSAMLSA-N 0.000 description 1
- RAUPFUCUDBQYHE-AVGNSLFASA-N Asn-Phe-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RAUPFUCUDBQYHE-AVGNSLFASA-N 0.000 description 1
- YUOXLJYVSZYPBJ-CIUDSAMLSA-N Asn-Pro-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O YUOXLJYVSZYPBJ-CIUDSAMLSA-N 0.000 description 1
- SONUFGRSSMFHFN-IMJSIDKUSA-N Asn-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O SONUFGRSSMFHFN-IMJSIDKUSA-N 0.000 description 1
- OOXUBGLNDRGOKT-FXQIFTODSA-N Asn-Ser-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OOXUBGLNDRGOKT-FXQIFTODSA-N 0.000 description 1
- UGXYFDQFLVCDFC-CIUDSAMLSA-N Asn-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O UGXYFDQFLVCDFC-CIUDSAMLSA-N 0.000 description 1
- HCZQKHSRYHCPSD-IUKAMOBKSA-N Asn-Thr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HCZQKHSRYHCPSD-IUKAMOBKSA-N 0.000 description 1
- BCADFFUQHIMQAA-KKHAAJSZSA-N Asn-Thr-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BCADFFUQHIMQAA-KKHAAJSZSA-N 0.000 description 1
- KSZHWTRZPOTIGY-AVGNSLFASA-N Asn-Tyr-Gln Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O KSZHWTRZPOTIGY-AVGNSLFASA-N 0.000 description 1
- NSTBNYOKCZKOMI-AVGNSLFASA-N Asn-Tyr-Glu Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O NSTBNYOKCZKOMI-AVGNSLFASA-N 0.000 description 1
- XLDMSQYOYXINSZ-QXEWZRGKSA-N Asn-Val-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N XLDMSQYOYXINSZ-QXEWZRGKSA-N 0.000 description 1
- XEDQMTWEYFBOIK-ACZMJKKPSA-N Asp-Ala-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O XEDQMTWEYFBOIK-ACZMJKKPSA-N 0.000 description 1
- ATYWBXGNXZYZGI-ACZMJKKPSA-N Asp-Asn-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O ATYWBXGNXZYZGI-ACZMJKKPSA-N 0.000 description 1
- ZELQAFZSJOBEQS-ACZMJKKPSA-N Asp-Asn-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZELQAFZSJOBEQS-ACZMJKKPSA-N 0.000 description 1
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 1
- QXHVOUSPVAWEMX-ZLUOBGJFSA-N Asp-Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXHVOUSPVAWEMX-ZLUOBGJFSA-N 0.000 description 1
- IJHUZMGJRGNXIW-CIUDSAMLSA-N Asp-Glu-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IJHUZMGJRGNXIW-CIUDSAMLSA-N 0.000 description 1
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 1
- OVPHVTCDVYYTHN-AVGNSLFASA-N Asp-Glu-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OVPHVTCDVYYTHN-AVGNSLFASA-N 0.000 description 1
- HSPSXROIMXIJQW-BQBZGAKWSA-N Asp-His Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 HSPSXROIMXIJQW-BQBZGAKWSA-N 0.000 description 1
- HOBNTSHITVVNBN-ZPFDUUQYSA-N Asp-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N HOBNTSHITVVNBN-ZPFDUUQYSA-N 0.000 description 1
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 description 1
- HXVILZUZXFLVEN-DCAQKATOSA-N Asp-Met-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O HXVILZUZXFLVEN-DCAQKATOSA-N 0.000 description 1
- SJLDOGLMVPHPLZ-IHRRRGAJSA-N Asp-Met-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SJLDOGLMVPHPLZ-IHRRRGAJSA-N 0.000 description 1
- PCJOFZYFFMBZKC-PCBIJLKTSA-N Asp-Phe-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PCJOFZYFFMBZKC-PCBIJLKTSA-N 0.000 description 1
- KPSHWSWFPUDEGF-FXQIFTODSA-N Asp-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(O)=O KPSHWSWFPUDEGF-FXQIFTODSA-N 0.000 description 1
- MVRGBQGZSDJBSM-GMOBBJLQSA-N Asp-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)N MVRGBQGZSDJBSM-GMOBBJLQSA-N 0.000 description 1
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 1
- BRRPVTUFESPTCP-ACZMJKKPSA-N Asp-Ser-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O BRRPVTUFESPTCP-ACZMJKKPSA-N 0.000 description 1
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 1
- UTLCRGFJFSZWAW-OLHMAJIHSA-N Asp-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O UTLCRGFJFSZWAW-OLHMAJIHSA-N 0.000 description 1
- VHUKCUHLFMRHOD-MELADBBJSA-N Asp-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O VHUKCUHLFMRHOD-MELADBBJSA-N 0.000 description 1
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 101150076489 B gene Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000510930 Brachyspira pilosicoli Species 0.000 description 1
- 101100505076 Caenorhabditis elegans gly-2 gene Proteins 0.000 description 1
- 101100284231 Caenorhabditis elegans his-24 gene Proteins 0.000 description 1
- 101100512078 Caenorhabditis elegans lys-1 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108010060123 Conjugate Vaccines Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- HHWQMFIGMMOVFK-WDSKDSINSA-N Gln-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O HHWQMFIGMMOVFK-WDSKDSINSA-N 0.000 description 1
- XXLBHPPXDUWYAG-XQXXSGGOSA-N Gln-Ala-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XXLBHPPXDUWYAG-XQXXSGGOSA-N 0.000 description 1
- DLOHWQXXGMEZDW-CIUDSAMLSA-N Gln-Arg-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O DLOHWQXXGMEZDW-CIUDSAMLSA-N 0.000 description 1
- LWDGZZGWDMHBOF-FXQIFTODSA-N Gln-Glu-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O LWDGZZGWDMHBOF-FXQIFTODSA-N 0.000 description 1
- LLRJEFPKIIBGJP-DCAQKATOSA-N Gln-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N LLRJEFPKIIBGJP-DCAQKATOSA-N 0.000 description 1
- MAGNEQBFSBREJL-DCAQKATOSA-N Gln-Glu-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N MAGNEQBFSBREJL-DCAQKATOSA-N 0.000 description 1
- XKBASPWPBXNVLQ-WDSKDSINSA-N Gln-Gly-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XKBASPWPBXNVLQ-WDSKDSINSA-N 0.000 description 1
- DWDBJWAXPXXYLP-SRVKXCTJSA-N Gln-His-Arg Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N DWDBJWAXPXXYLP-SRVKXCTJSA-N 0.000 description 1
- MTCXQQINVAFZKW-MNXVOIDGSA-N Gln-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N MTCXQQINVAFZKW-MNXVOIDGSA-N 0.000 description 1
- GURIQZQSTBBHRV-SRVKXCTJSA-N Gln-Lys-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GURIQZQSTBBHRV-SRVKXCTJSA-N 0.000 description 1
- KSKFIECUYMYWNS-AVGNSLFASA-N Gln-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N KSKFIECUYMYWNS-AVGNSLFASA-N 0.000 description 1
- VHLZDSUANXBJHW-QWRGUYRKSA-N Gln-Phe Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VHLZDSUANXBJHW-QWRGUYRKSA-N 0.000 description 1
- JNVGVECJCOZHCN-DRZSPHRISA-N Gln-Phe-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O JNVGVECJCOZHCN-DRZSPHRISA-N 0.000 description 1
- JUUNNOLZGVYCJT-JYJNAYRXSA-N Gln-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N JUUNNOLZGVYCJT-JYJNAYRXSA-N 0.000 description 1
- RWQCWSGOOOEGPB-FXQIFTODSA-N Gln-Ser-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O RWQCWSGOOOEGPB-FXQIFTODSA-N 0.000 description 1
- VOUSELYGTNGEPB-NUMRIWBASA-N Gln-Thr-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O VOUSELYGTNGEPB-NUMRIWBASA-N 0.000 description 1
- UEILCTONAMOGBR-RWRJDSDZSA-N Gln-Thr-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UEILCTONAMOGBR-RWRJDSDZSA-N 0.000 description 1
- ATRHMOJQJWPVBQ-DRZSPHRISA-N Glu-Ala-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ATRHMOJQJWPVBQ-DRZSPHRISA-N 0.000 description 1
- MPZWMIIOPAPAKE-BQBZGAKWSA-N Glu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N MPZWMIIOPAPAKE-BQBZGAKWSA-N 0.000 description 1
- DIXKFOPPGWKZLY-CIUDSAMLSA-N Glu-Arg-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O DIXKFOPPGWKZLY-CIUDSAMLSA-N 0.000 description 1
- PBEQPAZRHDVJQI-SRVKXCTJSA-N Glu-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N PBEQPAZRHDVJQI-SRVKXCTJSA-N 0.000 description 1
- GLWXKFRTOHKGIT-ACZMJKKPSA-N Glu-Asn-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GLWXKFRTOHKGIT-ACZMJKKPSA-N 0.000 description 1
- MLCPTRRNICEKIS-FXQIFTODSA-N Glu-Asn-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MLCPTRRNICEKIS-FXQIFTODSA-N 0.000 description 1
- FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 description 1
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 1
- CLROYXHHUZELFX-FXQIFTODSA-N Glu-Gln-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O CLROYXHHUZELFX-FXQIFTODSA-N 0.000 description 1
- QJCKNLPMTPXXEM-AUTRQRHGSA-N Glu-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O QJCKNLPMTPXXEM-AUTRQRHGSA-N 0.000 description 1
- ZJFNRQHUIHKZJF-GUBZILKMSA-N Glu-His-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O ZJFNRQHUIHKZJF-GUBZILKMSA-N 0.000 description 1
- QLPYYTDOUQNJGQ-AVGNSLFASA-N Glu-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N QLPYYTDOUQNJGQ-AVGNSLFASA-N 0.000 description 1
- SNFUTDLOCQQRQD-ZKWXMUAHSA-N Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SNFUTDLOCQQRQD-ZKWXMUAHSA-N 0.000 description 1
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 1
- DWBBKNPKDHXIAC-SRVKXCTJSA-N Glu-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(O)=O DWBBKNPKDHXIAC-SRVKXCTJSA-N 0.000 description 1
- SJJHXJDSNQJMMW-SRVKXCTJSA-N Glu-Lys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O SJJHXJDSNQJMMW-SRVKXCTJSA-N 0.000 description 1
- CUPSDFQZTVVTSK-GUBZILKMSA-N Glu-Lys-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O CUPSDFQZTVVTSK-GUBZILKMSA-N 0.000 description 1
- RBXSZQRSEGYDFG-GUBZILKMSA-N Glu-Lys-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O RBXSZQRSEGYDFG-GUBZILKMSA-N 0.000 description 1
- SOEPMWQCTJITPZ-SRVKXCTJSA-N Glu-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N SOEPMWQCTJITPZ-SRVKXCTJSA-N 0.000 description 1
- RXESHTOTINOODU-JYJNAYRXSA-N Glu-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCC(=O)O)N RXESHTOTINOODU-JYJNAYRXSA-N 0.000 description 1
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 1
- JLCYOCDGIUZMKQ-JBACZVJFSA-N Glu-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)O)N JLCYOCDGIUZMKQ-JBACZVJFSA-N 0.000 description 1
- SITLTJHOQZFJGG-XPUUQOCRSA-N Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SITLTJHOQZFJGG-XPUUQOCRSA-N 0.000 description 1
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 1
- RMWAOBGCZZSJHE-UMNHJUIQSA-N Glu-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N RMWAOBGCZZSJHE-UMNHJUIQSA-N 0.000 description 1
- QXUPRMQJDWJDFR-NRPADANISA-N Glu-Val-Ser Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXUPRMQJDWJDFR-NRPADANISA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- MFVQGXGQRIXBPK-WDSKDSINSA-N Gly-Ala-Glu Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFVQGXGQRIXBPK-WDSKDSINSA-N 0.000 description 1
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 1
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 1
- GRIRDMVMJJDZKV-RCOVLWMOSA-N Gly-Asn-Val Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O GRIRDMVMJJDZKV-RCOVLWMOSA-N 0.000 description 1
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 1
- CQZDZKRHFWJXDF-WDSKDSINSA-N Gly-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CN CQZDZKRHFWJXDF-WDSKDSINSA-N 0.000 description 1
- AQLHORCVPGXDJW-IUCAKERBSA-N Gly-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)CN AQLHORCVPGXDJW-IUCAKERBSA-N 0.000 description 1
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 1
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 1
- IUZGUFAJDBHQQV-YUMQZZPRSA-N Gly-Leu-Asn Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IUZGUFAJDBHQQV-YUMQZZPRSA-N 0.000 description 1
- FHQRLHFYVZAQHU-IUCAKERBSA-N Gly-Lys-Gln Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O FHQRLHFYVZAQHU-IUCAKERBSA-N 0.000 description 1
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 1
- PTIIBFKSLCYQBO-NHCYSSNCSA-N Gly-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN PTIIBFKSLCYQBO-NHCYSSNCSA-N 0.000 description 1
- PCPOYRCAHPJXII-UWVGGRQHSA-N Gly-Lys-Met Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O PCPOYRCAHPJXII-UWVGGRQHSA-N 0.000 description 1
- WDEHMRNSGHVNOH-VHSXEESVSA-N Gly-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)CN)C(=O)O WDEHMRNSGHVNOH-VHSXEESVSA-N 0.000 description 1
- PFMUCCYYAAFKTH-YFKPBYRVSA-N Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CN PFMUCCYYAAFKTH-YFKPBYRVSA-N 0.000 description 1
- ZWRDOVYMQAAISL-UWVGGRQHSA-N Gly-Met-Lys Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CCCCN ZWRDOVYMQAAISL-UWVGGRQHSA-N 0.000 description 1
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 1
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 1
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 1
- AWASVTXPTOLPPP-MBLNEYKQSA-N His-Ala-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AWASVTXPTOLPPP-MBLNEYKQSA-N 0.000 description 1
- WMKXFMUJRCEGRP-SRVKXCTJSA-N His-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N WMKXFMUJRCEGRP-SRVKXCTJSA-N 0.000 description 1
- JWTKVPMQCCRPQY-SRVKXCTJSA-N His-Asn-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JWTKVPMQCCRPQY-SRVKXCTJSA-N 0.000 description 1
- RXVOMIADLXPJGW-GUBZILKMSA-N His-Asp-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RXVOMIADLXPJGW-GUBZILKMSA-N 0.000 description 1
- BQFGKVYHKCNEMF-DCAQKATOSA-N His-Glu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 BQFGKVYHKCNEMF-DCAQKATOSA-N 0.000 description 1
- AKEDPWJFQULLPE-IUCAKERBSA-N His-Glu-Gly Chemical compound N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O AKEDPWJFQULLPE-IUCAKERBSA-N 0.000 description 1
- YADRBUZBKHHDAO-XPUUQOCRSA-N His-Gly-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C)C(O)=O YADRBUZBKHHDAO-XPUUQOCRSA-N 0.000 description 1
- KWBISLAEQZUYIC-UWJYBYFXSA-N His-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CN=CN2)N KWBISLAEQZUYIC-UWJYBYFXSA-N 0.000 description 1
- CZVQSYNVUHAILZ-UWVGGRQHSA-N His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 CZVQSYNVUHAILZ-UWVGGRQHSA-N 0.000 description 1
- FHGVHXCQMJWQPK-SRVKXCTJSA-N His-Lys-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O FHGVHXCQMJWQPK-SRVKXCTJSA-N 0.000 description 1
- LDFWDDVELNOGII-MXAVVETBSA-N His-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CN=CN1)N LDFWDDVELNOGII-MXAVVETBSA-N 0.000 description 1
- XMAUFHMAAVTODF-STQMWFEESA-N His-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 XMAUFHMAAVTODF-STQMWFEESA-N 0.000 description 1
- GNBHSMFBUNEWCJ-DCAQKATOSA-N His-Pro-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O GNBHSMFBUNEWCJ-DCAQKATOSA-N 0.000 description 1
- PYNPBMCLAKTHJL-SRVKXCTJSA-N His-Pro-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O PYNPBMCLAKTHJL-SRVKXCTJSA-N 0.000 description 1
- CWSZWFILCNSNEX-CIUDSAMLSA-N His-Ser-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CWSZWFILCNSNEX-CIUDSAMLSA-N 0.000 description 1
- VIJMRAIWYWRXSR-CIUDSAMLSA-N His-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 VIJMRAIWYWRXSR-CIUDSAMLSA-N 0.000 description 1
- ILUVWFTXAUYOBW-CUJWVEQBSA-N His-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)N)O ILUVWFTXAUYOBW-CUJWVEQBSA-N 0.000 description 1
- CSRRMQFXMBPSIL-SIXJUCDHSA-N His-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CN=CN3)N CSRRMQFXMBPSIL-SIXJUCDHSA-N 0.000 description 1
- SWBUZLFWGJETAO-KKUMJFAQSA-N His-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O SWBUZLFWGJETAO-KKUMJFAQSA-N 0.000 description 1
- VLDVBZICYBVQHB-IUCAKERBSA-N His-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])CC1=CN=CN1 VLDVBZICYBVQHB-IUCAKERBSA-N 0.000 description 1
- WYKXJGWSJUULSL-AVGNSLFASA-N His-Val-Arg Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O WYKXJGWSJUULSL-AVGNSLFASA-N 0.000 description 1
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 1
- VSZALHITQINTGC-GHCJXIJMSA-N Ile-Ala-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VSZALHITQINTGC-GHCJXIJMSA-N 0.000 description 1
- VAXBXNPRXPHGHG-BJDJZHNGSA-N Ile-Ala-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)N VAXBXNPRXPHGHG-BJDJZHNGSA-N 0.000 description 1
- RWIKBYVJQAJYDP-BJDJZHNGSA-N Ile-Ala-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RWIKBYVJQAJYDP-BJDJZHNGSA-N 0.000 description 1
- IPYVXYDYLHVWHU-GMOBBJLQSA-N Ile-Asn-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N IPYVXYDYLHVWHU-GMOBBJLQSA-N 0.000 description 1
- WKXVAXOSIPTXEC-HAFWLYHUSA-N Ile-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O WKXVAXOSIPTXEC-HAFWLYHUSA-N 0.000 description 1
- KTGFOCFYOZQVRJ-ZKWXMUAHSA-N Ile-Glu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O KTGFOCFYOZQVRJ-ZKWXMUAHSA-N 0.000 description 1
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 description 1
- UWLHDGMRWXHFFY-HPCHECBXSA-N Ile-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@@H]1C(=O)O)N UWLHDGMRWXHFFY-HPCHECBXSA-N 0.000 description 1
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 1
- TVYWVSJGSHQWMT-AJNGGQMLSA-N Ile-Leu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N TVYWVSJGSHQWMT-AJNGGQMLSA-N 0.000 description 1
- PMMMQRVUMVURGJ-XUXIUFHCSA-N Ile-Leu-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O PMMMQRVUMVURGJ-XUXIUFHCSA-N 0.000 description 1
- OVDKXUDMKXAZIV-ZPFDUUQYSA-N Ile-Lys-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OVDKXUDMKXAZIV-ZPFDUUQYSA-N 0.000 description 1
- YSGBJIQXTIVBHZ-AJNGGQMLSA-N Ile-Lys-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O YSGBJIQXTIVBHZ-AJNGGQMLSA-N 0.000 description 1
- AKOYRLRUFBZOSP-BJDJZHNGSA-N Ile-Lys-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)N AKOYRLRUFBZOSP-BJDJZHNGSA-N 0.000 description 1
- MASWXTFJVNRZPT-NAKRPEOUSA-N Ile-Met-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)O)N MASWXTFJVNRZPT-NAKRPEOUSA-N 0.000 description 1
- WMDZARSFSMZOQO-DRZSPHRISA-N Ile-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WMDZARSFSMZOQO-DRZSPHRISA-N 0.000 description 1
- SAVXZJYTTQQQDD-QEWYBTABSA-N Ile-Phe-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SAVXZJYTTQQQDD-QEWYBTABSA-N 0.000 description 1
- VZSDQFZFTCVEGF-ZEWNOJEFSA-N Ile-Phe-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O VZSDQFZFTCVEGF-ZEWNOJEFSA-N 0.000 description 1
- YKZAMJXNJUWFIK-JBDRJPRFSA-N Ile-Ser-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)N YKZAMJXNJUWFIK-JBDRJPRFSA-N 0.000 description 1
- ZNOBVZFCHNHKHA-KBIXCLLPSA-N Ile-Ser-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZNOBVZFCHNHKHA-KBIXCLLPSA-N 0.000 description 1
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 1
- ZYVTXBXHIKGZMD-QSFUFRPTSA-N Ile-Val-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ZYVTXBXHIKGZMD-QSFUFRPTSA-N 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 101150062031 L gene Proteins 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- HFKJBCPRWWGPEY-BQBZGAKWSA-N L-arginyl-L-glutamic acid Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HFKJBCPRWWGPEY-BQBZGAKWSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 1
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 1
- CLVUXCBGKUECIT-HJGDQZAQSA-N Leu-Asp-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CLVUXCBGKUECIT-HJGDQZAQSA-N 0.000 description 1
- NFNVDJGXRFEYTK-YUMQZZPRSA-N Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O NFNVDJGXRFEYTK-YUMQZZPRSA-N 0.000 description 1
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
- HPBCTWSUJOGJSH-MNXVOIDGSA-N Leu-Glu-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HPBCTWSUJOGJSH-MNXVOIDGSA-N 0.000 description 1
- LESXFEZIFXFIQR-LURJTMIESA-N Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(O)=O LESXFEZIFXFIQR-LURJTMIESA-N 0.000 description 1
- FMEICTQWUKNAGC-YUMQZZPRSA-N Leu-Gly-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O FMEICTQWUKNAGC-YUMQZZPRSA-N 0.000 description 1
- APFJUBGRZGMQFF-QWRGUYRKSA-N Leu-Gly-Lys Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN APFJUBGRZGMQFF-QWRGUYRKSA-N 0.000 description 1
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 1
- XWOBNBRUDDUEEY-UWVGGRQHSA-N Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 XWOBNBRUDDUEEY-UWVGGRQHSA-N 0.000 description 1
- BKTXKJMNTSMJDQ-AVGNSLFASA-N Leu-His-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N BKTXKJMNTSMJDQ-AVGNSLFASA-N 0.000 description 1
- QLDHBYRUNQZIJQ-DKIMLUQUSA-N Leu-Ile-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QLDHBYRUNQZIJQ-DKIMLUQUSA-N 0.000 description 1
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 1
- ZGUMORRUBUCXEH-AVGNSLFASA-N Leu-Lys-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZGUMORRUBUCXEH-AVGNSLFASA-N 0.000 description 1
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 1
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 1
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 1
- IDGZVZJLYFTXSL-DCAQKATOSA-N Leu-Ser-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IDGZVZJLYFTXSL-DCAQKATOSA-N 0.000 description 1
- KZZCOWMDDXDKSS-CIUDSAMLSA-N Leu-Ser-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KZZCOWMDDXDKSS-CIUDSAMLSA-N 0.000 description 1
- RGUXWMDNCPMQFB-YUMQZZPRSA-N Leu-Ser-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RGUXWMDNCPMQFB-YUMQZZPRSA-N 0.000 description 1
- ADJWHHZETYAAAX-SRVKXCTJSA-N Leu-Ser-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ADJWHHZETYAAAX-SRVKXCTJSA-N 0.000 description 1
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 1
- KLSUAWUZBMAZCL-RHYQMDGZSA-N Leu-Thr-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O KLSUAWUZBMAZCL-RHYQMDGZSA-N 0.000 description 1
- GZRABTMNWJXFMH-UVOCVTCTSA-N Leu-Thr-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZRABTMNWJXFMH-UVOCVTCTSA-N 0.000 description 1
- ISSAURVGLGAPDK-KKUMJFAQSA-N Leu-Tyr-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O ISSAURVGLGAPDK-KKUMJFAQSA-N 0.000 description 1
- WFCKERTZVCQXKH-KBPBESRZSA-N Leu-Tyr-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O WFCKERTZVCQXKH-KBPBESRZSA-N 0.000 description 1
- 241000985284 Leuciscus idus Species 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 1
- WQWZXKWOEVSGQM-DCAQKATOSA-N Lys-Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN WQWZXKWOEVSGQM-DCAQKATOSA-N 0.000 description 1
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 1
- DNEJSAIMVANNPA-DCAQKATOSA-N Lys-Asn-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DNEJSAIMVANNPA-DCAQKATOSA-N 0.000 description 1
- 108010062166 Lys-Asn-Asp Proteins 0.000 description 1
- BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 1
- QUCDKEKDPYISNX-HJGDQZAQSA-N Lys-Asn-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QUCDKEKDPYISNX-HJGDQZAQSA-N 0.000 description 1
- HKCCVDWHHTVVPN-CIUDSAMLSA-N Lys-Asp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O HKCCVDWHHTVVPN-CIUDSAMLSA-N 0.000 description 1
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 1
- KYNNSEJZFVCDIV-ZPFDUUQYSA-N Lys-Ile-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O KYNNSEJZFVCDIV-ZPFDUUQYSA-N 0.000 description 1
- OJDFAABAHBPVTH-MNXVOIDGSA-N Lys-Ile-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O OJDFAABAHBPVTH-MNXVOIDGSA-N 0.000 description 1
- QBEPTBMRQALPEV-MNXVOIDGSA-N Lys-Ile-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN QBEPTBMRQALPEV-MNXVOIDGSA-N 0.000 description 1
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 1
- YDDDRTIPNTWGIG-SRVKXCTJSA-N Lys-Lys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O YDDDRTIPNTWGIG-SRVKXCTJSA-N 0.000 description 1
- XBZOQGHZGQLEQO-IUCAKERBSA-N Lys-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN XBZOQGHZGQLEQO-IUCAKERBSA-N 0.000 description 1
- AIXUQKMMBQJZCU-IUCAKERBSA-N Lys-Pro Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O AIXUQKMMBQJZCU-IUCAKERBSA-N 0.000 description 1
- BOJYMMBYBNOOGG-DCAQKATOSA-N Lys-Pro-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O BOJYMMBYBNOOGG-DCAQKATOSA-N 0.000 description 1
- YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 1
- LOGFVTREOLYCPF-RHYQMDGZSA-N Lys-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-RHYQMDGZSA-N 0.000 description 1
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 1
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 1
- MIMXMVDLMDMOJD-BZSNNMDCSA-N Lys-Tyr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O MIMXMVDLMDMOJD-BZSNNMDCSA-N 0.000 description 1
- YQAIUOWPSUOINN-IUCAKERBSA-N Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN YQAIUOWPSUOINN-IUCAKERBSA-N 0.000 description 1
- UGCIQUYEJIEHKX-GVXVVHGQSA-N Lys-Val-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O UGCIQUYEJIEHKX-GVXVVHGQSA-N 0.000 description 1
- TXTZMVNJIRZABH-ULQDDVLXSA-N Lys-Val-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TXTZMVNJIRZABH-ULQDDVLXSA-N 0.000 description 1
- GILLQRYAWOMHED-DCAQKATOSA-N Lys-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN GILLQRYAWOMHED-DCAQKATOSA-N 0.000 description 1
- HMZPYMSEAALNAE-ULQDDVLXSA-N Lys-Val-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMZPYMSEAALNAE-ULQDDVLXSA-N 0.000 description 1
- LMKSBGIUPVRHEH-FXQIFTODSA-N Met-Ala-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(N)=O LMKSBGIUPVRHEH-FXQIFTODSA-N 0.000 description 1
- AETNZPKUUYYYEK-CIUDSAMLSA-N Met-Glu-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O AETNZPKUUYYYEK-CIUDSAMLSA-N 0.000 description 1
- SXWQMBGNFXAGAT-FJXKBIBVSA-N Met-Gly-Thr Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SXWQMBGNFXAGAT-FJXKBIBVSA-N 0.000 description 1
- USBFEVBHEQBWDD-AVGNSLFASA-N Met-Leu-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O USBFEVBHEQBWDD-AVGNSLFASA-N 0.000 description 1
- HOZNVKDCKZPRER-XUXIUFHCSA-N Met-Lys-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HOZNVKDCKZPRER-XUXIUFHCSA-N 0.000 description 1
- ZRACLHJYVRBJFC-ULQDDVLXSA-N Met-Lys-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZRACLHJYVRBJFC-ULQDDVLXSA-N 0.000 description 1
- NLDXSXDCNZIQCN-ULQDDVLXSA-N Met-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)CC1=CC=CC=C1 NLDXSXDCNZIQCN-ULQDDVLXSA-N 0.000 description 1
- DSZFTPCSFVWMKP-DCAQKATOSA-N Met-Ser-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN DSZFTPCSFVWMKP-DCAQKATOSA-N 0.000 description 1
- KZKVVWBOGDKHKE-QTKMDUPCSA-N Met-Thr-His Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 KZKVVWBOGDKHKE-QTKMDUPCSA-N 0.000 description 1
- 150000001205 NO derivatives Chemical class 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 1
- HTTYNOXBBOWZTB-SRVKXCTJSA-N Phe-Asn-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N HTTYNOXBBOWZTB-SRVKXCTJSA-N 0.000 description 1
- MQVFHOPCKNTHGT-MELADBBJSA-N Phe-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O MQVFHOPCKNTHGT-MELADBBJSA-N 0.000 description 1
- JXWLMUIXUXLIJR-QWRGUYRKSA-N Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JXWLMUIXUXLIJR-QWRGUYRKSA-N 0.000 description 1
- OHUXOEXBXPZKPT-STQMWFEESA-N Phe-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=CC=C1 OHUXOEXBXPZKPT-STQMWFEESA-N 0.000 description 1
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 1
- BNRFQGLWLQESBG-YESZJQIVSA-N Phe-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O BNRFQGLWLQESBG-YESZJQIVSA-N 0.000 description 1
- GLJZDMZJHFXJQG-BZSNNMDCSA-N Phe-Ser-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O GLJZDMZJHFXJQG-BZSNNMDCSA-N 0.000 description 1
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 1
- GTMSCDVFQLNEOY-BZSNNMDCSA-N Phe-Tyr-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N GTMSCDVFQLNEOY-BZSNNMDCSA-N 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- FELJDCNGZFDUNR-WDSKDSINSA-N Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FELJDCNGZFDUNR-WDSKDSINSA-N 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 1
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 1
- LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 1
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 1
- OCYROESYHWUPBP-CIUDSAMLSA-N Pro-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 OCYROESYHWUPBP-CIUDSAMLSA-N 0.000 description 1
- VZKBJNBZMZHKRC-XUXIUFHCSA-N Pro-Ile-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O VZKBJNBZMZHKRC-XUXIUFHCSA-N 0.000 description 1
- CLJLVCYFABNTHP-DCAQKATOSA-N Pro-Leu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O CLJLVCYFABNTHP-DCAQKATOSA-N 0.000 description 1
- WFIVLLFYUZZWOD-RHYQMDGZSA-N Pro-Lys-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WFIVLLFYUZZWOD-RHYQMDGZSA-N 0.000 description 1
- RPLMFKUKFZOTER-AVGNSLFASA-N Pro-Met-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1 RPLMFKUKFZOTER-AVGNSLFASA-N 0.000 description 1
- POQFNPILEQEODH-FXQIFTODSA-N Pro-Ser-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O POQFNPILEQEODH-FXQIFTODSA-N 0.000 description 1
- BGWKULMLUIUPKY-BQBZGAKWSA-N Pro-Ser-Gly Chemical compound OC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BGWKULMLUIUPKY-BQBZGAKWSA-N 0.000 description 1
- ITUDDXVFGFEKPD-NAKRPEOUSA-N Pro-Ser-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ITUDDXVFGFEKPD-NAKRPEOUSA-N 0.000 description 1
- IURWWZYKYPEANQ-HJGDQZAQSA-N Pro-Thr-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O IURWWZYKYPEANQ-HJGDQZAQSA-N 0.000 description 1
- CXGLFEOYCJFKPR-RCWTZXSCSA-N Pro-Thr-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O CXGLFEOYCJFKPR-RCWTZXSCSA-N 0.000 description 1
- CWZUFLWPEFHWEI-IHRRRGAJSA-N Pro-Tyr-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O CWZUFLWPEFHWEI-IHRRRGAJSA-N 0.000 description 1
- 108010025216 RVF peptide Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 101100460203 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new2 gene Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 1
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 1
- RZEQTVHJZCIUBT-WDSKDSINSA-N Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N RZEQTVHJZCIUBT-WDSKDSINSA-N 0.000 description 1
- BGOWRLSWJCVYAQ-CIUDSAMLSA-N Ser-Asp-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BGOWRLSWJCVYAQ-CIUDSAMLSA-N 0.000 description 1
- GHPQVUYZQQGEDA-BIIVOSGPSA-N Ser-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N)C(=O)O GHPQVUYZQQGEDA-BIIVOSGPSA-N 0.000 description 1
- UFKPDBLKLOBMRH-XHNCKOQMSA-N Ser-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N)C(=O)O UFKPDBLKLOBMRH-XHNCKOQMSA-N 0.000 description 1
- WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 description 1
- YZMPDHTZJJCGEI-BQBZGAKWSA-N Ser-His Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 YZMPDHTZJJCGEI-BQBZGAKWSA-N 0.000 description 1
- RJHJPZQOMKCSTP-CIUDSAMLSA-N Ser-His-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O RJHJPZQOMKCSTP-CIUDSAMLSA-N 0.000 description 1
- CAOYHZOWXFFAIR-CIUDSAMLSA-N Ser-His-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O CAOYHZOWXFFAIR-CIUDSAMLSA-N 0.000 description 1
- LWMQRHDTXHQQOV-MXAVVETBSA-N Ser-Ile-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LWMQRHDTXHQQOV-MXAVVETBSA-N 0.000 description 1
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 1
- DOSZISJPMCYEHT-NAKRPEOUSA-N Ser-Ile-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O DOSZISJPMCYEHT-NAKRPEOUSA-N 0.000 description 1
- SBMNPABNWKXNBJ-BQBZGAKWSA-N Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO SBMNPABNWKXNBJ-BQBZGAKWSA-N 0.000 description 1
- LRWBCWGEUCKDTN-BJDJZHNGSA-N Ser-Lys-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LRWBCWGEUCKDTN-BJDJZHNGSA-N 0.000 description 1
- CRJZZXMAADSBBQ-SRVKXCTJSA-N Ser-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO CRJZZXMAADSBBQ-SRVKXCTJSA-N 0.000 description 1
- PTWIYDNFWPXQSD-GARJFASQSA-N Ser-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N)C(=O)O PTWIYDNFWPXQSD-GARJFASQSA-N 0.000 description 1
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 1
- GDUZTEQRAOXYJS-SRVKXCTJSA-N Ser-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GDUZTEQRAOXYJS-SRVKXCTJSA-N 0.000 description 1
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 1
- ILZAUMFXKSIUEF-SRVKXCTJSA-N Ser-Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ILZAUMFXKSIUEF-SRVKXCTJSA-N 0.000 description 1
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
- DYEGLQRVMBWQLD-IXOXFDKPSA-N Ser-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CO)N)O DYEGLQRVMBWQLD-IXOXFDKPSA-N 0.000 description 1
- VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 description 1
- ATEQEHCGZKBEMU-GQGQLFGLSA-N Ser-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N ATEQEHCGZKBEMU-GQGQLFGLSA-N 0.000 description 1
- MFQMZDPAZRZAPV-NAKRPEOUSA-N Ser-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N MFQMZDPAZRZAPV-NAKRPEOUSA-N 0.000 description 1
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- XYEXCEPTALHNEV-RCWTZXSCSA-N Thr-Arg-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XYEXCEPTALHNEV-RCWTZXSCSA-N 0.000 description 1
- SWIKDOUVROTZCW-GCJQMDKQSA-N Thr-Asn-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O SWIKDOUVROTZCW-GCJQMDKQSA-N 0.000 description 1
- PQLXHSACXPGWPD-GSSVUCPTSA-N Thr-Asn-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PQLXHSACXPGWPD-GSSVUCPTSA-N 0.000 description 1
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 1
- XDARBNMYXKUFOJ-GSSVUCPTSA-N Thr-Asp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XDARBNMYXKUFOJ-GSSVUCPTSA-N 0.000 description 1
- OYTNZCBFDXGQGE-XQXXSGGOSA-N Thr-Gln-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O OYTNZCBFDXGQGE-XQXXSGGOSA-N 0.000 description 1
- BECPPKYKPSRKCP-ZDLURKLDSA-N Thr-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O BECPPKYKPSRKCP-ZDLURKLDSA-N 0.000 description 1
- NIEWSKWFURSECR-FOHZUACHSA-N Thr-Gly-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O NIEWSKWFURSECR-FOHZUACHSA-N 0.000 description 1
- KBBRNEDOYWMIJP-KYNKHSRBSA-N Thr-Gly-Thr Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KBBRNEDOYWMIJP-KYNKHSRBSA-N 0.000 description 1
- LUMXICQAOKVQOB-YWIQKCBGSA-N Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O LUMXICQAOKVQOB-YWIQKCBGSA-N 0.000 description 1
- AHOLTQCAVBSUDP-PPCPHDFISA-N Thr-Ile-Lys Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O AHOLTQCAVBSUDP-PPCPHDFISA-N 0.000 description 1
- MEJHFIOYJHTWMK-VOAKCMCISA-N Thr-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O MEJHFIOYJHTWMK-VOAKCMCISA-N 0.000 description 1
- XSEPSRUDSPHMPX-KATARQTJSA-N Thr-Lys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XSEPSRUDSPHMPX-KATARQTJSA-N 0.000 description 1
- IQHUITKNHOKGFC-MIMYLULJSA-N Thr-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IQHUITKNHOKGFC-MIMYLULJSA-N 0.000 description 1
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 1
- MUAFDCVOHYAFNG-RCWTZXSCSA-N Thr-Pro-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MUAFDCVOHYAFNG-RCWTZXSCSA-N 0.000 description 1
- PRTHQBSMXILLPC-XGEHTFHBSA-N Thr-Ser-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PRTHQBSMXILLPC-XGEHTFHBSA-N 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 1
- BEZTUFWTPVOROW-KJEVXHAQSA-N Thr-Tyr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O BEZTUFWTPVOROW-KJEVXHAQSA-N 0.000 description 1
- RPECVQBNONKZAT-WZLNRYEVSA-N Thr-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H]([C@@H](C)O)N RPECVQBNONKZAT-WZLNRYEVSA-N 0.000 description 1
- VMSSYINFMOFLJM-KJEVXHAQSA-N Thr-Tyr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCSC)C(=O)O)N)O VMSSYINFMOFLJM-KJEVXHAQSA-N 0.000 description 1
- CKHWEVXPLJBEOZ-VQVTYTSYSA-N Thr-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O CKHWEVXPLJBEOZ-VQVTYTSYSA-N 0.000 description 1
- FYBFTPLPAXZBOY-KKHAAJSZSA-N Thr-Val-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O FYBFTPLPAXZBOY-KKHAAJSZSA-N 0.000 description 1
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- BABINGWMZBWXIX-BPUTZDHNSA-N Trp-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N BABINGWMZBWXIX-BPUTZDHNSA-N 0.000 description 1
- QZOSVNLXLSNHQK-UWVGGRQHSA-N Tyr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QZOSVNLXLSNHQK-UWVGGRQHSA-N 0.000 description 1
- WAPFQMXRSDEGOE-IHRRRGAJSA-N Tyr-Glu-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O WAPFQMXRSDEGOE-IHRRRGAJSA-N 0.000 description 1
- NZFCWALTLNFHHC-JYJNAYRXSA-N Tyr-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NZFCWALTLNFHHC-JYJNAYRXSA-N 0.000 description 1
- QJKMCQRFHJRIPU-XDTLVQLUSA-N Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QJKMCQRFHJRIPU-XDTLVQLUSA-N 0.000 description 1
- USYGMBIIUDLYHJ-GVARAGBVSA-N Tyr-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 USYGMBIIUDLYHJ-GVARAGBVSA-N 0.000 description 1
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 1
- QSFJHIRIHOJRKS-ULQDDVLXSA-N Tyr-Leu-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QSFJHIRIHOJRKS-ULQDDVLXSA-N 0.000 description 1
- PMHLLBKTDHQMCY-ULQDDVLXSA-N Tyr-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMHLLBKTDHQMCY-ULQDDVLXSA-N 0.000 description 1
- CGWAPUBOXJWXMS-HOTGVXAUSA-N Tyr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 CGWAPUBOXJWXMS-HOTGVXAUSA-N 0.000 description 1
- PSALWJCUIAQKFW-ACRUOGEOSA-N Tyr-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N PSALWJCUIAQKFW-ACRUOGEOSA-N 0.000 description 1
- JXGUUJMPCRXMSO-HJOGWXRNSA-N Tyr-Phe-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 JXGUUJMPCRXMSO-HJOGWXRNSA-N 0.000 description 1
- QPOUERMDWKKZEG-HJPIBITLSA-N Tyr-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QPOUERMDWKKZEG-HJPIBITLSA-N 0.000 description 1
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 1
- JHDZONWZTCKTJR-KJEVXHAQSA-N Tyr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JHDZONWZTCKTJR-KJEVXHAQSA-N 0.000 description 1
- JAQGKXUEKGKTKX-HOTGVXAUSA-N Tyr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 JAQGKXUEKGKTKX-HOTGVXAUSA-N 0.000 description 1
- GZWPQZDVTBZVEP-BZSNNMDCSA-N Tyr-Tyr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O GZWPQZDVTBZVEP-BZSNNMDCSA-N 0.000 description 1
- SQUMHUZLJDUROQ-YDHLFZDLSA-N Tyr-Val-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O SQUMHUZLJDUROQ-YDHLFZDLSA-N 0.000 description 1
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 1
- ABSXSJZNRAQDDI-KJEVXHAQSA-N Tyr-Val-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ABSXSJZNRAQDDI-KJEVXHAQSA-N 0.000 description 1
- 108010064997 VPY tripeptide Proteins 0.000 description 1
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 1
- OGNMURQZFMHFFD-NHCYSSNCSA-N Val-Asn-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N OGNMURQZFMHFFD-NHCYSSNCSA-N 0.000 description 1
- HHSILIQTHXABKM-YDHLFZDLSA-N Val-Asp-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O HHSILIQTHXABKM-YDHLFZDLSA-N 0.000 description 1
- SCBITHMBEJNRHC-LSJOCFKGSA-N Val-Asp-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N SCBITHMBEJNRHC-LSJOCFKGSA-N 0.000 description 1
- SZTTYWIUCGSURQ-AUTRQRHGSA-N Val-Glu-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SZTTYWIUCGSURQ-AUTRQRHGSA-N 0.000 description 1
- WDIGUPHXPBMODF-UMNHJUIQSA-N Val-Glu-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N WDIGUPHXPBMODF-UMNHJUIQSA-N 0.000 description 1
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 1
- WFENBJPLZMPVAX-XVKPBYJWSA-N Val-Gly-Glu Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O WFENBJPLZMPVAX-XVKPBYJWSA-N 0.000 description 1
- PMDOQZFYGWZSTK-LSJOCFKGSA-N Val-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C PMDOQZFYGWZSTK-LSJOCFKGSA-N 0.000 description 1
- HQYVQDRYODWONX-DCAQKATOSA-N Val-His-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)O)N HQYVQDRYODWONX-DCAQKATOSA-N 0.000 description 1
- APEBUJBRGCMMHP-HJWJTTGWSA-N Val-Ile-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 APEBUJBRGCMMHP-HJWJTTGWSA-N 0.000 description 1
- JKHXYJKMNSSFFL-IUCAKERBSA-N Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN JKHXYJKMNSSFFL-IUCAKERBSA-N 0.000 description 1
- XXWBHOWRARMUOC-NHCYSSNCSA-N Val-Lys-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O)N XXWBHOWRARMUOC-NHCYSSNCSA-N 0.000 description 1
- MLADEWAIYAPAAU-IHRRRGAJSA-N Val-Lys-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N MLADEWAIYAPAAU-IHRRRGAJSA-N 0.000 description 1
- UOUIMEGEPSBZIV-ULQDDVLXSA-N Val-Lys-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UOUIMEGEPSBZIV-ULQDDVLXSA-N 0.000 description 1
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 description 1
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 1
- DLRZGNXCXUGIDG-KKHAAJSZSA-N Val-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O DLRZGNXCXUGIDG-KKHAAJSZSA-N 0.000 description 1
- DFQZDQPLWBSFEJ-LSJOCFKGSA-N Val-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DFQZDQPLWBSFEJ-LSJOCFKGSA-N 0.000 description 1
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 1
- STTYIMSDIYISRG-UHFFFAOYSA-N Valyl-Serine Chemical compound CC(C)C(N)C(=O)NC(CO)C(O)=O STTYIMSDIYISRG-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- ZVDPYSVOZFINEE-BQBZGAKWSA-N alpha-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O ZVDPYSVOZFINEE-BQBZGAKWSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- INJRKJPEYSAMPD-UHFFFAOYSA-N aluminum;silicic acid;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O INJRKJPEYSAMPD-UHFFFAOYSA-N 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009640 blood culture Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940031670 conjugate vaccine Drugs 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 101150012763 endA gene Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 101150070420 gyrA gene Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 101150085823 hsdR gene Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 238000001325 log-rank test Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 108010044348 lysyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 108010072591 lysyl-leucyl-alanyl-arginine Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 101150022503 phoR gene Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- 229960001973 pneumococcal vaccines Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108010079317 prolyl-tyrosine Proteins 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- ZZIZZTHXZRDOFM-XFULWGLBSA-N tamsulosin hydrochloride Chemical compound [H+].[Cl-].CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-XFULWGLBSA-N 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 1
- 108010001055 thymocartin Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Popisují se streptokokové proteiny a polynukleotidy, které je kódují. Uvedené proteiny jsou antigenní, a proto jsou pouzitelnými vakcinacními komponenty pri profylaxi nebo terapii streptokokové infekce. Také se popisují rekombinantní zpusoby produkce proteinových antigenu stejne jako zpusoby diagnózy detekující streptokokovou bakteriální infekci.
Description
Izolovaný polynukleotid, vektor, hostitelská buňka, způsob produkce, izolovaný polypeptid, chimérový polypeptid, vakcinační prostředek a použití
Oblast techniky
Popisují se antigeny, zvláště pak proteinové antigeny patogenu Streptococcus pneumoniae, kleré se používají jako vakcinační komponenty při terapii a/nebo profylaxi.
Dosavadní stav techniky
Mikroorganizmus 5.pneumoniae je důležité agens onemocnění u lidí, zvláště mezi novorozenci, u přestárlých a u imunokompromitovaných osob. Je to bakterie, často izolovaná po celém světě u is pacientů s invazivním onemocněním, jako je bakteriémie/septikémie, pneumoniae, meningitida, vykazující vysokou morbiditu a mortalitu. Dokonce i přes vhodnou léčbu antibiotiky vede pneumokokové infekce k řadě úmrtí. Ačkoli příchod antimikrobiálních léků snížil celkovou úmrtnost při pneumokokovém onemocnění, hlavním problémem v dnešní době je existence rezistentních pneumokoků. Účinné pneumokokové vakcíny by mohly mít hlavní dopad na morbiditu a morta20 litu spojenou s onemocněním způsobeným mikroorganizmem S.pneumoniae. Takové vakcíny se mohou také potencionálně použít při prevenci zánětu středního ucha u kojenců a malých dětí.
Úsilí spojené s vývojem pneumokokové vakcíny se obecně koncentrovalo na vytvoření imunitních odezev na pneumokokový kapsulámí polysacharid. Identifikovalo se více než 80 pneumoko25 kových kapsulámích sérotypů na bázi antigenních rozdílů. V současné době dostupná pneumokoková vakcína obsahující 23 kapsulámích polysacharidu, které nejčastěji způsobují onemocnění, vykazuje podstatné nedostatky spojené primárně s nízkou imonogenností některých kapsulámích polysacharidů, rozmanitost sérotypů a rozdíly při distribuci sérotypů v čase, v geografických oblastech a ve věkových skupinách. Selhání existujících vakcín a kapsulámích konjugovaných vakcín, kteréjsou v současné době ve vývoji, za účelem ochrany malých dětí proti všem sérotypům mikroorganizmu S.pneumoniae podporuje hodnoceni jiných komponentů uvedeného mikroorganizmu. Ačkoli imunogennost kapsulámích polysacharidů se může zlepšit, specifita sérotypů bude stále představovat hlavní omezení vakcín založených na polysacharidech. Použití antigenně konzervativního imunogenního pneumokokového proteinového antigenu buď samotné35 ho nebo v kombinaci s dalšími komponenty nabízí možnost pneumokokové vakcíny založené na proteinu.
Přihláška WO98/18930 zveřejněná 7. 5. 1998 nazvaná „Steptococcus Pneumoniae antigens and vaccines“ popisuje jisté polypeptidy, kteréjsou antigenní. Avšak nepopisuje se žádná biologická aktivita těchto polypeptidů.
Proto existuje nutnost najít streptokokové antigeny, které se mohou použít jako vakcinační komponenty pro profylaxi a/nebo terapii streptokokové infekce.
Podstata vynálezu
Vynález se týká izolovaného polynukleotidu, který kóduje polypeptid vybraný z
a) polypeptid obsahující aminokyselinovou sekvenci identickou nejméně z 95 % se sekvencí uvedenou v SEQ ID č. 4, 58, 60, 63, 73, 74, nebo 79
b) polypeptid obsahující aminokyselinovou sekvenci identickou nejméně z 99% se sekvencí uvedenou v SEQ ID č. 4, 14, 58, 60, 63, 73, 74 nebo 79, a
c) polypeptid obsahující aminokyselinovou sekvenci uvedenou v SEQ ID č. 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 nebo 79,
- H přičemž kódovaný polypeptid je schopný u jedince vyvolat imunitní odpověď na Streptokoka.
Vynález dále popisuje vektory obsahující výše uvedený polynukleotid operativně spojený 5 s oblastí řídící expresi, stejně jako hostitelské buňky transfekované uvedenými vektory a metody produkující polypeptidy, které zahrnují kultivaci uvedených hostitelských buněk za podmínek vhodných pro expresi.
Dále vynález popisuje nové polypeptidy kódované polynukleotidy podle vynálezu.
Dále vynález popisuje izolovaný polypeptid vybraný z
a) izolovaného polypeptidů zahrnujícího aminokyselinovou sekvenci identickou nejméně z 95 % s aminokyselinovou sekvencí uvedenou v SEQ ID č. 4, 58, 60, 63, 73, 74 nebo 79,
b) izolovaného polypeptidů zahrnujícího aminokyselinovou sekvenci identickou nejméně z
99 % s aminokyselinovou sekvencí uvedenou v SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 73, 74 nebo 79, nebo
c) izolovaného polypeptídu zahrnujícího aminokyselinovou sekvenci uvedenou v SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 nebo 79, přičemž izolovaný polypeptid je schopný u jedince vyvolat imunitní odpověď na Streptokoka.
Dále je popsán izolovaný polynukleotid kódující polypeptid, který vykazuje alespoň 70% shodu s druhým polypeptidem vykazujícím sekvenci vybranou z SEQ ID NO: 2, 4, 6, 8, 10, 14, 16, 55 až 75, 77 až 79, 81, 83 nebo s jejich fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid, který má alespoň 95% shodu s druhým polypeptidem, který obsahuje sekvenci vybranou z SEQ ID NO: 2, 4, 6, 8, 10, 14, 16, 55 až 75, 77 až 79, 81, 83 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 2, 4, 8, 10, 14, 16, 55 až 75, 77 až 79, 81,83 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s dru35 hým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 2, 4, 8, 10, 14, 16, 55 až 75, 77 až 79, 81,83 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 2, 4, 8, 10, 14, 16, 55 až
75, 77 až 79 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 2, 8, 10, 16, 55, 56, 57, 58, 59, 64, 65, 66, 78 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 2, 8, 10, 16, 55, 56, 57, 59, 64, 65, 66, 78 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 4, 14, 58, 60, 61, 62, 63,
67, 68, 69, 70, 71, 72, 73, 74, 75, 77, 79 nebo jeho fragmenty, analogy nebo deriváty.
-2CZ 303675 B6
Příklad 12:
Tento příklad popisuje klonování a expresi chimérového genu kódujícího chiméro vý polypeptid odpovídající karboxy koncové oblasti BVH-3 ve fúzi na C-konci s karboxy-terminální oblastí
BVH-11 a dodatečné ochrany pozorované po vakcinaci chimérovým polypeptidem.
Ze studie popsané shora v textuje zřejmé, že BVH-3 a BVH-11 jsou serologicky odlišné molekuly, kteréjsou současně přítomny na mikroorganizmu S.pneumoniae. Výsledky imunologických studií myší ukazují, že oba proteiny jsou dobrými kandidáty na vakcínu. Tyto proteiny mají io potenciál poskytovat ochranu proti všem pneumokokům bez ohledu na sérotyp. Přestože tyto dva proteiny sdílí epitopy a sekvence, vykazují různé charakteristiky a mohou sloužit k různým biologickým funkcím. Tudíž imunizace proti dvěma proteinům může poskytnout lepší ochranu než, když probíhá každá jednotlivě. Aby se toto dalo testovat, může se zkoumat několik cest, kde se aplikuje BVH-3 a BVH-11 v plné délce nebo ve zkrácené formě v kombinaci nebo v konjugaci, is Popisuje se genetické inženýrství fúzního genu BVH-3-BVH-11 a protein nazvaný NEW12 (SEQ ID NO: 76 a SEQ ID NO: 58) a potencionální použití proteinu NEW 12 jako vakcíny.
Genové fragmenty BVH-3 a BVH-11 odpovídající 3'konci genů, které se amplifikovaly pomocí
PCR za použití párů oligonukleotidů připravených tak, aby se amplifikovaly fragmenty překrý20 vající nukleotidy 1414 až 3117 (SEQ ID NO: 1) a nukleotidy 1060 až 2520 (SEQ ID NO: 3) z mikroorganizmu S.pneumoniae kmen SP64 genů BVH-3 a BVH-11. Používané primery
HAMJ278 a HAMJ279, HAMJ282 a HAMJ283 měly na 5'konci místo rozeznávané restrikční endonukleázou, což umožňuje přímé klonování amplifikováného produktu do rámce štěpeného plazmidového vektoru pET21b(+) (tabulka č. 2). Produkty amplifikované PCR se štěpily restrikčními endonukleázami a ligovaly se do linearizovaného plazmidového vektoru pET21b( ·) štěpeného podobným způsobem. Výsledné plazmidové konstrukce se potvrdily analýzou nukleotidové sekvence, Rekombinantní plazmid pET21b(+) obsahující PCR produkt Ndel-HindlII BVH-3 se linearizoval štěpením restrikčními enzymy HindlII a Notl pro klonování do rámce HindlII-Notl fragmentu DNA získaného z rekombinantního vektoru pET21(+), který obsahuje fragment genu BVH-11. Klony se nejdříve stabilizovaly v mikroorganizmu E. coli DH5a a pak se zavedly do mikroorganizmu A. coli BL21(XDE3) za účelem exprese chimérové molekuly pneumokokového proteinu. Rekombinantní chimérový polypeptid nazvaný NEW 12 se exprimoval jako C-terminální fúze s His-tag. Exprimovaný rekombinantní protein NEW 13 se čistil z frakcí supematantů získaných z centrifugace sonikovaných kultur mikroorganizmu E. coli indukovaných 1PTG za použití pryskyřice His-Bind s cheláty kovů (QIAgen, Chatsworth, CA).
Podle stejného postupu popsaného shora v textuje možné zkonstruovat jiné chimérové polypeptidy, jako výsledek současné exprese New 1 a New 4, New 1 a New 5, New 1 a New 10 nebo New 1 a New 14. Konstrukce se může provést tak, že New 1 leží proti směru exprese nebo po směru exprese New 4, New 5, New 10, BVH-11B nebo New 14. Je také možné zkonstruovat jiné chimérové poíypeptidy, jako výsledek současné exprese více jak dvou fragmentů libovolného BVH-3, BVH-11 nebo BVH-11-2.
Skupiny 8 samic myší BALB/c (Charles River) se imunizovaly podkožně dvakrát v tří týdenních intervalech s 25 pg buď His«Tag-fúze NEW1 čištěného na základě afinity BVH-1 IB nebo proteinu NEW 12 v přítomnosti 15 pg adjuvans QuilA. Deset až čtrnáct dní po poslední imunizaci se myším aplikovala zesilovací dávka virulentního S.pneumoniae. Jak se ukázalo dříve, molekuly NEW1 a BVH-1 IB obsahující aminokyseliny 472 až 1039 z proteinu BVH-3 a aminokyseliny 354 a 840 z proteinu BVH-11, odpovídají částem proteinů schopným vyvolat ochrannou imunit50 ní odezvu. Aby se stanovilo, zda chimérový polypeptid podstatně zlepší ochranu ve srovnání s proteiny tvořící jednotlivé části, zesilovací dávka se provedla způsobem, kdy se neočekávaná ochrana s molekulami NEW1 a BVH-1 B. Je zajímavé, že chimérový protein NEW12 vyvolal ochranu proti myším virulentním kmenům WU2 a P4201. Sedm z osmi myší imunizovaných sNEW12 jsou stále živé 10 dní po zesilovací dávce, zatímco 28 myší z 32 imunizovaných
-34CZ 303675 B6
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 60 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 62 nebo jeho fragmenty, analogy nebo deriváty.
io Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 64 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s dru15 hým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 67 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 68 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 69 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 72 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 74 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s dru35 hým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 77 nebo jeho fragmenty, analogy nebo deriváty.
Dále je popsán izolovaný polynukleotid kódující polypeptid vykazující alespoň 70% shodu s druhým polypeptidem, který vykazuje sekvenci vybranou z SEQ ID NO: 2, 4, 6, 8, 10 nebo jeho fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sekvencí SEQ ID NO: 2, 4, 6, 8, 10 nebo jejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sekvencí SEQ ID NO: 2, 4, 6, 8, 10, 14, 16, 55 až 75, 77 až 79, 81,83 nebo jejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sek50 věnci SEQ ID NO: 2, 4, 6, 8, 10, 14, 16, 55 až 75, 77 až 79, 81, 83 nebo jejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sekvencí SEQ ID NO: 2, 4, 6, 8, 10, 14, 16, 55 až 75, 77 až 79 nebo jejich fragmenty, analogy nebo deriváty.
-4CZ 303675 R6
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sekvencí SEQ ID NO: 2, 4, 10, 14, 16 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci SEQ ID NO: 2 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci SEQ ID NO: 4 nebojejich fragmenty, analogy nebo deriváty.
io
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci SEQ ID NO: 10 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci 15 SEQ ID NO: 14 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci SEQ ID NO: 16 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sekvencí SEQ ID NO: 10, 55 až 75, 77, 78, 79 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 72, 74, 77 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 72, 74, 77 nebo jejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 72, 74, 77 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci SEQ ID NO: 58 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci SEQ ID NO: 62 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci SEQ ID NO: 64 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci 45 SEQ ID NO: 67 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvencí SEQ ID NO: 68 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci SEQ ID NO: 74 nebojejich fragmenty, analogy nebo deriváty.
Dále jsou popsány polypeptidy charakterizované aminokyselinovou sekvencí obsahující sekvenci
SEQ ID NO: 77 nebojejich fragmenty, analogy nebo deriváty.
-5CZ 303675 B6
V dalším provedení vynálezu se také popisují chimémí polypeptidy, které obsahují jeden nebo více polypeptidu nebo jejich fragmenty, analogy nebo deriváty.
Vjíném provedení vynálezu se také popisují chimémí polypeptidy, které obsahují jeden nebo více polypeptidů nebo jejich fragmenty, analogy nebo deriváty, jako je uvedeno na obrázcích.
V dalším provedení vynálezu se popisuje chimémí polypeptid zahrnující dva nebo více polypeptidů, kde aminokyselinová sekvence každého ze dvou nebo více polypeptidů zahrnuje aminokyselinovou sekvenci vybranou z aminokyselinové sekvence uvedené v SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 nebo 79, kde dva nebo více polypeptidů jsou spojené za vzniku chimérního polypeptidu, přičemž kódovaný polypeptid je schopný u jedince vyvolat imunitní odpověď na Streptokoka.
Vynález dále popisuje chimémí polypeptid uvedený výše, kde chimémí polypeptid obsahuje dva nebo více polypeptidů, kde aminokyselinová sekvence každého ze dvou nebo více polypeptidů zahrnuje aminokyselinovou sekvenci vybranou z aminokyselinové sekvence uvedené v SEQ ID ě. 58, 60, 62, 67, 68, 74 a 77, kde dva nebo více polypeptidů jsou spojené za vzniku chimémího polypeptidu.
Dále jsou popsány chimémí polypeptidy, které obsahují dva nebo více polypeptidů vybraných ze skupiny zahrnující SEQ ID NO: 2„ 4, 6, 8, 10, 14, 16, 55 až 75, 77 až 79, 81, 83 nebo jejich fragmenty, analogy nebo deriváty jsou spojeny a tvoří chimémí polypeptid.
Dále je popsán chimérní polypeptid obsahující dva nebo více polypeptidů vybraných z SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 72, 74, 77 nebo jejich fragmenty, analogy nebo deriváty, přičemž polypeptidy nebo fragmenty, analogy nebo deriváty jsou spojeny a tvoří chimérní polypeptid.
Dále je popsán chimémí polypeptid obsahující dva nebo více polypeptidů vybraných z SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 74, 77 nebo jejich fragmenty, analogy nebo deriváty, přičemž polypeptidy nebo fragmenty, analogy nebo deriváty jsou spojeny a tvoří chimémí polypeptid.
V dalším provedení chimémí polypeptid obsahuje dva nebo více polypeptidů vybraných z SEQ ID NO: 10, 62, 64, 67, 68, 74, 77 nebo jejich fragmenty, analogy nebo deriváty, přičemž polypeptidy nebo fragmenty, analogy nebo deriváty jsou spojeny a tvoří chimémí polypeptid.
V dalším provedení chimémí polypeptid obsahuje mezi 2 a 5 polypeptidy,
V dalším provedení vynálezu chimémí polypeptid obsahuje mezi 2 až 4 polypeptidy.
V dalším provedení vynálezu chimémí polypeptid obsahuje mezi 2 až 3 polypeptidy,
V dalším provedení vynálezu chimérní polypeptid obsahuje 2 polypeptidy.
V dalším provedení vynálezu se popisuje chimémí polypeptid výše uvedený, obecného vzorce (I):
A-(B)m-(C)n-D (I) kde m je 0 nebo 1, n je 0 nebo 1,
Aje vybrán ze SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 a 79;
-6CZ 303675 B6
B je vybrán ze SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 a 79;
C je vybrán ze SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 a 79; a
D je vybrán ze SEQ ID č. 4, 14. 58, 60, 62. 63, 67, 68, 73, 74, 77 a 79.
V dalším provedení vynálezu je výše uvedený chimérní polypeptid obecného vzorce (I);
A-CBj^O-D (I) kde m je 0 nebo 1, n je 0 nebo 1,
A je vybrán ze SEQ ID č. 58, 60, 62, 67, 68, 74 a 77;
B je vybrán ze SEQ ID č. 58, 60, 62, 67, 68, 74 a 77;
C je vybrán ze SEQ ID č. 58, 60, 62, 67, 68, 74 a 77; a
D je vybrán ze SEQ ID č. 58, 60, 62, 67, 68, 74 a 77.
V dalším provedení vynálezu je popsán výše uvedený chimémí polypeptid, kde chimérní polypeptid je fúzovaný se sacharidem.
Dále je popsán chimérní polypeptid kde symbol A vybral ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 72, 74, 77 nebo jejich fragmentů, analogů nebo derivátů, symbol B vybral ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 72, 74, 77 nebo jejich fragmentů, analogů nebo derivátů, symbol C vybral ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 72, 74, 77 nebo jejich fragmentů, analogů nebo derivátů a symbol D vybral ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 72, 74, 77 nebo jejich fragmentů, analogů nebo derivátů.
V dalším provedení se symbol Λ vybral ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 74, 77 nebo jejich fragmentů, analogů nebo derivátů, symbol B vybral ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 74, 77 nebo jejich fragmentů, analogů nebo derivátů, symbol C vybral ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 74, 77 nebo jejich fragmentů, analogů nebo derivátů a symbol D vybral ze sekvencí SEQ ID NO: 10, 58, 60, 62, 64, 67, 68, 69, 74, 77 nebo jejich frag50 mentů, analogů nebo derivátů.
V jiném provedení vynálezu chimérové polypeptidy podle vynálezu obsahují ty polypeptidy, kde jsou přítomny následující provedení buď nezávisle nebo v kombinaci.
-7 CZ 303675 B6
V dalším provedení symbol A je sekvence SEQ ID NO: 10, 58, 62, 64, 67, 68, 74, 77 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol A je sekvence SEQ ID NO: 10 nebo její fragmenty, analogy nebo 5 deriváty.
V dalším provedení symbol A je sekvence SEQ ID NO: 58 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol A je sekvence SEQ ID NO: 58 nebo její fragmenty, analogy nebo io deriváty.
V dalším provedení symbol A je sekvence SEQ ID NO: 62 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol A je sekvence SEQ ID NO: 64 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol A je sekvence SEQ ID NO: 67 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol A je sekvence SEQ ID NO: 68 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol A je sekvence SEQ ID NO: 74 nebo její fragmenty, analogy nebo 25 deriváty.
V dalším provedení symbol A je sekvence SEQ ID NO deriváty.
nebo její fragmenty, analogy nebo
V dalším provedení symbol B je sekvence SEQ ID NO: 10, 58, 62, 64, 67, 68, 74, 77 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol B je sekvence SEQ ID NO: 10 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol B je sekvence SEQ ID NO: 58 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol B je sekvence SEQ ID NO: deriváty.
nebo její fragmenty, analogy nebo
V dalším provedení symbol deriváty.
B je sekvence SEQ ID NO:
nebo její fragmenty, analogy nebo
V dalším provedení symbol deriváty.
B je sekvence SEQ ID NO:
nebo její fragmenty, analogy nebo
V dalším provedení symbol B je sekvence SEQ ID NO: 68 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol B je sekvence SEQ ID NO: 74 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol B je sekvence SEQ ID NO: 77 nebo její fragmenty, analogy nebo deriváty.
-8C7. 303675 B6
V dalším provedení symbol C je sekvence SEQ ID NO: 10, 58, 62, 64, 67, 68, 74, 77 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol C je sekvence SEQ ID NO: 10 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol C je sekvence SEQ ID NO: 58 nebo její fragmenty, analogy nebo deriváty.
io
V dalším provedení symbol C je sekvence SEQ ID NO: 62 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol C je sekvence SEQ ID NO: 64 nebo její fragmenty, analogy nebo 15 deriváty.
V dalším provedení symbol C je sekvence SEQ ID NO: 67 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol C je sekvence SEQ ID NO: 68 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol C je sekvence SEQ ID NO: 74 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol C je sekvence SEQ ID NO: 77 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol D je sekvence SEQ ID NO: 10, 58, 62, 64, 67, 68, 74, 77 nebo její 30 fragmenty, analogy nebo deriváty.
V dalším provedení symbol D je sekvence SEQ ID NO: 10 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol D je sekvence SEQ ID NO: 58 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol D je sekvence SEQ ID NO: 62 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol D je sekvence SEQ ID NO: 64 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol D je sekvence SEQ ID NO: 67 nebo její fragmenty, analogy nebo 45 deriváty.
V dalším provedení symbol D je sekvence SEQ ID NO: 68 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol D je sekvence SEQ ID NO: 74 nebo její fragmenty, analogy nebo deriváty.
V dalším provedení symbol D je sekvence SEQ ID NO: 77 nebo její fragmenty, analogy nebo deriváty.
-9CZ 303675 B6
V dalším provedení vynálezu symbol m je 0.
V dalším provedení vynálezu symbol n je 0.
V dalším provedení vynálezu symbol m a n jsou 0.
V dalším provedení vynálezu symbol man jsou 0, symbol A je sekvence SEQ ID NO: 64 nebo její fragmenty, analogy nebo deriváty, symbol B je sekvence SEQ ID NO: 62 nebo její fragmenty, analogy nebo deriváty. V jiném provedení vynálezu symbol man jsou 0, symbol A je io sekvence SEQ ID NO: 62 nebo její fragmenty, analogy nebo deriváty.
Dále jsou popsány všechny nukleotidy kódující polypeptidy a chimérové polypeptidy.
V dalším provedení vynálezu polypeptidy nebo chimérové polypeptidy v souladu s vynálezem is jsou antigenní.
V dalším provedení vynálezu polypeptidy nebo chimérové polypeptidy se mohou vyvolat imunitní odpověď u jedince.
V dalším provedení vynálezu se také popisují polypeptidy, které jsou schopny vyvolat protilátky, které mají vazebnou specifitu pro polypeptidy nebo chimérové polypeptidy podle vynálezu, jak se definuje shora v textu.
Protilátky, které „vykazují vazebnou specifitu“ jsou protilátky, které rozeznávají a váží se na vybraný polypeptid, ale které v podstatě nerozeznávají a neváží se najiné molekuly ve vzorku, které přirozeně zahrnují vybraný peptid. Specifické navázání se může stanovit za použití testu ELISA, kde se vybraný polypeptid používá jako antigen.
Pokud není definováno jinak, všechny zde používané technické a vědecké termíny mají stejný význam, který je běžný v oboru, do kterého vynález spadá. Všechny publikace, patentové přihlášky, patenty a jiné zde uvedené reference jsou zahrnuty jako celek. V případě konfliktu se budou kontrolovat přítomné specifikace zahrnující definice. Navíc materiály, metody a příklady jsou pouze ilustrativní nejsou omezující.
Termín „fragmenty“, „deriváty“ nebo „analogy“ popsaných póly peptidů zahrnují ty polypeptidy, kde jeden nebo více aminokyselinových zbytků se nahradily konzervativním nebo nekonzervativním aminokyselinovým zbytkem (výhodně konzervativním) a který může být přirozený nebo nepřirozený. V jednom provedení deriváty a analogy polypeptidů podle vynálezu budou vykazovat přibližně 70% shodu se sekvencemi uvedenými na obrázcích nebo s jejich fragmenty. To znamená, že 70 % zbytků je stejných. V dalším provedení polypeptidy budou vykazovat homologii vyšší než 75 %. V dalším provedení polypeptidy budou vykazovat homologii vyšší než 80 %.
V dalším provedení polypeptidy budou vykazovat homologii vyšší než 80 %. V dalším provedení polypeptidy budou vykazovat homologii vyšší než 85 %. V dalším provedení polypeptidy budou vykazovat homologii vyšší než 90 %. V dalším provedení polypeptidy budou vykazovat homolo45 gií vyšší než 95 %. V dalším provedení polypeptidy budou vykazovat homologii vyšší než 99 %.
V dalším provedení deriváty a analogy polypeptidů podle vynálezu budou vykazovat méně než přibližně 20 substitucí, úprav nebo delecí aminokyselinových zbytků, výhodné je méně než 10. Preferované substituce jsou ty, co jsou v oboru známé jako konzervované, to znamená, že substituované zbytky sdílí fyzikální nebo chemické vlastnosti, jako je hydrofóbnost, velikost, náboj nebo funkční skupiny.
Vynález popisuje polypeptidy, které zahrnují polypeptidy a chimérové polypeptidy.
Vynález dále popisuje polypeptidy, které fúzují sjinými sloučeninami, které mění biologické nebo farmakologické vlastnosti polypeptidů. To je polyethylenglykol (PEG), který zvyšuje polo- 10 CZ 303675 B6 čas rozpadu, vedoucí nebo sekreční aminokyselinové sekvence, které zjednodušují čištění, prepro- a prosekvence a (poly)sacharidy.
Dále v těchto situacích, kde se zjistilo, že aminokyselinové oblasti jsou polymorfní, může být nutné změnit jednu nebo více určitých aminokyselin, aby se účinněji napodobily různé epitopy různých streptokokových kmenů.
Polypeptidy podle vynálezu se však mohou upravovat terminál ní -NH2 acylací (například acetylací nebo amidací thioglykolovou kyselinou, terminální karboxyamidací, například amoniakem nebo methylaminem), což způsobuje vyšší stabilitu, zvýšení hydrofóbnosti pro spojení nebo navázání na podklad nebo na jinou molekulu.
Vynález dále popisuje hetero- a homopolypeptidové multiméry polypeptidových fragmentů, analogů a derivátů. Tyto polymemí formy zahrnují například jeden nebo více polypeptidů, které se síťují například jeden nebo více polypeptidů, které se síťují pomocí síťovacích činidel, jako je avidin/biotik, gluteraldehyd nebo dimethylsuperimidát. Takové polymemí formy také zahrnují polypeptidy obsahující dva nebo více tandemových nebo obrácených kontinuálních sekvencí, které vznikají z multicistronní mRNA vytvořené technologií rekombinace DNA. Je výhodné, aby fragment, analog nebo derivát polypeptidů podle vynálezu obsahoval alespoň jednu antigenní oblast, to je alespoň jeden epitop.
Aby se dosáhlo vytvoření antigenních polymerů (to je syntetických multímérů), mohou se využívat polypeptidy, které mají bishaloacetylové skupiny, nitroarylhalidy nebo podobně, kde činidla jsou specifická pro thioskupiny.
Proto vazba mezi dvěma merkaptoskupinami různých peptidů může být jednoduchá nebo může obsahovat spojovací skupinu alespoň dvou v typickém případě alespoň čtyř a ne více než 16, ale obvykle ne více než přibližně 14 atomů uhlíku.
V určitém provedení, polypeptidové fragmenty, analogy a deriváty podle vynálezu neobsahují počáteční zbytek methionin. Je výhodné, aby polypeptidy nezahrnovaly vedoucí nebo sekreční sekvence (signální sekvence). Signální Část polypeptidů podle vynálezu se může stanovit podle metod molekulární biologie. V obecném případě polypeptid se může izolovat ze streptokokové kultury a následně sekvenovat, aby se stanovil počáteční zbytek zralého proteinu a tak sekvence zralého polypeptidů.
Existují vakcinační kompozice obsahující jeden nebo více streptokokových polypeptidů podle vynálezu ve směsi s farmaceuticky přijatelným nosičovým ředidlem nebo adjuvans. Vhodná adjuvans zahrnují oleje, to znamená Freundovo úplné nebo neúplné adjuvans, sole, to je
AlK(SO4)2, AlNa(SO4)2, A1NH4(SO4)2, oxid křemičitý, kaolin, karbonové polynukleotidy, to znamená póly IC a póly AU. Preferované adjuvans zahrnují QuilA a Alhydrogel. Vakcíny podle vynálezu se mohou aplikovat parenterálně injekcí, rychlou infúzí, nasofaryngeální absorpcí, dermatoabsorpcí nebo bukálně nebo orálně. Farmaceuticky přijatelné nosiče také zahrnují toxoid tetanu.
Vakcinační kompozice podle vynálezu se mohou použít při léčbě nebo profylaxi streptokokové infekce a/nebo onemocnění a symptomů zprostředkovaných streptokokovou infekcí, jak se popisuje v publikaci P. R. Murray (Ed.), E. J. Baron, M. A. Pfaller, F, C. Tenover and R. H. Yolken. Manual of Clinical Microbiology, ASM Press, Washington, D.C., šesté vydání, 1995, 1482p.
V jednom provedení vynálezu vakcinační kompozice podle vynálezu se používají pří léčbě nebo profylaxi meningitidy, zánětu středního ucha, bakteriémie nebo pneumoníe. V jednom provedení vynálezu vakcinační kompozice podle vynálezu se používají při léčbě nebo profylaxi streptokokové infekce a/nebo onemocnění a symptomů spojených se streptokokovou infekcí, zvláště s mikroorganizmy S.pneumoniae, streptokoky skupiny A (S.pyogenes), streptokoky skupiny B (GBSneboS. agalactiae), S. dysgalactiae, S. uberis, S. nocardia stej nějako Staphylococus auře us.
-II CZ 303675 B6
V dalším provedení vynálezu streptokoková infekce je spojená s mikroorganizmem S. pmeumoniae.
V určitém provedení vynálezu se vakcíny aplikují tem jedincům, pro něž jsou streptokokové infekce nebezpečné, jako jsou kojenci, přestárlí a i munokompromito vání jedinci.
Termín Jedinec“ zahrnuje savce. V dalším provedení vynálezu je savec člověk.
Vakcinační kompozice se výhodně vyskytují v jednotkové dávkové formě. Ta obsahuje přibližně
0,001 až 100 pg/kg (antigen/tělesná hmotnost) a výhodnější je 0,01 až 10 pg/kg a nejvýhodnější je 0,1 až 1 pg/kg 1 až 3 krát s intervalem přibližně 1 až 6 týdnů mezi jednotlivými imunizacemi.
Dále jsou popsány polynukleotidy kódující polypeptidy charakterizované aminokyselinovou sekvencí vybranou ze sekvencí SEQ ID NO: 2, 4, 6, 8, 10, 14, 16, 55 až 75, 77 až 79, 81, 83 nebo jejich fragmenty, analogy nebo deriváty.
V jednom provedení se polynukleotidy zobrazily v sekvenci SEQ ID NO: 1, 3, 5, 7, 9, 11, 12, 13, 15, 76, 80, 82, které mohou zahrnovat otevřené čtecí rámce (ORF), kódující polypeptidy podle vynálezu. Bude vhodné, aby se polynukleotidové sekvence ilustrované na obrázcích mohly upra20 vit degenerativními kodony, které ještě stále kódují polypeptidy podle vynálezu. Dále se popisují polynukleotidy, které hybridizují s polynukleotidovými sekvencemi, které se popisují shora v textu) (nebo sjejich komplementární sekvencí) vykazující 50% shodu mezi sekvencemi.
V jednom provedení vynálezu existuje mezi sekvencemi alespoň 70% shoda. V jednom provedení vynálezu existuje mezi sekvencemi alespoň 75% shoda. V jednom provedení vynálezu existuje mezi sekvencemi alespoň 80% shoda. V jednom provedení vynálezu existuje mezi sekvencemi alespoň 85% shoda. V jednom provedení vynálezu existuje mezi sekvencemi alespoň 90% shoda.
V dalším provedení polynukleotidy mohou hybridizovat za přísných podmínek, to znamená, že vykazují alespoň 95% shodu. V dalším provedení existuje více jak 97% shoda.
V dalším popsaném provedení polynukleotidy jsou ty, kteréjsou zobrazeny v sekvenci SEQ ID NO: 1,3, 7, 9, 11, 12, 13, 15, 76, 80, 82 kódující polypeptidy podle vynálezu.
V jiném provedení polynukleotidy jsou ty zobrazené v sekvenci SEQ ID NO: 1, 3, 7, 9, 1 1, 12, 13, 15, 76, 80, 82, které mohou zahrnovat otevřené čtecí rámce (ORF) kódující polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 1, 3, 7, 9, 11, 12, 13, 15, 76, které mohou zahrnovat otevřené čtecí rámce (ORF) kódující polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty ilustrované v sekvenci SEQ ID NO: 1, 3, 7, 9, 11, 12, 13, 15, 76, které mohou zahrnovat otevřené čtecí rámce (ORF), které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty ilustrované v sekvenci SEQ ID NO: 1, 7, 9, 11, 15,
76, které mohou zahrnovat otevřené čtecí rámce (ORF), které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 1, 9, 11, 15, 76, které mohou zahrnovat otevřené čtecí rámce (ORF), které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 1, 7, 9, 11, které mohou zahrnovat otevřené čtecí rámce (ORF), které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 1, které kódují polypeptidy podle vynálezu.
- 12 CZ 303675 B6
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 7, které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 9, které kódují polypeptidy podle vynálezu.
V dalším provedeni polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 11, které kódují polypeptidy podle vynálezu.
ίο V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 15, které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 3, 12, 13, 76, které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvencí SEQ ID NO: 3, které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 12, které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 13, které kódují polypeptidy podle vynálezu.
V dalším provedení polynukleotidy jsou ty uvedené v sekvenci SEQ ID NO: 76, které kódují polypeptidy podle vynálezu.
Pro odborníky bude výhodné, aby nukleotidy zahrnovaly jak DNA tak RNA.
Vynález také zahrnuje polynukleotidy komplementární s polynukleotidy popsanými v tomto dokumentu.
Polynukleotidy kódující polypeptidy podle vynálezu nebo jejich fragmenty, analogy nebo deriváty se mohou použít při metodě imunizace pomocí DNA. To znamená, že se DNA může začle35 nit do vektoru, který se po zavedení injekcí replikuje a exprimuje, čímž se produkuje antigenní polypeptid in vivo. Například polynukleotidy se mohou začlenit do plazmidového vektoru, kde jsou řízeny promotorem CMV, který je funkční v eukaryontních buňkách. Je výhodné, když se vektor zavede injekcí do svalu.
Vynález dále popisuje způsob produkce polypeptidu kódovaného polynukleotidem podle vynálezu, kdy se hostitelská buňka kultivuje za podmínek vhodných pro expresi polypeptidu, polypeptid z hostitelské buněčné kultury dále izoluje. Polypeptid je rekombinantní polypeptid.
Způsob produkce polypeptidů podle vynálezu rekombinantními technikami tak, že polynukleotid kódující uvedený polypeptid se exprimuje v hostitelské buňce a získá se exprimovaný póly peptidový produkt. V jiném případě se polypeptidy mohou produkovat zavedenými syntetickými chemickými technikami. To znamená syntézou oligopeptidů v roztoku nebo na pevné fázi, které se ligují za vzniku celého polypeptidu (bloková ligace).
Obecné metody získání a hodnocení polynukleotidů a polypeptidů se popisují v následujících publikacích: Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor, N. Y., 1989, Current Protocols in Molecular Biology, Edited by Ausubel F. M. et al., John Wiley and Sons, lne. New York, PCR Cloning Protocols, z Molecular Cloning to Genetíc Engineering, ed. White B. A., Humana Press, Totowa, New Jersey, 1997, 490 p., Protein Purifi55 cation, Principles and Practices, Scopes R. K., Springer-Verlag, New York, 3rd Edition, 1993,
- 13 CZ 303675 B6
380 p., Current Protocols in Immunology, Edited by Colígan J. E. et at, John Wiley and Sons lne., New York.
V případě rekombinantní produkce se hostitelské buňky transfekovaly vektory, které kódují 5 polypeptíd a pak se kultivovaly v nutričním médiu, které se upravilo, aby bylo vhodné pro aktivační promotory, selekční transformanty nebo amplifikaci genů. Vhodné vektory jsou ty, které přežijí a replikují se ve vybraném hostiteli a zahrnují chromozomální, nechromozomální a syntetické sekvence DNA, například bakteriální plazmidy, fágovou DNA, bakuloviry, kvasinkové plazmidy, vektory získané z kombinací plazmidu a fágové DNA. Polypeptidová sekvence se io může začlenit do vektoru do vhodného místa za použití restrikčních enzymů, jako je operativní spojení s expresívní řídící oblastí, která obsahuje promotor, místo pro navázání ribozómu (oblast shody nebo Shine-Dalgamova sekvence) a operátor (řídící element). Mohou se vybrat jednotlivé komponenty expresívní řídící oblasti, které jsou vhodné pro daného hostitele a vektor podle zavedených principů molekulární biologie (popisuje se v publikaci Sambrook et al., Molecular
Cloning: a Laboratory Manual, 2nd ed., Cold Spring Harbor, N.Y., 1989, Current Protocols in Molecular Biology, Edited by Ausubel F. M. et al., John Wiley and Sons, lne. New York). Vhodné promotory zahrnují, ale nejsou omezeny na promotor LTR nebo SV40, E.coli lac, tac nebo trp a promotor fága lambda PL. Vektory s výhodou začleňují počátek replikace stejně jako selekční markéry. To znamená gen rezistence na ampicilin. Vhodné bakteriální vektory zahrnují pET, pQE70, pQE60, pQE-9, pbs, pDlO phagescript, psiX174, pbluescript SK, pbsks, pNH8A, pNHlóa, pNH18A, pNH46A, ptrc99a, pKK223-3, pKK233-3, pDR540, pRIT5 a eukaryontní vektory pBlueBacIII, pWLNEO, pSV2CAT, pOG44, pXTl, pSG, pSVK3, pBPV, pMSG a pSVL. Hostitelské buňky mohou být bakteriální, to znamená E. coli, Bacillus subtilis, Streptomyces, houbové to znamená Aspergillus niger, Aspergillus nidulans, kvasinky, to znamená Saccharo25 myces nebo eukaryontní, to znamená CHO a COS.
Po expresi polypeptidu v kultuře se buňky v typickém případě sklidily centrifugací, pak se porušily fyzikálním nebo chemickým způsobem (jestliže exprimovaný polypeptíd se nevylučuje do média) a získal se výsledný surový extrakt, z něhož se izoluje polypeptíd. Čištění polypeptidu z kultivačního média nebo lyzátu se může dosáhnout zavedenou metodou závislou na vlastnostech polypeptidu. To znamená precipitací síranem amonným nebo ethanolem, kyselou extrakcí, chromatografií s výměnou iontů, chromatografií na fosfocelulóze, chromatografií s hydrofóbními interakcemi, hydroxy lapat ito vou chromatografií a lektinovou chromatografií. Konečného Čištění se může dosáhnout za použití HPLC.
Polypeptíd se může exprimovat s nebo bez vedoucí a sekreční sekvence. V tomto případě se může vedoucí sekvence odstranit za použití posttranslačního zpracování (popisuje se v publikaci US 4 431 739, US 4 425 437 a US 4 338 397) nebo se může odstranit následně chemickou cestou, aby se izoloval exprimovaný polypeptíd.
Streptokovové polypeptídy podle vynálezu se mohou použít při diagnostickém testu vhodném pro zjištění streptokokové infekce, zvláště infekce mikroorganizmem S.pneumoniae. Je možné použít několik diagnostických metod, které například detekují mikroorganizmus Streptococcus v biologickém vzorku. Postupy jsou následující:
a) získání biologického vzorku od pacienta
b) inkubace protilátky nebo jejího fragmentu, který reaguje se streptokokovým polypeptidem podle vynálezu, s biologickým vzorkem za vzniku směsi a
c) detekce specificky vázaného antigenu nebo vázaného fragmentu ve směsi, která indikuje přítomnost protilátky specifické pro streptokok.
Odborníkovi je zřejmé, že tento diagnostický test může mít několik forem, které zahrnují imunologický test, jako je ELISA, radioimunologický test nebo test latexovou aglutínací, podstatný pro stanovení, zda protilátky specifické pro protein jsou v organizmu přítomny.
- 14CZ 303675 B6
Sekvence DNA kódující polypeptidy podle vynálezu se mohou také použít k navržení sond DNA vhodných pro použití při detekci přítomnosti streptokoka v biologickém vzorku, kde se očekává přítomnost takových bakterií. Detekční metoda podle vynálezu zahrnuje:
a) získání biologického vzorku od pacienta,
b) inkubace jedné nebo více sond DNA, které mají sekvenci DNA kódující polypeptid podle vynálezu nebo její fragmenty s biologickým vzorkem, přičemž vzniká směs a
c) detekce specificky vázané sondy DNA ve směsi, což indikuje přítomnost streptokokové bakterie.
io Sondy DNA se také mohou použít při detekci cirkulujících streptokoků, to znamená nukleové kyseliny mikroorganizmu S.pneumoniae, ve vzorku, například použitím polymerázové řetězcové reakce, jako metody pro diagnostiku streptokokové infekce. Sonda se může syntetizovat za použití běžné metody a může se mobilizovat na pevné fázi nebo se může značit deteko vatě lnou značkou. Preferovaná sonda DNA pro tuto aplikaci je oligomer, který má sekvenci komplemen15 tární alespoň přibližně s šesti spojitými nukleotidy polypeptidů mikroorganizmu S.pneumoniae podle vynálezu.
Jinou diagnostickou metodou vhodnou pro detekci streptokoka u pacienta je:
a) značení protilátky, která reaguje s polypeptidem podle vynálezu, nebo jejího fragmentu dete20 kovanou značkou,
b) aplikace značené protilátky nebo značeného fragmentu pacientovi a
c) detekce specificky vázané značené protilátky nebo značeného fragmentu u pacienta, což indikuje přítomnost streptokoka.
Dále vynález popisuje použití streptokokových polypeptidů podle vynálezu jako imunogenů vhodných pro produkci specifických protilátek pro diagnostiku a zvláště při léčbě streptokokové infekce. Vhodné protilátky se mohou stanovit za použití vhodných testovacích metod, například měřením schopnosti určité protilátky pasivně chránit testovací model proti streptokokové infekci. Jedním příkladem zvířecího modelu je myší model popsaný v příkladech. Protilátkou může být celá protilátka nebo její fragment vázající antigen a může patřit k libovolné třídě imunoglobulinů.
Protilátka nebo její fragment může pocházet ze zvířete, specificky ze savce a více specificky z myši, krysy nebo člověka. Může to být přirozená protilátka nebo její fragment nebo je-1 í to nutné rekombinantní protilátka nebo fragment protilátky. Termín rekombinantní protilátka nebo fragment protilátky znamená protilátku nebo protilátkový fragment, který se produkoval za pou35 žití techniky molekulární biologie. Protilátka nebo fragment protilátky může být polyklonální nebo s výhodou monoklonální. Může být specifický pro řadu epitopů spojených s polypeptidy mikroorganizmu S.pneumoniae, aleje výhodné, kdyžje specifický pouze projeden polypeptid.
Vynález dále popisuje bez omezení nové antigeny označené BVH-3, BVH-11, BVH-11-2,
BVH-28 a BVH-71. Vynález dále popisuje zkrácené polypeptidy obsahující fragmenty nových antigenů označených BVH—3, BVH-11, BVH—11—2, BVH-28 a BVH-71. Vynález dále popisuje chimérové polypeptidy obsahující fragmenty nových antigenů označených BVH-3, BVH-11, BVH-11-2, BVH-28 a BVH-71. Následuje tabulka shrnující vztah mezí antigeny podle vynálezu:
| Rodina | nukleotid SEQ ID NO: | polypeptid SEQ ID NO: |
| BVH-3 | ||
| BVH-3 | 1/11 | 2 |
| BVH-3A | 7 | 8 |
| BVH-3B | 9 | 10 |
| BVH-3 SP63 | 15 | 16 |
| BVH-3M | 55 | |
| BVH-3AD | 56 | |
| L-BVH-3AD | 57 | |
| Newl2 | 76 | 58 |
| BVH-3C | 59 | |
| Newl | 64 | |
| New2 | 65 | |
| New3 | 66 | |
| Newl 5 | 78 | |
| BVH-11 | ||
| BVH-11 | 3, 12 | 4 |
| BVH-11-2 | 13 | 14 |
| BVH-11M | 60 | |
| BVH-11A | 61 | |
| BVH-11B také známý jako NBW13 | 62 | |
| BVH-11C | 63 | |
| New4 | ||
| News | ||
| New6 | 69 | |
| New7 | 70 | |
| New8 | 71 | |
| New9 | 72 | |
| BVH-11-2M | 73 | |
| NewlO | 74 | |
| Newll | 75 | |
| Newl 2 | 76 | 58 |
| Newl 4 | 77 | |
| Newl 6 | 79 | |
| BVH-28 |
- 16CZ 303675 B6
| BVH-28 | 5 | 6 |
| BVH-71 | ||
| GBS | 80 | 81 |
| GAS | 82 | 83 |
Přehled obrázků na výkresech
Na obrázku č. 1 je zobrazena sekvence genu BVH-3 SEQ ID NO: 1.
Na obrázku č. 2 je zobrazena aminokyselinová sekvence proteinu BVH-3 SEQ ID NO: 2.
io Na obrázku č. 3 je zobrazena sekvence DNA genu BVH-11 SEQ ID NO: 3.
Na obrázku č. 4 je aminokyselinová sekvence proteinu BVH-11 SEQ ID NO: 4.
Na obrázku č. 5 je sekvence DNA genu BVH-28 SEQ ID NO: 5.
Na obrázku č. 6 je aminokyselinová sekvence proteinu BVH-28 SEQ ID NO: 6.
Na obrázku č. 7 je sekvence DNA genu BVH-3A, která odpovídá 5'konci BVH-3 SEQ ID NO: 7.
Na obrázku č. 8 je aminokyselinová sekvence proteinu BVH-3 A SEQ ID NO: 8.
Na obrázku č. 9 je sekvence DNA genu BVH-3 B, který odpovídá 3'konci SEQ ID NO: 9.
Na obrázku č. 10 je aminokyselinová sekvence proteinu BVH-3B SEQ ID NO: 10.
Na obrázku č. 11 je znázorněno porovnání předpovězených aminokyselinových sekvencí otevřeného čtecího rámce BVH-3 z WU2, RX1, JNR.7/87, SP64, P4241 a A66 kmenů S.pneumoniae za použití programu Clustal W ze softwaru pro analýzu sekvencí Mac Vector (verze 6.5). Pod uspořádáním sekvence existuje znázornění shody, kde symboly * a . indikují shodné a podobné aminokyselinové zbytky.
Na obrázku č. 12 je znázorněno porovnání předpovězených aminokyselinových sekvencí otevřených čtecích rámců z kmenů WU2, Rxl, JNR.7/87, SP64, P4241, 166 a SP63 mikroorganizmu
S.pneumoniae za použití programu Clustal W pocházejícího ze softwaru pro analýzu sekvencí MacVector (verze 6.5). Pod uspořádáním je znázorněna shoda, kde symboly * a . indikují shodné a podobné aminokyselinové zbytky.
Na obrázku č. 13 jsou znázorněny předpovězené aminokyselinové sekvence proteinu BVH-11, které pochází z různých kmenů S.pneumoniae. Stupeň shody (Ϊ) a podobnosti (S) se stanovily za použití programu Clustal W ze softwaru pro analýzu sekvence (verze 6.5).
Na obrázku ě. 14 je sekvence DNA obsahující celý gen BVH-3 (otevřený čtecí rámec s nukleotidy 1777 až 4 896), SEQ ID NO: 11.
Na obrázku č. 15 je sekvence DNA obsahující úplný gen BVH-11 (ORF s nukleotidy 45 až 2567) SEQ ID NO: 12.
- ÍTCZ 303675 B6
Na obrázku č. 16 je znázorněna sekvence DNA obsahující úplný gen BVH-11-2 (ORF znukleotidy 1 Maž2630), SEQIDNO: 13.
Na obrázku č. 17 je aminokyselinová sekvence proteinu BVH-11-2 SEQ ID NO: 14.
Na obrázku č. 18 je sekvence DNA genu SP63 BVH-3 SEQ ID NO: 15.
Na obrázku ě. 19 je znázorněna aminokyselinová sekvence proteinu SP63 BVH-3 SEQ ID NO: 16.
io
Na obrázku č. 20 je aminokyselinová sekvence proteinu BVH-3M SEQ ID NO: 55.
Na obrázku č. 21 je znázorněna aminokyselinová sekvence proteinu BVH—3AD SEQ ID NO: 56.
Na obrázku č. 22 je znázorněna aminokyselinová sekvence proteinu L-BVH-3-AD SEQ ID NO: 57.
Na obrázku č. 23 je znázorněna aminokyselinová sekvence proteinu NEW12 SEQ ID NO: 58.
Na obrázku č. 24 je znázorněna aminokyselinová sekvence proteinu BVH-3C SEQ ID NO: 59.
Na obrázku č. 25 je znázorněna aminokyselinová sekvence proteinu BVH-1 lm SEQ ID NO: 60.
Na obrázku č. 26 je znázorněna aminokyselinová sekvence proteinu BVH-11A SEQ ID NO: 61.
Na obrázku č. 27 je znázorněna aminokyselinová sekvence proteinu BVH-11B (také nazvaná Newl3) SEQIDNO: 62.
Na obrázku č. 28 je znázorněna aminokyselinová sekvence proteinu BVH-11C SEQ ID NO: 63.
Na obrázku č. 29 je znázorněna aminokyselinová sekvence proteinu NEW1 SEQ ID NO: 64.
Na obrázku č. 30 je znázorněna aminokyselinová sekvence proteinu NEW2 SEQ ID NO: 65.
Na obrázku č. 31 je znázorněna aminokyselinová sekvence proteinu NEW3 SEQ ID NO: 66.
Na obrázku č. 32 je znázorněna aminokyselinová sekvence proteinu NEW4 SEQ ID NO: 67.
Na obrázku č. 33 je znázorněna aminokyselinová sekvence proteinu NEW5 SEQ ID NO: 68.
Na obrázku č. 34 je znázorněna aminokyselinová sekvence proteinu NEW6 SEQ ID NO: 69.
Na obrázku č. 35 je znázorněna aminokyselinová sekvence proteinu NEW7 SEQ ID NO: 70.
Na obrázku č. 36 je znázorněna aminokyselinová sekvence proteinu NEW8 SEQ ID NO: 71.
Na obrázku č. 37 je znázorněna aminokyselinová sekvence proteinu NEW9 SEQ ID NO: 72.
Na obrázku č. 38 je znázorněna aminokyselinová sekvence proteinu BVH-11-2M SEQ ID 50 NO: 73.
Na obrázku č. 39 je znázorněna aminokyselinová sekvence proteinu NEW 10 SEQ ID NO: 74.
Na obrázku č. 40 je znázorněna aminokyselinová sekvence proteinu NEW11 SEQ ID NO: 75.
- 18CZ 303675 B6
Na obrázku č. 41 je znázorněna sekvence DNA NEW12 SEQ ID NO: 76.
Na obrázku č. 42 je znázorněna aminokyselinová sekvence proteinu NEW 14 SEQ ID NO: 77.
Na obrázku č. 43 je znázorněna aminokyselinová sekvence proteinu NEW 15 SEQ ÍD NO; 78.
Na obrázku č. 44 je znázorněna aminokyselinová sekvence proteinu NEW 16 SEQ ID NO: 79.
Na obrázku č. 45 je znázorněna sekvence DNA genu GBS BVH-71 SEQ ID NO: 80.
Na obrázku Č. 46 je znázorněna aminokyselinová sekvence proteinu GBS BVH-71 SEQ ID NO: 81.
Na obrázku č. 47 je znázorněna sekvence DNA genu GAS BVH-71 SEQ ID NO: 82.
Na obrázku č. 48 je znázorněna aminokyselinová sekvence proteinu GAS BVH-71 SEQ ID NO: 83.
Příklady provedení vynálezu
Příklad 1:
Tento příklad ilustruje klonování genů S.pneumoniae.
Kódující oblast genu S.pneumoniae BVH-3 (SEQ ID NO: 1) a kódující oblast genu
S.pneumoniae BVH-28 (SEQ ID NO: 5) se amplifikovaly pomocí PCR. (systém DNA Thermal Cycler GeneAmp PCR, 2400 Perkin Elmer, San Jose, CA) z genomové DNA séroskupiny 6 mikroorganizmu S.pneumoniae kmen SP64 za použití oligonukleotidů, které obsahovaly extenze bází, přičemž se začlenilo restrikční místo rozeznávané restrikčním enzymem Bglll (AGATCT) a Xbal (TCTAGA). Produkty PCR se izolovaly z agarózového gelu za použití extrakčního kitu QIAquick od firmy QIAgen (Chatsworth, CA), štěpeného restrikčními enzymy Bglll-Xbal (Pharmacia Canada lne., Baie ďUrfé, Canada), extrahovaného směsí chloroform:fenol a srážené35 ho ethanolem. Superlinkerový vektor pSL301 (lnvitrogen, San Diego, CA) se štěpil restrikčním enzymem Bglll a Xbal a čistil se z agarózového gelu za použití extrakčního kitu QIAquick od firmy QIAgen (Chatsworth, CA). Fragmenty genomové DNA Bglll-Xbal se ligovaly do vektoru pSL30 štěpeného Bglíl-Xba. Ligované produkty se transformovaly do mikroorganizmu E. coli kmen DH5a [f80 lacZ DM15 endAA, recM ksdRAl (rK“mK+ sw/?E44-///Z-l 1 gvrAóó rtVAl D (Zť7cZYA-č7rgF)U169] (Gibco BRL, Gaithersburg, MD) podle Simanisovy metody (Hanahan, D, DNA Clonning, 1985, D. M. Glover (ed), pp. 109-135). Rekombinantní plazmidy pSL301 (rpSL301) obsahující buď BVH-3 nebo BVH-28 se čistily za použití kitu QIAgen (Chatsworth, CA) a inzerty DNA se potvrdily analýzou nukleotidových sekvencí (Taq Dye Deoxy Terminátor Cycle Sequencing kit, ABI, Foster City, CA). Rekombinantní rpSL301 (rpSL301), se štěpil restrikčními enzymy Bglll (AGATCT) a Xhol (CTCGAG). Fragmenty DNA BglII-Xhol se čistily za použití extrakčního kitu QIAquick od firmy QIAgen (Chatsworth, CA). Expresívní vektor pET-32c(+) (Novagen, Madison, Wl) obsahující sekvenci thioredoxin-His-Tag se štěpil restrikčním enzymem BamHI (CGATCC) a Xhol a gel se extrahoval za použití extrakčního kitu QIAquick od firmy QIAgen (Chatsworth, CA). Fragmenty DNA BglII-Xhol se ligovaly do vek50 toru BamHI-XhoI pET-32c(+) za vzniku kódující sekvence pro fúzní protein thioredoxinHis.Tag-BVH-3 nebo thioredoxin-His.Tag-BVH-28. Ligované produkty se transformovaly do mikroorganizmu E. coli kmen DH5a [f80 lacZ DM15 enďAl, recAl hsdR!7 (rK'mK+) 5w/?E44 thi\ i^gyrA$6 relM D (/í7cZYA-czrgF)U169] (Gibco BRL, Gaithersburg, MD) podle Simansovy metody (Hanahan, D. DNA Clonning, 1985, D. M. Glover (ed), pp. 109-135). Rekombinantní plazmidy pET-32c(+) se čistily za použití kitu QIAgen (Chatsworth, CA) a nukleotidových sek• · -19CZ 303675 B6 věnci ve fúzních místech thioredoxin-His.Tag a inzert DNA se ověřil sekvenováním DNA (Taq Dye Deoxy Terminátor Cycle Sequencing kit, ABI, Foster City, CA).
Příklad 2:
Tento příklad ilustruje klonování genů proteinu mikroorganizmu S.pneumoniae do CMV plazmídu pCMV-GH.
ío Kódující oblast DNA proteinu mikroorganizmu S.pneumoniae se začlenila do fáze po směru exprese genu lidského růstového hormonu (hGH), jehož transkripci řídí cytomegalovirový promotor (CMV) v plazmidovém vektoru pCMV-GH (popisuje se v publikaci Tang et al., Nátuře, 1992, 356: 152). Promotor CMV není v plazmídu v buňkách organizmu E. coli funkční, aleje aktivní po aplikaci plazmídu do eukaryontních buněk. Do vektoru se také začlenil gen rezistence na ampicilin.
Kódující oblast genu BVH-3 (SEQ ID NO: 1) a BVH-28 (SEQ ID NO: 5) se získal z plazmídu rpS1301 (popisuje se v příkladu 1) za použití restrikčních enzymů BglII (AGATCT) a Xbal (TCTAGA). Štěpené produkty se čistily z agarózového gelu za použití extrakčního kitu
QIAquick od firmy QIAgen (Chatsworth, CA). Vektor pCMV-GH (získal se z laboratoře Dr. Stephen A. Johnston, Department of Biochemistry, The University of Texas, Dallas, Texas) obsahující lidský růstový hormon se štěpil restrikěnímí enzymy BglII a Xbal za vzniku fúzních proteinů a čistil se z agarózového gelu za použití extrakčního kitu QIAquick od firmy Qiagen (Chatsworth, CA). Fragmenty DNA BglII-Xhol se ligo vály do vektoru pCMV-GH štěpeného restrikčními BglII-Xbal za vzniku fúzního proteinu hGH-BVH-3 nebo hGH-BVH-28 za řízení promotoru CMV. Ligované produkty se transformovaly do mikroorganizmu E. coli kmen DH5A [fSO lacZ DM15 í?«í/A1, recAl Asó/R.17 (rKmK+) s«pE44 thi-\ l~°gyrA96 re/Al D (ZófcZYAíwgF)U169] (Gibco BRL, Gaithersburg, MD) Simansovou metodou (popisuje se v publikaci Hanahan, D. DNA Clonning, 1985, D. M. Glover (ed), pp. 109-135). Rekombinantní plazmidy pCMV se čistily za použití kitu QIAgen (QIAgen, Chatsworth, CA).
Kódující oblast genu BVH-11 (SEQ ID NO: 3) se amplifikovala pomocí PCR (DNA Therman Cycler GeneAmp PCR systém 2400 Perkin Elmer, San Jose, CA) z genomové DNA séroskupiny 6 organizmu S.pneumoniae, kmen SP64 za použití oligonukleotidů, které obsahovaly extenze bází, přičemž se přidaly restrikční místa BglII (AGATCT) a HindiII (AAGCTT). Produkt PCR se čistil z agarózového gelu za použiti extrakčního kitu QIAquick od firmy QIAgen (Chatsworth, CA) štěpeného restrikčními enzymy (Pharmacia Canada lne., Baie ďUrfe, Canada) a extrahoval se směsí fenolu a chloroformu a srážel se ethanolem. Vektor pCMV-GH (získal se z laboratoře Dr. Stephen A. Johnston, Department of Biochemistry, The University of Texas, Dallas, Texas) se štěpil restrikčními enzymy BglII a Hind III a čistil se z agarózového gelu za použití extrakčního kitu od firmy Qiagen (Chatsworth, CA). Fragment DNA BglII-Hind III za vzniku fúzního proteinu hGH-BVH-11, který řídí promotor CMV. Ligované produkty se transformovaly do mikroorganizmu E. coli kmen DH5A [fSO lacZ DM15 ew/Al, m-Al A.$y/R17 (rK'mK+) s«/?E44 thi—\ 1 °gyrA96 re/Al D (/acZYA-argF)U169] (Gibco BRL, Gaithersburg, MD) podle Simanso45 vy metody (popisuje se v publikaci Hanahan, D. DNA Clonning, 1985, D. M. Glover (ed), pp. 109-135). Rekombinantní plazmid pCMV se čistil za použití sady QIAgen (Chatsworth, CA) a nukleotidová sekvence inzertu DNA se ověřila sekvenováním DNA.
Příklad 3:
Tento příklad ilustruje použití DNA za účelem vyvolání imunitní odpovědi antigenů S.pneumoniae.
-20( 7 303675 B6
Skupina 8 myší samic BALB/c (Charles River, St-Constant, Quebec, Canada) se imunizovala intramuskulámí injekcí o objemu 50 μΐ třikrát ve dvou nebo třítýdenních intervalech pomocí 100 pg rekombinantní ho pCMV-GH, který kóduje gen BVH-3, BVH-11 nebo Β V H-2 8 v přítomnosti 50 pg plazmidů pCMV-GH-GM-CSF exprimujícího stimulační faktor granulo5 cyt-makrofágových kolonií (GM-CSF) (získal se z laboratoře Dr. Stephen A. Johnstona, Department of Biochemistry, The university of Texas, Dallas, Texas). Jako kontrola se skupině myší injekcí zavedlo 100 pg pCMV-GH v přítomnosti 50 pg pCMV GH-GM CSF. Krevní vzorky se získaly před každou imunizací a sedm dní po třetí injekci a odezva na sérové protilátky se stanovila pomocí testu ELISA za použití potahovacího antigenu thioredoxin-His.Tag-fúzního io proteinu S.pneumoniae. DNA imunizace s rekombinantním plazmidem pCMV-GH kódujícím BVH-3, BVH-11 nebo BVH-28 protein S.pneumoniae vyvolala protilátky proti rekombinantnímu proteinu. Reciproční titr protilátek definovaný jako nej vyšší ředění séra, při kterém hodnoty absorbance byly 0,1 nad hodnotu pozadí, je nad 4xl03.
Příklad 4:
Tento příklad ilustruje produkci a čištění rekombinantních proteinů mikroorganizmu S.pneumoniae. Rekombinantní plazmidy pET obsahující gen BVH-3, BVH-11 nebo BVH-28 odpovídající SEQ ID NO: 1, SEQ ID NO: 3 nebo SEQ ID NO: 5 se transformovaly elektroporací (zařízení Gene Pusler II, BIO-RAD Labs, Mississauga, Canada) do mikroorganizmu E. coli kmen AD494 (DE3) (Dara leul(&~] DlacYJ4 DphoA. PvuII phoR DmalF3 F’[lac (lacf!)pro] trxb::Kan) (Novagen, Madison, WI). V tomto kmenu mikroorganizmu E. coli promotor T7 řídící expresi fúzního proteinu je specificky rozeznáván T7 RNA polymerázou (přítomnou na profágu
1DE3), jejíž gen je řízen promotorem lac, který je indukovatelný isopropyl-p-D-thiogalaktopyranosidem (IPTG). Transformant AD494(DE3)/rpET se kultivoval při teplotě 37 °C za stálého míchání při 250 ot./min. v půdě LB (pepton 10g/l, kvasinkový extrakt 5g/l, NaCI 10g/I) obsahující 100 pg ampicilinu (Sigma-Aldrich Canada Ltd., Oakville, Canada vjednom mililitru až hodnota AĎOo dosáhla hodnoty 0,6. Za účelem indukovat produkci fúzního proteinu thioredoxin30 His.Taq-BVH-3, thioredoxin-His.Tag-BVH-11 nebo thtoredoxÍn-His.Tag-BVH-28 se buňky inkubovaly po dobu dalších 2 hodin v přítomnosti IPTG v konečné koncentraci lmM. Indukované buňky ze 100 ml kultuiy se shromáždily centrifugací a zmrazily se při teplotě -70 °C.
Čištění fúzních proteinů z rozpustné cytoplazmatické frakce AD494(DE3)/rpET indukované
IPTG se provedlo afinitní chromatografií založenou na schopnosti sekvence His.Tag (6 konsekutivních histidinových zbytků) vázat se na dvoj mocné kationty (Ni2+) i mobilizované na His. vazné chelatační pryskyřici. Shromážděné buňky získané ze 100 ml kultury indukované IPTG se resuspendovaly v PBS pufrovaném fosforečnanem: 500mM NaCI pH7,l, sonikovaly se a centrifugovaly se při 20 000 x g po dobu 20 minut, aby se odstranil odpad. Supematant se filtroval (použila se membrána s velikostí pórů 0,22 pm) a umístila se na předem naplněnou chelatační kolonu H i Trap® (Pharmacia Biotech, Baie ďUrfé, Canada). Thioredoxin-His.Tag-fúzní protein S.pneumoniae se eluoval 1M imidazol-500mM NaCl-PBS pH7,l. Odstranění sole a imidazolu ze vzorku se provedlo dialýzou proti PBS při teplotě 4 °C. Množství fúzního proteinu získaného z rozpustné frakce mikroorganizmu E. coli se stanovilo pomocí MicroBca (Pierce, Rockford,
Illinois).
Příklad 5:
Tento příklad ilustruje ochranu myší proti fatální pneumokokové infekci imunizací.
Skupiny 8 samic myší BALB/c (Charles River) se imunizovaly podkožně třikrát ve třítýdenních intervalech buď 25 pg fúzního proteinu thioredoxin-His.Tag-BVH-3 v přítomnosti 15 pg adjuvans QuilA (Cedarline Laboratories Ltd., Homby, Canada) nebo jako kontrola sc samotným
-2Τ~ adjuvans QuilA v PBS. Krevní vzorky se sebraly z orbitálního sinusu v den 1, 22 a 43 před každou imunizací a sedm dní (den 50) následující po třetí injekci. O jeden týden později se myším opětně aplikovalo přibližně 106 jednotek tvořících kolonie mikroorganizmu S.pneumoniae kmen WU2. Vzorky inokula pro posilovači injekci mikroorganizmem S.pneumoniae se nanesly na plotnu na čokoládový agar, aby se stanovily jednotky tvořící kolonie a ověřila se zesilující dávka. Úmrtí se zaznamenávaly v období 14 dní a čtrnáctý den po zesilovací injekci se myš, která přežila, usmrtila a v krevních vzorcích se testovala přítomnost organizmů S.pneumoniae. Data jsou uvedena v tabulce č. 1.
io Předem čelendžovaná séra se analyzovala za účelem zjištění přítomnosti protilátek, které reagují s mikroorganizmem S.pneumoniae pomocí standardních imunologických testů. Test ELISA a imunoblot indikují, že imunizace s rekombinantním proteinem mikroorganizmu S.pneumoniae produkovaném v mikroorganizmu E. coli vyvolalo protilátky reaktivní s rekombinantním a přirozeným pneumokokovým proteinem.
Tabulka č. 1: Ochrana zprostředkovaná rekombinantním proteinem BVH-3
| imunogen | počet živých myší:počtu zemřelých myši 14 dní po zesilovací injekci | střední hodnota dní usmrcení |
| BVH-3 | 8:0 | déle jak 14 |
| žádný | 0:8 | 1 |
Všechny myši imunizované rekombinantním proteinem BVH-3 přežily infekci, zatímco žádná z kontrolních myší, které se aplikovalo samotné adjuvans nepřežila. Existuje podstatný rozdíl v počtu myší, které přežily ve dvou skupinách myší (P<0,0001, test „log rank“ pro neparametrickou analýzu křivky přežití, P=0,0002, Fisherův exaktní test). Všechny krevní kultury získané z myší, které přežily jsou negativní 14. den po zesilovací injekci.
Příklad 6:
Tento příklad popisuje klonování genů BVH-3 a BVH-11 z různých kmenů mikroorganizmu S.pneumoniae a molekulovou konzervaci těchto genů.
Molekulové analýza chromozomální DNA z různých izolátů S.pneumoniae se sondami DNA, které překlenou různé oblasti BVH-3 nebo BVH-11 ukázaly přítomnost jedné kopie genu. Kopie dvou genů BVH-11 nejsou identické a geny se libovolně označily BVH-11 (SEQ ID NO: 12, ORF obsahující nukleotidy 45 až 2567) a BVH-11-2 (SEQ ID NO: 13, ORF obsahující nukleotidy 1 Maž 2630).
První aminokyseliny kódujících oblastí BVH-3 a BVH-11 mají charakteristiky vedoucích sek40 věnci, které jsou také známy jako signální peptidy. Signální štěpící místo peptidázy L-X-X-C z lipoproteinových modifikačních/zpracovatelských míst bylo přítomné v sekvencích. Zralé proteiny BVH-3, BVH-11 a BVH-11-2 z mikroorganizmu S.pneumoniae SP64 mají 1019, 821 a 819 aminokyselin. Oblasti genů mikroorganizmu S.pneumoniae kódující zralý BVH-3 nazývaný BVH-3M (nukleotidy 1837-4896., SEQ ID NO: 11), BVH-11M (nukleotidy 102-2567, SEQ ID
NO: 12) a BVH-11-2M (nukleotidy 171-2630, SEQ ID NO: 13) se amplifikovaly pomocí PCR (DNA Thermal Cycler GeneAmp PCR systém 2400 Perkin Elmer, San Jose, CA) z genomové
-22C/. 303675 B6
DNA 6 nebo 7 kmenů organizmu S.pneumoniae. Klinické izoláty mikroorganizmu S.pneumoniae SP64 séroskupina 6 a SP63 séroskupina 9 se získaly z laboratoře „de la santé publique du Québec, sainte-Anne-de-Bellevue“. Sérotyp 4 kmen JNR.7/78 se získal od Andrew Camilli. Tufts University School of Medicine, Boston. Kmen Rxl nekapsulámí derivát kmene D39 typ 2 a kmen A66 typ 3 a WU2 se získal od Dr. Davida E. Brilese z instituce University of Alabama, Birmingham a klinický izolát P4241 typ 3 se získal z instituce „centre de recherche en infectiologie du centre hospitalier de 1'universitě Laval, Sainte-Foy“. Sada nukleotidových primerů OCRR479-OCRR480, HAMJ160-OCRR488 a HAMJ 160-HAMJ186, které obsahovaly extenzi bází pro další restrikční místa, se použila při amplifikací genu BVH-3, BVH11 a BVH-11-2 io s výjimkou genu BVHI1 z kmene SP64, který se amplifikoval za použití sady primerů, který obsahuje HAMJ487 a OCRR488. Příměrové sekvence jsou uvedeny dále v textu (tabulka č. 2). Produkty PCR se čistily z agarózového gelu za použití extrakčního kitu QIAquick od firmy QIAgen (Chatsworth, CA) a štěpily se restrikčními enzymy BglII-Xbal nebo BglII-HindiII (Pharmacia Canada lne., Baie ďUrfé, Canada). Produkty štěpící reakce se čistily za použití PCR čistícího kitu QIAquick od firmy QIAgen (Chatsworth, CA). Produkty PCR se ligovaly do vektoru pSL301 štěpeného restrikčními enzymy BglII-Hindlíl. Ligované produkty se transformovaly do mikroorganizmu E. coli kmen DH5a [φ80 lacZ, ΔΜ15 <?WA1 recAl Z/.sc/Rl7 (rK*mK‘) snpE44 thi-Yk gyrA96 re/Al A(/ť3cZYA-argF)U 169] (Gibco BRL, Gaithersburg, MD) Simanisovy metody (Hanahan, D. DNA Cloning, 1985, D. M. Glover (ed), pp. 109-135). Rekombinantní plazmidy pSL301 (rpSL301) obsahující BVH-3, BVH-11 nebo BVH-11-2 se čistily za použití sady QIAgen (Chatsworth, CA) a inzerty DNA se sekvenovaly (Taq Dye Deoxy Terminátor Cycle Sequencing kit, Abi, Foster City, CA). Obrázky č. 11 a 12 znázorňují sekvenci získanou z dedukovaných aminokyselinových sekvencí BVH-3 a BVH-11. Porovnání sekvencí proteinu BVH-3 ukázalo 99 až 100% shodu se sekvencemi pro všechny kmeny s tou výjimkou, že BVH25 3 ze séroskupiny 9 kmene SP69 (SEQ ID NO: 15 a SEQ ID NO: 16) postrádá 177 aminokyselin odpovídajících zbytkům 244 až 420 v sekvenci proteinu BVH-3 mikroorganizmu S.pneumoniae SP64. Analýza sekvencí dalších kmenů séroskupiny 9 ukázala molekulu BVH-3, která má stejnou deleci ve třech ze čtyř kmenů. To naznačuje, že 3 kmeny jsou členy klonu mikroorganizmu S.pneumoniae séroskupina 9.
Porovnání 13—ti nukleotidových sekvencí BVH-11 získaných ze sedmi kmenů mikroorganizmu S.pneumoniae, ukázalo, že nukleotidové sekvence jsou velmi podobné. Počítačová analýza (MacVector, Clustal W 1.4) za použití vícenásobného uspořádání předpokládaných proteinových sekvencí BVH-11 ukázala, že tyto sekvence jsou ze 75 % shodné a z 82 % homologní v délce
834 aminokyselin. Párové uspořádání ukázalo 80 % až 100 % shody (obrázek č. 13). Sekvence vykazují vysokou podobnost v celkové organizaci. Různorodost primární sekvence těchto proteinů je skoro omezena na posledních 125 aminokyselin v C-terminální části proteinů. Tato oblast obsahuje doménu. Testování této domény ukázalo dvě skupiny sekvencí. Prvních devět sekvencí z obrázku č. 13 patří do jedné skupiny, zatímco poslední 4 sekvence patří do jiné skupiny. Hod40 nota 39 % shody se získala, když se porovnaly sekvence domény 13 proteinů (MacVector, Clustal W 1.4). Hodnota shody se zvýšila na více jak 92 %, když se porovnaly sekvence spadající do stejné skupiny.
Příklad 7:
Tento příklad ilustruje homologii částí genů BVH-3 a BVH-11.
Molekulární analýza sondami DNA získaná z genů BVH-3 a BVH-11 indikovala, že BVH-3 a
BVH-11 jsou příbuzné. Při studii hybridizace dot blot sonda DNA obsahuje buď BVH-3 nebo BVH-11. Sekvence genu hybridizovala s oběma geny BVH-3 a BVH-i 1, což indikuje, že geny BVH-3 a BVH-11 sdílejí homologní sekvence. Porovnání sekvencí ukázalo, že ORF a proteiny byly ze 43 a 33 % shodné. Bližší testování ukázalo, že oblast odpovídající aminokyselinám 1 až 225 v BVH-3 a 1 až 228 v BVH-11 byly ze 73 a 75 % shodné na úrovni DNA a proteinu. Nao55 pak 3'oblasti odpovídající aminokyselinám 226 až 1003 z BVH-3 a aminokyselinám 229 až 840
z BVH-11 byly pouze ze 34 a 22 % shodné na úrovni DNA a proteinu. Tak 5'konce genů BVH3 a BVH-11 se jeví, že obsahují vysoce konzervativní sekvence, zatímco zbývající části genů jsou vysoce divergentní. Tyto výsledky naznačují, že BVH-3 a BVH-11 mohou sdílet podobné funkce zprostředkované sekvencí přítomnou v konzervativní oblasti, zatímco funkce specifické pro BVH-3 a BVH-11 mohou být zprostředkovány sekvencemi v divergentní oblasti.
Příklad 8:
io Tento příklad popisuje klonování zkrácených genů BVH-3, BVH-11 a BVH-11-2 polymerázovou řetězcovou reakcí (PCR) a expresi zkrácených molekul BVH-3 a BVH-11.
Genové fragmenty se amplifikovaly pomocí PCR za použití párů oligonukleotidů, které se vytvořily za účelem amplífikace fragmentů, které překlenou gen BVH-3 (SEQ ID NO: 1 a SEQ ID
NO: 11), BVH-11 (SEQ ID NO: 3 a SEQ ID NO: 12) nebo BVH-11-2 (SEQ ID NO: 13), který pochází z mikroorganizmu S.pneumoniae kmen SP64. Každý z primerů měl na svém 5'konci místo, které rozeznává restrikční enzym, čímž umožnil přímé klonování amplifikovaného produktu do rámce štěpeného plazmídového vektoru (tabulka č. 2 a 3). Produkty amplifikované PCR se štěpily restrikčními endonukleázami a ligovaly se do linearizovaného plazmidu pSL301 (popi20 suje se v příkladu 1), pCMV-GH (popisuje se v příkladu 2 nebo expresívní vektor pET (Novagen, Madison, WI) štěpený podobně nebo enzymem, který produkuje kompatibilní kohezivní konce. Rekombinantní pSL301 a rekombinantní plazmidy pCMV-GH se štěpily restrikčními enzymy za účelem klonování do expresívního vektoru pET. Klony se nejdříve stabilizovaly v mikroorganizmu E. coli DH5a a pak se zavedly do mikroorganizmu E. coli BL21(XDE3) nebo
AD494 (XDE3) za účelem exprese zkrácené formy molekul BVH-3 nebo BVH-11. Každá z výsledných plazmidových konstrukcí se potvrdila analýzou nukleotidové sekvence. Rekombinantní proteiny se exprimovaly jako N-terminální fúze s thioredoxinem a His-Tag nebo jako Cterminální fúze s His-tag. Exprimované rekombinantní proteiny se čistily z frakcí supematantu získaných z centrifugace sonikovaných kultur mikroorganizmu E. coli indukovaných IPTG za použití His-Bind kovové chelatační pryskyřice (QIAgen, Chatsworth, CA). Vytvořené genové produkty se popisují v tabulce č. 3. Genové produkty odpovídající N-terminální oblasti zahrnující signální sekvenci se označily jako lipidované proteiny nebo lipoproteiny (L-proteiny). Genové produkty odpovídající N-terminální oblasti postrádající signální sekvenci se identifikovaly jako protein bez signální sekvence (w/o ss).
Tabulka č. 2: Seznam oligonukleotidových primerů pro PCR
| Primer | SEQ. ID. | sekvence 5'-3' | poloha nukleotidu | restřik. místa |
| OCRR479 | 17 | cagtagatctgtgcctatgcactaaac | SEQ ID 1:6178 | BglH |
| OCRR480 | 18 | gatctctagactactgctattccttacgctatg | SEQ ID 11 :49094887 | Xbal |
| OCRR497 | 19 | atcactcgagcattacctggataatcctgt | SEQ ID 1 :15251506 | Xhol |
| OCRR498 | 20 | ctgctaagcttatgaaagatttagat | SEQ ED 1:15341548 | HindlD |
-24 CZ 303675 B6
| OCRR 499 | 21 | gatac tcgagc Igctattc c ttac | SEQ ID 11 :49064893 | Xhol |
| HAMJ 172 | 22 | gaatctcgagttaagctgctgctaattc | SEQ ID 1 : 675-661 | Xhol |
| HAMJ 247 | 23 | gacgctcgagcgctatgaaatcagataaattc | SEQ ID 1:3117-3096 | Xhol |
| HAMJ 248 | 24 | gacgctcgagggcattacctggataatcctgttcatg | SEQ ID 1 :1527-1501 | Xhol |
| HAMJ 249 | 25 | cagtagatctcttcatcatttattgaaaagagg | SEQ ID 11 : 1749-1771 | BglII |
| HAMJ 278 | 26 | ttatttcttccatatggacttgacagaagagcaaattaag | SEQ ID 1 :1414-1437 | Ndel |
| HAMJ 279 | 27 | cgccaagcttcgctatgaaatcagataaattc | SEQ ID 1 :3117-3096 | HindHI |
| HAMJ 280 | 28 | cgccaagcttttccacaatataagtcgattgatt | SEQ ID 1 :2400-2377 | Hindm |
| HAMJ 281 | 29 | ttatttcttccatatggaagtacctatcttggaaaaagaa | SEQ ID 1 :2398-2421 | Ndel |
| HAMJ 300 | 30 | ttatttcttccatatggtgcctatgcactaaaccagc | SEQ ID 1 :6282 | Ndel |
| HAMJ 313 | 31 | ataagaatgcggccgcttccacaatataagtcgattgatt | SEQ ID 1 :2400-2377 | Notl |
| OCRR 487 | 32 | cagtagatctgtgcttatgaactaggtttgc | SEQ ID 3:5879 | BglII |
| OCRR 488 | 33 | gatcaagcttgctgctacctttacttactctc | SEQ ID 12 :2577-2556 | HindHI |
| HAMJ 171 | 34 | ctgagatatccgttatcgttc aaacc | SEQ ID 3 :1060-1075 | EcoRV |
| HAMJ 251 | 35 | ctgcaagcttítaaaggggaataatacg | SEQ ID 3:1059-1045 | Hindm |
| HAMJ 264 | 36 | cagtagatctgcagaagccttcctatctg | SEQ ID 3 :682700 | BglII |
| HAMJ 282 | 37 | tcgcc aagcttcgttatcgttcaaaccattggg | SEQ ID 3:10601081 | HindHI |
| HAMJ 283 | 38 | ataagaatgcggccgccttactctcctttaataaagccaat agtt | SEQ ID 3 :2520-2492 | Ndel |
| HAMJ 284 | 39 | catgccatggacattgatagtctcttgaaacagc | SEQ ID 3 :856880 | Ncol |
| HAMJ 285 | 40 | cgccaagcttcttactctcctttaataaagccaatag | SEQ ID 3 :2520-2494 | HindHI |
| HAMJ 286 | 41 | cgacaagcttaacatggtcgctagcgttacc | SEQ ID 3:2139-2119 | Hindm |
| HAMJ 287 | 42 | cataccatgggcctttatgaggcacctaag | SEQ ID 3 :2014-2034 | Ncol |
| HAMJ 288 | 43 | cgacaagcttaagtaaatcítcagcctctctcag | SEQ ID 3 :2376-2353 | Hindm |
-25-CZ 303675 B6
| HAMJ289 | 44 | gataccatggctagcgaccatgttcaaagaa | SEQ ID 3 :2125-2146 | Ncol |
| HAMJ 290 | 45 | cgccaagcttatcatccactaacttgactttateac | SEQ ID 3:1533-1508 | Hindm |
| HAMJ 291 | 46 | cataccatggatattcttgccttcttagctccg | SEQ ID 3:1531-1554 | Ncol |
| HAMJ 301 | 47 | catgccatggtgcttatgaactaggtttgc | SEQ ID 3:5979 | Ncol |
| HAMJ 302 | 48 | cgccaagctttagcgttaccaaaaccattatc | SEQ ID 3 :2128-2107 | HindlII |
| HAMJ 160 | 49 | gtattagatctgttcctatgaacttggtcgtcacca | SEQ ID 13: 172-196 | BglH |
| HAMJ 186 | 50 | cgcctctagactactgtataggagccgg | SEQ ID 13: 2460-2443 | Xbal |
| HAMJ 292 | 51 | catgccatggaaaacatttcaagccttttacgtg | SEQ ID 11: 754-778 | Ncol |
| HAMJ 293 | 52 | cgacaagcttctgtataggagccggttgactttc | SEQ ID 11: 2457-2434 | HindUI |
| HAMJ 294 | 53 | catgccatggttcgtaaaaataaggcagaccaag | SEQ ID 11 : 2038-2062 | Ncol |
| HAMJ 297 | 54 | catgccatggaagcctattggaatgggaag | SEQ ID 11 : 622-642 | Ncol |
-26CZ 303675 B6
Tabulka č. 3: Seznam zkrácených genových produktů 3VH-3 a BVH-11 vytvořených z mikroorganizmu pneumoniae SP64
| klonovací vektor | *··« O □ u | d-4 o □ u | $ CM | 3 a | £ u 1 | X O f o ct | £ u CM TO í | £ íM <? Ě O. | 'ΐβ CM co 4 | ✓“S +, jí CM É £t | JO CM É Cl | i J3 CM É Cc | T CM Í3 ťX | £ o CM Ě Ct | + 'w' XJ CM £ | £ Ό 1—» έ ct | + O CM É3 ct |
| dt · w Q | in | KO | r- | o | cn | o | rd | CM | co | V | ID | KO | X | CT* | o . | id | |
| W H | m | in | TO | tH | in | KO | KjO | CO | KO | KO | KO | KO | KO | K0 | Ό | Γ- * | t- |
| CO | |||||||||||||||||
| íTí | LO | LO | |||||||||||||||
| o | CN | CO | |||||||||||||||
| LO | CN | 1 | |||||||||||||||
| 1 rd | i—1 | O ' CM | ___l | ___ | ._. | ___ | co | CM | o | i—1 | |||||||
| CN | cn | CN | ___ | ____ | —- | O | o | co | — | ΟΊ | o | I—1 | cn | TO | | LO | | ||
| Ή | co | (Tt | O | v | v | CO | O | co | v | r- | |||||||
| r-J Φ | o | co | 'kt | >P | oa | co | o | o | o | co | l KO | 1 | ch | ||||
| »P | cn | 1—1 | >d | o | OO | -TO | 1 | i | i—! | OO | i—1 | 1 | CM | o | 00 | ||
| co d- | -r—l | o | 1 | -l—l | 1—1 | 1 | v | co | 1 | 1 | 1 | KO | 00 | Γ- | f\| | ||
| i J | LO | CN | 1 | O | O | LO | CM | CN | CN | o | X | CM | KO | ||||
| ,Χ | 0 | 1 | <—1 | 0 | i—1 | CM | co | CM | r— | Γ- | o | CN | —* | '—' | |||
| o | ,—I | LO | CM | — | - | co | -— | \ř-j | kH | ||||||||
| C H J o Εί | £ | >d | >d —1 | . C | d | C | d | -H d >d | Ή C >d | d >P 1 i | C 4-J | ||||||
| O ít}[ | d | C | d | d | O | 0 | O | C | d | d | o | P | P | -I—' r-l | -H | ||
| (0 ; | o | o | o | O | O | 44 | 44 | 44 | O | o | o | 44 | v—1 | 4 | ’ 1 r-* | r· | |
| 44 'O! | pí | 44 | -V | 44 | o | 44 | 44 | 44 | • | c | d | 1-d > | t-i > | ||||
| •h d | v | s | N. | £ | x | U | u | - | u | > | > | ||||||
| Md (U1 | ' X | X | o | X | 45 | O | CJ | o | ,—1 | ||||||||
| -a > ί • P Ol C Tt | CO t 1 | CO I | (O I | CO , 1 | o | i—1 i—I | I—1 i—1 1 i | rH l—1 I | (—1 ϊ—1 I | co 1 | co i | co I | 1-1 τ—1 i | rH rH l | τ—3 rH 1 | i—L 1 | i—1 1 |
| ω Ό' Ό -XI 'Ή -I | 1 , X | 1 x | 1 X | I X | 1 X | 1 | 1 X | rr: | X | X | X | X | X | X | X | X > X | X > X |
| 1 > | > | > | í> | > | > | > | > | > | > | > | > | > | > | > | |||
| ί m | PO | X | X | X | X | X | X | X | X | X | X | X | CQ | X | |||
| Ή 3 | § | ||||||||||||||||
| d c &) -d >U cu (0 P | Q | co | £ | X | CJ | ||||||||||||
| £ | l | fa | CJ | t—1 | lH | i-4 | c—1 | ||||||||||
| co I | co I | § | co 1, | co | | τ—1 * f | H j | r4 j | r4 | rd | CM | CO | v* | m | KO | p. | 00 | |
| d o | 1 | 1 | X I | s | S | s | 5 : | 5 | 5 | fe | |||||||
| N S-l | Ě> | s | E> | Ě* | £> | CJ | ζ | X | W | w | X | W | M | Ci] | íd | ||
| o tr | m | X | X | ta | X | X | ffl | X | X | £ | £ | £ | £ | E | £ | ||
| o | Γ- | cn | cn | CM | OO | Γ- | X | co | cn | o | σ> | LD | KD | TO | o | ||
| co | cn | v | cn | ΙΟ- | OO | ΟΟ | TO | co | o | co | r· | 00 | TO | TO | co | cn | |
| v | V» | cm | v< | Ι—1 | V | V | V | v | CN | ÍN | CM | CN | CM | CN | CM | CM | |
| o4 | 04 | dí | 04 | Ό | X | X | X | X | 1“3 | Ϊ2 | •Ό | d) | dj | dj | |||
| •d ί Γ | & | (ň | 04 | X | X | X | X | £ | Ξ | £ | £ | £ | £ | £ | £ | ||
| M <D ε | o O | O o | tc | 8 I co | X | o o | O O | o o I | CJ O | X | 1 | X 1 | X | X i | X | X 1 | X 1 |
| Ή | i ao | 1 CT\ | 1 co | 1 Cn | Γ- | i—1 | 1 <d | v | co | OO | v | v | Γ- | TO | v | ||
| d ÍX | Γ | r- | cn | r~ | ΟΟ | TO | £- | CO | [> | Γ- | X | X | co | ΟΟ | TO | TO | |
| v | T? | Ol | V | V | v s | CM | rd | ΓΜ | CM | η | CM | CM | CM | CM | CM | CM | |
| fti Ό Ct 15 <J « CL, | 04 04 | K P4 | dJ | 04 04 | 04 o4 | 5 | t) £ | di | di | d) | d? | b | d) £ | d) | d) § | B | |
| O O | O O | hL( | O O | o o | o o | X | «c X | X | i | X | X | X | < X | X | X | X |
27CZ 303675 B6
| *O w 04 É cu | o 3 CO cu | £ x> 04 í | $ Ό 04 í | 2 X» »—1 04 t | *5^ 04 t | z**\ : JD ·-* CM É CU | $ X) 1 |
| Ol | co | xř | Lf) | OJ | o- | X | cn |
| r | O- | r- | LO | o- | f* . | r* | |
| OO | co | _____ on an | o o □o ) | cn o θ' 1 O | |||
| co | OO | co | co | ---- | LQ | r-H | OJ |
| r“1 | co | OO | co | o | 1 | CM | |
| ο- | OO | I | t | xr | o- | '— | |
| ι | 1 | *H | cn | 00 | OJ | • | |
| i—1 | o | O | on | 1 | OJ | >L-i | |
| i—1 | OJ | CM | LQ | v7 | '—’ | TO | |
| m | >ÍM | m ro | £ | -ro O | 0 | ||
| Ή | ro | c | c | >n | £ | ||
| o | o | • | +J | S | |||
| >H | O | λ; | C | •rl | • | q | |
| +-> | >. | O | c | o | |||
| -H | £ | O | o | x | > | o | |
| a > | OJ | 04 | 04 | ó | CM | 3 . | |
| r~4 | 1 H | 1 i—t | 1 1—í | (—1 | f τ—1 | rH | |
| ,—1 | r-t | 1-1 | ,—! I | i—I 1 | 1—1 1 | CO I | rH |
| 1 X | 1 X | 1 X | 1 X | 1 X | I X | X | 1 X |
| > | > | > | > | > | > | > | > |
| x | x | X | X | X | X . | X 1 | X |
| S ÍM í r-1 t-i | o | t-4 | X r-f r4 | xř | LO | LO | |
| cn | , | t-4 | t-4 | 1 | r-J | »—í | i-M |
| 3 | X | w 3 | 1 | Š | s X 3 | £ § | 3 |
| lo | co | xf | co | ο- | CO | Ol | |
| cn | co | cn | on | 00 | χ | i—1 | o |
| ÍM | r-1 | Ol | 04 | OJ | 04 | co | ro |
| g | b | b | b | b | b | b | b |
| 1 | X | $ | X | X | X | X | X |
| ] | 1 | I | t | 1 | 1 | 1 | t |
| lo | o | OJ | co | 04 | LQ | O | r~i |
| 00 | lo | on | on | 00 | OO | O | O |
| OJ | t-1 | Ol | OJ | OJ | CM | CO | ΓΟ |
| b | b X | b | b | b | b | b | |
| X | < X | X | X | X | X | X | X |
C7 303675 Β6
Příklad 9:
Tento příklad popisuje izolaci monoklonálních protilátek (Mab) a použití Mab za účelem charakterizace proteinových epitopů BVH-3, BVH-11 a BVH-112.
Samice myší BALB/c (Charles River) se imunizovaly podkožně genovými produkty BVH-3, BVH-l I nebo BVH-11-2, které pochází z mikroorganizmu E. coli kmen SP64 v přítomnosti 15 μg adjuvans QuilA (Cedarlane Laboratories Ltd, Homby, Canada). Jedna sada myší se imunizovala (fúzní experiment 1) v den 1 a 14 25 gg fúzního proteinu thioredoxin-His»Tag-BVH-3M io čištěného na základě afinity. Druhá skupina myší se imunizovala třikrát ve třítýdenních intervalech 25 gg thioredoxin-His»Tag-BVH-l 1M. Třetí skupina myší (fúzní experiment 3) se imunizovala v den 1 a 15 25 μg fúzního proteinu thioredoxin-HÍs»Tag-BVH-l 1-2M. Čtvrtá skupina myší (fúzní experiment 4) se imunizovala v den 1 25 μβ fúzního proteinu thioredoxin-His»TagBVH-11B čištěného na základě afinity a zesilovací dávka se aplikovala intravenózní injekcí v den 16 a 37 rekombinantním BVH-11B v PBS. Tři až čtyři dni před fúzí se myším aplikovala intravenózně injekce s 25 μβ antigenu suspendovaného v samotném PBS. Hybridomy se produkovaly fúzí buněk sleziny spolu s nesekrečními buňkami myelomu SP2/0, jak se popisuje v publikaci J. Hamel et al. J. Med. Microbiol., 23, pp 163-170 (1987)). Supematanty kultur hybridomů se zpočátku sledovaly testem ELISA podle postupu popsaného v publikaci J. Hamel et al.
J. Med. Microbiol., 23, pp 163-170 (1987)) za použití destiček potažených přípravkem čištěním rekombinantních proteinů nebo suspenzí buněk mikroorganizmu S.pnuemoniae usmrcených teplem. Pozitivní hybridomy se vybraly na základě reaktivity v testu ELISA s radou antigenů, pak se klonovaly pomocí omezeného ředění, pomnožily se a zamrazily se.
Hybridomy se pak testovaly v testu ELISA nebo westernovým imunoblotem proti genovým produktům BVH-3 a BVH-11 za účelem charakterizovat epitopy rozeznávané pomocí monoklonálních protilátek. Genové produkty BVH-3 a BVH-11 sdílí běžné epitopy s šesti druhy monoklonálních protilátek (H3-I-F9, H3-1-D4, H3-1-H12, H11-1-E7, H11-1-H10 a HI 1-1.1-Gl 1), které vykazují reaktivitu s oběma proteiny (tabulka č. 4). Molekuly BVH-11 a BVH-11-2 z mikroorganizmu S.pneumoniae SP64 sdílí běžné epitopy, které nejsou přítomny na BVH-3 s monoklonálními protilátkami (3A1, 13C11, 10H10, 1D8, 10G9, 10A2, 3E8, 10D7, 2H7 a 6H7), a reagují s oběma rekombinantnímí proteiny BVH-11 a BVH-11-2 (tabulka č. 5).
Tabulka č. 4: Reaktivita imunoreaktivních monoklonálních protilátek s řadou genových produktů BVH-3 a BVH-1 L
| MAb | a* imunoreaktivita s | ||||||
| BVH-3M 21-1039 | BVH-3A 21-509 | BVH-3B 512-1039 | BVH-3C 21-225 | HEW2 472-800 | NEW3 800-1039 | BVH-11M 20-840 | |
| H3-1-F9 | + | + | - | + | - | - | + |
| H3-1-D4 | + | + | - | + | - | - | + |
| H3-1-HI2 | + | + | + | - | - | + | |
| H3-2-G2 | + | + | - | - | - | - | - |
| H3-3-A1 | + | + | - | - | - | - | - |
| H3-4-D3 | + | - | + | - | - | - | |
| H11-1-E7 | + | + | - | + | - | - | + |
| H10 | + | + | + | + | |||
| Hll- 1.1-G11 | + 1 | + | + | + |
QZ 303675 B6
Tabulka č. 5: Reaktivita monoklonálních protilátek vytvořených proti proteinu BVH-11-2 z mikroorganizmu S.pneumoniae kmen SP64 s řadou genových produktů BVH-11.
| Mab. * | b.imunoreaktivita s· | |||||||
| c. BVH-11 produkt | d.BVH-U-2 produkt | |||||||
| BVK-llM 20-840 | NEWS 286-511 | NEW9 511-713 | BVH-11B 354-840 | BVH-ll-2 20-838 | NEW10 271-838 | NEW11 699-838 | NEW14 227-699 | |
| 3A1 | + | + | - | + | + | + | - | + |
| 13C1 | + | + | + | + | + | + | - | + |
| 10H10 | + | + | + | + | + | + | - | + |
| 1D8 | + | + | - | + | + | + | - | + |
| 10G9 | + | - | - | + | 4- | + | - | + |
| 10A2 | + | - | - | + | + | + | - | + |
| 3E8 | + | - | - | + | + | + | - | + |
| 10D7 | + | - | - | + | + | + | - | + |
| 2H7 | + | - | - | - | + | - | - | - |
| 6H7 | + | - | - | - | + | - | - | - |
| 3A4 | - | - | - | - | + | + | + | - |
| 14H6 | - | - | - | - | + | + | + | - |
| 7G2 | - | - | - | - | + | + | - | + |
| 13H10 | - | - | - | - | + | - | - | + |
| 7E8 | - | - | - | - | + | - | - | - |
| 7H6 | - | - | - | - | + | - | - | - |
a Monoklonální protilátky v této tabulce nejsou reaktivní s rekombinantní molekulou BVH-3
Výsledky získané z imunoreaktivních studií monoklonálních protilátek (tabulka č. 4 a 5) jsou v souladu s proteinovými sekvencemi získanými z genových sekvencí. Monoklonální protilátky zkříženě reagující s molekulami BVH-3 a BVH-11 rozeznávaly protein BVH-3C odpovídající io konzervativní oblasti a specifické monoklonální protilátky proti BVH-11 a BVH-11-2 reagovaly s epitopy umístěnými v různých částech těchto molekul. BVH-3 a BVH-11 a BVH-11 a BVH11-2 se mohou odlišit na základě jejich reaktivity s monoklonálními protilátkami.
Příklad 10:
Tento příklad ilustruje současnou expresi genových produktů BVH-3 a BVH-11 pomocí S.pneumoniae.
Standardní metoda westernová blotu se použila pro zkoumání, zda se geny BVH-3 a BVH-11 exprimovaly v mikroorganizmu S.pneumoniae. Mikroorganizmus S.pneumoniae kmen SP64 a SP63 se nechaly růst přes noc při teplotě 37 °C v atmosféře 5% CO2 na plotnách s čokoládovým agarem. Bakterie se resuspendovaly v PBS a usmrtily se teplem při teplotě 56 °C po dobu 20 minut. Při přípravě antigenů se suspenze mikroorganizmu S.pneumoniae ošetřila vzorkovým pufrem, který obsahuje SDS a 2-merkaptoethanol po dobu 5 minut pri teplotě 100 °C, Pneumokokové proteinové antigeny se rozdělily elektroforézou SDS-PAGE způsobem popsaným v publikaci Laemmli, Nátuře, 227, pp. 680-685 (1970). Po SDS-PAGE se proteiny přenesly elektroforeticky z gelu na nitrocelulózovou membránu způsobem Towbin, Proč. Nati. Acad. Sci. USA, 76, pp. 4350-4354 (1979)) a testovaly se s myším sérem nebo monoklonálními protilátkami.
Detekce antigenů, které reagují s protilátkami, se uskutečnila nepřímým testem ELISA za použití konjugovaných imunoglobulinů proti myším a barevného substrátu. Když se antisérum vytvořené
-30CZ 303675 B6 proti rekombinantnímu BVH-3 testovalo proti antigenům mikroorganizmu S.pneumoniae SP64. detekovaly se dva reaktivní pruhy, které mají zjevnou molekulovou hmotnost 127 kDa a 99 kDa. Když se použily monoklonální protilátky H3-1-F9, H3-1D4, H3-1-H12, Hl 1-1-E7, Η11-1.1G11 jednotlivě jako imunologické sondy, detekovaly se také pruhy, které mají stejnou zjevnou molekulovou hmotnost. Naopak monoklonální protilátky specifické pro molekulu BVH-3 detekovaly pouze pruh o molekulové hmotnosti 127 kDa a monoklonální protilátky specifické pro BVH-1 l detekovaly pouze pruh o molekulové hmotnosti 99 kDa, tak potvrdily identitu pruhů o molekulové hmotnosti 127 a 33 kDa jako pruhy odpovídající BVH-3 a BVH-11. Tyto studie poskytují důkaz, že proteiny BVH-3 a BVH-11 jsou současně přítomny v mikroorganizmu io S.pneumoniae. Avšak výsledky jsou konzistentní s předešlým pozorováním, že BVH-3 a BVH11 vykazují epitopy, které jsou běžné pro oba proteiny a epitopy, které jsou exkluzivní pro každý uvedený protein.
U mikroorganizmu S.pneumoniae SP64 zralé proteiny BVH-3, BVH-11 a BVH-11-2 jsou pro15 teiny obsahující 1019, 821 a 819 aminokyselin s předpovídanou molekulovou hmotností 112,5 kDa, 92,4 kDa a 91,7 kDa. Ačkoli zde existuje rozdíl mezi molekulovou hmotností předpovězenou ze sekvence a vypočítanou molekulovou hmotností na základě SDS-PAGE, BVH-3 se může lišit od BVH-11 vyšší molekulovou hmotností. Molekuly BVH-3 pocházející z mikroorganizmu S.pneumoniae kmen SP63 a mají zjevnou molekulovou hmotnost 112 kDa na SDS-PAGE ve srovnání se 127 kDa v případě BVH-3 kmene SP64. Tyto data jsou konzistentní s delecí 177 aminokyselinových zbytků BVH-3 mikroorganizmu S.pneumoniae kmen SP63.
Příklad 11:
Tento příklad popisuje ochranu potvrzenou v experimentální infekci myší vakcinovaných rekombinantními genovými produkty BVH-3 nebo BVH-11.
Skupiny 7 nebo 8 samic myší BALB/c (Charles River) se imunizovaly třikrát podkožně v interva30 lech tří týdnů bud’ fúzním proteinem thioredoxin-His.Taq-BVH-3M čištěným na základě afinity, fúzním proteinem thioredoxin-His.Tag-BVH-1 ÍM čištěným na základě afinity nebo samotným adjuvans QuilA v PBS, což slouží jako kontrola. 12 až 14 dní po třetí imunizaci se myším aplikovala intravenózně posilující dávka mikroorganizmu S.pneumoniae kmen WU2 nebo intranasálně s kmenem P4241. Vzorky posilující aplikace mikroorganizmu S.pneumoniae se nanesly na plotny s čokoládovým agarem, aby se stanovil počet jednotek tvořících kolonie a aby se ověřila dávka zesilující injekce. Posilující dávka byla přibližně 106 jednotek tvořících kolonie. Úmrtí se zaznamenávalo po dobu 14 dní a čtrnáctý den po posilující dávce se myši usmrtily a vzorky krve se testovaly v přítomnosti organizmů S.pneumoniae. Data o přežití jsou uvedeny v tabulce č. 6 a 7.
Tabulka ě. 6: Ochrana zprostředkovaná rekombinantní mi proteiny BVH-3M a BVH-1 ÍM při experimentální infekci virulentním mikroorganizmem S.pneumoniae WU2.
| experiment | imunogen | živý : mrtvý3 | střední počet dnů přežití |
| 1 | BVH-3M | 8 : 0 | víc jak 14 |
| žádný | 0 : 8 | 1 | |
| 2 | BVH-11M | 8 : 0 | víc jak 14 |
| žádný | 0 : 8 | 1 |
a Počet živých myší : počtu mrtvých myší čtrnáctý den po posilující injekci
Tabulka č. 7: Ochrana zprostředkovaná rekombinantním i proteiny BVH-3 M a BVH-1 ÍM v experimentálním zánětu plic virulentním mikroorganizmem S.pneumoniae P4241
| experiment | imunogen | živý : mrtvý* | střední počet dnů přežití |
| 1 | BVH-3M | 6 : 1 | víc jak 14 |
| žádný | 1 ; 7 | 4,5 | |
| 2 | BVH-3M | 8 : 0 | víc jak 14 |
| BVH-1Ím | 8 : 0 | víc jak 14 | |
| žádný | 0 : 8 | 4 |
a Počet živých myší: počtu mrtvých myší čtrnáctý den po posilující injekci
Všechny myši imunizované rekombinantním proteinem BVH-3M nebo BVH-1 ÍM přežily infekci kmenem WU2, zatímco žádná z kontrolních myší, které se aplikovalo samotné adjuvans nepřežila. Všechny myši mimo jedné imunizované rekombinantním proteinem BVH-3 M nebo BVH-1 ÍM přežily infekci P4241, zatímco přežila pouze jedna kontrolní myš, které se aplikovalo samotné adjuvans. Všechny herno kultury z myší, které přežily jsou negativní čtrnáctý den po zesilovací injekci. Tyto výsledky jasně ukazují, že oba produkty BVH-3M a BVH-1 ÍM vyvolávají ochrannou imunitní odezvu proti pneumokokům u myší. Skutečnost, že tyto proteiny jsou vysoce konzervativní mezi izoláty S.pneumoniae zdůrazňují potenciál BVH-3 a BVH-11 jako kandidátů univerzální vakcíny. Proteiny BVH-3 a BVH-11 ze séroskupiny 6 mikroorganizmu S.pneumoniae kmen SP64 vyvolaly ochranu proti pneumokokovým infekcím kmeny různých kapsulámích sérotypů.
V ideálním případě vakcína, která by mohla chránit proti pneumokokovému onemocnění by mohla zajistit ochranu proti meningitidě, zánětu středního ucha, bakteriémii a zápalu plic. BVH3 a BVH-11 chrání experimentální modely proti letální systémové infekci nebo zápalu plic, což naznačuje, že u lidí vakcíny založené na proteinu BVH-3 a BVH-11 by mohly redukovat výskyt širokého spektra onemocnění způsobeného všemi druhy S.pneumoniae nezávisle na kapsulámímu sérotypů.
Data z tabulky č. 6 a 7 jasně naznačují, že BVH-3 a BVH-11 jsou molekuly vyvolávající ochranu proti mikroorganizmu S.pneumoniae. Není však známo, zda ochrana může být zprostředkována specifickými sekvencemi, které nejsou sdíleny molekulami BVH-3 a BVH-11.
Skupiny samic myší BALB/c (Charles River) se imunizovaly podkožně třikrát v třítýdenních intervalech buď fúzním proteinem thioredoxin-His.Tag-BVH-3AD, -BVH-3B nebo -BVH-3C v přítomnosti 15 pg adjuvans QuilA (Cederlane Laboratories Ltd, Homby, Canada). Kontrolní myši se imunizovaly samotným adjuvans QuilA v PBS nebo fúzním proteinem thioredoxinHis.Tag nebo thioredoxin-His.Tag-fúzní protein (His-Thio) v přítomnosti QuilA.
Aby se stanovila schopnost ochrany sady zkrácených proteinů značených NEW4, NEWS, NEW6, NEW7, NEW8, NEW9, NEW10, NEW11, NEW14 a BVH-11B, skupina samic myší BALB/c (Charles River) se imunizovala podkožně dvakrát v tří týdenních intervalech 25 pg His.Tag-fúzní protein čištěným na základě afinity v přítomnosti 15 pg adjuvans QuilA. Deset až čtrnáct dní po poslední imunizaci se myším aplikovala zesilující injekce virulentním mikroorganizmem
S.pneumoniae. Výsledky indikují, že BVH-3B, zkrácená molekula BVH-3 obsahující aminokyseliny 512 až 1039 vyvolala ochranu proti kmenům, WU2 a P4241, kteréjsou virulentní pro myši. Podobně molekuly BVH-11, NEW4 a NEWS, zkrácené molekuly BVH-11 obsahující aminokyseliny 354 až 840, 286 až 840 a 286 až 713 vyvolaly ochranu proti experimentální zesi-32CZ 303675 B6 lovací dávce zavedené intravenózní injekcí obsahující WU2 a intranasální zesilovací dávce obsahující P4241. Vakcinace pomocí NEW 10 a NEW 14 obsahující aminokyseliny 272 až 838 a 227 až 699 z molekuly BVH-11-2 také vedou k ochraně proti usmrcení kmeny pneumokoků. Tylo výsledky indikují, že oblast obsahující 428 aminokyselin skládající se z aminokyselin 286 až 713 a 272 až 699 proteinů BVH-11 a BVH-11-2 mikroorganizmu S.pneumoniae SP64 obsahovala ochranné epitopy. Tato oblast je vysoce konzervativní vykazující celkovou 91% shodu a 94% homologii mezi třinácti sekvencemi proteinu BVH-11.
Tabulka č. 8: Hodnocení ochrany vyvolané vakcinaci myší genovými produkty BVH-3 a BVH-11
| posiluj ící s WU2 | dávka | posiluj ící P4241 | dávka | ||
| Experiment | Imunogen | Živý : mrtvý'* | střední počet dni přežiti | ž i vý : mrtvý' | střední počet dní přežití |
| žádný | 0 : 8 | 1,5 | 1 : 7 | 4,5 |
| NEW4 NEW5 NEW7 BVH-11M | 8 : 8 : 0 : 8 : | : 0 : 0 : 8 : 0 | >14 >14 2 >14 | 8 : 8 : 0 : 8 : | O 00 o o | >14 >14 5 >14 | |
| T | žádný | 0 : | : 8 | 1 | 0 : | : 8 | 4 |
| NEWS | 8 : | : 0 | >14 | 8 : | : 0 | >14 | |
| NEW8 | 0 : | ; 8 | 1,5 | 0 : | : 8 | 5, 5 | |
| NEW9 | 3 : | : 5 | 3,5 | 2 : | ; 6 | 7 | |
| BVH-11M | 8 : | : 0 | >14 | 8 : | : 0 | >14 | |
| 3b | žádný | 0 : | ; 8 | 1 | 0 | 8 | 4 |
| NEW6 | 0 : | : 8 | 1 | 4 | 4 | 10,5C | |
| NEW10 | 8 : | ; 0 | >14 | 8 | 0 | >14 | |
| NEW11 | 0 : | ; 8 | 1,5 | 1 | 7 | 6 | |
| BVH-11M | 8 : | : 0 | >14 | 8 | 0 | >14 | |
| ř | žádný | 0 : | : 8 | 2 | 0 : | : 8 | 4 |
| BVH-11M | 7 : | : 1 | >14 | 8 : | ; 0 | >14 | |
| NEW14 | 8 : | : 0 | >14 | 8 : | : 0 | >14 | |
| 5 | H i s - T h i o | 0 : | : 8 | 2 | |||
| BVH-3AD | 1 : | : 7 | 2,5 | ||||
| BVH-3B | 5 : | : 3 | >14 | ||||
| 6 | His-Thio | 0 : | : 8 | 1 | |||
| BVH-3C | 0 : | : 8 | 1 |
3 Počet živých myší: počet mrtvých myší čtrnáctý den po zesilovací dávce b zesilovací dávka v případě WU2 byla 105 jednotek tvořících kolonie c myši žijící déle než 14 dní sc pro stanovení střední hodnoty započítal čas přežití 14 dní.
Příklad 12:
Tento příklad popisuje klonování a expresi chimérového genu kódujícího ch i měrový polypeptid odpovídající karboxykoncové oblasti BVH-3 ve fúzi na C-konci s karboxy-terminální oblastí
BVH-11 a dodatečné ochrany pozorované po vakcinaci chimérovým polypeptidem.
Ze studie popsané shora v textuje zřejmé, že BVH—3 a BVH—11 jsou serologicky odlišné molekuly, které jsou současně přítomny na mikroorganizmu S.pneumoniae. Výsledky imunologických studií myší ukazují, že oba proteiny jsou dobrými kandidáty na vakcínu. Tyto proteiny mají io potenciál poskytovat ochranu proti všem pneumokokům bez ohledu na sérotyp. Přestože tyto dva proteiny sdílí epítopy a sekvence, vykazují různé charakteristiky a mohou sloužit k různým biologickým funkcím. Tudíž imunizace proti dvěma proteinům může poskytnout lepší ochranu než, když probíhá každá jednotlivě. Aby se toto dalo testovat, může se zkoumat několik cest, kde se aplikuje BVH—3 a BVH-11 v plné délce nebo ve zkrácené formě v kombinaci nebo v konjugaci.
Popisuje se genetické inženýrství fúzního genu BVH-3-BVH-11 a protein nazvaný NEW12 (SEQ ID NO: 76 a SEQ ID NO: 58) a potencionální použití proteinu NEW 12 jako vakcíny.
Genové fragmenty BVH-3 a BVH-11 odpovídající 3'konci genů, které se amp li fíková ly pomocí PCR za použití párů oligonukleotidů připravených tak, aby se amplifikovaly fragmenty překrý20 vající nukleotidy 1414 až 3117 (SEQ ID NO: 1) a nukleotidy 1060 až 2520 (SEQ ID NO: 3) z mikroorganizmu S.pneumoniae kmen SP64 genů BVH-3 a BVH-11. Používané příměry HAMJ278 a HAMJ279, HAMJ282 a HAMJ283 měly na 5'konci místo rozeznávané restrikční endonukleázou, což umožňuje přímé klonování amplifikovaného produktu do rámce štěpeného plazmidového vektoru pET21b(+) (tabulka č. 2). Produkty amplifikované PCR se štěpily restrikčními endonukleázami a ligovaly se do linearizovaného plazmidového vektoru pET21b(+) štěpeného podobným způsobem. Výsledné plazmidové konstrukce se potvrdily analýzou nukleotidové sekvence. Rekombinantní plazmid pET21b(+) obsahující PCR produkt Ndel-HindlII BVH-3 se linearizoval štěpením restrikčními enzymy HindlII a Notl pro klonování do rámce HindlII-Notl fragmentu DNA získaného z rekombinantního vektoru pET21(+), který obsahuje fragment genu BVH-11. Klony se nejdříve stabilizovaly v mikroorganizmu E. coli DH5a a pak se zavedly do mikroorganizmu E. coli BL21(ÁDE3) za účelem exprese chimérové molekuly pneumokokového proteinu. Rekombinantní chimérový polypeptid nazvaný NEW 12 se exprimoval jako C-terminální fúze s His-tag. Exprimovaný rekombinantní protein NEW 13 se čistil z frakcí supernatantů získaných z centrifugace sonikovaných kultur mikroorganizmu E. coli indukovaných IPTG za použití pryskyřice His-Bind s cheláty kovů (QIAgen, Chatsworth, CA).
Podle stejného postupu popsaného shora v textuje možné zkonstruovat jiné chimérové polypeptidy, jako výsledek současné exprese New 1 a New 4, New 1 a New 5, New 1 a New 10 nebo New 1 a New 14. Konstrukce se může provést tak, že New 1 leží proti směru exprese nebo po směru exprese New 4, New 5, New 10, BVH-11B nebo New 14. Je také možné zkonstruovat jiné chimérové polypeptidy, jako výsledek současné exprese více jak dvou fragmentů libovolného BVH-3, BVH-11 nebo BVH-11-2.
Skupiny 8 samic myší BALB/c (Charles River) se imunizovaly podkožně dvakrát v tří týdenních intervalech s 25 pg bud’ His«Tag-fúze NEW1 čištěného na základě afinity BVH-11B nebo proteinu NEW12 v přítomnosti 15 pg adjuvans QuilA. Deset až čtrnáct dní po poslední imunizaci se myším aplikovala zesilovací dávka virulentního S.pneumoniae. Jak se ukázalo dříve, molekuly NEW1 a BVH-11B obsahující aminokyseliny 472 až 1039 z proteinu BVH-3 a aminokyseliny 354 a 840 z proteinu BVH-11, odpovídají částem proteinů schopným vyvolat ochrannou imunit50 ní odezvu. Aby se stanovilo, zda chimérový polypeptid podstatně zlepší ochranu ve srovnání s proteiny tvořící jednotlivé části, zesilovací dávka se provedla způsobem, kdy se neočekávaná ochrana s molekulami NEW1 a BVH-1B. Je zajímavé, že chimérový protein NEW12 vyvolal ochranu proti myším virulentním kmenům WU2 a P4201. Sedm z osmi myší imunizovaných s NEW 12 jsou stále živé 10 dní po zesilovací dávce, zatímco 28 myší z 32 imunizovaných
-34C7 303675 B6
NEW1, BVH-11B, BVH-3M nebo samotným adjuvans zemřelo pět dní po zesilující dávce. Tudíž vakcinace myší pomocí NEW 12 poskytuje nejvyšší stupen ochrany proti celendži WIJ2. Tyto výsledky indikují, že imunizace chimérovým polypeptidem a pravděpodobně kombinace genových produktů BVH- 3 a BVH-11 mohou poskytovat další ochranu vedle té, která se získala aplikací samotných antigenu BVH-3 nebo BVH-11.
Tabulka č. 9: Hodnocení ochrany vyvolané vakcinaci myší chimérovou molekulou NEW 12
| Čelendž WU2 | Čelendž P4241 | ||||||
| imunogen | živé | : mrtvé’ | střední přežít i | hodnota | živé : mrtvé’ | střední přežiti | hodnota |
| žádný | 0 : | 8 | 1 | 0 : 8 | 5 | ||
| NEW1 | 2 : | 6 | 2 | 1 : 7 | 8 | ||
| BVH-11B | 1 : | 7 | 3,5 | 8 : 0 | více | jak 14 | |
| NEW12 | 6 : | 2 | více | jak 14 | 7 : 1 | více | jak 14 |
| BVH-3M | 1 : | 7 | 3 | 8 : 1 | ví ce | jak 14 |
Příklad 13:
V příkladu se popisuje identifikace dalších sekvencí příbuzných BVH-3 a BVH-11 u druhu Streptococcus jiného než je S.pneumoniae.
Drive se ukázalo, že BVH-3, BVH-11 a BVH-11-2 je rodina příbuzných proteinů, které sdílejí běžné sekvence. Provedl se průzkum homologie s nukleotidovou sekvencí z konzervativní oblasti těchto genů a porovnáním se sekvencemi z GenBank a EMBL za použití FASTA. Nejvíce podstatná homologie se pozorovala při srovnání s genem 2,469 kb, který kóduje protein s vypočítanou molekulovou hmotností 92 kDa (SEQ ID NO: 81) neznámé funkce v mikroorganizmu S. agalactiae. také se nazývá streptokokus skupiny B nebo GBS. Gen se označil jak BVH—71. Protein vykazující 99,2% identitu a 99,5 % podobnost s proteinem GBS se také identifikoval v mikroorganizmu S.pyogenes. který se také nazývá streptokokus skupiny A nebo GAS (SEQ ID NO: 83. 5'oblast sekvencí BVH-71 (SEQ ID NO: 80 a SEQ ID NO: 82), která pokrývá nukleotidy 1 až 717 demonstruje 58 a 60% shodu s konzervativními oblastmi genů BVH-3 (nukleotidy 1 až 675) a BVH-11 (nukleotidy 1 až 684). Prvních 239 aminokyselin přeložených sekvencí otevřeného čtecího rámce BVH-71 GBS a GAS jsou 51 a 54 % shodných s prvními 225 a 228 aminokyselinami BVH-3 a BVH-11.Navíc k podobnosti struktury streptokokové proteiny BVH-3, BVH-11 a BVH-71 také sdílí antigenní epitopy. Pruh o molekulové hmotnosti 97 kDa se projevil na westernových biotech celých buněk GBS a GAS za použití monoklonálních protilátek Hl 1—1.1—Gl 1 reaktivních s konzervativními oblastmi BVH-3 a BVH-11. Podobně rekombinantní proteiny BVH-71 GAS a GBS se detekovaly analýzou westernovým imunoblotem.
Tyto výsledky indikují, že proteiny BVH-71, BVH-3 a BVH-11 mohou sdílet podobné funkce. Výsledky také naznačují, že proteiny BVH-71 se mohou použít jako komponenty proteinových vakcín proti streptokokům. V dalším provedení podle vynálezu se mohou použít proteiny BVH40 71 jako komponenty proteinové vakcíny proti GAS a GBS.
-35=7-— CZ 303675 B6
Seznam sekvencí <210> 1 <211> 3120 párů bází <212> DNA <213> mikroorganizmus S.pneumoniae <400> 1 atg aaa ttt agt aaa aaa tat ata gca get gga tca get gtt atc gta 48 tcc ttg agt cta tgt gcc tat gca cta aac cag cat cgt tcg cag gaa 96 aat aag gac aat aat cgt gtc tet tat gtg gat ggc age cag tca agt 144 cag aaa agt gaa aac ttg aca cca gac cag gtt age cag aaa gaa gga 192 att cag get gag caa att gta atc aaa att aca gat cag ggc tat gta 240 acg tca cac ggt gac cac tat cat tac tat aat ggg aaa gtt cct tat 288 gat gcc ctc ttt agt gaa gaa ctc ttg atg aag gat cca aac tat caa 336 ctt aaa gac get gat att gtc aat gaa gtc aag ggt ggt tat atc atc 384 aag gtc gat gga aaa tat tat gtc tac ctg aaa gat gca get cat get 432 gat aat gtt ega act aaa gat gaa atc aat cgt caa aaa caa gaa cat 480 gtc aaa gat aat gag aag gtt aac tet aat gtt get gta gca agg tet 528 cag gga ega tat acg aca aat gat ggt tat gtc ttt aat cca get gat 576 att atc gaa gat acg ggt aat get tat atc gtt cct cat gga ggt cac 624 tat cac tac att ccc aaa age gat tta tet. get agt gaa tta gca gca 672 get aaa gca cat ctg get gga aaa aat atg caa ccg agt cag tta age 720 tat LeL Lea aca get agt gac aat aac acg caa tet gta gca aaa gga 768 tca act age aag cca gca aat aaa tet gaa aat ctc cag agt ctt ttg 816 aag gaa ctc tat gat tca cct age gcc caa cgt tac agt gaa tca gat 864 ggc ctg gtc ttt gac cct get aag att atc agt cgt aca cca aat gga 912 gtt qcg att ccg cat ggc gac cat tac cac ttt att cct tac age aag 960 ctt tet get tta gaa gaa aag att gcc aga atg gtg cct atc agt gga 1008 act ggt tet aca gtt tet aca aat gca aaa cct aat gaa gta gtg tet 1056 agt cta ggc agt ctt tca age aat cct tet tet tta acg aca agt aag 1104 gag ctc tet tca gca tet gat ggt tat att ttt aat cca aaa gat atc 1152 gtt gaa gaa acg get aca get tat att gta aga cat ggt gat cat ttc 1200 cat tac att cca aaa tca aat caa att ggg caa ccg act ctt cca aac 1248 aat agt cta gca aca cct tet cca tet ctt cca atc aat cca gga act 1296 tca cat gag aaa cat gaa gaa gat gga tac gga ttt gat get aat cgt 1344 att atc get gaa gat gaa tca ggt ttt gtc atg agt cac gga gac cac 1392 aat cat tat ttc ttc aag aag gac ttg aca gaa gag caa att aag get 1440 gcg caa aaa cat tta gag gaa gtt aaa act agt cat aat gga tta gat 1488 tet ttg tca tet cat gaa cag gat tat cca ggt aat gcc aaa gaa atg 1536 aaa gat tta gat aaa aaa atc gaa gaa aaa att get ggc att atg aaa 1584 caa tat ggt gtc aaa cgt gaa agt att gtc gtg aat aaa gaa aaa aat 1632 gcg att att tat ccg cat gga gat cac cat cat gca gat ccg att gat 1680 gaa cat aaa ccg gtt gga att ggt cat tet cac agt aac tat gaa ctg 1728 ttt. aaa CCC gaa gaa gga gtt get aaa aaa gaa ggg aat aaa gtt tat 1776 act gga gaa gaa tta acg aat gtt gtt aat ttg tta aaa aat agt acg 1824 ttt aat aat caa aac ttt act cta gcc aat ggt caa aaa ege gtt tet 1872 ttt agt ttt ccg cct gaa ttg gag aaa aaa tta ggt atc aat atg cta 1920 gta aaa tta ata aca cca gat gga aaa gta ttg gag aaa gta tet ggt 1968 aaa gta ttt gga gaa gga gta ggg aat att gca aac ttt gaa tta gat 2016 caa cct tat tta cca gga caa aca ttt aag tat act atc get tca aaa 2064 gat tat cca gaa gta agt tat gat ggt aca ttt aca gtt cca acc tet 2112 tta get tac aaa atg gcc agt caa acg att ttc tat cct ttc cat gca 2160 qgg gat act tat tta aga gtg aac cct caa ttt gca gtg cct aaa gga 2208 act gat get tta gtc aga gtg ttt gat gaa ttt cat gga aat get tat 2256 tta gaa aat aac tat aaa gtt ggt gaa atc aaa tta ccg att ccg aaa 2304 tta aac caa gga aca acc aga acg gcc gga aat aaa att cct gta acc 2352
36CZ 303675 B6
| ttc | atg | gca | a a t | gct | tat | ttg | gac | aat | caa | tcg | act | tat | att | gtg | gaa |
| gta | cct | atc | ttg | gaa | aaa | gaa | aat. | caa | act | gat | aaa | cca | agt | att | cta |
| cca | caa | ttt | aaa | agg | aat | aaa | gca | caa | gaa | aac | tea | aaa | ctt | gat | gaa |
| aag | gta | gaa | gaa | cca | aag | act | agt | gag | aag | gta | gaa | aaa | gaa | aaa | ctt |
| tet | gaa | act | ggg | aat | agt. | act | agt | aat | tea | acg | tta | gaa | gaa | gtt | cct |
| aca | gtg | gat | cct | gta | caa | gaa | aaa | gta | gca | cl cl ci | ttt | gct | gaa | agt | tat |
| ggg | atg | aaq | cta | gaa | aat | gtc | ttg | ttt | aat | atg | gac | gga | aca | att | gaa |
| tta | tat | tta | cca | tea | gga | gaa | gtc | att | aaa | aag | aat | atg | gca | gat | ttt |
| aca | gga | gaa | gca | cct | caa | gga | aat | ggt | gaa | aat | aaa | cca | tet | gaa | aat |
| gga | aaa | gta | tet | act | gga | aca | gt t | gag | aac | caa | cca | aca | gaa | aat | aaa |
| cca | gca | gat | tet | tta | cca | gag | gca | cca | aac | gaa | aaa | cct | gta | aaa | cca |
| gaa | aac | tea | acg | gat | aat | gga | atg | ttg | aat | cca | gaa | ggg | aat | gtg | ggg |
| agt | gac | cct | atg | tta | gat | cca | gca | tta | gag | gaa | gct | cca | gca | gta | gat |
| cct | gta | caa | gaa | aaa | tta | gaa | aaa | ttt | aca | gct | agt | tac | gga | tta | ggc |
| tta | gat | agt | gtt | ata | ttc | aat | atg | gat | gga | acg | att | gaa | tta | aga | ttg |
| cca | agt | gga | gaa | gtg | ata | aaa | aag | aat | tta | tet | gat | ttc | ata | gcg | |
| taa |
2400 24 48 24 96 2 54 4 2592 2640 2688 2736 27 8 4 2832 2880 2928 2 97 6 3024 307 2 3117 3120 <210> 2 <211> 1039 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 2
| Met 1 | Lys | Phe | Ser | Lys 5 | Lys | Tyr | Ile | Ala | Ala 10 | Gly | Ser | Ala | Val | Ile 15 | Val |
| Ser | Leu | Ser | Leu | Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Lys | Asp | Asn | Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser |
| 35 | 40 | 45 | |||||||||||||
| Gin | Lys | Ser | Glu | Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly |
| 50 | 55 | 60 | |||||||||||||
| Ile | Gin | Ala | Glu | Gin | Ile | Val | Ile | Lys | lle | Thr | Asp | Gin | Gly | Tyr | Val |
| 65 | 70 | 75 | 80 | ||||||||||||
| Thr | Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ala | Leu | Phe | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin |
| 100 | 105 | 110 | |||||||||||||
| Leu | Lys | Asp | Ala | Asp | Ile | Val· | Asn | Glu | Val | Lys | Gly | Gly | Tyr | lle | Ile |
| 115 | 120 | 125 | |||||||||||||
| Lys | Val | Asp | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala |
| 130 | 135 | 140 | |||||||||||||
| Asp | Asn | Val. | Arg | Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His |
| 145 | 150 | 155 | 160 | ||||||||||||
| Val | Lys | Asp | Asn | Glu | Lys | V a 1 | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser |
| 165 | 170 | 17 5 | |||||||||||||
| Gin | Gly | Arg | Tyr | Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp |
| 180 | 185 | 190 | |||||||||||||
| Ile | Ile | Glu | Asp | Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His |
| 195 | 200 | 205 | |||||||||||||
| Tyr | His | Tyr | lle | Pro | Lys | Ser | Asp | Leu | Ser | Al a | Ser | Glu | Leu | Ala | Al a |
| 210 | 215 | 220 | |||||||||||||
| Ala | Lys | Ala | His | Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Tyr | Ser | Ser | Thr | Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly |
| 245 | 250 | 255 | |||||||||||||
| Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu |
| 260 | 265 | 270 | |||||||||||||
| Lys | C.lu | Leu | Tyr | Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp |
| 260 | 265 | 270 | |||||||||||||
| Lys | Glu | Leu | Tyr | Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp |
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Val | Phe | Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly |
| 2 90 | 295 | 300 | |||||||||||||
| Val | Ala | Ile | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Ser | Ala | Leu | Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly |
| 325 | 330 | 335 | |||||||||||||
| Thr | Gly | Ser | Thr | Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ser | Leu | Gly | Ser | Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Leu | Ser | Ser | Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile |
| 370 | 375 | 380 | |||||||||||||
| Val | Glu | Glu | Thr | Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe |
| 385 | 390 | 395 | 400 | ||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn |
| 405 | 410 | 415 | |||||||||||||
| Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr |
| 420 | 425 | 430 | |||||||||||||
| Ser | His | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg |
| 435 | 440 | 445 | |||||||||||||
| Ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His |
| 450 | 455 | 4 60 | |||||||||||||
| Asn | Hi s | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Val |
| 465 | 470 | 4 75 | 480 | ||||||||||||
| Arg | Lys | Asn | Ile |
<210> 9 <211 > 1587 párů bází <212> DNA
| <213> mikroorganizmus S. pneumoniae <221> CDS <222> (1)...(1584) | |||||||||||||||
| <400> 9 | aaa Lys | atc Ile | gaa Glu | gaa Glu 10 | aaa Lys | att Ile | gct Ala | ggc Gly | att Ile 15 | atg Met | |||||
| atg Met 1 | aaa Lys | gat Asp | tta Leu | gat Asp 5 | aaa Lys | ||||||||||
| aaa | caa | tat | ggt | gtc | aaa | cgt | gaa | agt | att | gtc | gtg | aat | aaa | gaa | aaa |
| Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys |
| 20 | 25 | 30 | |||||||||||||
| aat | gcg | att | att. | tat | ccg | cat | gga | gat | cac | cat | cat | gca | gat | ccg | att |
| Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile |
| 35 | 40 | 45 | |||||||||||||
| gat | gaa | cat | aaa | ccg | gtt | gqa | att | ggt | cat | tet | cac | agt | aac | tat | gaa |
| Asp | G1 u | His | Lys | Pro | Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu |
| 50 | 5 5 | 60 | |||||||||||||
| ctg | ttt | aaa | ccc | gaa | gaa | gga | gtt | gct | aaa | aaa | gaa | ggg | aat | aaa | gtt |
| Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val |
| 65 | 70 | 75 | 80 | ||||||||||||
| tat | act | gga | gaa | gaa | tta | acg | aat | gtt | gtt | aat | ttg | tta | aaa | aat | agt |
144
192
240
238
- 52 C7 303675 B6
| Tyr | Thr | Gly | Glu | Glu 85 | Leu | Thr | Asn | Val | Val 90 | Asn | Leu | Leu | Lys | Asn 95 | Ser | |
| acg | ttt | aat | aa t | caa | aac | ttt | act | cta | gcc | aat | ggt | caa | aaa | cgc | gtt | 336 |
| Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | |
| 100 | 105 | 110 | ||||||||||||||
| tet | ttt | agt | ttt | ccg | cct | gaa | ttg | gag | aaa | aaa | tta | ggt | atc | aat | atg | 384 |
| Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | |
| 115 | 120 | 125 | ||||||||||||||
| cta | gta | aaa | tta | ata | aca | cca | gat | gga | aaa | gta | ttg | gag | aaa | gta | tet | 432 |
| Leu | Val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | |
| 130 | 135 | 140 | ||||||||||||||
| ggt | aaa | gta | ttt | gga | gaa | gga | gta | ggg | aat | att | gca | aac | ttt | gaa | tta | 480 |
| Gly | Lys | Val | Phe | Gly | Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | |
| 145 | 150 | 155 | 160 | |||||||||||||
| gat | caa | cct | tat | tta | cca | gga | caa | aca | ttt | aag | tat | act | atc | gct | tea | 528 |
| Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | |
| 165 | 170 | 175 | ||||||||||||||
| aaa | gat | tat | cca | gaa | gta | agt | tat | gat | ggt | aca | ttt | aca | gtt | cca | acc | 57 6 |
| Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | |
| ISO | 185 | 190 | ||||||||||||||
| tet | tta | gct | tac | aaa | atg | gcc | agt | caa | acg | att | ttc | tat | cct | ttc | cat | 624 |
| Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | |
| 195 | 200 | 205 | ||||||||||||||
| gca | ggg | gat | act | tat | tta | aga | gtg | aac | cct | caa | ttt | gca | gtg | cct | aaa | 672 |
| Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | |
| 210 | 215 | 220 | ||||||||||||||
| gga | act | gat | gct | tta | g t c | aga | gtg | ttt | gat | gaa | 1.11 | cat | gga | aat | gct | 72 0 |
| Gly | Thr | Asp | Ala | Leu | Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | |
| 225 | 230 | 235 | 240 | |||||||||||||
| tat | tta | gaa | aat | aac | tat | aaa | gtt | ggt | gaa | atc | aaa | tta | ccg | att | ccg | 768 |
| Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | |
| 245 | 2 50 | 255 | ||||||||||||||
| aaa | tta | aac | caa | gga | aca | acc | aga | acg | gcc | gga | aat | aaa | att | cct | gta | 816 |
| Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | |
| 260 | 265 | 270 | ||||||||||||||
| acc | ttc | atg | gca | aat | gct | tat | ttg | gac | aat | caa | tcg | act | tat | att | gtg | 864 |
| Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | |
| 275 | 280 | 285 | ||||||||||||||
| gaa | gta | cct | atc | ttg | gaa | aaa | gaa | aat | caa | act | gat | aaa | cca | agt | att | 912 |
| Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | |
| 290 | 295 | 300 | ||||||||||||||
| cta | cca | caa | ttt | s aa | agg | aat | aaa | gca | caa | gaa | aac | tea | aaa | ct t | gat | 960 |
| Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | |
| 305 | 310 | 315 | 320 |
5?
| gaa Glu | aag Lys | gta Val | gaa Glu | gaa Glu 325 | cca Pro | aag Lys | act Thr | agt Ser | gag Glu 330 | aag Lys | gta Val | gaa Glu | aaa Lys | gaa Glu 335 | aaa 1008 Lys | |
| ctt | tct | gaa | act | ggg | aat | agt | act | agt | aat | tca | acg | tta | gaa | gaa | gtt | 1056 |
| Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | |
| 340 | 345 | 350 | ||||||||||||||
| cct | aca | gtg | gat | cct | gta | caa | gaa | aaa | gt a | gca | aaa | ttt | get | gaa | agt | 1104 |
| Pro | Thr | Val | Asp | Pro | Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | |
| 355 | 360 | 365 | ||||||||||||||
| tat | ggg | atg | aag | cta | gaa | aat | gtc | ttg | ttt | aat | atg | gac | gga | aca | att | 1152 |
| Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | lle | |
| 370 | 375 | 380 | ||||||||||||||
| gaa | tta | tat | tta | cca | tca | gga | gaa | gtc | att | aaa | aag | aat | atg | gca | gat | 1200 |
| Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | Val | lle | Lys | Lys | Asn | Met | Ala | Asp | |
| 335 | 390 | 395 | 400 | |||||||||||||
| ttt | aca | gga | gaa | gca | cct | caa | gga | aat | ggt | gaa | aat | aaa | cca | tet | gaa | 1248 |
| Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | |
| 4 05 | 410 | 415 | ||||||||||||||
| aat | gga | aaa | gta | tet | act | gga | aca | gtt | gag | aac | caa | cca | aca | gaa | aat | 1296 |
| Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | |
| 4 20 | 425 | 430 | ||||||||||||||
| aaa | cca | gca | gat | tet | tta | cca | gag | gca | cca | aac | gaa | aaa | cct | gta | aaa | 1.34 4 |
| Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | |
| 435 | 440 | 445 | ||||||||||||||
| cca | gaa | aac | tca | acg | gat | aat | gga | atg | ttg | aat | cca | gaa | ggg | aat | gtg | 1392 |
| Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | |
| 450 | 455 | 460 | ||||||||||||||
| ggg | agt | gac | cct | atg | tta | gat | cca | gca | tta | gag | gaa | get | cca | gca | gta | 1440 |
| Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | |
| 465 | 470 | 475 | 480 | |||||||||||||
| gat | cct | gta | caa | gaa | aaa | tta | gaa | aaa | ttt | aca | get | agt | tac | gga | tta | 1488 |
| Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | |
| 4 85 | 4 90 | 495 | ||||||||||||||
| ggc | tta | gat | agt | gtt | ata | ttc | aat | atg | gat | gga | acg | att | gaa | tta | aga | 1536 |
| Gl.y | Leu | Asp | Ser | Val | lle | Phe | Asn | Met | Asp | Gly | Thr | lle | Glu | Leu | Arg | |
| 500 | 505 | 510 | ||||||||||||||
| ttg | cca | agt | gqa | gaa | gtg | ata | aaa | aag | aat | tta | tet | gat | ttc | ata | gcg | 1584 |
| Leu | Pro | Ser | Gly | Glu | Val | Tle | Lys | Lys | Asn | Leu | Ser | Asp | Phe | lle | Ala | |
| 51 5 | 520 | 525 | ||||||||||||||
| taa | 1587 | |||||||||||||||
| <210> | 10 | |||||||||||||||
| <211> | 528 aminokyselin | |||||||||||||||
| <212> | protein | |||||||||||||||
| <213> | m | ikroorganizmus | S.pneumoniae | |||||||||||||
| <400> | 10 |
54C7 303675 B6
| Ťlet | Lys | Asp | Leu | Asp 5 | Lys | Lys | Ile | Glu | Glu 10 | Lys | Ile | Ala | Gly | Ile 15 | Met |
| Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | Val | Va L | Asn | Lys | Glu | Lys |
| 20 | 25 | 30 | |||||||||||||
| Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile |
| 35 | 40 | 45 | |||||||||||||
| Asp | Glu | HÍS | Lys | Pro | Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu |
| 50 | 55 | 60 | |||||||||||||
| Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val |
| 65 | 70 | 75 | 80 | ||||||||||||
| Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser |
| 85 | 90 | 95 | |||||||||||||
| Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val |
| 100 | 105 | 110 | |||||||||||||
| Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met |
| 115 | 120 | 125 | |||||||||||||
| Leu | Val | Lys | Leu | I le | Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser |
| 130 | 135 | 140 | |||||||||||||
| Gly | Lys | Val | Phe | Gly | Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser |
| 165 | 170 | 175 | |||||||||||||
| Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr | As p | Gly | Thr | Phe | Thr | Val | Pro | Thr |
| 180 | 185 | 190 | |||||||||||||
| Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His |
| 195 | 200 | 205 | |||||||||||||
| Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys |
| 210 | 215 | 220 | |||||||||||||
| Gly | Thr | Asp | Ala | Leu | Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala |
| 225 | 230 | 235 | 240 | ||||||||||||
| Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro |
| 245 | 250 | 255 | |||||||||||||
| Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | Val |
| 260 | 265 | 270 | |||||||||||||
| Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val |
| 275 | 280 | 285 | |||||||||||||
| Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile |
| 290 | 295 | 300 | |||||||||||||
| Leu | Pro | Cin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp |
| 305 | 310 | 315 | 320 | ||||||||||||
| Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Gl u | Lys |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val |
| 340 | 345 | 350 | |||||||||||||
| Pro | Thr | Val | Asp | Pro | Val | Gin | Glu | Lys | Val. | Ala | Lys | Phe | Ala | Glu | Ser |
| 355 | 360 | 365 | |||||||||||||
| Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile |
| 370 | 375 | 380 | |||||||||||||
| Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu |
| 405 | 410 | 415 | |||||||||||||
| Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Gl u | Lys | Pro | Val· | Lys |
| 435 | 440 | 445 |
Pro Glu Asn Ser Thr Asp Asn Gly Met Leu Asn Pro Glu Gly Asn Val 450 455 460
Gly Ser Asp Pro Met Leu Asp Pro Ala Leu Glu Glu Ala Pro Ala Val
465 470 475 480
Asp Pro Val Gin Glu Lys Leu Glu Lys Phe Thr Ala Ser Tyr Gly Leu
485 450 455
Gly Leu Asp Ser Val Ile Phe Asn Met Asp Gly Thr Ile Glu Leu Arg
500 505 510
Leu Pro Ser Gly Glu Val Ile Lys Lys Asn Leu Ser Asp Phe Ile Ala
515 520 525 <210> 11 <211> 5048 párů bází <212> DNA <213> mikroorganizmus S.pneumoniae <400> 11 aattccttgt cgggtaagtt ccgacccgca cgaaaggcgt aatgatttgg gcactgtctc 60 aacgagagac tcggtgaaat tttagtacct gtgaagatgc aggttacccg cgacaggacg 120 gaaagacccc atggagcttt actgcagttt gatattgagt gtctgtacca catgtacagg 180 ataggtagga gtctaagaga tcgggacgcc agtttcgaag gagacgctgt tgggatacta 240 cccttgtgtr atggccactc taacccagat aggtgatccc tatcggagac agtgtctgac 300 gggcagtttg aotggggcag tcgcctccta aaaggtaacg gaggcgccca aaggttccct 360 cagaatggtt ggaaatcatt cgcagagtgt aaaggtataa gggagcttga ctgcgagagc 420 tacaactcga gcagggacga aagtcgggct tagtgatccg gtggttccgt atggaagggc 480 catcgctcaa cggataaaag ctaccctggg gataacaggc ttatctcccc caagagttca 540 catcgacggg gaggtttggc acctcgatgt cggctcgtcg catcctgggg ctgtagtcgg 600 tcccaagggt tgggctgttc gcccattaaa gcggcacgcg agctgggttc agaacgtcgt 660 gagacagttc ggtccctatc cgtcgcgggc gtaggaaatt tgagaggatc tgctoctagt 720 acgagagqac cagagtggac ttaccgctgg tgtaccagtt gtcttgccaa aggcatcgct 780 gggtagctat gtagggaagg gataaacgct gaaagcatct aagtgtgaaa cccacctcaa 840 gatgagattt cccatgatta tatatcagta agagccctga gagatgatca ggtagatagg 900
LLagaagLyg aagLgtggcg acacatgtag cggactaata ctaatagctc gaggacttat 960 ccaaagtaac tgagaatatg aaagcgaacg gttttcttaa attgaataga tattcaattt 1020 tgagtaggta ttactcagag ttaagtgacg atagcctagg agatacacct gtacccatgc 1080 cgaacacaga agttaagccc tagaacqccg gaagtagttg ggggttgccc cctgtgagat 1140 agggaagtcg cttagctcta gggagtttag ctcagctggg agagcatctg ccttacaagc 1200 agagggtcag cggttcgatc ccgttaactc ccaaaggtcc cgtagtgtag cggttatcac 1260 gtcgcccLgt cacggcgaag atcgcgggtt cgattcccgt cgggaccgtt taaggtaacg 1320 caagttattt tagactcgtt agctcagttg gtagagcaat tgacttttaa tcaatgggtc 1380 actggttcga gcccagtacg ggtcatatat gcgggtttgg cggaattcta atctctttga 1440 aatcatcttc tctcaccttc caaaactcta ttacct.ctta ttataccaca tttcaatcrt 1500 caacttccca gtaatataag cacctctggc qaaaaaagtt tcaatgtcct aaagtaataa 1560 gtgaatccaa ttcaggaact ccaagaacaa aagaaacatc tggtgtcaca agtattggat 1620 ggcacagagt cacgtggtag tctgacccta gcagaaattt taaatagtaa actatttact 1680 ggttaattaa atggttaaat aaccggttta qaaaactatt. taataaagta aaagaagttg 1740 agaaaaaact tcatcattta ttgaaatgag ggatttatga aatttagtaa aaaatatata 1800 gcagctggat cagctgttat cgtatccttg agtctatgtg cctatgcact aaaccagcat 1860 egttcgcagg aaaataagga caataatcgt qtctcttatg tggatggcag ccagtcaagt 1920 cagaaaagtg aaaacttgac accagaccag gttagccaga aagaaggaat tcaggctgag 1580 caaattgtaa tcaaaattac agatcagggc tatgtaacgt cacacggtga ccactatcat 2040 íactataatg ggaaagttcc ttatgatgcc ctctttagtg aagaactctt gatgaaggat 2100 ccaaactatc aacttaaaga cgetgatatt gtcaatgaag tcaagggtgg ttatatcatc 2160 aaggtcgatg gaaaatatta tgtctacctg aaagatgcag ctcatgctga taatgttcga 2220 actaaagatg aaatcaatcg tcaaaaacaa gaacatgtca aagataatga gaaggttaac 2280 tctaatgttg ctgtagcaag gtcLcaggga cgatatacga caaatgatgg ttatgtcttt 2340 aatccagctg aLattatcga agatacgggt aatgcttata tcgttcctca tggaggtcac 2400 tatcactaca tícccaaaag cgatttatct qctagtgaat tagcagcagc taaagcacat 2460 ctggctggaa aaaatatgea accgagtcag ttaagctatt uttcaacagc tagtgacaat 2520
-56Q7. 303675 B6 aacacgc.aat ctgtagcaaa aggatcaact- agcaagccag caaat.aaatc tqaaaatctc 2bS0 cagaqtcttt tqaaggaact ctatgattca cctagcgccc aacgttacag tgaalcagat 2640 gqcctggtct t Lgaccctgc taagattatc agtcgtacac caaatggagt tgcgattccg 27 00 catqgcgacc attaccactt tattccttac aqcaagcttt ctgctttaga agaaaagatt 2/60 qccaqaatgg tgcctatcag tggaactggt tctacagttt ctacaaatgc aaaacctaat 2820 gaagtagtat ctaatctagg cagtctttca agcaatcctt cttctttaac gacaagtaaq 2880 gagcLctcLL cagcatctga tggttatatt tttaatccaa aagatatcgt tgaagaaacg 2940 gctacagctt atattgraag acatggtgat catttccatt acattccaaa atcaaatcaa 3000 attgggcaac cgactcttcc aaacaatagt ctagcaacac cttctccatc tcttccaatc 3060 aatccaggaa cttcacatga gaaacatgaa gaagatggat acggatttga tgctaatcgt 3120 attatcgctg aagatgaatc aggttttgtc atgagtcacg gagaccacaa tcattatttc 3180 ttcaagaagg acttgacaga agagcaaatt aaggctgcgc aaaaacattt agaggaagtt 3240 aaaactagtc ataatggatt agattctttg tcatctcatg aacaggatta tccaggtaat 3300 gccaaagaaa tgaaagattt agataaaaaa atcgaagaaa aaattgctgg cattatgaaa 3360 caatatggtg tcaaacgtga aagtattgtc gtgaataaag aaaaaaatgc gattattt.at 3420 ccgcatggag atcaccatca tgcagatccg attgatgaac ataaaccggt tggaattggt 3480 cattctcaca gtaactatga actgtttaaa cccgaagaag gagttgctaa aaaagaaggg 3540 aataaagttt atactggaga agaattaacg aatgttgtta atttgttaaa aaatagtacg 3600 tttaataatc aaaactttac tctagccaat ggtcaaaaac gcgtttcttt tagttttccg 3660 cctgaattgg sgaaaaaatt aggtatcaat atgctagtaa aattaataac accagatgga 3720 aaagtattgg agaaagtatc tggtaaagta tttggagaag gagtagggaa tattgcaaac 3780 tttgaattag atcaacctta tttaccagga caaacattta agtatactat cgcttcaaaa 3840 gattatccag aagtaagtta tgatggtaca tttacagttc caacetcttt agcttacaaa 3900 atggccagtc aaacgatttt ctatcctttc catgcagggg atacttattt aagagtgaac 3960 cctcaatttg cagtgcctaa aggaactgat gctttaqtca gagtgtttga lgaatttcal 4020 ggaaatgctt atttagaaaa taactataaa gttggtgaaa tcaaattacc gattccgaaa 4080 ttaaaccaag gaacaaccag aacggccgga aataaaattc ctgtaacctt catggcaaat 4140 gcttatttgg acaatcaatc gacttatatt gtggaagtac ctatcttgga aaaagaaaat 4200 caaactgata aaccaagtat tctaccacaa tttaaaagga ataaagcaca agaaaactca 4260 aaacttgatg aaaaggtaga agaaccaaag actagtgaga aggtagaaaa agaaaaactt 4320 tctgaaactg ggaatagtac tagtaattca acgttagaag aagttcctac agtggatcct 4380 gtacaagaaa aagtagcaaa atttgctgaa agttatggga tgaagctaga aaatgtcttg 4440 cttaatatgg acggaacaat tgaattatat ttaccatcag gagaagtcat taaaaagaat 4500 atggcagatt ttacaggaga agcacctcaa ggaaatggtg aaaataaacc atctgaaaat 4560 ggaaaagtat ctactggaac agttgagaac caaccaacag aaaataaacc agcagattct 4620 ttaccagagg caccaaacga aaaacctgta aaaccagaaa actcaacgga taatggaatg 4680 ttgaatccag aagggaatgt qgggagtgac cctatgttag atccagcatt agaggaagct 4740 ccagcagtag atcctgtaca agaaaaatta gaaaaattta cagctagtta cggattaggc 4800 ttagatagtg ttatattcaa tatggatgga acgattgaat taagattgce aagtggagaa 4860 gtgataaaaa agaatttatc tgatttcata gcgtaaggaa tagcagtaga aaaagtctga 4920 atcaaaaatg aagttctctc aaaagttaga aataaaactc tgactttggg agaatttcat 4980 tttattatta atatataaaa tttcttgaca tacaacttaa aaagaggtgg aatatttact 5040 agttaatt 5048 <210> 12 <211> 2647 párů bází <212> DNA <213> mikroorgan izmus 5.pneumoniae <400> 12 cagagatctt agtgaatcaa atatacttaa gaaaagagga aagaatgaaa atcaataaaa 60 aatatctagc tgggtcagta gctacacttg ttttaagtgt ctgtgcttat gaactaggtt 120 tqcatcaagc tcaaactgta aaagaaaata atcgtgtttc ctatatagat ggaaaacaag 180 cgacgcaaaa aacggagaat ttgactcctg atgaggttag caagcgtgaa ggaatcaacg 240 ccgaacaaat cgtcatcaaa attacggatc aaggttatgt gacctctcat ggagaccatt 300 atcattacta taatggcaag gtcccttatg atgccatcat cagtgaagag ctcctcatga 360 aagatccgaa ttatcagttg aaggattcag acattgtcaa tgaaatcaag ggtggttatg 420 tcattaaggt aaacggtaaa tactatgttt accttaagga tgcagctcat gcggataatg 480 tccgtacaaa agaagaaatc aatcgqcaaa aacaagaaca tagtcageat cgtgaaggag 540 ggacttcagc aaacgatggt gcggtagcct ttgcacgttc acagggacgc tacaccacag 600 atgatggtta tatcttcaat gcatctgata tcategaaga tacgggcgat gcctatatcg 660 ttcctcatgg agatcattac cattacattc ctaagaatga gttafceaget agcgagttgg 720 ctgctgcaga agccttccta tctggtcggg aaaatctgtc aaatttaaga acctatcgcc 780 gacaaaatag cgataacact ccaagaacaa actgggtacc ttctgtaagc aatccaggaa 840 ctacaaatac taacacaagc aacaacagca acactaacag tcaagcaagt caaagtaatg 900 acattgatag tctcttgaaa cagctctaca aactgccttt gagtcaacgc catgtagaat 960 ctgatggcct tattttcgac ccagcgcaaa tcacaagtcg aaccgccaga ggtgtagctg 1020 tccctcatgg taaccattac cactttatcc cttatgaaca aatgtctgaa ttggaaaaac 1080 gaattgctcg tattattccc cttcgttatc gttcaaacca ttgggtacca gattcaagac 1140 cagaagaacc aagtccacaa ccgactccag aacctagtcc aagtccgcaa cctgcaccaa 1200 atcctcaacc agctccaagc aatccaattq atgagaaatt ggtcaaagaa gctgttcgaa 1260 aagtaggcga tggttatgtc tttgaggaga atggagtttc tcgttatatc ccagccaaga 1320 atctttcagc agaaacagca gcaggcattg atagcaaact ggccaagcag gaaagtttat 1380 ctcaLaagct aggagctaag aaaactgacc tcccatctag tgatcgagaa ttttacaata 1440 aggcttatga cttactagca agaattcacc aagatttact tgataataaa ggtcgacaag 1500 ttgattttga ggctttggat aacctgttgg aacgactcaa ggatgtctca agtgataaag 1560 tcaagttagt ggatgatatt cttgccttct tagctccgat tcgtcatcca gaacgtttag 1620 gaaaaccaaa tgcgcaaatt acctacactg atgatgagat tcaagtagcc aagttggcag 1680 gcaagtacac aacagaagac ggttatatct ttgatcctcg tgatataacc agtgatgagg 1740 gggatgccta tgtaactcca catatgaccc atagccactg gattaaaaaa gatagtttgt 1800 ctgaagctga gagagcggca gcccaggctt atgctaaaga gaaaggtttg acccctcctt 1860 cgacagacca teaggattea ggaaatactg aggcaaaagg ageagaaget atctacaacc 1920 gcgtgaaagc agctaagaag gtgccacttg atcgtatgcc ttacaatctt caatatactg 1980 tagaagtcaa aaacggtagt ttaatcatac ctcattatga ccattaccat aacatcaaat 2040 ttgagtggtt tgacgaaggc ctttatgagg cacctaaggg gtatactctt gaggatcttt 2100 tggcgactgt caaatactat gtcgaacatc caaacgaacg tccgcattca gataatggtt 2160 ttggtaacgc tagcgaccat gttcaaagaa acaaaaatgg tcaagctgat accaatcaaa 2220 cggaaaaacc aagcgaggag aaacctcaga cagaaaaacc tgaggaagaa acccctcgag 2280 aagagaaacc acaaagcgag aaaccagagt ctccaaaacc aacagaggaa ccagaagaag 2340 aatcaccaga ggaatcagaa gaacctcagg tcgagactga aaaggttgaa gaaaaactga 2400 gagaggctga agatttactt gcaaaaatcc aggatccaat tatcaagtcc aatgccaaag 2460 agactctcac aggattaaaa aataatttac tatttggcac ccaggacaac aatactatta 2520 tggcagaagc tgaaaaacta ttggctttat taaaggagag taagtaaagg tageageatt 2580 ttctaactcc taaaaacagg ataggagaac gggaaaacga aaaatgagag cagaatgtga 2640 gttctag 2647
| <210> | 13 |
| <211> | 2639 párů bází |
| <212> | DNA |
| <213> | mikroorganizmus S.pneumoniae |
| <221> | CDS |
| <222> | (114)...(2627) |
| <400> | 13 |
gggtcttaaa actctgaatc ctttagaggc agacccacaa aatgacaaga cctatttaga aaatctggaa gaaaatatga gtgttctagc agaagaatta aagtgaggaa aga atg
Met
116
| aaa Lys | atc Ile | aat Asn | aaa Lys 5 | a a a Lys | tat Tyr | cta Leu | gca Ala | ggt Gly 10 |
| agt | gtt | tgt | tcc | tat | gaa | ctt | ggt | cgt |
| Ser | Val | Cys | Ser | Tyr | Glu | Leu | Gly | Arg |
| 20 | 25 |
| tea Ser | gtg Val | gca Al a | gtc Val | ctt Leu 15 | gcc Ala | cta Leu | 164 |
| cac | caa | gct | ggt | cag | gtt | aag | 212 |
| His | Gin | Ala | Gly 30 | Gin | Val | Lys |
-58C7. 303675 R6
260
| aaa | gag | tet | aat | ega | gtt | tet | tat | ata | gat | ggt | gat | cag | get | ggt | caa |
| Lys | Glu | Ser | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Asp | Gln | Ala | Gly | Gln |
| 35 | 40 | 45 | |||||||||||||
| aag | gca | gaa | aat | ttg | aca | cca | gat | gaa | gtc | agt | aag | aga | gag | ggg | atc |
| Lys | Ala | Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile |
| 50 | 55 | 60 | 65 | ||||||||||||
| aac | gcc | gaa | caa | att | gtt | atc | aag | att | acg | gat | caa | ggt | tat | gtg | acc |
| Asn | Ala | Glu | Gln | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gln | Gly | Tyr | Val | Thr |
| 70 | 7 5 | 80 | |||||||||||||
| tet | cat | gga | gac | cat | tat | cat | tac | tat | aat | ggc | aag | gtt | cct | tat | gat |
| Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp |
| 85 | 90 | 95 | |||||||||||||
| gcc | atc | atc | agt | gaa | gaa | ctt | ctc | atg | aaa | gat | ccg | aat | tat | cag | ttg |
| Ala | Ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu |
| 100 | 105 | 110 | |||||||||||||
| aag | gat | tea | gac | att | gtc | aat | gaa | atc | aag | ggt | ggc | tat | gtg | att | aag |
| Lys | Asp | Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys |
| 115 | 120 | 125 | |||||||||||||
| gta | gac | gga | aaa | tac | tat | gtt | tac | ctt | aaa | gat | gcg | gcc | cat | gcg | gac |
| Val | Asp | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp |
| 130 | 135 | 140 | 145 | ||||||||||||
| aat | att | cgg | aca | aaa | gaa | gag | att | aaa | cgt | cag | aag | cag | gaa | cac | agt |
| Asn | Ile | Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gln | Lys | Gln | Glu | His | Ser |
| 150 | 155 | 160 | |||||||||||||
| cat | aat | cat | aac | t ca | aga | gca | gat | aat | get | gtt | get | gca | gcc | aga | gcc |
| His | Asn | His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Al a | Ala | Ala | Arg | Ala |
| 165 | 170 | 175 | |||||||||||||
| caa | gga | cgt | tat | aca | acg | gat | gat | ggg | tat | atc | ttc | aat | gca | tet | gat |
| Gln | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp |
| 180 | 185 | 190 | |||||||||||||
| atc | att | gag | gac | acg | ggt | gat | get | tat | atc | gtt | cct | cac | ggc | gac | cat |
| Ile | Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His |
| 195 | 200 | 205 | |||||||||||||
| tac | cat | tac | att | cct | aag | aat | gag | t ta | tea | get | age | gag | tta | get | get |
| Tyr | His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 210 | 215 | 220 | 225 | ||||||||||||
| gca | gaa | gcc | tat | tgg | aat | ggg | aag | cag | gga | tet | cgt | cct | tet | tea | agt |
| Ala | Glu | Ala | Tyr | Trp | Asn | Gly | Lys | Gln | Gly | Ser | Arg | Pro | Ser | Ser | Ser |
| 230 | 235 | 240 | |||||||||||||
| tet | agt | tat | aat | gca | aat | cca | gtt | caa | cca | aga | ttg | tea | gag | aac | cac |
| Ser | Ser | Tyr | Asn | Ala | Asn | Pro | Val | Gln | Pro | Arg | Leu | Ser | Glu | Asn | His |
| 24 5 | 250 | 255 | |||||||||||||
| aat | ctg | act | gtc | act | cca | act | tat | cat | caa | aat | caa | ggg | gaa | aac | att |
308
356
404
452
500
548
596
644
692
740
788
836
884
932
| Asn | Leu | Thr 260 | Val | Thr | Pro | Thr | Tyr 265 | His | Gin | Asn | Gin | Gly 270 | Glu | Asn | Ile | |
| tea | age | ctt | tta | cgt | gaa | ttg | tat | get | aaa | ccc | tta | tea | gaa | ego | cat | 980 |
| Ser | Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | |
| 275 | 280 | 285 | ||||||||||||||
| gta | gaa | tet | gat | ggc | ctt | att | ttc | gac | cca | gcg | caa | atc | aca | agt | ega | 1028 |
| Va 1 | Glu | Ser | Asp | Gly | Leu | Tle | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | |
| 290 | 295 | 300 | 305 | |||||||||||||
| acc | gcc | aga | ggt | gta | get | gtc | cct | cat | ggt | aac | cat | tac | cac | ttt | atc | 1076 |
| Thr | Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | |
| 310 | 315 | 320 | ||||||||||||||
| cct | tat | gaa | caa | atg | tet | gaa | ttg | gaa | aaa | ega | att | get | cgt | att | att | 1124 |
| Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | He | Ala | Arg | Ile | Ile | |
| 325 | 330 | 335 | ||||||||||||||
| ccc | ctt | cgt | tat | cgt | tea | aac | ca t | tgg | gta | cca | gat | tea | aga | cca | gaa | 1172 |
| Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | |
| 340 | 345 | 350 | ||||||||||||||
| caa | cca | agt | cca | caa | tcg | act | ccg | gaa | cct | agt | cca | agt | ctg | caa | cct | 1220 |
| Gin | Pro | Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Leu | Gin | Pro | |
| 355 | 360 | 365 | ||||||||||||||
| gca | cca | aat. | cct | caa | cca | get | cca | age | aat | cca | att | gat | gag | aaa | ttg | 1268 |
| Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | |
| 370 | 375 | 380 | 385 | |||||||||||||
| gtc | aaa | gaa | get | gtt | ega | aaa | gta | ggc | gat | ggt | tat | gtc | ttt | gag | gag | 1316 |
| Val | Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | |
| 390 | 395 | 400 | ||||||||||||||
| aat | gga | gtt | tet | cgt | tat | atc | cca | gcc | aag | gat | ctt | tea | gca | gaa | aca | 1364 |
| Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | |
| 405 | 410 | 415 | ||||||||||||||
| gca | qca | ggc | att | gat | age | aaa | ctg | gcc | aag | cag | gaa | agt | tta | tet | cat | 1412 |
| Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | |
| 420 | 425 | 430 | ||||||||||||||
| aag | cta | gga | get | aag | aaa | act | gac | ctc | cca | tet | agt | gat | ega | gaa | ttt | 1460 |
| Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | |
| 435 | 440 | 445 | ||||||||||||||
| tec | aat | aag | get | tat | gac | tta | cta | gca | aga | att | cac | caa | gat | tta | ctt | 1508 |
| Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Al a | Arg | Tle | His | Gin | Asp | Leu | Leu | |
| 4 50 | 455 | 460 | 465 | |||||||||||||
| gat | aat | aaa | ggt | ega | caa | gtt | gat | ttt | gag | gtt | ttg | gat | aac | ctg | ttg | 1556 |
| Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu | Asp | Asn | Leu | Leu | |
| 470 | 475 | 480 | ||||||||||||||
| gaa | ega | ctc | aag | gat | gtc | tea | agt | gat | aaa | gtc | aag | tta | gtg | gat | gat | 1604 |
| Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | |
| 4 85 | 4 90 | 495 |
60CZ 303675 R6
| att Ile | ctt Leu | gcc Ala 500 | ttc Phe | tta Leu | gct Ala | ccg Pro | att Ile 50 5 | cgt Arg | cat H i s | cca Pro | gaa Glu | cgt Arg 510 | tta Leu | gga Gly | aaa Lys | 16 52 |
| cca | aat | gcg | caa | att | acc | tac | act | ga t. | gat | gag | att | caa | gta | qcc | aag | 1700 |
| Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Al a | Lys | |
| 515 | 5 20 | 525 | ||||||||||||||
| ttg | gca | ggc | aag | tac | aca | aca | gaa | gac | ggt | tat | atc | ttt | gat | cct | cgt | 1748 |
| Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | |
| 530 | 535 | 540 | 545 | |||||||||||||
| gat | ata | acc | agt | gat | gag | ggg | gat | gcc | tat | gta | act | cca | cat | atg | acc | 1796 |
| Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | |
| 550 | 555 | 560 | ||||||||||||||
| cat | age | cac | tgg | att | aaa | aaa | gat | agt | ttg | tet | gaa | gct | gag | aga | gcg | 1844 |
| His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | |
| 565 | 570 | 575 | ||||||||||||||
| gca | gcc | cag | gct | tat | gct | aaa | gag | aaa | ggt | ttg | acc | cct | cct | t cg | aca | 1892 |
| Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | |
| 580 | 585 | 590 | ||||||||||||||
| gac | cac | cag | gat | tca | gga | aat | act | gag | gca | aaa | gga | gca | gaa | gct | atc | 1940 |
| Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | |
| 595 | 600 | 605 | ||||||||||||||
| tac | aac | cqc | gtg | éi či cJ | gca | gct | aag | aag | gtg | cca | ctt | gat | cgt | atg | cct | 1988 |
| Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | |
| 610 | 615 | 620 | 625 | |||||||||||||
| tac | aat | ct t | caa | tat | act | gta | gaa | gtc | aaa | aac | ggt | agt | tta | atc | ata | 2036 |
| Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | |
| 630 | 635 | 640 | ||||||||||||||
| cct | cat | tat | gac | cat | tac | cat | aac | atc | aaa | ttt | gag | tgg | ttt | gac | gaa | 2084 |
| Pro | His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | |
| 645 | 650 | 655 | ||||||||||||||
| ggc | ctt | tat | gag | gca | cct | aag | ggg | tat | agt | ctt | gag | gat | ctt | ttg | gcg | 2132 |
| Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | |
| 660 | 665 | 670 | ||||||||||||||
| act | gtc | aag | tac | tat | gtc | gaa | cat | cca | 33C | gaa | cgt | ccg | cat | tca | gat | 2180 |
| Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | |
| 67 5 | 680 | 685 | ||||||||||||||
| aat | ggt | ttt | ggt | aac | gct | agt | gac | cat | gtt | cgt | aaa | aat | aag | gca | gac | 2228 |
| Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | |
| 690 | 695 | 700 | 705 | |||||||||||||
| caa | gat | agt | aaa | cct | gat | gaa | gat | aag | gaa | cat | gat | gaa | gta | agt | gag | 2276 |
| Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | Ser | Glu | |
| 710 | 715 | 7 20 | ||||||||||||||
| cca | act | cac | cct | gaa | tet | gat | gaa | aaa | gag | aat | cac | gct | ggt | tta | aat | 2324 |
| Pro | Thr | His | Pro 725 | Glu | Ser | Asp | Glu | Lys 730 | Glu | Asn | His | Ala | Gly 735 | Leu | Asn | |
| cct | tea | gca | gat | aat | ctt | tat | aaa | cca | age | act | gat | acg | gaa | gag | aca | 2372 |
| Pro | Ser | Al a | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | |
| 740 | 745 | 750 | ||||||||||||||
| gag | gaa | gaa | gct | gaa | gat | acc | aca | gat | gag | gct | gaa | att | cct | caa | gta | 2420 |
| Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | |
| 755 | 760 | 765 | ||||||||||||||
| gag | aat | tet | gtt | att | aac | gct | aag | ata | gca | gat | gcg | gag | gcc | ttg | cta | 2468 |
| Glu | Asn | Ser | Val | Ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | |
| 770 | 7 75 | 780 | 785 | |||||||||||||
| gaa | aaa | gta | aca | gat | cct | agt | att | aga | caa | aat | gct | atg | gag | aca | ttg | 2516 |
| Glu | Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | |
| 790 | 795 | 800 | ||||||||||||||
| act | ggt | cta | aaa | agt | agt | ctt | ctt | ctc | gga | acg | aaa | gat | aat | aac | act | 2564 |
| Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | |
| 805 | 810 | 815 | ||||||||||||||
| att | tea | gca | gaa | gta | gat | agt | ctc | ttg | gct | ttg | tta | aaa | gaa | agt | caa | 2612 |
| Ile | Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | |
| 820 | 825 | 830 |
ccg gct cct ata cag tagtaaaatg aa 2639
Pro Ala Pro Ile Gin
835 <210> <211>
<212>
<213> <400>
848 aminokyselin protein mikroorganizmus S.pneumoniae 14
| Met 1 | Lys | Ile | Asn | Lys 5 | Lys | Tyr | Leu | Ala | Gly 10 | Ser | Val | Ala | Val | Leu 15 | Ala |
| Leu | Ser | Val | Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | Val |
| 20 | 25 | 30 | |||||||||||||
| Lys | Lys | Glu | Ser | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly |
| 3 5 | 40 | 45 | |||||||||||||
| Gin | Lys | Ala | Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly |
| 50 | 55 | 60 | |||||||||||||
| Ile | Asn | Ala | Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val |
| 65 | 70 | 75 | 80 | ||||||||||||
| Thr | Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ala | ll.e | 1 le | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin |
| 100 | 105 | 110 | |||||||||||||
| Leu | Lys | A s p | Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile |
| 1 15 | 120 | 125 | |||||||||||||
| Lys | V a 1 | Asp | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala |
| 1 3 U | 135 | 140 | |||||||||||||
| Asp | Asn | Ile | Arg | Thr | Lys | Glu | Glu | I le | Lys | Arg | Gin | Lys | Gin | Glu | Hi s |
| 145 | 150 | 155 | 160 | ||||||||||||
| Ser | His | Asn | His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Ala | Ala | Ala | Arg |
| 165 | 170 | 175 | |||||||||||||
| Ala | Gin | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | lle | Phe | Asn | Ala | Ser |
| 180 | 185 | 190 | |||||||||||||
| Asp | lle | lle | G.1 u | Asp | Thr | Gly | Asp | Ala | Tyr | ile | Val | Pro | His | Gly | Asp |
| 1 95 | 200 | 205 | |||||||||||||
| His | Tyr | His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ala | Glu | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ser | Ser | Ser | Tyr | Asn | Ala | Asn | Pro | Val | Gin | Pro | Arg | Leu | Ser | Glu | Asn |
| 245 | 250 | 255 | |||||||||||||
| His | Asn | Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn |
| 260 | 265 | 270 | |||||||||||||
| T 1 e | Ser | Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg |
| 275 | 280 | 285 | |||||||||||||
| His | Val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Al a | Gin | Tle | Thr | Ser |
| 290 | 295 | 300 | |||||||||||||
| Arg | Thr | Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe |
| 305 | 310 | 315 | 320 | ||||||||||||
| Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile |
| 325 | 330 | 335 | |||||||||||||
| Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro |
| 340 | 345 | 350 | |||||||||||||
| Glu | Gin | Pro | Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Leu | Gin |
| 355 | 360 | 365 | |||||||||||||
| Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys |
| 370 | 37 5 | 380 | |||||||||||||
| Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gl y | Tyr | Val | Phe | Glu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro | Al a | T.ys | Asp | Leu | Ser | Ala | Glu |
| 405 | 410 | 415 | |||||||||||||
| Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser |
| 420 | 425 | 430 | |||||||||||||
| His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu |
| 435 | 440 | 445 | |||||||||||||
| Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu |
| 450 | 455 | 460 | |||||||||||||
| Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu | Asp | Asn | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp |
| 485 | 490 | 495 | |||||||||||||
| Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | lle | Arg | His | Pro | Glu | Arg | Leu | Gly |
| 500 | 505 | 510 | |||||||||||||
| Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala |
| 515 | 520 | 525 | |||||||||||||
| Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro |
| 530 | 535 | 540 | |||||||||||||
| Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met |
| 545 | 550 | 555 | 560 | ||||||||||||
| Thr | His | Ser | His | Trp | 11 e | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg |
| 565 | 570 | 575 | |||||||||||||
| Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser |
| 580 | 585 | 590 | |||||||||||||
| Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala |
| 595 | 600 | 605 | |||||||||||||
| Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met |
| 610 | 615 | 620 | |||||||||||||
| Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile |
Μ
| 625 | 630 | 635 | 640 | ||||||||||||
| Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp |
| 645 | 650 | 655 | |||||||||||||
| Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu |
| 660 | 665 | 670 | |||||||||||||
| Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser |
| 675 | 680 | 685 | |||||||||||||
| Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala |
| 690 | 695 | 700 | |||||||||||||
| Asp | Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | Ser |
| 705 | 710 | 715 | 720 | ||||||||||||
| Glu | Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu |
| 725 | 730 | 735 | |||||||||||||
| Asn | Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu |
| 740 | 745 | 750 | |||||||||||||
| Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin |
| 755 | 760 | 765 | |||||||||||||
| Val | GlU | Asn | Ser | Val | Ile | Asn | Ala | Lys | ile | Ala | Asp | Ala | Glu | Ala | Leu |
| 770 | 775 | 780 | |||||||||||||
| Leu | Glu | Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr |
| 7 85 | 790 | 795 | 800 | ||||||||||||
| Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn |
| 805 | 810 | 815 | |||||||||||||
| Thr | Ile | Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser |
| 820 | 825 | 830 | |||||||||||||
| Gin | Pro | Ala | Pro | Ile | Gin |
835 <210> 15 <211> 2528 párů bází <212> DNA <213> mikroorganizmus Xpneumoniae <221 > CDS <222> (1)...(2520) <400> 15
| tgt Cys 1 | gcc Ala | tat Tyr | gca Ala | cta Leu 5 | aac Asn | cag Gin | cat His | cgt Arg | tcg Ser 10 | cag Gin | gaa Glu | aat Asn | aag Lys | gac Asp 15 | aat Asn |
| aat | cgt | gtc | tet | tat | gtg | gat | ggc | age | cag | tea | agt | cag | aaa | agt | gaa |
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| aac | ttg | aca | cca | gac | cag | gtt | age | cag | aaa | gaa | gga | att | cag | gct | gag |
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| caa | att | gta | atc | aaa | att | aca | gat | cag | ggc | tat | gta | acg | tea | cac | ggt |
| G1. n | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| gat | cac | tat | cat | tac | tat | aat | ggg | aaa | gtt | cct | tat | gat | gcc | ctc | ttt |
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| agt | gaa | gaa | ctc? | ttg | atg | aag | gat | cca | aac | tat | caa | ct t | aaa | gac | gct |
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 |
144
192
240
288
-64CZ 303675 R6
| gat Asp | att Ile | gtc Val | aat Asn 100 | gaa Glu | gtc Val | aag Lys | ggt Gly | ggt Gly 105 | tv Tyr | atc Ile | atc Ile | aag Lys | gtc Val 110 | gat Asp | gga Gly | 336 |
| aaa | tat | tat | gtc | tac | ctg | aaa | gat | gca | gct | cat | gct | gat | aat | gtt | ega | 38 4 |
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | AJ a | His | Ala | Asp | Asn | Val | Arg | |
| 115 | 120 | 125 | ||||||||||||||
| act | aaa | gat | gaa | atc | aat | cgt | caa | aaa | caa | gaa | cat | gt c | aaa | gat | aat | 4 3? |
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn | |
| 130 | 135 | 140 | ||||||||||||||
| gag | aag | gtt | aac | tet | aat | gtt | gct | gta | gca | agg | tet | cag | gga | ega | tat | 480 |
| Glu | Lys | Val | Asn | Ser | Asn | Val | Al a | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr | |
| 145 | 150 | 155 | 1 60 | |||||||||||||
| acg | aca | aat | gat | ggt | tat | gtc | ttt | aat | cca | gct | gat | att | atc | gaa | gat | 52 8 |
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp | |
| 165 | 170 | 175 | ||||||||||||||
| acg | ggt | aat | gct | tat | atc | gtt | cct | cat | gga | ggt | cac | tat | cac | tac | att | 576 |
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Tle | |
| 180 | 185 | 190 | ||||||||||||||
| CCC | aaa | agc | gat | tta | tet | gct | agt | gaa | tta | gca | gca | gct | aaa | gca | cat | 624 |
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His | |
| 195 | 200 | 205 | ||||||||||||||
| c t. g | gct | gga | aaa | aat | atg | caa | ccg | agt | cag | tta | agc | tat | tet | tea | aca | 67 2 |
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr | |
| 210 | 215 | 220 | ||||||||||||||
| cct | tet | cca | tet | ctt | cca | atc | aat | cca | gga | act | tea | cat | gag | aaa | cat | 720 |
| Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | |
| 225 | 230 | 235 | 240 | |||||||||||||
| gaa | gaa | gat | gga | tac | qga | ttt | gat | gct | aat | cgt | att | atc | gct | gaa | gat | 768 |
| Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | |
| 245 | 250 | 255 | ||||||||||||||
| gaa | tea | ggt | ttt | gtc | atg | agt | cac | gga | gac | cac | aat | cat | tat | ttc | ttc | 816 |
| Glu | Ser | Gly | Phe | Val | Met | Ser | Hi.s | Gly | Asp | His | Asn | His | Tyr | Phe | Phe | |
| 260 | 265 | 270 | ||||||||||||||
| aag | aag | gac | ttg | aca | gaa | gag | caa | att | aag | gct | gcg | caa | aaa | cat | tta | 864 |
| Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | |
| 275 | 280 | 285 | ||||||||||||||
| gag | gaa | gtt | aaa | act | agt | cat | aat | gga | tta | gat | tet | ttg | tea | tet | cat | 912 |
| Glu | Glu | Val | Lys | Thr | Ser | Sis | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | |
| 290 | 295 | 300 | ||||||||||||||
| gaa | cag | gat | tat | cca | agt | aat | gcc | aaa | gaa | atg | aaa | gat | tta | gat | aaa | 960 |
| Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | |
| 305 | 310 | 315 | 320 | |||||||||||||
| aaa | ale | gaa | gaa | aaa | att | gct | gg^ | at t. | atg | ddd | caa | tat | ggt | gtc | aaa | 1008 |
A*
| Lys | Ile | Glu | Glu | Lys | Tle | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | |
| 325 | 330 | 3 35 | ||||||||||||||
| cgt | gaa | agt | att | gtc | gtg | aat | aaa | gaa | aaa | aat | gcg | att | att | tat | ccg | 1056 |
| Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | |
| 34 0 | 345 | 350 | ||||||||||||||
| cat | gga | gat | cac | cat | cat | gca | gat | ccg | att | gat | gaa | cat | aaa | ccg | gtt | 1104 |
| His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | |
| 355 | 360 | 365 | ||||||||||||||
| gga | att | ggt | cat | tet | cac | agt | aac | tat | gaa | ctg | ttt | aaa | ccc | gaa | gaa | 1152 |
| Gly | Ile | Gly | His | Ser | Hi s | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | |
| 37 0 | 375 | 380 | ||||||||||||||
| gga | gtt | gct | aaa | aaa | gaa | ggg | aat | aaa | gtt | tat | act | gga | gaa | gaa | tta | 1200 |
| Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | |
| 385 | 390 | 395 | 400 | |||||||||||||
| acg | aat | gtt | gtt | aat | ttg | tta | aaa | aat | agt | acg | ttt | aat | aat | caa | aac | 1248 |
| Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | |
| 405 | 410 | 415 | ||||||||||||||
| ttt | act | cta | gcc | aat | ggt | caa | aaa | cgc | gtt | tet | ttt | agt | ttt | ccg | cct | 1296 |
| Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | |
| 420 | 425 | 430 | ||||||||||||||
| gaa | ttg | gag | aaa | aaa | tta | ggt | atc | aat | atg | cta | gta | aaa | tta | ata | aca | 1344 |
| Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | |
| 435 | 440 | 445 | ||||||||||||||
| cca | gat | gga | aaa | gta | ttg | gag | aaa | gta | tet | ggt | aaa | gta | ttt | gga | gaa | 13 92 |
| Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | |
| 450 | 455 | 460 | ||||||||||||||
| gga | gta | ggg | aat | att | gca | aac | ttt | gaa | tta | gat | caa | cct | tat | tta | cca | 1440 |
| Gly | Val | Gl y | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | |
| 465 | 470 | 475 | 480 | |||||||||||||
| gga | caa | aca | ttt | aag | tat | act | atc | gct | tea | aaa | gat | tat | cca | gaa | gta | 1488 |
| Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | |
| 485 | 490 | 495 | ||||||||||||||
| agt | tat | gat | ggt | aca | ttt | aca | gtt | cca | acc | tet | tta | gct | tac | aaa | atg | 1536 |
| Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | |
| 500 | 505 | 510 | ||||||||||||||
| gcc | agt. | caa | acg | att | ttc | tat | cct | ttc | cat | gca | ggg | gat | act | tat | tta | 1584 |
| Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | |
| 515 | 520 | 525 | ||||||||||||||
| aga | gtg | aac | cct | caa | ttt | gca | gtg | cct | aaa | gga | act | gat | gct | tta | gtc | 1632 |
| Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | |
| 530 | 535 | 540 | ||||||||||||||
| aga | gtg | ttt | gat | gaa | ttt | cat | gga | a a t | gct | tat | tta | gaa | aat | aac | tat | 1680 |
| Arg | va 1 | Phe | Asp | G1 u | Phe | His | G1 y | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr |
545 550 555 560
-66C7 303675 B6 aaa gtt ggt gaa atc aaa tta ccg att ccg aaa tta aac caa gga aca 1728
Lys Val Gly Glu lle Lys Leu Pro lle Pro Lys Leu Asn Gin Gly Thr
565 570 575 acc aga acg gcc gga aat aaa att cct gta acc ttc atg gca aat get. 1776
Thr Arg Thr Ala Gly Asn Lys lle Pro Val Thr Phe Met. Ada Asn Ala
580 585 590 tat ttg gac aat caa tcg act tat att gtg gaa gta cct atc ttg gaa 1824
Tyr Leu Asp Asn Gin Ser Thr Tyr lle Val Glu Val Pro lle Leu Glu
595 600 605 aaa gaa aat caa act gat aaa cca agt att cta cca caa ttt aaa agg 1872
Lys Glu Asn Gin Thr Asp Lys Pro Ser lle Leu Pro Gin Phe Lys Arg
610 615 620 aat aaa gca caa gaa aac tca aaa ctt gat gaa aag gta gaa gaa cca 1920
Asn Lys Ala Gin Glu Asn Ser Lys Leu Asp Glu Lys Val Glu Glu Pro
625 630 635 640 aag act agt gag aag gta gaa aaa gaa aaa ctt tet gaa act ggg aat 1968
Lys Thr Ser Glu Lys Val Glu Lys Glu Lys Leu Ser Glu Thr Gly Asn
645 650 655 agt act agt aat tca acg tta gaa gaa gtt cct aca gtg gat cct gta 2016
Ser Thr Ser Asn Ser Thr Leu Glu Glu Val Pro Thr Val Asp Pro Val
660 665 670 caa gaa aaa gta gca aaa ttt get gaa agt tat ggg atg aag cta gaa 2064
Gin Glu Lys Val Ala Lys Phe Ala Glu Ser Tyr Gly Met Lys Leu Glu
675 680 685 aat gtc ttg ttt aat atg gac gga aca att gaa tta tat tta cca tcg 2112
Asn Val Leu Phe Asn Met Asp Gly Thr lle Glu Len Tyr Leu Pro Ser
690 695 700 gga gaa gtc att aaa aag aat atg gca gat ttt aca gga gaa gca cct 2160
Gly Glu Val lle Lys Lys Asn Met Ala Asp Phe Thr Giy Glu Ala Pro
705 710 715 720 caa gga aat ggt gaa aat aaa cca tet gaa aat gga aaa gta tet act 2208
Gin Gly Asn Gly Glu Asn Lys Pro Ser Glu Asn Gly Lys Val Ser Thr
725 730 735 gga aca gtt gag aac caa cca aca gaa aat aaa cca gca gat tet tta 2256
Gly Thr Val Glu Asn Gin Pro Thr Glu Asn Lys Pro Ala Asp Ser Leu
740 745 750 cca gag gca cca aac gaa aaa cct gta aaa cca gaa aac tca acg gat 2304
Pro Glu Ala Pro Asn Glu Lys Pro Val Lys Pro Glu Asn Ser Thr Asp
755 760 765 aat gga atg ttg aat cca gaa ggg aat gtg ggg agt gac cct atg tta 2352
Asn Gly Met Leu Asn Pro Glu Gly Asn Val Gly Ser Asp Pro Met Leu
7 0 7 7 5 7 8 0 gat. tca gca tta gag gaa get cca gca gta gat cct gta caa gaa aaa 2400
O
| Asp 785 | Ser | Ala | Leu | Glu | Glu 790 | Ala | Pro | Ala | Val | Asp 795 | Pro | Val | Gin | Glu | Lys 800 | |
| tta | gaa | aaa | ttt | aca | get | agt | tac | gga | tta | ggc | tta | gat | agt | gtt | ata | 2448 |
| Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | |
| 805 | 810 | 815 | ||||||||||||||
| ttc | aat | atg | gat | gga | acg | att | gaa | tta | aga | ttg | cca | agt | gga | gaa | gtg | 2496 |
| Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | |
| 820 | 825 | 830 | ||||||||||||||
| ata | aaa | aag | aat | tta | ttg | atc | tca | tagcgtaa | 2528 | |||||||
| Ile | Lys | Lys | Asn | Leu | Leu | Ile | Ser | |||||||||
| 835 | 840 |
<210> <211>
<212>
<213> <400>
840 aminokyselin protein mikroorganizmus S.pneumoniae 16
| Cys 1 | Ala | Tyr | Ala | Leu 5 | Asn | Gin | His | Arg | Ser 10 | Gin | Glu | Asn | Lys | Asp 15 | Asn |
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | Hi s | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val. | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gl y | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His |
| 225 | 230 | 235 | 240 | ||||||||||||
| Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp |
| 245 | 250 | 255 | |||||||||||||
| G1 u | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe | Phe |
| 260 | 265 | 270 | |||||||||||||
| Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu |
| 27 5 | 280 | 285 | |||||||||||||
| Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His |
-68 C7 303675 B6
| 290 | 295 | 300 | |||||||||||||
| Glu | Gln | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys |
| 305 | 310 | 315 | 32 0 | ||||||||||||
| Lys | Tle | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gln | Tyr | Gly | Val | Lys |
| 325 | 330 | 335 | |||||||||||||
| Arg | G.1 u | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro |
| 340 | 345 | 350 | |||||||||||||
| His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val |
| 355 | 360 | 365 | |||||||||||||
| Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu |
| 370 | 375 | 380 | |||||||||||||
| Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gln | Asn |
| 405 | 410 | 415 | |||||||||||||
| Phe | Thr | Leu | Ala | Asn | Gly | Gln | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro |
| 420 | 425 | 430 | |||||||||||||
| Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr |
| 435 | 440 | 445 | |||||||||||||
| Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Giy | Glu |
| 450 | 455 | 460 | |||||||||||||
| Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gln | Pro | Tyr | Leu | Pro |
| 465 | 470 | 475 | 480 | ||||||||||||
| Gly | Gln | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val |
| 485 | 4 90 | 495 | |||||||||||||
| Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met |
| 500 | 505 | 510 | |||||||||||||
| Ala | Ser | Gln | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu |
| 515 | 520 | 525 | |||||||||||||
| Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val |
| 530 | 535 | 540 | |||||||||||||
| Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gln | Gly | Thr |
| 5 65 | 570 | 575 | |||||||||||||
| Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala |
| 580 | 585 | 590 | |||||||||||||
| Tyr | Leu | Asp | Asn | Gln | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu |
| 595 | 600 | 605 | |||||||||||||
| Lys | Glu | Asn | Gln | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gln | Phe | Lys | Arg |
| 610 | 615 | 620 | |||||||||||||
| Asn | Lys | Ala | Gln | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro |
| 625 | 630 | 635 | 640 | ||||||||||||
| Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn |
| 645 | 650 | 655 | |||||||||||||
| Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro | Val |
| 660 | 665 | 670 | |||||||||||||
| Gln | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu |
| 675 | 680 | 685 | |||||||||||||
| Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser |
| 690 | 695 | 700 | |||||||||||||
| Gly | Glu | Val | Tle | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro |
| 705 | 710 | 715 | 720 | ||||||||||||
| Gln | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr |
| 725 | 730 | 735 | |||||||||||||
| Gly | Thr | Val | Glu | Asn | Gln | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu |
| 740 | 745 | 7 50 | |||||||||||||
| Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp |
----CZ 303675 B6
| 755 | 760 | 765 | |||||||||||||
| Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu |
| 770 | 775 | 780 | |||||||||||||
| Asp | Ser | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile |
| 805 | 810 | 815 | |||||||||||||
| Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val |
| 820 | 825 | 830 | |||||||||||||
| Ile | Lys | Lys | Asn | Leu | Leu | Ile | Ser | ||||||||
| 835 | 840 |
| <210> | 17 |
| <211> | 27 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| <400> | 17 |
cagtagatct gtgcctatgc actaaac 27
| <210> | 18 |
| <211> | 33 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| <400> | 18 |
gatctctaga ctactgctat tccttacgct atg
| <210> | 19 |
| <211> | 30 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| <400> | 19 |
| atcac | tcgag cattacctgg ataatcct |
| <210> | 20 |
| <211> | 26 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| <400> | 20 |
ctgctaagct tatgaaagat ttagat
| <210> | 21 |
| <211> | 24 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| <400> | 21 |
<210> 22 <211> 28 párů bází gatactcgag ctgctattcc ttac
-70C7 303675 R6
| 5 | <212> DNA <213> umělá sekvence <223> oligonukleotidový primer PCR <400> 22 gaatctcgag ttaagctgct gctaattc | |
| <210> | 23 | |
| <211> | 32 párů bází | |
| <212> | DNA | |
| 10 | <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR | |
| <400> | 23 | |
| gacgctcgag cgctatgaaa tcagataaat | ||
| 15 | <210> | 24 |
| <211> | 37 párů bází | |
| <212> | DNA | |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| 20 | <400> | 24 |
| gacgctcgag ggcattacct ggataatcct | ||
| <210> | 25 | |
| <211> | 33 párů bází | |
| 25 | <212> | DNA |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| <400> | 25 | |
| cagtagatct cttcatcatt tattgaaaag | ||
| 30 | ||
| <210> | 26 | |
| <211> | 40 párů bází | |
| <212> | DNA | |
| <213> | umělá sekvence | |
| 35 | <223> | oligonukleotidový primer PCR |
| <400> | 26 | |
| ttatttcttc catatggact tgacagaaga | ||
| <210> | 27 | |
| 40 | <211> | 32 párů bází |
| <212> | DNA | |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| <400> | 27 | |
| 45 | cgccaa | gctt cgctatgaaa tcagataaat |
| <210> | 28 | |
| <211> | 34 párů bází | |
| <212> | DNA | |
| 50 | <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR | |
| <400> | 28 |
cgccaagctt ttccacaata taagtcgatt gatt
| <210> | 29 | |
| <211> | 40 párů bází | |
| 5 | <212> | DNA |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| <400> | 29 | |
| ttatttcttc catatggaag tacctatctt | ||
| 10 | ||
| <210> | 30 | |
| <211> | 37 párů bází | |
| <212> | DNA | |
| <213> | umělá sekvence | |
| 15 | <223> | oligonukleotidový primer PCR |
| <400> | 30 | |
| ttatttcttc catatqgtgc ctatgcacta | ||
| <210> | 31 | |
| 20 | <211> | 40 párů bází |
| <212> | DNA | |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| <400> | 31 | |
| ataagaatgc ggccgcttcc acaatataag | ||
| 25 | ||
| <210> | 32 | |
| <211> | 31 párů bází | |
| <212> | DNA | |
| 30 | <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR | |
| <400> | 32 | |
| cagtagatct gtgcttatga actaggtttg | ||
| 35 | <210> | 33 |
| <211> | 32 párů bází | |
| <212> | DNA | |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| 40 | <400> | 33 |
| gatcaagctt gctgctacct ttacttactc | ||
| <210> | 34 | |
| <211> | 26 párů bází | |
| 45 | <212> | DNA |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| <400> | 34 |
ctgagatatc cgttatcgtt caaacc
-72C? 303675 R6
| <210> | 35 |
| <211> | 28 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| 5 <223> | oligonukleotidový primer PCR |
<400> 35 ctgcaagctt ttaaagggga ataatacg
| <210> | 36 | |
| 10 | <211> | 29 párů bází |
| <212> | DNA | |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| <400> | 36 | |
| 15 | cagtagatct gcagaagcct tcctatctg | |
| <210> | 37 | |
| <211> | 33 párů bází | |
| <212> | DNA | |
| 20 | <213> | umělá sekvence |
<223> oligonukleotidový primer PCR <400> 37 tcgccaagct tcgttatcgt tcaaaccatt ggg
| 25 <210> | 38 |
| <211> | 45 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| 30 <400> | 38 |
ataagaatgc ggccgcctta ctctccttta ataaagccaa tagtt
| <210> <211> | 39 34 párů bází | |
| 35 | <212> | DNA |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| <400> | 39 | |
| catgccatgg acattgatag tctcttgaaa | ||
| 40 | ||
| <210> | 40 | |
| <211> | 37 párů bází | |
| <212> | DNA | |
| <213> | umělá sekvence | |
| 45 | <223> | oligonukleotidový primer PCR |
<400> 40 cgccaagctt cttactctcc tttaataaag ccaatag
| <210> | 41 | |
| 50 | <211> | 31 párů bází |
| <212> | DNA | |
| <213> | umělá sekvence |
7?
<223> oligonukleotidový primer PCR <400> 41 cgacaagctt aacatggtcg ctagcgttac c
| <210> | 42 |
| <211> | 30 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| <400> | 42 |
cat accatgg gcctttatga ggcacctaag
| <210> | 43 |
| <211> | 34 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| <400> | 43 |
cgacaagctt aagtaaatct tcagcctctc tcag <210> 44 <211> 31 párů bází <212> DNA <213> umělá sekvence <223> oligonukleotidový primer PCR <400> 44 gataccatgg ctagcgacca tgttcaaaga a <210> 45 <211> 36 párů bází <212> DNA <213> umělá sekvence <223> oligonukleotidový primer PCR <400> 45 cgccaagctt atcatccact aacttgactt tatcac <210> 46 <211> 33 párů bází <212> DNA <213> umělá sekvence <223> oligonukleotidový primer PCR <400> 46 cataccatgg atattcttgc cttcttagct ccg <210> 47 <211> 30 párů bází <212> DNA <213> umělá sekvence <223> oligonukleotidový primer PCR <400> 47 catgccatgg tgcttatgaa ctaggtttgc
-74C7 303675 R6
| <210> | 48 |
| <211> | 32 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| <400> | 48 |
cgccaagctt tagcgttacc aaaaccatta tc <210> 49 <211> 36 párů bází <212> DNA <213> umělá sekvence <223> oligonukleotidový primer PCR <400> 49 gtattagatc tgttcctatg aacttggtcg tcacca
| <210> | 50 | |
| <211> | 28 párů bází | |
| <212> | DNA | |
| 20 | <213> | umělá sekvence |
<223> oligonukleotidový primer PCR <400> 50 cgcctctaga ctactgtata ggagccgg
| 25 <210> | 51 |
| <211> | 34 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
| 30 <400> | 51 |
catgccatgg aaaacatttc aagcctttta cgtg
| <210> <211> | 52 34 párů bází | |
| 35 | <212> | DNA |
| <213> | umělá sekvence | |
| <223> | oligonukleotidový primer PCR | |
| <400> | 52 | |
| cgacaagctt ctgtatagga gccggttgac | ||
| 40 | ||
| <210> | 53 | |
| <211> | 34 párů bází | |
| <212> | DNA | |
| <213> | umělá sekvence | |
| 45 | <223> | oligonukleotidový primer PCR |
| <400> | 53 |
catgccatgg ttcgtaaaaa taaggcagac caag
| <210> | 54 |
| <211> | 30 párů bází |
| <212> | DNA |
| <213> | umělá sekvence |
| <223> | oligonukleotidový primer PCR |
<400> 54 catgccatgg aagcctattg gaatgggaag <210> 55 <211> 1019 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 55
| Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val. | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Va 1 | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | lle | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 14 5 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 1 95 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
-76C7, 303675 B6
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | G i u | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| Hi s | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Gl u |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 4 90 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gl y | Asp | His | His | Hi s | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| V a 1 | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 57 0 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Tle | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Al a | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr- | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
7?
| 675 | 680 | 685 | |
| Met Ala 690 | Ser Gin | Thr Ile Phe Tyr Pro Phe 695 | His Ala Gly Asp Thr Tyr 700 |
| Leu Arg 705 | Val Asn | Pro Gin Phe Ala Val Pro 710 | Lys Gly Thr Asp Ala Leu 715 720 |
| Val Arg | Val Phe | Asp Glu Phe His Gly Asn 725 730 | Ala Tyr Leu Glu Asn Asn 735 |
| Tyr Lys | Val Gly 740 | Glu Ile Lys Leu Pro Ile 745 | Pro Lys Leu Asn Gin Gly 750 |
| Thr Thr | Arg Thr 755 | Ala Gly Asn Lys Ile Pro 760 | Val Thr Phe Met Ala Asn 765 |
| Ala Tyr 770 | Leu Asp | Asn Gin Ser Thr Tyr Ile 775 | Val Glu Val Pro Ile Leu 780 |
| Glu Lys 785 | Glu Asn | Gin Thr Asp Lys Pro Ser 790 | Ile Leu Pro Gin Phe Lys 795 800 |
| Arg Asn | Lys Ala | Gin Glu Asn Ser Lys Leu 805 810 | Asp Glu Lys Val Glu Glu 815 |
| Pro Lys | Thr Ser 820 | Glu Lys Val Glu Lys Glu 825 | Lys Leu Ser Glu Thr Gly 830 |
| Asn Ser | Thr Ser 835 | Asn Ser Thr Leu Glu Glu 840 | Val Pro Thr Val Asp Pro 845 |
| Val Gin 850 | Glu Lys | Val Ala Lys Phe Ala Glu 855 | Ser Tyr Gly Met Lys Leu 860 |
| Glu Asn 865 | Val Leu | Phe Asn Met Asp Gly Thr 870 | Ile Glu Leu Tyr Leu Pro 875 880 |
| Ser Gly | Glu Val | Ile Lys Lys Asn Met Ala 885 890 | Asp Phe Thr Gly Glu Ala 895 |
| Pro Gin | Gly Asn 900 | Gly Glu Asn Lys Pro Ser 905 | Glu Asn Gly Lys Val Ser 910 |
| Thr Gly | Thr Val 915 | Glu Asn Gin Pro Thr Glu 920 | Asn Lys Pro Ala Asp Ser 925 |
| Leu Pro 930 | Glu Ala | Pro Asn Glu Lys Pro Val 935 | Lys Pro Glu Asn Ser Thr 940 |
| Asp Asn 945 | Gly Met | Leu Asn Pro Glu Gly Asn 950 | Val Gly Ser Asp Pro Met 955 960 |
| Leu Asp | Pro Ala | Leu Glu Glu Ala Pro Ala 965 970 | Val Asp Pro Val Gin Glu 975 |
| Lys Leu | Glu Lys 980 | Phe Thr Ala Ser Tyr Gly 985 | Leu Gly Leu Asp Ser Val 990 |
| Ile Phe Asn Met Asp Gly Thr Ile Glu Leu 995 1000 Val Ile Lys Lys Asn Leu Ser Asp Phe Ile 1010 1015 <210> 56 <211> 489 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 56 | Arg Leu Pro Ser Gly Glu 1005 Ala | ||
| Cys Ala i | Tyr Ala | Leu Asn Gin His Arg Ser 5 10 | Gin Glu Asn Lys Asp Asn 15 |
| Asn Arg | Val Ser 20 | Tyr Val Asp Gly Ser Gin 25 | Ser Ser Gin Lys Ser Glu 30 |
| Asn Leu | Thr Pro 35 | Asp Gin Val Ser Gin Lys 40 | Glu Gly Ile Gin Ala Glu 45 |
| Gin Ile 50 | Val Tle | Lys Ile Thr Asp Gin Gly 55 | Tyr Val Thr Ser His Gly 60 |
| Asp His | Tyr His | Tyr Tyr Asn Gly Lys Val | Pro Tyr Asp Ala Leu Phe |
-78 CZ 303675 B6
| 65 | 70 | 75 | 30 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Gl u | Val | Lys | Gly | Gly | Tyr | ILe | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gl y | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val· | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyi | Ile | Val | Arg | His | Gly | Asp | HiS | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | I le | Ala | Glu |
| 420 | 42 5 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 430 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | |||||||
| 485 |
| <210> | 57 |
| <211> | 509 aminokyselin |
| <212> | protein |
| <213> | mikroorganizmus S.pneumoniae |
| <400> | 57 |
| Met | Lys | Phe | Ser | Lys Lys | Tyr | Ile | Ala | Ala | Gly | Ser | Ala | Val | Ile | Val |
| 1 | 5 | 10 | 15 | |||||||||||
| Ser | Leu | Ser | Leu | Cys Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu |
| 20 | 25 | 30 | ||||||||||||
| Asn | Lys | Asp | Asn | Asn Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser |
| 35 | 40 | 45 | ||||||||||||
| Gin | Lys | Ser | Glu | Asn Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly |
| 50 | 55 | 60 | ||||||||||||
| Ile | Gin | Ala | Glu | Gin Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val |
| 65 | 70 | 75 | 80 | |||||||||||
| Thr | Ser | His | Gly | Asp His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr |
| 85 | 90 | 95 | ||||||||||||
| Asp | Ala | Leu | Phe | Ser Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin |
| 100 | 105 | 110 | ||||||||||||
| Leu | Lys | Asp | Ala | Asp Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile |
| 115 | 120 | 125 | ||||||||||||
| Lys | Val | Asp | Gly | Lys Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala |
| 130 | ] 35 | 140 | ||||||||||||
| Asp | Asn | Val | Arg | Thr Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His |
| 145 | 150 | 155 | 160 | |||||||||||
| Val | Lys | Asp | Asn | Glu Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser |
| 165 | 170 | 175 | ||||||||||||
| Gin | Gly | Arg | Tyr | Thr Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp |
| 180 | 185 | 190 | ||||||||||||
| Ile | Ile | Glu | Asp | Thr Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His |
| 195 | 200 | 205 | ||||||||||||
| Tyr | His | Tyr | Ile | Pro Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 210 | 215 | 220 | ||||||||||||
| Ala | Lys | Ala | His | Leu Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser |
| 225 | 230 | 235 | 240 | |||||||||||
| Tyr | Ser | Ser | Thr | Ala Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly |
| 245 | 250 | 255 | ||||||||||||
| Ser | Thr | Ser | Lys | Pro Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu |
| 260 | 265 | 270 | ||||||||||||
| Lys | Glu | Leu | Tyr | Asp Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp |
| 275 | 280 | 285 | ||||||||||||
| Gly | Leu | Val | Phe | Asp Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly |
| 290 | 295 | 300 | ||||||||||||
| Val | Ala | Ile | Pro | His Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys |
| 305 | 310 | 315 | 320 | |||||||||||
| Leu | Ser | Ala | Leu | Glu Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly |
| 325 | 330 | 335 | ||||||||||||
| Thr | Gly | Ser | Thr | Val Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser |
| 340 | 345 | 350 | ||||||||||||
| Ser | Leu | Gly | Ser | Leu Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys |
| 355 | 360 | 365 | ||||||||||||
| Gl u | Leu | Ser | Ser | Ala Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile |
| 370 | 375 | 380 | ||||||||||||
| Va 1 | Glu | Glu | Thr | Ala Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe |
| 385 | 390 | 395 | 400 | |||||||||||
| His | Tyr | Ile | Pro | Lys Ser | Asn | Gin | Ile | Gl y | Gin | Pro | Thr | Leu | Pro | Asn |
| 405 | 410 | 415 | ||||||||||||
| Asn | Ser | Leu | Ala | Thr Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr |
| 420 | 4 25 | 430 | ||||||||||||
| Ser | His | Gl u | Lys | His Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg |
| 4 35 | 440 | 445 | ||||||||||||
| Ile | ile | Ala | Glu | Asp Glu | Ser | Gl y | Phe | Val | Met | Ser | His | Gly | Asp | His |
- 80C.7. 303675 B6
Lys Ala
480
Leu Asp
495
| 4 50 | |
| Asn | His |
| 465 | |
| Ala | Gln |
| Ser | Leu |
| Tyr | Phe |
| Lys | His |
| Ser | Ser 500 |
| Phe | Lys 470 |
| Leu | Glu |
| 485 | |
| His | Glu |
55
Lys Asp
Glu Val
Gln Asp
| Leu | Thr |
| Lys | Thr |
| 490 | |
| Tyr | Pro |
| 505 |
| 4 60 | |
| Glu | Glu |
| 475 | |
| Ser | His |
| Gly | Asn |
Gln Ile
Asn Gly
Ala <210> <211>
<212>
<213> <400>
1057 aminokyselin protein mikroorganizmus S.pneumoniae 58
| Asp 1 | Leu | Thr | Glu | Glu 5 | Gln | Ile | Lys | Ala | Ala 10 | Gln | Lys | His | Leu | Glu 15 | Glu |
| Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gln |
| 20 | 25 | 30 | |||||||||||||
| Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile |
| 35 | 40 | 45 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gln | Tyr | Gly | Val | Lys | Arg | Glu |
| 50 | 55 | 60 | |||||||||||||
| Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly |
| 65 | 70 | 75 | 80 | ||||||||||||
| Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly | Ile |
| 85 | 90 | 95 | |||||||||||||
| G1 y | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val |
| 100 | 105 | 110 | |||||||||||||
| Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn |
| 115 | 120 | 125 | |||||||||||||
| Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gln | Asn | Phe | Thr |
| 130 | 135 | 140 | |||||||||||||
| Leu | Ala | Asn | Gly | Gln | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro | Asp |
| 165 | 170 | 175 | |||||||||||||
| Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly | Val |
| 180 | 185 | 190 | |||||||||||||
| Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gln | Pro | Tyr | Leu | Pro | Gly | Gln |
| 195 | 200 | 205 | |||||||||||||
| Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr |
| 210 | 215 | 220 | |||||||||||||
| Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Gln | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val |
| 245 | 250 | 255 | |||||||||||||
| Asn | Pro | Gln | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg | Val |
| 260 | 265 | 270 | |||||||||||||
| Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val |
| 275 | 280 | 285 | |||||||||||||
| Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gln | Gly | Thr | Thr | Arg |
| 290 | 295 | 300 | |||||||||||||
| Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Asp | Asn | Gln | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu |
| 325 | 330 | 335 | |||||||||||||
| Asn | Gln | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gln | Phe | Lys | Arg | Asn | Lys |
| 340 | 345 | 350 | |||||||||||||
| Ala | Gln | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr |
| 370 | 375 | 380 | |||||||||||||
| Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro | Val | Gin | Glu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val |
| 405 | 410 | 415 | |||||||||||||
| Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu |
| 420 | 425 | 430 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly |
| 435 | 440 | 445 | |||||||||||||
| Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr |
| 450 | 455 | 460 | |||||||||||||
| Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly |
| 485 | 490 | 4 95 | |||||||||||||
| Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro |
| 500 | 505 | 510 | |||||||||||||
| Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu |
| 515 | 520 | 525 | |||||||||||||
| Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn |
| 530 | 535 | 540 | |||||||||||||
| Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | I le | Lys |
| 545 | 550 | 555 | 560 | ||||||||||||
| Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | Lys | Leu | Arg | Tyr | Arg | Ser | Asn | His |
| 565 | 570 | 575 | |||||||||||||
| Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro | Ser | Pro | Gin | Pro | Thr | Pro |
| 580 | 585 | 590 | |||||||||||||
| Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro |
| 595 | 600 | 605 | |||||||||||||
| Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val |
| 610 | 615 | 620 | |||||||||||||
| Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro |
| 62 5 | 630 | 635 | 640 | ||||||||||||
| Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu |
| 645 | 650 | 655 | |||||||||||||
| Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp |
| 660 | 665 | 670 | |||||||||||||
| Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu |
| 675 | 680 | 685 | |||||||||||||
| Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp |
| 690 | 695 | 700 | |||||||||||||
| Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser |
| 705 | 710 | 715 | 720 | ||||||||||||
| Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile |
| 7 25 | 730 | 735 | |||||||||||||
| Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr |
| 740 | 745 | 750 | |||||||||||||
| Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu |
| 7 55 | 760 | 765 | |||||||||||||
| Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp |
| 770 | 775 | 780 | |||||||||||||
| Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Tle | Lys | Lys | Asp |
| 785 | 790 | 795 | 800 | ||||||||||||
| Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu |
| 805 | 810 | 815 | |||||||||||||
| Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr |
-82C7. 303675 B6
| 820 | 825 | 830 | |
| Glu Ala | Lys Gly 835 | Ala Glu Ala Ile Tyr 840 | Asn Arg Val Lys Ala Ala Lys 845 |
| Lys Val 850 | Pro Leu | Asp Arg Met Pro Tyr 855 | Asn Leu Gin Tyr Thr Val Glu 860 |
| Val Lys 865 | Asn Gly | Ser Leu Ile Ile Pro 870 | His Tyr Asp His Tyr His Asn 875 880 |
| Ile Lys | Phe Glu | Trp Phe Asp Glu Gly 885 | Leu Tyr Glu Ala Pro Lys Gly 890 895 |
| Tyr Thr | Leu Glu 900 | Asp Leu Leu Ala Thr 905 | Val Lys Tyr Tyr Val Glu His 910 |
| Pro Asn | Glu Arg 915 | Pro His Ser Asp Asn 920 | Gly Phe Gly Asn Ala Ser Asp 925 |
| His Val 930 | Gin Arg | Asn Lys Asn Gly Gin 935 | Ala Asp Thr Asn Gin Thr Glu 940 |
| Lys Pro 945 | Ser Glu | Glu Lys Pro Gin Thr 950 | Glu Lys Pro Glu Glu Glu Thr 955 960 |
| Pro Arg | Glu Glu | Lys Pro Gin Ser Glu 965 | Lys Pro Glu Ser Pro Lys Pro 970 975 |
| Thr Glu | Glu Pro 980 | Glu Glu Glu Ser Pro 985 | Glu Glu Ser Glu Glu Pro Gin 990 |
| Val Glu | Thr Glu 995 | Lys Val Glu Glu Lys 1000 | Leu Arg Glu Ala Glu Asp Leu 1005 |
| Leu Gly 101C | Lys Ile 1 | Gin Asp Pro Ile Ile 1015 | Lys Ser Asn Ala Lys Glu Thr 1020 |
| Leu Thr 1025 | Gly Leu | Lys Asn Asn Leu Leu 1030 | Phe Gly Thr Gin Asp Asn Asn 1035 1040 |
| Thr Ile Lys | Met Ala | Glu Ala Glu Lys Leu 1045 | Leu Ala Leu Leu Lys Glu Ser 1050 1055 |
<210> <211>
<212>
<213> <400>
205 aminokyselin protein mikroorganizmus S.pneumoniae
| Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | dy | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Va 1 | Al a | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 1 60 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | ||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr |
| 180 | 185 | 190 | ||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | ||
| 195 | 200 | 205 |
<210> <211>
<212>
<213> <400>
821 aminokyselin protein mikroorganizmus S.pneumoniae 60
| Cys 1 | Ala | Tyr | Gl u | Leu 5 | Gly | Leu | His | Gin | Ala 10 | Gin | Thr | Val | Lys | Glu 15 | Asn |
| Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Lys | Gin | Ala | Thr | Gin | Lys | Thr | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ser |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gl y | Tyr | Val | Ile | Lys | Val | Asn | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Glu | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Ser | Gin | His | Arg |
| 130 | 135 | 140 | |||||||||||||
| Glu | Gly | Gly | Thr | Ser | Ala | Asn | Asp | Gly | Ala | Val | Ala | Phe | Ala | Arg | Ser |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gin | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Ile | Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | His | Tyr | Tle | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Ala | Giu | Ala | Phe | Leu | Ser | Gly | Arg | Glu | Asn | Leu | Ser | Asn | Leu | Arg | Thr |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Arg | Arg | Gin | Asn | Ser | Asp | Asn | Thr | Pro | Arg | Thr | Asn | Trp | Val | Pro |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ser | Val | Ser | Asn | Pro | Gly | Thr | Thr | Asn | Thr | Asn | Thr | Ser | Asn | Asn | Ser |
| 245 | 250 | 255 | |||||||||||||
| Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp | Ser | Leu | Leu |
| 260 | 265 | 270 | |||||||||||||
| Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin | Arg | His | Val | Glu | Ser | Asp |
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala | Arg | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr | Glu | Gin |
| 30 5 | 310 | 315 | 320 | ||||||||||||
| Met | Ser | Glu | Leu | Clu | Lys | Arg | Ile | Ala | Arg | Ile | I le | Pro | Leu | Arg | Tyr |
| 325 | 330 | 335 | |||||||||||||
| Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro | Ser | Pro |
| 340 | 34 5 | 350 | |||||||||||||
| Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro |
| 355 | 360 | 365 | |||||||||||||
| Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala |
- 84 CZ 303675 B6
| 370 | 37 5 | 380 | |||||||||||||
| Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser |
| 385 | 390 | 395 | 400 | ||||||||||||
| Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile |
| 405 | 410 | 415 | |||||||||||||
| Asp | Ser | Τ.νς | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Π o VJ j. y | Ala |
| 420 | 425 | 430 | |||||||||||||
| Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala |
| 435 | 440 | 445 | |||||||||||||
| Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly |
| 450 | 455 | 460 | |||||||||||||
| Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys |
| 465 | 4 70 | 475 | 480 | ||||||||||||
| Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe |
| 485 | 4 90 | 4 95 | |||||||||||||
| Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin |
| 500 | 505 | 510 | |||||||||||||
| Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Al a | Gl y | Lys |
| 515 | 520 | 525 | |||||||||||||
| Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser |
| 530 | 535 | 540 | |||||||||||||
| Asp | Glu | Gl y | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala |
| 565 | 570 | 575 | |||||||||||||
| Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp |
| 580 | 585 | 590 | |||||||||||||
| Ser | Gly | Asn | Thr | Glu | Al a | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val |
| 595 | 600 | 605 | |||||||||||||
| Lys | Al a | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Thr | Val | Gl u | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp |
| 62 5 | 630 | 635 | 640 | ||||||||||||
| His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu |
| 645 | 650 | 655 | |||||||||||||
| Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr |
| 660 | 665 | 670 | |||||||||||||
| Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | dy | Phe | Gly |
| 675 | 680 | 685 | |||||||||||||
| Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala | Asp | Thr |
| 690 | 695 | 700 | |||||||||||||
| Asn | Gl n | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | Glu | Lys | Pro |
| 705 | 710 | 715 | 720 | ||||||||||||
| Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys | Pro | Glu |
| 725 | 730 | 735 | |||||||||||||
| Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu | Glu | Ser |
| 740 | 745 | 750 | |||||||||||||
| Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | Leu | Arg | Glu |
| 755 | 760 | 765 | |||||||||||||
| Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile | Lys | Ser | Asn |
| 770 | 775 | 780 | |||||||||||||
| Al a | Tys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe | Gly | Thr |
| 785 | 790 | 7 95 | 800 | ||||||||||||
| Gin | Asp | Asn | Asn | Thr | ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu | Ala | Leu |
| 805 | 810 | 815 | |||||||||||||
| Leu | Lys | Glu | Ser | Lys | |||||||||||
| 820 |
<210> 61 <211> 334 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 61
| Cys 1 | Ala | Tyr | Glu | Leu 5 | Gly | Leu | His | Gin | Ala 10 | Gin | Thr | Val | Lys | Glu 15 | Asn |
| Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Lys | Gin | Ala | Thr | Gin | Lys | Thr | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | lle | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ser |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Tle | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Glu | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Ser | Gin | His | Arg |
| 130 | 135 | 140 | |||||||||||||
| Glu | Gly | Gly | Thr | Ser | Ala | Asn | Asp | Gly | Ala | Val | Ala | Phe | Ala | Arg | Ser |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gin | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | lle | Phe | Asn | Ala | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Ile | Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Ala | Glu | Ala | Phe | Leu | Ser | Gly | Arg | Glu | Asn | Leu | Ser | Asn | Leu | Arg | Thr |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Arg | Arg | Gin | Asn | Ser | Asp | Asn | Thr | Pro | Arg | Thr | Asn | Trp | Val | Pro |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ser | Val | Ser | Asn | Pro | Gly | Thr | Thr | Asn | Thr | Asn | Thr | Ser | Asn | Asn | Ser |
| 245 | 250 | 255 | |||||||||||||
| Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp | Ser | Leu | Leu |
| 260 | 265 | 270 | |||||||||||||
| Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin | Arg | His | Val | Glu | Ser | Asp |
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala | Arg | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Val. | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr | Glu | Gin |
| 305 | 310 | 315 | 320 | ||||||||||||
| Mel | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu | ||
| 325 | 330 |
io <210> 62 <211> 487 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 62
| Arg | Tyr | Arg | Ser | Asn | H i s | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ser | Pro | Gl.n | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro |
| 20 | 25 | 30 | |||||||||||||
| Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys |
-86CZ 303675 B6
| 35 | 40 | 45 | |||||||||||||
| Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | GJy |
| 50 | 55 | 60 | |||||||||||||
| Val | Ser | Arg | Tyr | lle | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 65 | 70 | 75 | 80 | ||||||||||||
| Gly | lle | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | T Ί 4-'t7 L4 |
| 85 | 90 | 95 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 100 | 105 | 110 | |||||||||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | lle | His | Gin | Asp | Leu | Leu | Asp | Asn |
| 115 | 120 | 125 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 130 | 135 | 140 | |||||||||||||
| Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | lle | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | lle | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 165 | 170 | 175 | |||||||||||||
| Ala | Gin | lle | Thr | Tyr | Thr | Asp | Asp | Glu | lle | Gin | Val | Ala | Lys | Leu | Ala |
| 180 | 185 | 190 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Tle | Phe | Asp | Pro | Arg | Asp | Tle |
| 195 | 200 | 205 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser |
| 210 | 215 | 220 | |||||||||||||
| His | Trp | lle | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 225 | 2 30 | 235 | 240 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 245 | 250 | 255 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | lle | Tyr | Asn |
| 260 | 265 | 270 | |||||||||||||
| Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 275 | 280 | 285 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | lle | lle | Pro | His |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | I ie | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val |
| 325 | 330 | 335 | |||||||||||||
| Lys | TyL | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly |
| 340 | 34 5 | 350 | |||||||||||||
| Phe | Gly | Asn | Ala | Ser | Asp | H ls | Val | Gin | Arg | Asn | Lys | Asn | Giy | Gin | Ala |
| 35 5 | 360 | 365 | |||||||||||||
| Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | Glu |
| 370 | 375 | 38 0 | |||||||||||||
| Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys |
| 385 | 390 | 395 | 400 | ||||||||||||
| Pro | Glu | Ser | Pro | Lys | Pro | Thr | Gl u | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu |
| 405 | 410 | 415 | |||||||||||||
| Glu | Ser | Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | Leu |
| 420 | 425 | 430 | |||||||||||||
| Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | lle | Gin | Asp | Pro | lle | lle | Lys |
| 435 | 440 | 445 | |||||||||||||
| Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe |
| 450 | 455 | 460 | |||||||||||||
| Giy | Thr | Gin | Asp | Asn | Asn | Thr | lle | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Leu | Leu | Lys | Glu | Ser | Lys | |||||||||
| 485 |
<210> <211> <212>
<213>
<400>
613 aminokyselin protein mikroorganizmus S.pneumoniae 63
| Ala 1 | Glu | Ala | Phe | Leu 5 | Ser | Gly | Arg | Glu | Asn 10 | Leu | Ser | Asn | Leu | Arg 15 | Thr |
| Tyr | Arg | Arg | Gin | Asn | Ser | Asp | Asn | Thr | Pro | Arg | Thr | Asn | Trp | Val | Pro |
| 20 | 25 | 30 | |||||||||||||
| Ser | Val | Ser | Asn | Pro | Gly | Thr | Thr | Asn | Thr | Asn | Thr | Ser | Asn | Asn | Ser |
| 35 | 40 | 45 | |||||||||||||
| Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp | Ser | Leu | Leu |
| 50 | 55 | 60 | |||||||||||||
| Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin | Arg | His | Val | Glu | Ser | Asp |
| 65 | 70 | 75 | 80 | ||||||||||||
| Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala | Arg | Gly |
| 85 | 90 | 95 | |||||||||||||
| Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr | Glu | Gin |
| 100 | 105 | 110 | |||||||||||||
| Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu | Arg | Tyr |
| 115 | 120 | 125 | |||||||||||||
| Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro | Ser | Pro |
| 130 | 135 | 140 | |||||||||||||
| Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala |
| 165 | 170 | 175 | |||||||||||||
| Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser |
| 180 | 185 | 190 | |||||||||||||
| Arg | Tyr | Ile | Pro | Ala | Lys | Asn | 'Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile |
| 195 | 200 | 205 | |||||||||||||
| Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala |
| 210 | 215 | 220 | |||||||||||||
| Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala |
| 225 | 230 | 235 | 240 | ||||||||||||
| Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly |
| 245 | 250 | 255 | |||||||||||||
| Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys |
| 260 | 265 | 270 | |||||||||||||
| Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe |
| 275 | 280 | 285 | |||||||||||||
| Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin |
| 290 | 295 | 300 | |||||||||||||
| Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Al a | Lys | Leu | Ala | Gly | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser |
| 325 | 330 | 335 | |||||||||||||
| Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp |
| 340 | 345 | 350 | |||||||||||||
| Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala |
| 355 | 360 | 365 | |||||||||||||
| Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp |
| 370 | 375 | 380 | |||||||||||||
| Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val |
| 335 | 390 | 395 | 400 | ||||||||||||
| Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin |
| 405 | 410 | 415 | |||||||||||||
| Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp |
- 88 CZ 303675 B6
| 420 | 425 | 430 | |||||||||||||
| His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu |
| 435 | 440 | 445 | |||||||||||||
| Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr |
| 450 | 455 | 4 60 | |||||||||||||
| Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly |
| 4 65 | 470 | 475 | 480 | ||||||||||||
| Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala | Asp | Thr |
| 485 | 490 | 495 | |||||||||||||
| Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | Glu | Lys | Pro |
| 500 | 505 | 510 | |||||||||||||
| Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys | Pro | Glu |
| 515 | 520 | 525 | |||||||||||||
| Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu | Glu | Ser |
| 530 | 535 | 540 | |||||||||||||
| Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | Leu | Arg | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Glu | Asp | Leu | Leu | Gly | Lys | ile | Gin | Asp | Pro | Tle | Ile | Lys | Ser | Asn |
| 565 | 570 | 575 | |||||||||||||
| Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe | Gly | Thr |
| 580 | 585 | 590 | |||||||||||||
| Gin | Asp | Asn | Asn | Thr | Tle | Met | Ala | Gl u | Ala | Glu | Lys | Leu | Leu | Ala | Leu |
| 595 | 600 | 605 | |||||||||||||
| Leu | Lys | Glu | Ser | Lys |
610 <210> <211>
<212>
<213> <400>
568 aminokyselin protein mikroorganizmus S.pneumoniae 64
| Asp 1 | Leu | Thr | Glu | Glu 5 | Gin | Ile | Lys | Ala | Ala 10 | Gin | Lys | His | Leu | Glu 15 | Glu |
| Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin |
| 20 | 25 | 30 | |||||||||||||
| Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile |
| 35 | 40 | 45 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu |
| 50 | 55 | 60 | |||||||||||||
| Ser | Ile | Val | Val | Asn | Lys | Gl u | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly |
| 65 | 7 0 | 75 | 80 | ||||||||||||
| Asp | Hís | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly | Ile |
| 85 | 90 | 95 | |||||||||||||
| Gly | Hís | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val |
| 100 | 105 | 110 | |||||||||||||
| Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn |
| 115 | 120 | 125 | |||||||||||||
| Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr |
| 130 | 135 | 140 | |||||||||||||
| Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro | Asp |
| 165 | 170 | 175 | |||||||||||||
| Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly | Val |
| 180 | 185 | 1 90 | |||||||||||||
| Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin |
| 195 | 200 | 205 | |||||||||||||
| Thr | Phe | I.ys | Tyr | Thr | Ile | Al a | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr |
| 210 | 215 | 220 | |||||||||||||
| Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val |
| 245 | 250 | 255 | |||||||||||||
| Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg | Val |
| 260 | 265 | 270 | |||||||||||||
| Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val |
| 275 | 280 | 285 | |||||||||||||
| Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg |
| 290 | 295 | 300 | |||||||||||||
| Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu |
| 325 | 330 | 335 | |||||||||||||
| Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys |
| 340 | 345 | 350 | |||||||||||||
| Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr |
| 370 | 375 | 380 | |||||||||||||
| Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro | Val | Gin | Glu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val |
| 405 | 410 | 415 | |||||||||||||
| Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu |
| 420 | 425 | 430 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly |
| 435 | 440 | 445 | |||||||||||||
| Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr |
| 450 | 455 | 4 60 | |||||||||||||
| Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly |
| 485 | 4 90 | 495 | |||||||||||||
| Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro |
| 500 | 505 | 510 | |||||||||||||
| Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu |
| 515 | 520 | 525 | |||||||||||||
| Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn |
| 530 | 535 | 540 | |||||||||||||
| Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys |
| 545 | 550 | 555 | 560 | ||||||||||||
| Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | ||||||||
| 565 |
<210> <211>
<212>
<213> <400>
329 aminokyselin protein mikroorganizmus S.pneumoniae 65
| Asp 1 | Leu | Thr | Glu | Glu 5 | Gin | Ile | Lys | Ala | Ala 10 | Gin | Lys | His | Leu | Glu 15 | Glu |
| Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin |
| 20 | 2 5 | 30 | |||||||||||||
| Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile |
| 3 5 | 40 | 45 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu |
-90C7. 303675 Bó
| 50 | 55 | 60 |
| Ser Ile Val Val Asn Lys | Glu Lys Asn Ala | Ile Ile Tyr Pro His Gly |
| 65 70 | 7 5 80 | |
| Asp His His His Ala Asp | Pro Ile Asp Glu | His Lys Pro Val Gly Ile |
| 85 | 90 | 95 |
| Gly His Ser His Ser Asn | Tyr Glu Leu Phe | Lys Pro Glu Glu Gly Val |
| 10 0 | 105 | 110 |
| Ala Lys Lys Glu Gly Asn | Lys Val Tyr Thr | Gly Glu Glu Leu Thr Asn |
| 115 | 120 | 125 |
| Val Val Asn Leu Leu Lys | Asn Ser Thr Phe | Asn Asn Gin Asn Phe Thr |
| 130 | 135 | 140 |
| Leu Ala Asn Gly Gin Lys | Arg Val Ser Phe | Ser Phe Pro Pro Glu Leu |
| 145 150 | 155 160 | |
| Glu Lys Lys Leu Gly Ile | Asn Met Leu Val | Lys Leu Ile Thr Pro Asp |
| 165 | 170 | 175 |
| Gly Lys Val Leu Glu Lys | Val Ser Gly Lys | Val Phe Gly Glu Gly Val |
| 180 | 185 | 190 |
| Gly Asn Ile Ala Asn Phe | Glu Leu Asp Gin | Pro Tyr Leu Pro Gly Gin |
| 195 | 200 | 205 |
| Thr Phe Lys Tyr Thr Ile | Ala Ser Lys Asp | Tyr Pro Glu Val Ser Tyr |
| 210 | 215 | 220 |
| Asp Gly Thr Phe Thr Val | Pro Thr Ser Leu | Ala Tyr Lys Met Ala Ser |
| 225 230 | 235 240 | |
| Gin Thr Ile Phe Tyr Pro | Phe His Ala Gly | Asp Thr Tyr Leu Arg Val |
| 245 | 250 | 255 |
| Asn Pro Gin Phe Ala Val | Pro Lys Gly Thr | Asp Ala Leu Val Arg Val |
| 260 | 265 | 270 |
| Phe Asp Glu Phe His Gly | Asn Ala Tyr Leu | Glu Asn Asn Tyr Lys Val |
| 275 | 280 | 285 |
| Gly Glu Ile Lys Leu Pro | Ile Pro Lys Leu | Asn Gin Gly Thr Thr Arq |
| 290 | 295 | 300 |
| Thr Ala Gly Asn Lys Ile | Pro Val Thr Phe | Met Ala Asn Ala Tyr Leu |
| 305 310 | 315 320 | |
| Asp Asn Gin Ser Thr Tyr | Ile Val Glu | |
| 325 | ||
| <210> 66 | ||
| <211> 240 aminokyselin | ||
| <212> protein | ||
| <213> mi kroorganizmus S.pneumoniae | ||
| <400> 66 | ||
| Glu Val Pro Ile Leu Glu | Lys Glu Asn Gin | Thr Asp Lys Pro Ser Ile |
| 1 5 | 10 | 15 |
| Leu Pro Gin Phe Lys Arg | Asn Lys Ala Gin | Glu Asn Ser Lys Leu Asp |
| 20 | 25 | 30 |
| Glu Lys Val Glu Glu Pro | Lys Thr Ser Glu | Lys Val Glu Lys Glu Lys |
| 35 | 40 | 45 |
| Leu Ser Glu Thr Gly Asn | Ser Thr Ser Asn | Ser Thr Leu Glu Glu Val |
| 50 | 55 | 60 |
| Pro Thr Val Asp Pro Val | Gin Glu Lys Val | Ala I.ys Phe Ala Glu Ser |
| 65 70 | 75 80 | |
| Tyr Gly Met Lys Leu Glu | Asn Val Leu Phe | Asn Met Asp Gly Thr Ile |
| 85 | 90 | 95 |
| Glu Leu Tyr Leu Pro Ser | Gly Glu Val Ile | Lys Lys Asn Met Ala Asp |
| 100 | 105 | 110 |
| Phe Thr Gly Glu Ala Pro | Gin Gly Asn Gly | Glu Asn Lys Pro Ser Glu |
| ] 15 | 120 | 125 |
| Asn Gly Lys Val Ser Thr | Gly Thr Val Glu | Asn Gin Pro Thr Glu Asn |
-to
| 130 | 1,35 | 140 | |||||||||||||
| Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys |
| 145 | 150 | 155 | 160 | ||||||||||||
| Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val |
| 165 | 170 | 175 | |||||||||||||
| Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val |
| 180 | 185 | 190 | |||||||||||||
| Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu |
| 195 | 200 | 205 | |||||||||||||
| Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg |
| 210 | 215 | 220 | |||||||||||||
| Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
| 225 | 230 | 235 | 240 |
<210> <211>
<212>
<213> <400
555 aminokyselin protein mikroorganizmus S.pneumoniae 67
| Asp Ile Asp Ser Leu Leu Lys Gin Leu Tyr Lys Leu Pro Leu Ser Gin | |||||||||||||||
| 1 | 5 | 10 | 15 | ||||||||||||
| Arg | His | Val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr |
| 20 | 25 | 30 | |||||||||||||
| Ser | Arg | Thr | Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His |
| 35 | 40 | 45 | |||||||||||||
| Phe | Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg |
| 50 | 55 | 60 | |||||||||||||
| Ile | Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg |
| 65 | 70 | 75 | 80 | ||||||||||||
| Pro | Glu | Glu | Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro |
| 85 | 90 | 95 | |||||||||||||
| Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu |
| 100 | 105 | HO | |||||||||||||
| Lys | Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe |
| 115 | 120 | 125 | |||||||||||||
| Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala |
| 130 | 135 | 140 | |||||||||||||
| Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg |
| 165 | 170 | 175 | |||||||||||||
| Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp |
| 180 | 185 | 190 | |||||||||||||
| Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn |
| 195 | 200 | 205 | |||||||||||||
| Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val |
| 210 | 215 | 220 | |||||||||||||
| Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val |
| 245 | 250 | 255 | |||||||||||||
| Ala | Lys | Lo u | Ala | Gl y | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp |
| 260 | 265 | 270 | |||||||||||||
| Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His |
| 275 | 280 | 285 | |||||||||||||
| Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu |
| 290 | 295 | 30 0 | |||||||||||||
| Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro |
-92CZ 303675 B6
| 305 | 310 | 315 | 320 | ||||||||||||
| Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu |
| 325 | 330 | 335 | |||||||||||||
| Ala | Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg |
| 340 | 34 5 | 350 | |||||||||||||
| Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gl y | Ser | Leu |
| 355 | 360 | 365 | |||||||||||||
| Ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe |
| 370 | 375 | 380 | |||||||||||||
| Asp | Glu | Gly | Leu | Tyr | Glu | Al a | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His |
| 405 | 4 10 | 415 | |||||||||||||
| Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys |
| 420 | 425 | 430 | |||||||||||||
| Asn | Gly | Gin | Ala | Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys |
| 435 | 440 | 445 | |||||||||||||
| Pro | Gin | Thr | Glu | Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro |
| 450 | 455 | 460 | |||||||||||||
| Gl n | Ser | Glu | Lys | Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Glu | Ser | Pro | Glu | Glu | Ser | Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val |
| 485 | 4 90 | 4 95 | |||||||||||||
| Glu | Glu | Lys | Leu | Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp |
| 500 | 505 | 510 | |||||||||||||
| Pro | Ile | Ile | Lys | Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn |
| 515 | 520 | 525 | |||||||||||||
| Asn | Leu | Leu | Phe | Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala |
| 530 | 535 | 540 | |||||||||||||
| Gl u | Lys | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys |
545 550 555 <210> 68 <211> 428 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 68
| Asp | Ile | Asp | Ser | Leu | Leu | Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin |
| 1 | 5 | 10 | 15 | ||||||||||||
| Arg | His | Val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | I le | Thr |
| 20 | 25 | 30 | |||||||||||||
| Ser | Arg | Thr | Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His |
| 35 | 40 | 45 | |||||||||||||
| Phe | Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg |
| 50 | 55 | 60 | |||||||||||||
| Ile | Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg |
| 65 | 70 | 75 | 80 | ||||||||||||
| Pro | Glu | Glu | Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro |
| 85 | 90 | 95 | |||||||||||||
| Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu |
| 100 | 105 | 110 | |||||||||||||
| Lys | Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe |
| 115 | 120 | 125 | |||||||||||||
| Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala |
| 130 | 135 | 140 | |||||||||||||
| Glu | Thr | Zkla | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg |
IOCZ 303675 B6
| 165 | 170 | 175 | |
| Glu | Phe Tyr Asn Lys Ala Tyr Asp Leu | Leu Ala Arg | Ile His Gin Asp |
| 180 185 | 190 | ||
| Leu | Leu Asp Asn Lys Gly Arg Gin Val | Asp Phe Glu | Ala Leu Asp Asn |
| 195 200 | 205 | ||
| Leu | Leu Glu Arg Leu Lys Asp Val Ser | Ser Asp Lys | Val Lys Leu Val |
| 210 215 | 220 | ||
| Asp | Asp Ile Leu Ala Phe Leu Ala Pro | Ile Arg His | Pro Glu Arg Leu |
| 225 | 230 | 235 | 240 |
| Gly | Lys Pro Asn Ala Gin Ile Thr Tyr | Thr Asp Asp | Glu Ile Gin Val |
| 245 | 250 | 255 | |
| Ala | Lys Leu Ala Gly Lys Tyr Thr Thr | Glu Asp Gly | Tyr Ile Phe Asp |
| 260 265 | 270 | ||
| Pro | Arg Asp Ile Thr Ser Asp Glu Gly | Asp Ala Tyr | Val Thr Pro His |
| 275 280 | 285 | ||
| Met | Thr His Ser His Trp Ile Lys Lys | Asp Ser Leu | Ser Glu Ala Glu |
| 290 295 | 300 | ||
| Arg | Ala Ala Ala Gin Ala Tyr Ala Lys | Glu Lys Gly | Leu Thr Pro Pro |
| 305 | 310 | 315 | 320 |
| Ser | Thr Asp His Gin Asp Ser Gly Asn | Thr Glu Ala | Lys Gly Ala Glu |
| 325 | 330 | 335 | |
| Ala | Ile Tyr Asn Arg Val Lys Ala Ala | Lys Lys Val | Pro Leu Asp Arg |
| 340 345 | 350 | ||
| Met | Pro Tyr Asn Leu Gin Tyr Thr Val | Glu Val Lys | Asn Gly Ser Leu |
| 355 360 | 365 | ||
| Ile | Ile Pro His Tyr Asp His Tyr His | Asn Ile Lys | Phe Glu Trp Phe |
| 370 375 | 380 | ||
| Asp | Glu Gly Leu Tyr Glu Ala Pro Lys | Gly Tyr Thr | Leu Glu Asp Leu |
| 385 | 390 | 395 | 400 |
| Leu | Ala Thr Val Lys Tyr Tyr Val Glu | His Pro Asn | Glu Arg Pro His |
| 405 | 410 | 415 | |
| Ser | Asp Asn Gly Phe Gly Asn Ala Ser | Asp His Val | |
| 420 425 | |||
| <210> | 69 | ||
| <211> | 121 aminokyselin | ||
| <212> | protein | ||
| <213> | mikroorganizmus S.pneumoniae | ||
| <400> | 69 | ||
| Gly | Leu Tyr Glu Ala Pro Lys Gly Tyr | Thr Leu Glu | Asp Leu Leu Ala |
| 1 | 5 | 10 | 15 |
| Thr | Val Lvs Tyr Tyr Val Glu His Pro | Asn Glu Arg | Pro His Ser Asp |
| 20 25 | 30 | ||
| Asn | Gly Phe Gly Asn Ala Ser Asp His | Val Gin Arg | Asn Lys Asn Gly |
| 35 40 | 45 | ||
| Gin | Ala Asp Thr Asn Gin Thr Glu Lys | Pro Ser Glu | Glu Lys Pro Gin |
| 50 55 | 60 | ||
| Thr | Glu Lys Pro Glu Glu Glu Thr Pro | Arg Glu Glu | Lys Pro Gin Ser |
| 65 | 70 | 75 | 80 |
| Glu | Lys Pro Glu Ser Pro Lys Pro Thr | Glu Glu Pro | Glu Glu Glu Ser |
| 85 | 90 | 95 | |
| Pro | Glu Glu Ser Glu Glu Pro Gin Val | Glu Thr Glu | Lys Val Glu Glu |
| 100 105 | 110 | ||
| Lys | Leu Arg Glu Ala Glu Asp Leu Leu | ||
| 115 120 | |||
| <210> | 70 | ||
| <211> | 132 aminokyselin |
-94CZ 303675 Βό <212> protein <213> mikroorganizmus S.pneumoniae <400> 70
| Ala 1 | Ser | Asp | His | Val 5 | Gln | Arg | Asn |
| Gln | Thr | Glu | Lys 20 | Pro | Ser | Glu | Glu |
| Glu | Glu | Thr 35 | Pro | Arg | Glu | Glu | Lys 40 |
| Pro | Lys 50 | Pro | Thr | Glu | Glu | Pro 55 | Glu |
| Glu 65 | Pro | Gln | Val | Glu | Thr 70 | Glu | Lys |
| Glu | Asp | Leu | Leu | Gly 85 | Lys | Ile | Gln |
| Lys | GJu | Thr | Leu 100 | Thr | Gly | Leu | Lys |
| Asp Lys | Asn Glu 130 | Asn 115 Ser | Thr Lys | Ile | Met | Ala | Glu 120 |
| Lys | Asn 10 | Gly | Gln | Ala | Asp | Thr 15 | Asn |
| Lys 25 | Pro | Gln | Thr | Glu | Lys 30 | Pro | Glu |
| Pro | Gln | Ser | Glu | Lys 45 | Pro | Glu | Ser |
| Glu | Glu | Ser | Pro 60 | Glu | Glu | Ser | Glu |
| Val | Glu | Glu 75 | Lys | Leu | Arg | Glu | Ala 80 |
| Asp | Pro 90 | Ile | Ile | Lys | Ser | Asn 95 | Ala |
| Asn 105 | Asn | Leu | Leu | Phe | Gly 110 | Thr | Gln |
| Ala | Glu | Lys | Leu | Leu 125 | Ala | Leu | Leu |
<210> 71 <211 > 226 aminokyselin <212> protein <213> mikroorganizmus & pneumoniae <400> 71
| Asp 1 | Ile | Asp | Ser | Leu 5 | Leu | Lys | Gln |
| Arg | His | Val | Glu 20 | Ser | Asp | dy | Leu |
| Ser | Arg | Thr 35 | Ala | Arg | Gly | Val | Ala 40 |
| Phe | Ile 50 | Pro | Tyr | Glu | Gln | Met 55 | Ser |
| Ile 65 | Ile | Pro | Leu | Arg | Tyr 70 | Arg | Ser |
| Pro | Glu | Glu | Pro | Ser 85 | Pro | Gln | Pro |
| Gln | Pro | Ala | Pro 100 | Asn | Pro | Gln | Pro |
| Lys | Leu | Val 115 | Lys | Glu | Ala | Val | Arg 120 |
| Glu | Glu 130 | Asn | Gly | Val | Ser | Arg 135 | Tyr |
| Glu 145 | Thr | Ala | Ala | Gly | Ile 150 | Asp | Ser |
| Ser | His | Lys | Leu | Gly 165 | Ala | Lys | Lys |
| Glu | Phe | Tyr | Asn 180 | Lys | Ala | Tyr | Asp |
| Leu | Leu | Asp 195 | Asn | Lys | Gly | Arg | Gln 200 |
| Leu Asp | Leu 210 Asp | Glu | Arg | Leu | Lys | Asp 215 | Val |
| Leu | Tyr 10 | Lys | Leu | Pro | Leu | Ser 15 | Gln |
| Ile 25 | Phe | Asp | Pro | Ala | Gln 30 | Ile | Thr |
| Val | Pro | His | Gly | Asn 45 | His | Tyr | His |
| Glu | Leu | Glu | Lys 60 | Arg | Ile | Ala | Arg |
| Asn | His | Trp 75 | Val | Pro | Asp | Ser | Arg 80 |
| Thr | Pro 90 | Glu | Pro | Ser | Pro | Ser 95 | Pro |
| Ala 105 | Pro | Ser | Asn | Pro | Ile 110 | Asp | Glu |
| Lys | Val | Gly | Asp | Gly 125 | Tyr | Val | Phe |
| Ile | Pro | Ala | Lys 140 | Asn | Leu | Ser | Ala |
| Lys | Leu | Ala 155 | Lys | Gln | Glu | Ser | Leu 160 |
| Thr | Asp 170 | Leu | Pro | Ser | Ser | Asp 175 | Arg |
| Leu 185 | Leu | Ala | Arg | Tle | His 190 | Gln | Asp |
| Val | Asp | Phe | Glu | Ala 205 | Leu | Asp | Asn |
| Ser | Ser | Asp | Lys 220 | Val | Lys | Leu | Val |
225 <210> 72 <211> 203 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 72
| Asp 1 | Ile | Leu | Ala | Phe 5 | Leu Ala | Pro | Ile | Arg 10 | His | Pro | Glu | Arg | Leu 15 | Gly | |
| Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala |
| 20 | 25 | 30 | |||||||||||||
| Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro |
| 35 | 40 | 45 | |||||||||||||
| Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met |
| 50 | 55 | 60 | |||||||||||||
| Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser |
| 85 | 90 | 95 | |||||||||||||
| Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala |
| 100 | 105 | 110 | |||||||||||||
| Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met |
| 115 | 120 | 125 | |||||||||||||
| Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile |
| 130 | 135 | 140 | |||||||||||||
| Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp |
| 145 | 150 | 155 | 160 | ||||||||||||
| Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu |
| 165 | 170 | 175 | |||||||||||||
| Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser |
| 180 | 185 | 190 | |||||||||||||
| Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | |||||
| 195 | 200 |
<210> 73 <211 > 819 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 73
| Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | Val | Lys | Lys | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ser | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asp |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Va 1 | Tyr | Leu | Lys | Asp | Ai a | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 1 40 | |||||||||||||
| His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Ala | Ala | Ala | Arg | Ala | Gin | G1 y |
| 14 5 | 150 | 155 | 160 | ||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Al a | Ser | Asp | Ile | Ile |
-96CZ 303675 B6
| 165 | 170 | 175 | |||||||||||||
| Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His | Tyr | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | Tle | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Gl u | Leu | Ala | Ala | Ala | Giu |
| 195 | 200 | 205 | |||||||||||||
| A_l a | Tyr | Trp | Asn | j. y | Τ , Λ | Gin | Gly | r* ~ oči | Arg | Pro | Ser | Ser | Ser | Ser | o „ |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Asn | Ala | Asn | Pro | Val | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Arg | Gly | Va L | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin | Pro |
| 32 5 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Leu | Gin | Pro | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Giy |
| 370 | 375 | 380 | |||||||||||||
| Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 38 5 | 390 | 395 | 400 | ||||||||||||
| Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Tyr | Asp) | Leu | Leu | Ala | Arg | Tle | Hn s | Gin | Asp | Leu | Leu | Asp | Asn |
| 4 35 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 460 | |||||||||||||
| Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu |
| 465 | 4 70 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 490 | 495 | |||||||||||||
| Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Al a |
| 500 | 505 | 510 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile |
| 515 | 520 | 525 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser |
| 530 | 535 | 540 | |||||||||||||
| His | Trp | I le | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 570 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn |
| 580 | 585 | 590 | |||||||||||||
| Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Tle | Ile | Pro | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | Tle | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
H7
| 625 | 630 | 635 | 640 |
| Tyr Glu | Ala Pro Lys Gly | Tyr Ser Leu Glu Asp Leu | Leu Ala Thr Val |
| 645 | 650 | 655 | |
| Lys Tyr | Tyr Val Glu His | Pro Asn Glu Arg Pro His | Ser Asp Asn Gly |
| 660 | 665 | 670 | |
| Phe Gly | Asn Ala Ser Asp | His Val Arg Lys Asn Lys | Ala Asp Gin Asp |
| 675 | 680 | 685 | |
| Ser Lys | Pro Asp Glu Asp | Lys Glu His Asp Glu Val | Ser Glu Pro Thr |
| 690 | 695 700 | ||
| His Pro | Glu Ser Asp Glu | Lys Glu Asn His Ala Gly | Leu Asn Pro Ser |
| 705 | 710 | 715 | 720 |
| Ala Asp | Asn Leu Tyr Lys | Pro Ser Thr Asp Thr Glu | Glu Thr Glu Glu |
| 725 | 730 | 735 | |
| Glu Ala | Glu Asp Thr Thr | Asp Glu Ala Glu Ile Pro | Gin Val Glu Asn |
| 740 | 745 | 750 | |
| Ser Val | Ile Asn Ala Lys | Ile Ala Asp Ala Glu Ala | Leu Leu Glu Lys |
| 755 | 760 | 765 | |
| Val Thr | Asp Pro Ser Ile | Arg Gin Asn Ala Met Glu | Thr Leu Thr Gly |
| 770 | 775 780 | ||
| Leu Lys | Ser Ser Leu Leu | Leu Gly Thr Lys Asp Asn | Asn Thr Ile Ser |
| 785 | 790 | 795 | 800 |
| Ala Glu | Val Asp Ser Leu | Leu Ala Leu Leu Lys Glu | Ser Gin Pro Ala |
| 805 | 810 | 815 | |
| Pro Ile | Gin | ||
| <210> 74 | |||
| <211> 568 aminokyselin | |||
| <212> protein | |||
| <213> mikroorganizmus S.pneumoniae | |||
| <400> 74 |
| Glu | Asn | Ile | Ser | Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser |
| 1 | 5 | 10 | 15 | ||||||||||||
| Glu | Arg | His | Val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile |
| 20 | 25 | 30 | |||||||||||||
| Thr | Ser | Arg | Thr | Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr |
| 35 | 40 | 45 | |||||||||||||
| His | Phe | Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala |
| 50 | 55 | 60 | |||||||||||||
| Arg | lle | Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser |
| 65 | 70 | 75 | 80 | ||||||||||||
| Arg | Pro | Glu | Gin | Pro | Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser |
| 85 | 90 | 95 | |||||||||||||
| Leu | Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp |
| 100 | 105 | 110 | |||||||||||||
| Glu | Lys | Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val |
| 115 | 120 | 125 | |||||||||||||
| Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser |
| 130 | 135 | 140 | |||||||||||||
| Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser |
| 145 | 1 50 | 155 | 160 | ||||||||||||
| Leu | Ser | H i s | Lys | Leu | Gly | Al a | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin |
| 180 | 185 | 190 | |||||||||||||
| Asp | Leu | Le u | Asp | Asn | T.ys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu | Asp |
| 195 | 200 | 205 | |||||||||||||
| Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu |
-98 Q7. 303675 B6
| 210 | 215 | ||||||
| Val 225 | Asp | Asp | Ile | Leu | Ala 230 | Phe | Leu |
| Leu | Gly | Lys | Pro | Asn 245 | Ala | Gin | Ile |
| Val | Ala | Lys | Leu 260 | Ala | Gly | Lys | Tyr |
| Asp | Pro | Arg 275 | Asp | Ile | Thr | Ser | Asp 280 |
| His | Met 290 | Thr | His | Ser | His | Trp 295 | Ile |
| Glu 305 | Arg | Ala | Ala | Ala | Gin 310 | Ala | Tyr |
| Pro | Ser | Thr | Asp | His 325 | Gin | Asp | Ser |
| Glu | Ala | Ile | Tyr 340 | Asn | Arg | Val | Lys |
| Arg | Met | Pro 355 | Tyr | Asn | Leu | Gin | Tyr 360 |
| Leu | Ile 370 | Ile | Pro | His | Tyr | Asp 375 | His |
| Phe 385 | Asp | Glu | Gly | Leu | Tyr 390 | Glu | Ala |
| Leu | Leu | Ala | Thr | Val 405 | Lys | Tyr | Tyr |
| His | Ser | Asp | Asn 420 | Gly | Phe | Gly | Asn |
| Lys | Ala | Asp 435 | Gin | Asp | Ser | Lys | Pro 440 |
| Val | Ser 450 | Glu | Pro | Thr | His | Pro 455 | Glu |
| Gly 465 | Leu | Asn | Pro | Ser | Ala 470 | Asp | Asn |
| Glu | Glu | Thr | Glu | Glu 4 85 | Glu | Ala | Glu |
| Pro | Gin | Val | Glu 500 | Asn | Ser | Val | Ile |
| Ala | Leu | Leu 515 | Glu | Lys | Val | Thr | Asp 520 |
| Glu | Thr 530 | Leu | Thr | Gly | Leu | Lys 535 | Ser |
| Asn 545 | Asn | Thr | Ile | Ser | Ala 550 | Glu | Val |
| Glu | Ser | Gin | Pro | Ala 565 | Pro | ile | Gin |
| 220 | |||||||
| Ala | Pro | Ile 235 | Arg | His | Pro | Glu | Arg 240 |
| Thr | Tyr 250 | Thr | Asp | Asp | Glu | Ile 255 | Gin |
| Thr 265 | Thr | Glu | Asp | Gly | Tyr 270 | Ile | Phe |
| Glu | GJ y | Asp | Ala | Tyr 285 | Val | Thr | Pro |
| Lys | Lys | Asp | Ser 300 | Leu | Ser | Glu | Ala |
| Ala | Lys | Glu 315 | Lys | Gly | Leu | Thr | Pro 320 |
| Gly | Asn 330 | Thr | Glu | Ala | Lys | Gly 335 | Ala |
| Ala 345 | Ala | Lys | Lys | Val | Pro 350 | Leu | Asp |
| Thr | Val | Glu | Val | Lys 365 | Asn | Gly | Ser |
| Tyr | His | Asn | Ile 380 | Lys | Phe | Glu | Trp |
| Pro | Lys | Gly 395 | Tyr | Ser | Leu | Glu | Asp 400 |
| Val | Glu 410 | His | Pro | Asn | Glu | Arg 415 | Pro |
| Ala 425 | Ser | Asp | His | Val | Arg 430 | Lys | Asn |
| Asp | Glu | Asp | Lys | Glu 445 | His | Asp | Glu |
| Ser | Asp | Glu | Lys 460 | Glu | Asn | His | Ala |
| Leu | Tyr | Lys 475 | Pro | Ser | Thr | Asp | Thr 480 |
| Asp | Thr 490 | Thr | Asp | Glu | Ala | Glu 495 | Ile |
| Asn 505 | Ala | Lys | Ile | Ala | Asp 510 | Ala | Glu |
| Pro | Ser | Ile | Arg | Gin 525 | Asn | Ala | Met |
| Ser | Leu | Leu | Leu 540 | Gly | Thr | Lys | Asp |
| Asp | Ser | Leu 555 | Leu | Ala | Leu | Leu | Lys 560 |
| <210> | 75 |
| 5 <211> | 140 aminokyselin |
| <212> | protein |
| <213> | mikroorganizmus S.pnewnoniae |
| <400> | 75 |
| Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin |
| 1 | 5 | ||||||
| Glu | His | Asp | Glu | Val | Ser | Glu | Pro |
| 20 | |||||||
| Glu | Asn | His | Ala | Gly | Leu | Asn | Pro |
| 35 | 40 | ||||||
| Ser | Thr | As o | Thr | Glu | Glu | Thr | Glu |
| Asp | Ser 10 | Lys | Pro | Asp | Glu | Asp 15 | Lys |
| Thr 25 | His | Pro | Glu | Ser | Asp 30 | Glu | Lys |
| Ser | Ala | Asp | Asn | Leu 45 | Tyr | Lys | Pro |
| Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp |
1344
| Asn | Ser | Leu | Ala 420 | Thr | Pro | Ser | Pro | Ser 425 | Leu | Pro | Ile | Asn | Pro 430 | Gly | Thr |
| tca | cat | gag | aaa | cat | gaa | gaa | gat | gga | tac | gga | ttt | gat | get | aat | cgt |
| Ser | His | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg |
| 435 | 440 | 445 | |||||||||||||
| att | atc | get | gaa | gat | gaa | tca | ggt | ttt | gtc | atg | agt | cac | gga | gac | cac |
| Ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His |
| 450 | 455 | 460 | |||||||||||||
| aat | cat | tat | ttc | ttc | aag | aag | gac | ttg | aca | gaa | gag | caa | att | aag | gtg |
| Asn | His | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Val |
| 465 | 470 | 475 | 480 |
1392
1440
1455 cgc aaa aac att tag
| ' Arg Lys Asn Ile | |
| <210> | 8 |
| <211> | 484 aminokyselin |
| <212> | protein |
| <213> | mikroorganizmus S.pneumoniae |
| <400> | 8 |
| Met 1 | Lys | Phe Ser | Lys 5 | Lys Tyr Ile Ala | Ala 10 | Gly Ser | Ala | Val | Ue 15 | Val | |||||
| Ser | Leu | Ser | Leu | Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Lys | Asp | Asn | Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser |
| 35 | 40 | 45 | |||||||||||||
| Gin | Lys | Ser | Glu | Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly |
| 50 | 55 | 60 | |||||||||||||
| Ile | Gin | Ala | Glu | Gin | Ile | Val | Ue | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val |
| 65 | 70 | 75 | 80 | ||||||||||||
| Thr | Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ala | Leu | Phe | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin |
| 100 | 105 | 110 | |||||||||||||
| Leu | Lys | Asp | Ala | Asp | Ue | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ue | Ile |
| 115 | 120 | 125 | |||||||||||||
| Lys | Val | Asp | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala |
| 130 | 135 | 140 | |||||||||||||
| Asp | Asn | Val | Arg | Thr | Lys | Asp | Glu | Ue | Asn | Arg | Gin | Lys | Gin | Glu | His |
| 145 | 150 | 155 | 160 | ||||||||||||
| Val | Lys | Asp | Asn | Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser |
| 165 | 170 | 175 | |||||||||||||
| Gin | Gly | Arg | Tyr | Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp |
| 180 | 185 | 190 | |||||||||||||
| I Le | Ile | Glu | Asp | Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His |
| 195 | 200 | 205 | |||||||||||||
| Tyr | His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Al a | Ala |
| 210 | 215 | 220 | |||||||||||||
| Ala | Lys | Ala | His | Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser |
| 225 | 230 | 235 | 24 0 | ||||||||||||
| Tyr | Ser | Ser | Thr | Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly |
| 245 | 250 | 255 | |||||||||||||
| Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu |
| att Ile | atc Ile | gaa Glu ±95 | gat Asp | acg Thr | ggt Gly | aat Asn | gct Ala 2 00 | tat Tyr | atc Ile | gtt Val | cct Pro | cat His 203 | gga Gly | ggt G.ly | cac His | 624 |
| tat | cac | tac | att | CCC | aaa | age | gat | tta | tet | gct | agt | gaa | tta | gca | gca | 672 |
| Tyr | lira | Ti , -v- 1 yr | Tle | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | AJ a | |
| 210 | 215 | 220 | ||||||||||||||
| gct | aaa | gca | cat | ctg | gct | gga | aaa | aat | atg | caa | ccg | agt | cag | tta | age | 720 |
| Ala | Lys | Ala | His | Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | |
| 225 | 2 30 | 235 | 240 | |||||||||||||
| t a 1. | tet | t ca | aca | gct | agt | gac | aat | aac | acg | caa | tet | gta | gca | aaa | gga | 768 |
| Tyr | Ser | Ser | Thr | AI a | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | |
| 245 | 250 | 2 55 | ||||||||||||||
| tea | act | age | aag | cca | gca | aat | 3 3 a | tet | gaa | aat | ctc | cag | agt | ctt | ttg | 816 |
| Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | |
| 260 | 265 | 270 | ||||||||||||||
| aag | gaa | ctc | tat | gat | tea | cct | age | gcc | caa | cgt | tac | agt | gaa | tea | gat | 864 |
| Lys | Glu | Leu | Tyr | Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | |
| 275 | 280 | 285 | ||||||||||||||
| ggc | ctg | gtc | ttt | gac | cct | gct | aag | att | atc | aqt | cgt | aca | cca | aat | gga | 912 |
| Gly | Leu | Val | Phe | Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | |
| 290 | 295 | 300 | ||||||||||||||
| ytt | gcg | att | ccg | cat | ggc | gac | cat | tac | cac | ttt | att | cct | tac | age | aag | 960 |
| Val | Ala | Ile | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | |
| 305 | 310 | 315 | 320 | |||||||||||||
| ctt | tet | gct | tta | gaa | gaa | aag | att | gcc | aga | atg | gtg | cct | atc | agt | gga | 1008 |
| Leu | Ser | Ala | Leu | Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | |
| 32 5 | 330 | 335 | ||||||||||||||
| aut | ggt | tet | aca | gtt | tet | aca | aat | gca | aaa | cct | aat | gaa | gta | gtg | tet | 1056 |
| Thr | Gly | Ser | Thr | Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | |
| 340 | 345 | 350 | ||||||||||||||
| agt | cta | ggc | agt | ctt | tea | age | aat | cct | tet | Let | tta | acg | aca | agt | aag | 1104 |
| Ser | Leu | Gly | Ser | Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | |
| 355 | 360 | 365 | ||||||||||||||
| gag | ctc | tet | tea | gca | tet | gat | ggt | tat | att | ttt | aat | cca | aaa | gat | atc | 1152 |
| Glu | Leu | Ser | Ser | Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Tle | |
| 3V0 | 375 | 380 | ||||||||||||||
| gtt | gaa | gaa | acg | gct | aca | gct | tat | att | gta | aga | cat | ggt | gat | cat | ttc | 1200 |
| Val | Gl u | Gl u | Thr | Al a | Thr | Ala | Tyr | ile | Val | Arg | His | Gly | Asp | His | Phe | |
| 385 | 390 | 395 | 400 | |||||||||||||
| cat | tac | att | cca | aaa | tea | aat | caa | att | ggg | caa | ccg | act; | ctt | cca | aac | 1248 |
| His | Tyr | Ile | Pro | Lys | Ser | Asn | Gl n | ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | |
| 405 | 410 | 415 | ||||||||||||||
| a a t | agt | cta | gca | aca | cct | tet | cca | tet | ctt | cca | atc | aat | cca | gga | act | 1296 |
500
505
510
Thr Leu Ala Gly Ala Thr Ile Leu Ala Lys Lys Arg Met Lys 515 520 525 <210> <211>
<212>
<213> <221> <222> <400>
1455 párů bází
DNA mikroorganizmus S.pneumoniae CDS (1)-.(1452)
| atg | aaa | ttt | agt | aaa | aaa | tat | ata | gca | gct | gga | tea | gct | gtt | atc | gta |
| Met 1 | Lys | Phe | Ser | Lys 5 | Lys | Tyr | Ile | Ala | Ala 10 | Gly | Ser | Ala | Val | Ile 15 | Val |
| tcc | ttg | agt | cta | tgt | gcc | tat | gca | cta | aac | cag | cat | cgt | tcg | cag | gaa |
| Ser | Leu | Ser | Leu 20 | Cys | Ala | Tyr | Ala | Leu 25 | Asn | Gin | His | Arg | Ser 30 | Gin | Glu |
| aat | aag | gac | aat | aat | cgt | gtc | tet | tat | gtg | gat | ggc | agc | cag | tea | agt |
| Asn | Lys | Asp 35 | Asn | Asn | Arg | Val | Ser 40 | Tyr | Val | Asp | Gly | Ser 45 | Gin | Ser | Ser |
| cag | aaa | agt | gaa | aac | ttg | aca | cca | gac | cag | gtt | agc | cag | aaa | gaa | gga |
| Gin | Lys 50 | Ser | Glu | Asn | Leu | Thr 55 | Pro | Asp | Gin | val | Ser 60 | Gin | Lys | Glu | Gly |
| att | cag | gct | gag | caa | att | gta | atc | aaa | att | aca | gat | cag | ggc | tat | gta |
| Ile 65 | Gin | Ala | Giu | Gin | Ile 70 | Val. | Ile | Lys | Ile | Thr 75 | Asp | Gin | Gly | Tyr | Val 80 |
| acg | tea | cac | ggt | gac | cac | tat | cat | tac | tat | aat | ggg | aaa | gtt | cct | tat |
| Thr | Ser | His | Gly | Asp 85 | His | Tyr | His | Tyr | Tyr 90 | Asn | Gly | Lys | Val | Pro 95 | Tyr |
| gat | gcc | ctc | ttt | agt | gaa | gaa | ctc | ttg | atg | aag | gat | cca | aac | tat | caa |
| Asp | Ala | Leu | Phe 100 | Ser | Glu | Glu | Leu | Leu 105 | Met | Lys | Asp | Pro | Asn 110 | Tyr | Gin |
| ctt | aaa | gac | gct | gat | att | gtc | aat | gaa | gtc | aag | ggt | ggt | tat | atc | atc |
| I.eu | Lys | Asp 115 | Ala | Asp | Ile | Val | Asn 120 | Glu | Val | Lys | Gly | Gly 125 | Tyr | Ile | Ile |
| aag | gtc | gat | gga | aaa | tat | tat | gtc | tac | ctg | aaa | gat | gca | gct | cat | gct |
| Lys | Val 130 | Asp | Gly | Lys | Tyr | Tyr 135 | Val | Tyr | Leu | Lys | Asp 140 | Ala | Ala | His | Ala |
| gat | aat | gtt | ega | act | aaa | gat | gaa | atc | aat | cgt | caa | aaa | caa | gaa | cat |
| Asp 145 | Asn | Val | Arg | Thr | Lys 150 | Asp | Glu | Ile | Asn | Arg 155 | Gin | Lys | Gin | Glu | His 1 60 |
| gtc | aaa | gat | aat | gaq | aag | gtt | aac | tet | aat | gtt | gct | gta | gca | agg | t ct |
| Val | Lys | Asp | Asn | Glu 165 | Lys | Val | Asn | Ser | Asn 170 | Val | Ala | Val | Ala | Arg 175 | Ser |
| cag | gga | ega | tal | acg | aca | aat | gat | ggt | tat | gtc | ttt | aat | cca | gct | gat |
| Gin | Gly | Arg | Tyr | Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp |
180 185 190
4
192
240
288
336
384
432
480
528
576
-49CZ 303675 B6
| 35 | 40 | 45 | |||||||||||||
| Thr | Gin | Ala | Ala | Thr | Ser | Phe | Asn | Arg | Gly | Asn | Gly | Ser | Gin | Ala | Glu |
| 50 | 55 | 60 | |||||||||||||
| Gl n | Arg | Gly | Glu | Leu | Asp | Leu | Glu | Arg | Asp | Lys | Ala | Met | Lys | Ala | Val |
| 65 | 70 | 7 5 | 80 | ||||||||||||
| Ser | Glu | Tyr | Val | Gly | Lys | Met | Val | Arg | Asp | Ala | Tyr | Val | Lys | Ser | Asp |
| 85 | 90 | 95 | |||||||||||||
| Arg | Lys | Arg | His | Lys | Asn | Thr | Val | Ala | Leu | Val | Asn | Gin | Leu | Gly | Asn |
| 100 | 105 | 110 | |||||||||||||
| Ile | Lys | Asn | Arg | Tyr | Leu | Asn | Glu | Ile | Val | His | Ser | Thr | Ser | Lys | Ser |
| 115 | 120 | 125 | |||||||||||||
| Gin | Leu | Gin | Glu | Leu | Mel | Met | Lys | Ser | Gin | Ser | Glu | Val | Asp | Glu | Ala |
| 130 | 135 | 140 | |||||||||||||
| Val | Ser | Lys | Phe | Gl u | Lys | Asp | Ser | Phe | Ser | Ser | Ser | Ser | Ser | Gly | Ser |
| 145 | 150 | 155 | 160 | ||||||||||||
| Ser | Thr | Lys | Pro | Glu | Thr | Pro | Gin | Pro | Glu | Asn | Pro | Glu | His | Gin | Lys |
| 165 | 170 | 175 | |||||||||||||
| Pro | Thr | Thr | Pro | Ser | Pro | Asp | Thr | Lys | Pro | Ser | Pro | Gin | Pro | Glu | Gly |
| 180 | 185 | 190 | |||||||||||||
| T,ys | Lys | Pro | Ser | Val | Pro | Asp | Ile | Asn | Gin | Glu | Lys | Glu | Lys | Ala | Lys |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Val | Val | Thr | Tyr | Met | Ser | Lys | Ile | Leu | Asp | Asp | Ile | Gin | Lys |
| 210 | 215 | 220 | |||||||||||||
| His | His | Leu | Gin | Lys | Glu | Lys | His | Arq | Gin | Ile | Val | Ala | Leu | Ile | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Glu | Len | Asp | Glu | Leu | Lys | Lys | Gin | Ala | Leu | Ser | Glu | Ile | Asp | Asn | Val |
| 24 5 | 250 | 255 | |||||||||||||
| Asn | Thr | Lys | Val | Glu | Ile | Glu | Asn | Thr | Val | His | Lys | Ile | Phe | Ala | Asp |
| 260 | 265 | 270 | |||||||||||||
| Met | Asp | Ala | Val | Val | Thr | Lys | Phe | Lys | Lys | Gly | Leu | Thr | Gin | Asp | Thr |
| 275 | 280 | 285 | |||||||||||||
| Pro | Lys | Glu | Pro | Gly | Asn | Lys | Lys | Pro | Ser | Ala | Pro | Lys | Pro | Gly | Met |
| 290 | 295 | 300 | |||||||||||||
| Gin | Pro | Ser | Pro | Gin | Pro | Glu | Val | Lys | Pro | Gin | Leu | Glu | Lys | Pro | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val· | Lys | Pro |
| 325 | 330 | 335 | |||||||||||||
| Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro |
| 340 | 345 | 350 | |||||||||||||
| Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Pro | Gin | Pro | Clu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys |
| 370 | 375 | 380 | |||||||||||||
| Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ly s | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Gl u | Val | Lys | Pro | Gin | Pro | Glu |
| 405 | 410 | 415 | |||||||||||||
| Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu |
| 420 | 425 | 430 | |||||||||||||
| Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro |
| 435 | 440 | 445 | |||||||||||||
| Glu | Lys | Pro | Lys | Pro | Asp | Asn | Ser | Lys | Pro | Gin | Ala | Asp | Asp | Lys | Lys |
| 450 | 455 | 4 60 | |||||||||||||
| Pro | Ser | Thr | Thr | Asn | Asn | Leu | Ser | Lys | Asp | Lys | Gin | Pro | Ser | Asn | Gin |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Ser | Thr | Asn | Glu | Lys | Ala | Thr | Asn | Lys | Pro | Lys | Lys | Ser | Leu | Pro |
| 4 85 | 490 | 4 95 | |||||||||||||
| Ser | Thr | Gl y | Ser | Ile | Ser | Asn | Leu | Ala | Leu | Glu | Ile | Ala | Gly | Leu | Leu |
| 340 | 345 | 350 | ||||||||||||||
| aaa | cca | gag | gtt | aaa | ccg | cag | ccg | gaa | aaa | cca | aaa | cca | gag | gtt | aaa | 1104 |
| Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | |
| 355 | 360 | 365 | ||||||||||||||
| ccg | cag | ccg | gaa | aaa | cca | aaa | cca | gag | gtt | aaa | ccg | cag | ccg | gaa | aaa | 1152 |
| Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | |
| 370 | 375 | 380 | ||||||||||||||
| cca | aaa | cca | gag | gtt | aaa | ccg | cag | ccg | gaa | aaa | cca | aaa | cca | gag | gtt | 1200 |
| Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | |
| 385 | 390 | 395 | 400 | |||||||||||||
| aaa | ccg | cag | ccg | gaa | aaa | cca | aaa | cca | gag | gtt | aaa | ccg | cag | ccg | gaa | 1248 |
| Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | |
| 405 | 410 | 415 | ||||||||||||||
| aaa | cca | aaa | cca | gag | gtt | aaa | ccg | cag | ccg | gaa | aaa | cca | aaa | cca | gag | 1296 |
| Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | |
| 420 | 425 | 430 | ||||||||||||||
| gtt | aaa | ccg | caa | cca | gaa | aaa | cca | aaa | cca | gag | gtt | aaa | ccg | caa | cca | 1344 |
| Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | |
| 435 | 440 | 445 | ||||||||||||||
| gaa | aaa | cca | aaa | cca | gat | aat | agc | aag | cca | caa | gca | gat | gat | aag | aag | 1392 |
| Glu | Lys | Pro | Lys | Pro | Asp | Asn | Ser | Lys | Pro | Gin | Ala | Asp | Asp | Lys | Lys | |
| 450 | 455 | 460 | ||||||||||||||
| cca | tca | act | aca | aat | aat | tta | agc | aag | gac | aag | caa | cct | tet | aac | caa | 1440 |
| Pro | Ser | Thr | Thr | Asn | Asn | Leu | Ser | Lys | Asp | Lys | Gin | Pro | Ser | Asn | Gin | |
| 465 | 470 | 475 | 480 | |||||||||||||
| get | tca | aca | aac | gaa | aaa | gca | aca | aat | aaa | ccg | aag | aag | tca | ttg | cca | 1488 |
| Ala | Ser | Thr | Asn | Glu | Lys | Ala | Thr | Asn | Lys | Pro | Lys | LYS | Ser | Leu | Pro | |
| 485 | 490 | 495 | ||||||||||||||
| tca | act | gga | tet | att | tca | aat | cta | gca | ctt | gaa | att | gca | ggt | ctt | ctt | 1536 |
| Ser | Thr | Gly | Ser | lle | Ser | Asn | Leu | Ala | Leu | Glu | lle | Ala | Cly | Leu | Leu | |
| 500 | 505 | 510 | ||||||||||||||
| acc | ttg | gcg | ggg | gca | acc | att | ctt | get | aag | aaa | aga | atg | aaa | 1578 | ||
| Thr | Leu | Ala | Gly | Ala | Thr | lle | Leu | Ala | Lys | Lys | Arg | Met | Lys | |||
| 515 | 520 | 525 | ||||||||||||||
| tag | 1581 | |||||||||||||||
| <210> | 6 | |||||||||||||||
| <211> | 526 aminokyselin | |||||||||||||||
| <212> | protein | |||||||||||||||
| <213> | m | i ikroorganizmus S.pneumoniae |
<400> 6
| Met | Glu | Asn | lle | Asp | Met | Phe | Lys | Ser | Asn | His | Glu | Arg | Arg | Met | Arg |
| 1 | 5 | 10 | 15 | ||||||||||||
| Tyr | Ser | lle | Arg | Lys | Phe | Ser | Val | Gly | Val | Ala | Ser | Val | Ala | Val | Al a |
| 20 | 25 | 30 | |||||||||||||
| Ser | Leu | Phe | Met | Gly | Ser | Val | Val | His | Al a | Thr | Glu | Lys | Glu | Gly | Ser |
-47CZ 303675 B6
| att | aag | aac | agg | tat | ttg | aat | gaa | ata gtt | cat | tea | acc | tea | aaa | agc | 384 |
| T 1 e | Lys | Asn | Arg | Tyr | i .eu | Asn | Glu | Ile Val | His | Ser | Thr | Ser | Lys | Ser | |
| 115 | 12 0 | 125 | |||||||||||||
| caa | cta | cag | gaa | ctg | atg | atg | aag | agt caa | tea | gaa | gta | gat | gaa | gct | 432 |
| Cln | Leu | Gin | Glu | Leu | Met | Met | Lys | Ser Gin | Stu | Glu | Va i | Asp | Glu | Ala | |
| 130 | 135 | 140 | |||||||||||||
| ytg | tet | aaa | ttt | gaa | aag | gac | tea | ttt tet | tcg | tea | agt | tea | gga | tcc | 430 |
| Val | Ser | Lys | Phe | Glu | Lys | Asp | Ser | Phe Ser | Ser | Ser | Ser | Ser | Gly | Ser | |
| 145 | 1 50 | 155 | 160 | ||||||||||||
| tcc | act | aaa | cca | gaa | act | ccg | cag | ccg gaa | aat | cca | gag | cat | caa | aaa | 528 |
| Ser | Thr | Lys | Pro | Glu | Thr | Pro | Gin | Pro Glu | Asn | Pro | Glu | His | Gin | Lys | |
| 1 65 | 170 | 1 75 | |||||||||||||
| cca | aca | act | cca | tet | ccg | gat | acc | aaa cca | agc | cct | caa | cca | gaa | ggc | 576 |
| Pro | Thr | Thr | Pro | Ser | Pro | Asp | Thr | Lys Pro | Ser | Pro | Gin | Pro | Glu | Gly | |
| 180 | 185 | 190 | |||||||||||||
| aag | aaa | cca | agc | gta | cca | gac | att | aat cag | gaa | aaa | gaa | aaa | gct | aag | 624 |
| Lys | Lys | Pro | Ser | Val | Pro | Asp | Ile | Asn Gin | Glu | Lys | Glu | Lys | Ala | Lys | |
| 195 | 200 | 205 | |||||||||||||
| ctt | gct. | gta | gta | acc | tac | atg | agc | aag att | tta | gat | gat | ata | caa | aaa | 672 |
| Leu | Ala | Val | Val | Thr | Tvr | Met | Ser | Lys Tle | I.,eu | Asp | Asp | Ile | Gin | Lys | |
| 210 | 215 | 220 | |||||||||||||
| cat | cat | ctg | cag | aaa | gaa | aaa | cat | cgt cag | att | gtt | gct | ctt | att | aag | 720 |
| His | His | Leu | Gin | Lys | Glu | Lys | His | Arg Gin | Ile | Val | Al a | Leu | Ile | Lys | |
| 225 | 230 | 235 | 240 | ||||||||||||
| gag | ctt | gat | gag | ctt | aaa | aag | caa | gct ctt | tet | gaa | att | gat | aat | gta | 768 |
| Glu | Leu | Asp | Glu | Leu | Lys | Lys | Gin | Ala Leu | Ser | Glu | Ile | Asp | Asn | Val | |
| 245 | 250 | 255 | |||||||||||||
| aat | acc | aaa | gta | gaa | att | gaa | aat | aca gtc | cac | aag | ata | ttt | gca | gac | 816 |
| Asn | Thr | Lys | Val | Glu | Ile | Glu | Asn | Thr Val | His | Lys | Tle | Phe | Ala | Asp | |
| 260 | 265 | 270 | |||||||||||||
| atg | gat | gca | gtt | gtg | act | aaa | ttc | aaa aaa | ggc | tta | act | cag | gac | aca | 864 |
| Met | Asp | Ala | Val | Val | Thr | Lys | Phe | Lys Lys | Gly | Leu | Thr | Gin | Asp | Thr | |
| 275 | 280 | 285 | |||||||||||||
| cca | aaa | gaa | cca | ggt | aac | aaa | aaa | cca tet. | gct | cca | aaa | cca | ggt | atg | 912 |
| Pro | Lys | Glu | Pro | Glv | Asn | Lys | Lys | Pro Ser | Ala | Pro | Lys | Pro | Gly | Met | |
| 290 | 295 | 300 | |||||||||||||
| caa | cca | agt | cct | caa | cca | gag | gtt | aaa ccg | cag | ctg | gaa | aaa | cca | aaa | 960 |
| Gin | Pro | Se r | Pro | Gin | Pro | Glu | Val | Lys Pro | Gin | Leu | Glu | Lys | Pro | Lys | |
| 305 | 310 | 315 | 320 | ||||||||||||
| cca | gag | gtt | aaa | ccg | caa | cca | gaa | aaa cca | aaa | cca | gag | gtt | aaa | ccg | 1008 |
| Pro | Gin | Val | Lys | Pro | Gin | Pro | Glu | Lys Pro | Lys | Pro | Glu | Val | Lys | Pro | |
| 32 5 | 330 | 335 | |||||||||||||
| cag | ccg | gaa | aaa | cca | aaa | cca | gag | gtt. aaa | ccg | cag | ccg | gaa | aaa | cca | 1 056 |
| Gin | Pro | Gl u | Lys | Pro | Lys | Pro | Clu | Val Lys | Pro | Gl π | Pro | Gl u | Lys | Pro |
to
| Leu Tyr Glu Ala | Pro | Lys Gly Tyr Thr Leu Glu Asp Leu | Leu | Ala | Thr | ||||||||||
| 675 | 680 | 685 | |||||||||||||
| Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn |
| 690 | 695 | 700 | |||||||||||||
| Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin |
| 705 | 710 | 715 | 720 | ||||||||||||
| Ala | Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr |
| 725 | 730 | 735 | |||||||||||||
| Glu | Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu |
| 740 | 745 | 750 | |||||||||||||
| Lys | Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | GlU | Pro | Glu | Glu | Glu | Ser | Pro |
| 755 | 760 | 7 65 | |||||||||||||
| Glu | Glu | Ser | Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys |
| 770 | 775 | 780 | |||||||||||||
| Leu | Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile |
| 785 | 790 | 795 | 800 | ||||||||||||
| Lys | Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu |
| 805 | 810 | 815 | |||||||||||||
| Phe | Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Al a | Glu | Ala | Glu | Lys | Leu |
| 820 | 825 | 830 | |||||||||||||
| Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys | ||||||||
| 835 | 840 |
<210> 5 <211> 1581 párů bází <212> DNA <213> mikroorganizmus S.pneumoniae <221> CDS <222> (1)...(1578) <400> 5
| atg | gag | aat | ata | gac | atg | ttt | aaa | tca | aat | cat | gag | ega | aga | atg | cgt |
| Met 1 | Glu | Asn | Ile | Asp 5 | Met | Phe | Lys | Ser | Asn 10 | His | Glu | Arg | Arg | Met 15 | Arg |
| tat | tcc | att | cgt | aaa | ttt | agt | gta | gga | gta | gct | age | gta | gct | gtt | gcc |
| Tyr | Ser | Ile | Arg 20 | Lys | Phe | Ser | Val | Gly 25 | Val | Ala | Ser | Val | Ala 30 | Val | Ala |
| agt | ctt | ttt | atg | gga | agt | gtt | gta | cat | gcg | aca | gag | aaa | gag | gga | agt |
| Ser | Leu | Phe 35 | Met | Gly | Ser | Val | Val 40 | His | Ala | Thr | Glu | Lys 45 | Glu | Gly | Ser |
| acc | caa | gca | gcc | act | tet | ttt | aat | agg | gga | aat | gga | agt | cag | gca | gaa |
| Thr | Gin 50 | Ala | Ala | Thr | Ser | Phe 55 | Asn | Arg | Gly | Asn | Gly 60 | Ser | Gin | Ala | Glu |
| caa | cgt | gga | gaa | ctc | gat | tta | gaa | ega | gat | aag | gca | atg | aaa | gcg | gtc |
| Gin 65 | Arg | Gly | Glu | Leu | Asp 70 | Leu | Glu | Arg | Asp | Lys 7 5 | Ala | Met | Lys | Ala | Val 80 |
| agt | gaa | tat | gta | gga | aaa | atg | gtg | aga | gat | gcc | tat | gta | 3 £2 £1 | tca | gat |
| Ser | Glu | Tyr | Val | Gly 85 | Lys | Met | Val | Arg | Asp 90 | Ala | Tyr | Val | Lys | Ser 95 | Asp |
| aga | aaa | ega | cat | aaa | aat | act | gta | gct | cta | gtt | aac | cag | ttg | gga | aac |
| Arg | Lys | Arg | His 100 | Lys | Asn | Thr | Val | Ala 105 | Leu | Val | Asn | Gin | Leu 110 | Gly | Asn |
144
192
240
288
36
-45CZ 303675 B6
| Gl.y | Asp 210 | His | Tyr | His | Tyr | Ile 215 | Pro | Lys Asn | Glu Leu 220 | Ser | Ala | Ser | Glu | ||
| Leu | Ala | Al a | Ala | Glu | Ala | Phe | Leu | Ser | Gly | Arg | Glu | Asn | Leu | Ser | Asn |
| 225 | 2 30 | 235 | 240 | ||||||||||||
| Leu | Arg | Thr | Tyr | Arg | Arg | Gin | Asn | Ser | Asp | Asn | Thr | Pro | Arg | Thr | Asn |
| 245 | 250 | 255 | |||||||||||||
| Trp | Val | Pro | Ser | Val | Ser | Asn | Pro | Gly | Thr | Thr | Asn | Thr | Asn | Thr | Ser |
| 260 | 265 | 270 | |||||||||||||
| Asn | Asn | Ser | Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp |
| 275 | 280 | 285 | |||||||||||||
| Ser | Leu | Leu | Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin | Arg | His | Val |
| 290 | 295 | 300 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 325 | 330 | 335 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 340 | 345 | 350 | |||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu |
| 3 55 | 360 | 365 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala |
| 370 | 375 | 380 | |||||||||||||
| Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn |
| 405 | 410 | 415 | |||||||||||||
| Gly | val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala |
| 420 | 42 5 | 4 30 | |||||||||||||
| Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys |
| 435 | 440 | 445 | |||||||||||||
| Leu | G1 y | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr |
| 450 | 455 | 460 | |||||||||||||
| Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp |
| 4 65 | 470 | 475 | 480 | ||||||||||||
| Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu |
| 485 | 490 | 4 95 | |||||||||||||
| Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile |
| 500 | 505 | 510 | |||||||||||||
| Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro |
| 515 | 520 | 525 | |||||||||||||
| Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu |
| 530 | 535 | 540 | |||||||||||||
| Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp |
| o4 5 | 550 | 555 | 560 | ||||||||||||
| Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His |
| 565 | 570 | 575 | |||||||||||||
| Ser | His | Trp | Tle | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala |
| 580 | 585 | 590 | |||||||||||||
| Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp |
| 5 95 | 600 | 605 | |||||||||||||
| H is | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Al a | Glu | Ala | Ile | Tyr |
| 610 | 615 | 620 | |||||||||||||
| Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr |
| 625 | 630 | 635 | 640 | ||||||||||||
| Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro |
| 645 | 650 | 655 | |||||||||||||
| His | Tyr | Asp | His | Tyr | His | Asn | I.le | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly |
| 660 | 665 | 670 |
740 745 750
| aaa | cca | gaq | tet | cca | aaa | cca | aca | gag |
| Lys | Pro | Glu 755 | Ser | Pro | Lys | Pro | Thr 760 | Glu |
| gag | gaa | tea | gaa | gaa | cct | cag | gtc | gag |
| Glu | Glu 770 | Ser | Glu | Glu | Pro | Gln 775 | Val | Glu |
| ctg | aga | gag | get | gaa | gat | tta | ctt | gga |
| Leu 785 | Arg | Glu | Ala | Glu | Asp 790 | Leu | Leu | Gly |
| aag | tcc | aat | gcc | aaa | gag | act | ctc | aca |
| Lys | Ser | Asn | Ala | Lys 805 | Glu | Thr | Leu | Thr |
| ttt | ggc | acc | cag | gac | aac | aat | act | att |
| Phe | Gly | Thr | Gln 820 | Asp | Asn | Asn | Thr | Ile 825 |
| ttg | get | tta | tta | aag | gag | agt | aag | taa |
| Leu | Ala | Leu 835 | Leu | Lys | Glu | Ser | Lys 840 |
| gaa Glu | cca Pro | gaa Glu | gaa Glu 765 | gaa Glu | tea Ser | cca Pro | 2304 |
| act | gaa | aag | gtt | gaa | gaa | aaa | 2352 |
| Thr | Glu | Lys 780 | Val | Glu | Glu | Lys | |
| aaa | atc | cag | gat | cca | att | atc | 2400 |
| Lys | Ile 795 | Gln | Asp | Prc | Ile | Ile 800 | |
| gga | tta | aaa | aat | aat | tta | cta | 2448 |
| Gly 810 | Leu | Lys | Asn | Asn | Leu 815 | Leu | |
| atg | gca | gaa | get | gaa | aaa | cta | 2496 |
| Met | Ala | Glu | Ala | Glu 830 | Lys | Leu |
2523 <210> <211>
<212>
<213> <400>
840 aminokyselin protein mikroorganizmus S.pneumoniae 4
| Met | Lys | Ile | Asn | Lys | Lys | Tyr | Leu | Ala | Gly | Ser | Val | Ala | Thr | Leu | Val |
| 1 | 5 | 10 | 15 | ||||||||||||
| Leu | Ser | Val | Cys | Ala | Tyr | Glu | Leu | Gly | Leu | His | Gln | Ala | Gln | Thr | Val |
| 20 | 25 | 30 | |||||||||||||
| Lys | Glu | Asn | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Lys | Gln | Ala | Thr | Gln |
| 35 | 40 | 45 | |||||||||||||
| Lys | Thr | Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile |
| 50 | 55 | 60 | |||||||||||||
| Asn | Ala | Glu | Gln | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gln | Gly | Tyr | Val | Thr |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ala | Ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gln | Leu |
| 100 | 105 | 110 | |||||||||||||
| Lys | Asp | Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys |
| 115 | 120 | 125 | |||||||||||||
| Val | Asn | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp |
| 130 | 135 | 140 | |||||||||||||
| Asn | Val | Arg | Thr | Lys | Glu | Glu | Ile | Asn | Arg | Gln | Lys | Gln | Glu | His | Ser |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gln | His | Arg | Glu | Gly | Gly | Thr | Ser | Ala | Asn | Asp | Gly | Ala | Val | Ala | Phe |
| 165 | 170 | 175 | |||||||||||||
| Ala | Arg | Ser | Gln | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn |
| 180 | 185 | 190 | |||||||||||||
| Ala | Ser | Asp | Ile | Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His |
| 195 | 200 | 205 |
-43CZ 303675 B6
| ctt | gcc | ttc | tta gct | ccg | att | cgt | cat | cca | gaa | cgt | tta | gga | aaa | cca | 1584 |
| Leu | Ala | Phe | Leu Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | |
| 515 | 520 | 525 | |||||||||||||
| aat | gcg | caa | att acc | tac | act | gat | gat | gag | att | caa | gta | gcc | aag | ttg | 1632 |
| Asn | Ala | Gin | Ile Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | |
| 530 | 535 | 540 | |||||||||||||
| gca | ggc | aag | tac aca | aca | gaa | gac | ggt | tat | atc | ttt | gat | cct | cgt | gat | 1680 |
| Ala | Gly | Lys | Tyr Thr | Thr | Glu | Asp | Gl y | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | |
| 545 | 550 | 555 | 560 | ||||||||||||
| ata | acc | aqt | gat gag | ggg | gat | gcc | tat | gta | act | cca | cat | atg | acc | cat | 1728 |
| ile | Thr | Ser | Asp Glu | Gly | Asp | Ala | Tyr | Va 1 | Thr | Pro | His | Met | Thr | His | |
| 565 | 570 | 5/5 | |||||||||||||
| agc | cac | tgg | att aaa | aaa | gat | agt | ttg | tet | gaa | gct | gag | aga | gcg | gca | 1776 |
| Ser | His | Trp | Ile Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Al a | |
| 580 | 585 | 590 | |||||||||||||
| gcc | cag | gc.L | tat gct | aaa | gag | aaa | ggt | ttg | acc | cct | cct | tcg | aca | gac | 1824 |
| Ala | Gin | Ala | Tyr Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | |
| 595 | 600 | 605 | |||||||||||||
| cat | cag | gat | tea gga | aat | act | gag | gca | aaa | gga | gca | gaa | gct | atc | tac | 1872 |
| His | Gin | Asp | Ser Gly | Asn | Thr | Glu | Al a | Lys | Gly | Ala | Gl u | Ala | Ile | Tyr | |
| 610 | 615 | 620 | |||||||||||||
| aac | cgc | gtg | aaa gca | gct | aag | aag | gtg | cca | ctt | gat | cgt | atg | cct | tac | 1920 |
| Asn | Arg | Val | Lys Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | |
| 625 | 630 | 635 | 640 | ||||||||||||
| aat | ctt | caa | tat act | gta | gaa | gtc | aaa | aac | ggt | agt | tta | atc | ata | cct | 1968 |
| Asn | Leu | Gin | Tyr Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | |
| 645 | 650 | 65 5 | |||||||||||||
| cat | tat | gac | cat tac | cat | aac | atc | aaa | ttt | gag | tgg | ttt | gac | gaa | ggc | 2016 |
| His | Tyr | Asp | His Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | |
| 660 | 665 | 670 | |||||||||||||
| ctt | tat | gag | gca cct | aag | ggg | tat | a ct | ctt | gag | gat | Ctt | ttg | gcg | act | 2064 |
| Leu | , - x- 1 yr | Glu | Ala Pro | Lys | G.1 y | Tyr | Thr | Leu | Gl u | Asp | Leu | Leu | Ala | Thr | |
| 675 | 680 | 685 | |||||||||||||
| gtc | aag | tac | t.at gtc | gaa | cat | cca | aac | gaa | cgt | ccg | cat | tea | gat | aat | 2112 |
| Val | Lys | Tyr | Tyr Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | |
| 690 | 695 | 700 | |||||||||||||
| ggt | ttt | ggt | aac gct | agc | gac | cat | gtt | caa | aga | aac | aaa | aat | ggt | caa | 2160 |
| Gly | Phe | Gly | Asn Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | |
| 705 | 710 | 715 | 72 0 | ||||||||||||
| gct | gat | acc | aat caa | acg | gaa | aaa | cca | agc | gag | gag | aaa | cct | cag | aca | 2208 |
| Ala | Asp | Thr | Asn Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | |
| 725 | 730 | 735 | |||||||||||||
| gaa | aaa | cct | gag gaa | gaa | acc | cct | ega | gaa | gag | aaa | cca | caa | agc | gag | 2256 |
| Glu | Lys | Pro | Glu Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu |
275 280 285
| agt Ser | ctc Leu 290 | ttg Leu | aaa Lys | cag Gin | ctc Leu | tac Tyr 295 | aaa Lys | ctg Leu | cct Pro | ttg Leu | agt Ser 300 | caa Gin | ege Arg | cat His | gta Val | 912 |
| gaa | tet | gat | ggc | ctt | att | ttc | gac | cca | gcg | caa | atc | aca | agt | ega | acc | 960 |
| Glu | Ser | Asp | Gly | Leu | I le | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | |
| 305 | 310 | 315 | 320 | |||||||||||||
| gcc | aga | ggt | gta | get | gtc | cct | cat | ggt | aac | cat | tac | cac | ttt | atc | cct | 1008 |
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | |
| 325 | 330 | 335 | ||||||||||||||
| tat | gaa | caa | atg | tet | gaa | ttg | gaa | aaa | ega | att | get | cgt | att | att | ccc | 1056 |
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Al a | Arg | Ile | Ile | Pro | |
| 340 | 345 | 350 | ||||||||||||||
| ctt | cgt | tat | cgt | tea | aac | cat | tgg | gta | cca | gat | tea | aga | cca | gaa | gaa | 1104 |
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | |
| 355 | 360 | 365 | ||||||||||||||
| cca | agt | cca | caa | ccg | act | cca | gaa | cct | agt | cca | agt | ccg | caa | cct | gca | 1152 |
| Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | |
| 37 0 | 375 | 380 | ||||||||||||||
| cca | aat | cct | caa | cca | get | cca | age | aat | cca | att | gat | gag | aaa | ttg | gtc | 1200 |
| Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | |
| 385 | 390 | 395 | 400 | |||||||||||||
| aaa | gaa | get | gtt | ega | aaa | gta | ggc | gat | ggt | tat | gtc | ttt | gag | gag | aat | 1248 |
| Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | |
| 405 | 410 | 415 | ||||||||||||||
| gga | gtt | tet | cgt | tat | atc | cca | gcc | aag | aat | ctt | tea | gca | gaa | aca | gca | 1296 |
| Gly | Val | Ser | Arg | Tyr | Ile | Pro | AJ a | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | |
| 420 | 425 | 430 | ||||||||||||||
| gca | ggc | att | gat | age | aaa | ctg | gcc | aag | cag | gaa | agt | tta | tet | cat | aag | 1344 |
| Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | |
| 435 | 440 | 445 | ||||||||||||||
| cta | gga | get | aag | aaa | act | gac | ctc | cca | tet | agt | gat | ega | gaa | ttt | tac | 1 392 |
| Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | |
| 450 | 455 | 460 | ||||||||||||||
| aac | aag | get | tat | gac | tta | cta | gca | aga | att | cac | caa | gat | tta | ctt | gat | 1440 |
| Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | |
| 4 65 | 470 | 475 | 480 | |||||||||||||
| aat | aaa | ggt | ega | caa | gtt | gat | ttt | gag | get | ttg | gat | aac | ctg | ttg | gaa | 1488 |
| Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | |
| 485 | 490 | 495 | ||||||||||||||
| ega | ctc | aag | gat | gtc | tea | agt | gat | aaa | gtc | aag | tta | gtg | gat | gat | att | 1536 |
| Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | |
| 500 | 505 | 510 |
C7 303675 Bó aaa acq gag aat ttg act cct gat gag gtt agc aag cgt gaa gga atc 192
Lys Thr Glu Asn Leu Thr Pro Asp Glu Val Ser Lys Arg Glu Gly Tle
55 60 aac gcc gaa caa atc gtc atc aag att acg gat caa ggt tat gtg acc 240
Asn Ala Glu Gin Ile Val Ile Lys Ile Thr Asp Gin Gly Tyr Val Thr
70 75 80 tet cat gga gac cat tat cat tac tat aat ggc aag gtc cct tat gat 288
Ser His Gly Asp His Tyr His Tyr Tyr Asn Gly Lys Val Pro Tyr Asp
90 95 gcc atc atc agt gaa gag ctc ctc atg aaa gat ccg aat tat cag ttg 336
Ala Ile Ile Ser Glu Glu Leu Leu Met Lys Asp Pro Asn Tyr Gin Leu
100 105 110 aag gat tea gac att gtc aat gaa atc aag ggt ggt tat gtc att aag 384
Lys Asp Ser Asp Ile Val Asn Glu Ile Lys Gly Gly Tyr Val Ile Lys
115 120 125 gta aac ggt aaa tac tat gtt tac ctt aag gat gca gct cat gcg gat 432
Val Asn Gly Lys Tyr Tyr Val Tyr Len Lys Asp Ala Ala His Ala Asp
130 135 140 aat gtc cgt aca aaa gaa gaa atc aat cgg caa aaa caa gaa cat agt 480
Asn Val Arg Thr Lys Glu Glu Ile Asn Arg Gin Lys Gin Glu His Ser
145 150 155 160 cag cat cgt gaa gga ggg act tea gca aac gat ggt gcg gta gcc ttt 528
Gin His Arg Glu Gly Gly Thr Ser Ala Asn Asp Gly Ala Val Ala Phe
165 170 175 gca cgt tea cag gga cgc tac acc aca gat gat ggt tat atc ttc aat 576
Ala Arg Ser Gin Gly Arg Tyr Thr Thr Asp Asp Gly Tyr Ile Phe Asn
180 185 190 gca tet gat atc atc gaa gat acg ggc gat gcc tat atc gtt cct cat 624
Ala Ser Asp Ile Ile Glu Asp Thr Gly Asp Ala Tyr Ile Val Pro His
195 200 205 gga gat cat tac cat tac att cct aag aat gag tta tea gct agc gaq 672
Gly Asp His Tyr His Tyr Ile Pro Lys Asn Glu Leu Ser Ala Ser Glu
210 215 220 ttg gct gct gca gaa gcc ttc cta tet ggt cgg gaa aat ctg tea aat 720
Leu Ala Ala Ala Glu Ala Phe Leu Ser Gly Arq Glu Asn Leu Ser Asn
225 230 235 240 tta aga acc tat cgc ega caa aat agc gat aac act cca aga aca aac 768
Leu Arg Thr Tyr Arg Arg Gin Asn Ser Asp Asn Thr Pro Arg Thr Asn
245 250 255 tgg gta cct tet gta agc aat cca gga act aca aat act aac aca agc 816
Trp Val Pro Ser Val Ser Asn Pro Gly Thr Thr Asn Thr Asn Thr Ser
260 265 270 aac aac aqc aac act aac agt caa gca agt caa agt aat gac att gat 864
Asn Asn Ser Asn Thr Asn Ser Gin Ala Ser Gin Ser Asn Asp Ile Asp
| 740 | 745 | 7 50 | |
| Leu | Glu Asn Asn Tyr Lys | Val Gly Glu Ile Lys Leu Pro | Ile Pro Lys |
| 755 | 760 765 | ||
| Leu | Asn Gin Gly Thr Thr | Arg Thr Ala Gly Asn Lys Ile | Pro Val Thr |
| 770 | 775 780 | ||
| Phe | Met Ala Asn Ala Tyr | Leu Asp Asn Gin Ser Thr Tyr | Ile Val Glu |
| 785 | 790 | 795 | 800 |
| Val | Pro Ile Leu Glu Lys | Glu Asn Gin Thr Asp Lys Pro | Ser Ile Leu |
| 805 | 810 | 815 | |
| Pro | Gin Phe Lys Arg Asn | Lys Ala Gin Glu Asn Ser Lys | Leu Asp Glu |
| 820 | 825 | 830 | |
| Lys | Val Glu Glu Pro Lys | Thr Ser Glu Lys Val Glu Lys | Glu Lys Leu |
| 835 | 840 845 | ||
| Ser | Glu Thr Gly Asn Ser | Thr Ser Asn Ser Thr Leu Glu | Glu Val Pro |
| 850 | 855 860 | ||
| Thr | Val Asp Pro Val Gin | Glu Lys Val Ala Lys Phe Ala | Glu Ser Tyr |
| 8 65 | 870 | 875 | 880 |
| Gly | Met Lys Leu Glu Asn | Val Leu Phe Asn Met Asp Gly | Thr Ile Glu |
| 885 | 890 | 895 | |
| Leu | Tyr Leu Pro Ser Gly | Glu Val Ile Lys Lys Asn Met | Ala Asp Phe |
| 900 | 905 | 910 | |
| Thr | Gly Glu Ala Pro Gin | Gly Asn Gly Glu Asn Lys Pro | Ser Glu Asn |
| 915 | 920 925 | ||
| Gly | Lys Val Ser Thr Gly | Thr Val Glu Asn Gin Pro Thr | Glu Asn Lys |
| 930 | 935 940 | ||
| Pro | Ala Asp Ser Leu Pro | Glu Ala Pro Asn Glu Lys Pro | Val Lys Pro |
| 945 | 950 | 955 | 960 |
| Glu | Asn Ser Thr Asp Asn | Gly Met Leu Asn Pro Glu Gly | Asn Val Gly |
| 965 | 970 | 97 5 | |
| Ser | Asp Pro Met Leu Asp | Pro Ala Leu Glu Glu Ala Pro | Ala Val Asp |
| 980 | 985 | 990 | |
| Pro | Val Gin Glu Lys Leu | Glu Lys Phe Thr Ala Ser Tyr | Gly Leu Gly |
| 995 | 1000 1005 | ||
| Leu | Asp Ser Val Ile Phe | Asn Met Asp Gly Thr Ile Glu | Leu Arg Leu |
| 1010 | 1015 1020 | ||
| Pro | Ser Gly Glu Val Ile | Lys Lys Asn Leu Ser Asp Phe | Ile Ala |
| 1025 | , 103C | ) 1035 |
<210> 3 <211> 2523 párů bází <212> DNA <213> mikroorganizmus S.pneumoniae <221> CDS <222> (1)...(2520) <223> kódující oblast genu BVH-11 <400> 3
| atg Met 1 | aaa Lys | atc Ile | aat Asn | aaa Lys 5 | aaa Lys | tat Tyr | cta Leu | gct Al a | ggg Gly 10 | tca Ser | gt a Val | gct Al a | aca Thr | ctt Leu 15 | gtt Val |
| tta | agt | gtc | tgt | gct | tat | gaa | cta | ggt. | ttg | cat | caa | gct | caa | act | gta |
| Leu | Ser | Val | Cys | Ala | Tyr | Glu | Leu | Gl y | Leu | His | Gin | Ala | Gin | Thr | Val |
| 20 | 25 | 30 | |||||||||||||
| aaa | gaa | aat | aat | cgt | gtt | t cc | tat | ata | ga t | gga | aaa | caa | gcg | acg | caa |
| Lys | Glu | Asn | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Lys | G.l.n | Ala | Thr | Gin |
| 35 | 40 | 45 |
144
-39CZ 303675 BC
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Val | Phe | Asp | Pro | Ala | Lys | Tle | Ue | Ser | Arg | Thr | Pro | Asn | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Ue | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Ser | Ala | Leu | Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly |
| 325 | 330 | 335 | |||||||||||||
| Thr | Cly | Ser | Thr | Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ser | Leu | Gly | Ser | Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Leu | Ser | Ser | Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ue |
| 37 0 | 37 5 | 380 | |||||||||||||
| Val | Gl u | Glu | Thr | Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe |
| 385 | 390 | 395 | 400 | ||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asn | Gin | Tle | Gly | Gin | Pro | Thr | Leu | Pro | Asn |
| 405 | 410 | 415 | |||||||||||||
| Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr |
| 420 | 425 | 430 | |||||||||||||
| Ser | His | Glu | Lys | Hi s | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | A.sp | Ala | Asn | Arg |
| 435 | 440 | 445 | |||||||||||||
| Ue | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His |
| 450 | 455 | 4 60 | |||||||||||||
| Asn | His | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala |
| 465 | 470 | 4 75 | 480 | ||||||||||||
| Ala | Gin | Lys | His | Leu | Glu | Glu | Val | Lys | Thr | Ser | Hi s | Asn | Gly | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met |
| 500 | 505 | 510 | |||||||||||||
| Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Tle | Ala | Gly | Ue | Met | Lys |
| 515 | 520 | 525 | |||||||||||||
| Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn |
| 530 | 535 | 540 | |||||||||||||
| Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ue | Asp |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | His | Lys | Pro | Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu |
| 5 65 | 570 | 575 | |||||||||||||
| Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr |
| 580 | 585 | 590 | |||||||||||||
| Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr |
| 5 95 | 600 | 605 | |||||||||||||
| Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser |
| 610 | 615 | 620 | |||||||||||||
| Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu |
| 625 | 630 | 635 | 640 | ||||||||||||
| Val | Lys | Leu | I le | Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly |
| 645 | 650 | 655 | |||||||||||||
| Lys | Val | Phe | Gly | Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp |
| 660 | 665 | 670 | |||||||||||||
| Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ue | Ala | Ser | Lys |
| 67 5 | 680 | 685 | |||||||||||||
| Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser |
| 690 | 6 95 | 700 | |||||||||||||
| Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala |
| 705 | 710 | 715 | 720 | ||||||||||||
| Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly |
| 725 | 730 | 735 | |||||||||||||
| Thr | Asp | Ala | Leu | Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr |
| 50 | 55 | 60 | |||||||||||||
| Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | Asn | Ser | Val | Tle | Asn | Ala | Lys | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg |
| 85 | 90 | 95 | |||||||||||||
| Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu |
| 100 | 105 | 110 | |||||||||||||
| Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu |
| 115 | 120 | 125 | |||||||||||||
| Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin | ||||
| 130 | 135 | 140 |
| <210> | 76 |
| <211> | 3171 aminokyselin |
| <212> | protein |
| <213> | mikroorganizmus S.pneumoniae |
| <400> | 76 |
gacttgacag aagagcaaat taaggctgcg caaaaacatt tagaggaagt taaaactagt 60 cataatggat tagattcttt gtcatctcat gaacaggatt atccaggtaa tgccaaagaa 120 atgaaagatt tagataaaaa aatcgaagaa aaaattgctg gcattatgaa acaatatggt 180 gtcaaacgtg aaagtattgt cgtgaataaa gaaaaaaatg cgattattta tccgcatgga 240 gat:caccatc atgcagatcc gattgatgaa cataaaccgg ttggaattgg tcattctcac 300 agtaaccatg aactgtttaa acccgaagaa ggagttgcta aaaaagaagg gaataaagtt 360 tatactggag aagaattaac gaatgttgtt aatttgttaa aaaatagtac gtttaataat 420 caaaacttta ctctagccaa tggtcaaaaa cgcgtttctt ttagttttcc gcctgaattg 480 gagaaaaaat taggtatcaa tatgctagta aaattaataa caccagatgg aaaagtattg 540 gagaaagtat ctggtaaagt atttggagaa ggagtaggga atattgcaaa ctttgaatta 600 gatcaacctt atttaccagg acaaacattt aagtatacta tcgcttcaaa agattatcca 660 gaagtaagtt atgatggtac atttacagtt ccaacctctt tagcttacaa aatggccagt 720 caaacgattt tetatccttt ccatgcaggg gatacttatt taagagtgaa ccctcaattt 780 gcagtgccta aagqaactga tgctttagtc agagtgtttg atgaatttca tggaaatgct 840 tatttagaaa ataactat.aa agttgqtgaa atcaaattac cgattccgaa attaaaccaa 900 ggaacaacca gaacggccgg aaataaaatt cctgtaacct tcatggcaaa tgcttatttg 960 gacaatcaat egaettatat tgtggaagta cctatcttgg aaaaagaaaa tcaaactgat 1020 aaaccaagta ttctaccaca atttaaaagg aataaagcac aagaaaactc aaaacttgat 1080 gaaaaggtag aagaaccaaa gactagtgag aaggtagaaa aagaaaaact ttctgaaact 1140 gggaatagta ctagtaattc aacgttagaa gaagttccta cagtggatcc tgtacaagaa 1200 aaagtagcaa aatttgctga aagttatggg atgaagctag aaaatgtctt gtttaatatg 1260 gacggaacaa tLgaattata tttaccatca ggagaagtca ttaaaaagaa tatggcagat 1320 tttacaggag aagcacctca aggaaatggt gaaaataaac catctgaaaa tggaaaagta 1380 tctactggaa cagttgagaa ccaaccaaca gaaaataaac cagcagattc tttaccagag 1440 gcaccaaacg aaaaacctgt aaaaccagaa aactcaacgg ataatggaat gttgaatcca 1500 gaagggaatg tggggagtga ccctatgtta gatccagcat tagaggaagc tccagcagta 1560 gatcctgtac aagaaaaatt agaaaaattt acagctagtt acggattagg cttagatagt 1620 gttatattea atatggatgg aacgattgaa ttaagattgc caagtggaga agtgataaaa 1680 aagaatttat ctgatttcat agcgaagctt cgttatcgtt caaaccattg ggtaccagat 1740 teaagaccag aagaaccaag tccacaaccg actccagaac ctagtccaag tccgcaacct 1800 gcaccaaatc ctcaaccagc tccaagcaat ccaattgatg agaaattggt caaagaagct 1860 gttcgaaaag taggcgatgg ttatgtcttt gaggagaatg gagtttctcg ttatatccca 1920 gccaaqaa^c ttteageaga aacagcagca ggeattgata gcaaactggc caagcaggaa 1980 agtttatctc ataagctagg agctaagaaa actgacctcc catctagtga tcgagaattt 2040 tacaataagg cttatgactt actagcaaga attcaccaag atttacttga taataaaggt 2100 egaeaagttg attttgaggc tttggataac ctgttggaac gactcaagga tgtctcaagt 2160 gataaagtca agttagt.gga tgatattett gccttcttag ctccgattcg tcatccagaa 2220 cgtttaggaa aaccaaatgc gcaaattacc tacactgatg atgagattea agtagccaag 2280 ILggcaggca agtacacaac agaagacggt tatatctttg atcctcgtga tataaccagt 2340 gatgaggggg at.gcctatqt aactccacat atgacccata qccactggat taaaaaagat 2400 agtttgtctg aagctqaqag agcggcagcc caggcttatg ctaaagagaa aggtttgacc 2460
- 100C7. 303675 B6 cctccttcga tacaaccgcg tatactgtag atcaaat 11g gatcttttgg aatggttttg aatcaaacgg cctcgagaag gaagaagaat aaactgagag gccaaagaga actattatgg cagaccat ca tgaaagcagc aagtcaaaaa agtggtttga cgactgtcaa gtaaogctag aaaaaccaag agaaaccaca caccagagga aggctgaaga ctctcacagg cagaagctga ggattcagga taagaaggtg cggtagttta cgaaggcct t gtact atgtc cgaccatgtt cgaqgagaaa aagcgagaaa atcagaagaa tttacttgga attaaaaaat aatactgagg ccacttgatc atcatacctc tatgaqgcac gaacatccaa caaagaaaca cctcagacag ccagagtctc cctcaggtcg aaaatccagg aatttactat aaaactattg gctttattaa caaaaggagc gtatgcct ta attatgacca ctaaggggta acgaacgtcc aaaatggtca aaaaacctga caaaaccaac agactgaaaa atccaattat ttggcaccca aggagagtaa agaagctatc caatct.tcaa ttaccataac tactcttgag gcattcagat agctga Lacc ggaagaaacc agaggaacca ggttgaagaa caagtccaat ggacaacaat g
5 20 2580 2640 2700 2760 2820 2880 294 0 30 00 3060 3120 3171 <210> 77 <211> 473 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 77
| Glu 1 | Ala | Tyr | Trp | Asn 5 | Gly | Lys | Gin | Gly | Ser 10 | Arg | Pro | Ser | Ser | Ser 15 | Ser |
| Ser | Tyr | Asn | Ala | Asn | Pro | Val | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 20 | 25 | 30 | |||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Cin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 35 | 40 | 4 5 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 50 | 55 | 60 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Tle | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 85 | 90 | 95 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 100 | 105 | 110 | |||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 115 | 120 | 125 | |||||||||||||
| Pro | Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Leu | Gin | Pro | Ala |
| 130 | 135 | 140 | |||||||||||||
| Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val |
| 145 | 150 | 155 | 160 | ||||||||||||
| Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn |
| 165 | 170 | 175 | |||||||||||||
| Gly | Val | Ser | Ar g | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala |
| 180 | 185 | 190 | |||||||||||||
| Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys |
| 195 | 200 | 205 | |||||||||||||
| Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr |
| 210 | 215 | 220 | |||||||||||||
| Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp |
| 225 | 230 | 235 | 240 | ||||||||||||
| Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu | Asp | Asn | Leu | Leu | Glu |
| 245 | 250 | 255 | |||||||||||||
| Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile |
| 260 | 265 | 270 | |||||||||||||
| Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro |
| 275 | 280 | 285 | |||||||||||||
| Asn | Ala | Gin | I le | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu |
| 290 | 295 | 300 | |||||||||||||
| Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp |
| 305 | 310 | 315 | 320 |
| lle | Thr | Ser | Asp | Glu Gly Asp 325 | Ala | Tyr | Val 330 | Thr | Pro | His | Met | Thr 335 | His | ||
| Ser | His | Trp | Tle | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala |
| 340 | 345 | 350 | |||||||||||||
| Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp |
| 355 | 360 | 365 | |||||||||||||
| His | Gin | Asp | Ser | Giy | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | lle | Tyr |
| 370 | 375 | 380 | |||||||||||||
| Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr |
| 385 | 390 | 395 | 400 | ||||||||||||
| Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | lle | lle | Pro |
| 405 | 410 | 415 | |||||||||||||
| His | Tyr | Asp | His | Tyr | His | Asn | lle | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly |
| 420 | 425 | 430 | |||||||||||||
| Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr |
| 435 | 440 | 445 | |||||||||||||
| Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn |
| 450 | 455 | 460 | |||||||||||||
| Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | |||||||
| 465 | 4 70 |
<210> <211>
<212>
<213> <400>
780 aminokyselin protein mikroorganizmus S.pneumoniae 78
| Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | dy | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | lle | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | lle | Val | lle | Lys | lle | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | lle | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | lle | lle | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | lle | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| GJ. u | Lys | Val | Asn | Ser | Asn | Val | Al a | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Tle | lle | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | lle | Val | Pro | His | Gly | Gl y | His | Tyr | His | Tyr | lle |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 1 95 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 |
- 102 C7. 303675 B6
| Asp | Ser | Pro | Ser 260 | Ala | Gin | Arg | Tyr | Ser 265 | Glu | Ser | Asp | Gly | Leu 270 | Val | Phe |
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Giy | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Al a | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 4 60 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Va L | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 67 5 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 |
Ť0?
| Val Arg | Val | Phe Asp 725 | Glu | Phe | His Gly Asn Ala Tyr Leu Glu Asn Asn | ||||||||||
| 7 30 | 735 | ||||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | ||||
| 770 | 775 | 780 |
<210> <211>
<212>
<213> <400>
690 aminokyselin protein mikroorganizmus S.pneumoniae 79
| Cys 1 | Ala Tyr | Glu Leu 5 | Gly Leu His Gin Ala 10 | Gin Thr Val | Lys | Glu 15 | Asn | ||||||||
| Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Lys | Gin | Ala | Thr | Gin | Lys | Thr | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ser |
| 8 5 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Glu | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Ser | Gin | His | Arg |
| 130 | '135 | 140 | |||||||||||||
| Glu | Giv | Gly | Thr | Ser | Ala | Asn | Asp | Gly | Ala | Val | Ala | Phe | Ala | Arg | Ser |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gin | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Ile | Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Ala | Glu | Ala | Phe | Leu | Ser | Gly | Arg | Glu | Asn | Leu | Ser | Asn | Leu | Arg | Thr |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Arg | Arg | Gin | Asn | Ser | Asp | Asn | Thr | Pro | Arg | Thr | Asn | Trp | Val | Pro |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ser | Val | Ser | Asn | Pro | Gly | Thr | Thr | Asn | Thr | Asn | Thr | Ser | Asn | Asn | Ser |
| 245 | 250 | 255 | |||||||||||||
| Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp | Ser | Leu | Leu |
| 260 | 265 | 270 | |||||||||||||
| Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin | Arg | Hj 5 | Val | Glu | Ser | Asp |
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala | Arg | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr | Glu | Gin |
| 305 | 310 | 315 | 320 | ||||||||||||
| Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu | Arg | Tyr |
| 325 | 330 | 335 | |||||||||||||
| Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro | Ser | Pro |
| 34 0 | 345 | 350 |
- 104CZ 303675 B6
| Gin | Pro | Thr 355 | Pro | Glu | Pro | Ser | Pro 360 | Ser | Pro | Gin | Pro | Ala 365 | Pro | Asn | Pro |
| Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala |
| 370 | 375 | 380 | |||||||||||||
| Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser |
| 385 | 390 | 395 | 400 | ||||||||||||
| Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Al a | Ala | Gly | Ile |
| 405 | 410 | 4 15 | |||||||||||||
| Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala |
| 420 | 425 | 4 30 | |||||||||||||
| Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala |
| 435 | 440 | 445 | |||||||||||||
| Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly |
| 450 | 455 | 460 | |||||||||||||
| Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys |
| 465 | 470 | 475 | 480 | ||||||||||||
| Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe |
| 485 | 490 | 495 | |||||||||||||
| Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin |
| 500 | 505 | 510 | |||||||||||||
| Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys |
| 515 | 520 | 525 | |||||||||||||
| Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser |
| 530 | 535 | 540 | |||||||||||||
| Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala |
| 565 | 570 | 575 | |||||||||||||
| Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp |
| 580 | 585 | 590 | |||||||||||||
| Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val |
| 595 | 600 | 605 | |||||||||||||
| Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp |
| 625 | 630 | 635 | 640 | ||||||||||||
| His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu |
| 645 | 650 | 655 | |||||||||||||
| Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr |
| 660 | 665 | 670 | |||||||||||||
| Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly |
| 675 | 680 | 685 | |||||||||||||
| Asn | Ala |
690
| <210> | 80 |
| <211> | 2469 párů bází |
| <212> | DNA |
| <213> | mikroorganizmus S.pneumoniae |
| <400> | 80 |
gtgaagaaaa catatggtta tatcggctca gttgctgcca ttttactagc tactcatatt 60 ggaagttacc aacttggtaa gcatcatatg ggtctagcaa caaaggacaa tcagattgcc 120 tatattgatg acagcaaagg taaggcaaaa gcccctaaaa caaacaaaac gatggatcaa 180 atcagtgctg aagaaggcat ctctgctgaa cagatcgtag tcaaaattac tgaccaaygc 240 tatgtgacct cacacggtga ccattatcat ttttacaatg ggaaagttcc ttatgatgcg 300 attattagtg aagagttgtt gatgacggat cctaattacc gttttaaaca atcagacgtt 360 atcaatgaaa tcttagacgg ttacgttatt aaagtcaatg gcaactatta tgtttacetc 420 aagccaggta gtaagcgcaa aaacattcga accaaacaac aaattgctga gcaagtagcc 480 aaaggaacta aagaagctaa agaaaaaggt ttagctcaag tggcccatct cagtaaagaa 540 gaagttgcgg atttttagtc aatcactatc gcctactgga gccccaggtc cagccagata aaacaccaaa cgtcttgatt gtqatcaaat ccaagaagtc actgaggaca acctttcttg acgagtgatg acagctaaac ttggatgagg ttggatcagg gtaacaaaag gctcgtgatc gataagaagc gatgtgt.caa gttatcccac attgcaacag ccagggcatg ggtatgccaa ggtcgttttg acttttgtat accattaata aagaaaaata aagagcaatg tttatagaca caattagcac caattttata aacccttaa cagtcaatga cgacagatat attatattcc gtcaaaaaca gtaggaaagc acggtggcta gagatgagtt tgaaataccg caaacgcttt agt tatcacc atgactcagg gtcatcgcat cttatgtttt acggagatca tcgctaactg aacaaggcaa atggtaaagt aacttgattt attaccgtta gtctgccgat atattgatca tcasgtatgt aagagtcagg actggcaaat caacaccaga ggaaagatgg aatctgatct ctggtgatgc aaaaccaaca gtttaccaga aaaaaqctaa ataaaaatgg agcaaaaaga cattgatgat taaaaaggat aggtcgaggt cccaattcct tcatccagcg taaaggaaaa tcatgtggaa tgggtatgtg tcttgaaatg ttcagagcac caaagcttac tagtaaagaa tttccactat ggtgaaagca agaaaaacca gggctatatg gactcagatt tgacattgtt gcatgctggt tatccatgtc gatgcaacac ttcggtcatt tatccattet cggctatatt ctcctttagc atcccaagct tactgatacg gccaagtgaa ctatggtcta tatcgatcct tgaattggta caaggacgct ttaggagatg ttgtctccaa gctagaccgt gatgtgacgc cctcctaggc acctttaagg gaagatgggt gtgcctcatg gaattagcag tcaaaaccat ggaaaaggct tccattcatt ataggatttg aaaggtcaag ctctttgaca atgccaaaag gcctttgccg gacacaggta aatgctactt gttccgtatt cccgaagttc ccaaatgtta gctgaagaag ttcgatccac atcccaagag gagtggcaac gataaaccca gccagtaaag gatagageaa aagtatctca acttatgata atactacaga cttatttagt gtgagctagc ctgattaccg ctaaccctgg caaatgatgc aacttttaga tgatttttga gagateatta atcgatactt cagataaaga tagatggtaa cagtggataa gagaacttga ctgatgagct ctaaaaaagt atggtaagga aacaagaact ttgagccacg acgatactgg catggttgac gtccggatgt cgcctcttga ttcaaaaagc gagatgtttt cagatggcag aagctcaaga aagaaaagca aagaaaaaga ccctagaaga ttttccaacc tcaagacact cgatggctat acctcatggt tgctgcacaa cccgacacca acaaggtcat gtcacaaaac tcaactacac accgactcaa teatattate agctggccaa agtgacacat accatatgat atcaggagtt acaatatgag tgctgctgct gagtcgcaaa etatttetat aatgcttaaa acttgctgta aagttcgttt gcgcgatcag atggtctaag taaacgtgct cctagcagaa ggccaaagaa tteattgaga gttattggca acaggcagat ateagatgac tcatatcaat agaaggtgtc tcaacaaata
600
660
720
780
840
900
960
1020
1080
1140
1200
1260
1320
1380
1440
1500
1560
1620
1680
1740
1800
1860
1920
1980
2040
2100
2160
2220
2280
2340
2400
2460
2469 <210 <211>
<212>
<213> <400>
Sl
823 aminokyselin protein mikroorganizmus S.pneumoniae 81
| Val | Lys | Lys | Thr | Tyr | Gly | Tyr | I le | Gly | Ser | Val | Ala | Ala | Ile | Leu | Leu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ala | Thr | His | Ile | Gly | Ser | Tyr | Gin | Leu | Gly | Lys | His | His | Met | Gly | Leu |
| 20 | 25 | 30 | |||||||||||||
| Ala | Thr | Lys | Asp | Asn | Gin | ile | Ala | Tyr | Ile | Asp | Asp | Ser | Lys | Gly | Lys |
| 35 | 40 | 45 | |||||||||||||
| Ala | Lys | Ala | Pro | Lys | Thr | Asn | Lys | Thr | Met | Asp | Gin | Ile | Ser | Ala | Glu |
| 5 0 | 55 | 60 | |||||||||||||
| Glu | Gly | Ile | Ser | Ala | Glu | Gin | Ile | Val | Val | Lys | lle | Thr | Asp | Gin | Gly |
| 65 | 70 | 7 5 | 80 | ||||||||||||
| Tyr | Val | Thr | Ser | His | Gly | Asp | His | Tyr | His | Phe | Tyr | Asn | Gly | Lys | Val |
| 85 | 90 | 95 | |||||||||||||
| Pro | Tyr | Asp | Ala | Ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Thr | Asp | Pro | Asn |
| 100 | 105 | 110 | |||||||||||||
| Tyr | Arg | Phe | Lys | Gin | Ser | Asp | Val | Ile | Asn | Glu | Ile | Leu | Asp | Gly | Tyr |
| 115 | 120 | 125 | |||||||||||||
| Val | Ile | Lys | Val | Asn | Gly | Asn | Tyr | Tyr | Val | Tyr | Leu | Lys | Pro | Gly | Ser |
| 13C | 135 | 140 | |||||||||||||
| Tys | Arg | Lys | Asn | Ile | Arg | Thr | Lys | Gin | Gin | Ile | Ala | Glu | Gin | Val | Ala |
- 106CZ 303675 B6
| 145 | 150 | 155 | 160 | ||||||||||||
| Lys | Gly | Thr | Lys | Glu | Ala | Lys | Glu | Lys | Gly | Leu | Ala | Gln | Val | Ala | His |
| 165 | 170 | 17 5 | |||||||||||||
| Leu | Ser | Lys | G1 u | Glu | Val | Ala | Ala | Val | Asn | Glu | Ala | Lys | Arg | Gln | G1 y |
| 180 | 185 | 190 | |||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Sor | Pro | Thr | Asp | Ile | Ile |
| 195 | 200 | 205 | |||||||||||||
| Asp | Asp | Leu | Gly | Asp | Ala | Tyr | Leu | Val | Pro | His | Gly | Asn | His | Tyr | His |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Ile | Pro | Lys | Lys | Asp | Leu | Ser | Pro | Ser | Glu | Leu | Ala | Ala | Ala | Gln |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ala | Tyr | Trp | Ser | Gln | Lys | Gln | Gly | Arg | Gly | Ala | Arg | Pro | Ser | Asp | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Arg | Pro | Thr | Pro | Ala | Pro | Gly | Arg | Arg | Lys | Ala | Pro | Ile | Pro | Asp | Val |
| 260 | 265 | 270 | |||||||||||||
| Thr | Pro | Asn | Pro | Gly | Gln | Gly | His | Gln | Pro | Asp | Asn | Gly | Gly | Tyr | His |
| 275 | 280 | 285 | |||||||||||||
| Pro | Ala | Pro | Pro | Arg | Pro | Asn | Asp | Ala | Ser | Gln | Asn | Lys | His | Gln | Arg |
| 290 | 295 | 300 | |||||||||||||
| Asp | Glu | Phe | Lys | Gly | Lys | Thr | Phe | Lys | Glu | Leu | Leu | Asp | Gln | Leu | His |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Leu | Asp | Leu | Lys | Tyr | Arg | His | Val | Glu | Glu | Asp | Gly | Leu | Ile | Phe |
| 325 | 330 | 335 | |||||||||||||
| Glu | Pro | Thr | Gin | Val | Ile | Lys | Ser | Asn | Ala | Phe | Giy | Tyr | Val | Val | Pro |
| 340 | 345 | 350 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Ile | Ile | Pro | Arg | Ser | Gln | Leu | Ser | Pro | Leu |
| 355 | 360 | 365 | |||||||||||||
| Glu | Met | Glu | Leu | Ala | Asp | Arg | Tyr | Leu | Ala | Gly | Gln | Thr | Glu | Asp | Asn |
| 370 | 375 | 380 | |||||||||||||
| Asp | Ser | Gly | Ser | Glu | His | Ser | Lys | Pro | Ser | Asp | Lys | Glu | Val | Thr | His |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Phe | Leu | Gly | His | Arg | Ile | Lys | Ala | Tyr | Gly | Lys | Gly | Leu | Asp | Gly |
| 405 | 410 | 415 | |||||||||||||
| Lys | Pro | Tyr | Asp | Thr | Ser | Asp | Ala | Tyr | Val | Phe | Ser | Lys | Glu | Ser | Ile |
| 420 | 425 | 430 | |||||||||||||
| His | Ser | Val | Asp | Lys | Ser | Gly | Val | Thr | Ala | Lys | His | Giy | Asp | His | Phe |
| 4 35 | 440 | 445 | |||||||||||||
| His | Tyr | Ile | Gly | Phe | Gly | Glu | Leu | Glu | Gln | Tyr | Glu | Leu | Asp | Glu | Val |
| 450 | 455 | 460 | |||||||||||||
| Ala | Asn | Trp | Val | Lys | Al a | Lys | Gly | Gln | Ala | Asp | Glu | Leu | Ala | Ala | Ala |
| 465 | 470 | 475 | 480 | ||||||||||||
| Leu | Asp | Gln | Glu | Gln | Gly | Lys | Glu | Lys | Pro | Leu | Phe | Asp | Thr | Lys | Lys |
| 485 | 490 | 495 | |||||||||||||
| Val | Ser | Arg | Lys | Val | Thr | Lys | Asp | Giy | Lys | Val | Gly | Tyr | Met | Met | Pro |
| 500 | 505 | 510 | |||||||||||||
| Lys | Asp | Gly | Lys | Asp | Tyr | Phe | Tyr | Ala | Arg | Asp | Gln | Leu | Asp | Leu | Thr |
| 515 | 520 | 525 | |||||||||||||
| Gln | Ile | Ala | Phe | Ala | Glu | Gln | Glu | Leu | Met | Leu | Lys | Asp | Lys | Lys | His |
| 530 | 535 | 540 | |||||||||||||
| Tyr | Arg | Tyr | Asp | Ile | Val | Asp | Thr | Gly | Ile | Glu | Pro | Arg | Leu | Ala | Val |
| 545 | 550 | 555 | 560 | ||||||||||||
| Asp | Va 1 | Ser | Ser | Leu | Pro | Met | His | Ala | Gly | Asn | Ala | Thr | Tyr | Asp | Thr |
| 565 | 570 | 575 | |||||||||||||
| Gly | Ser | Ser | Phe | Val | Ile | Pro | His | Ile | Asp | His | Ile | His | Val | Val | Pro |
| 580 | 585 | 590 | |||||||||||||
| Tyr | Ser | Trp | Leu | Thr | Arg | Asp | Gln | Ile | Ala | Thr | Val | Lys | Tyr | Val | Met |
| 595 | 600 | 605 | |||||||||||||
| Gln | His | Pro | Glu | Val | Arg | Pro | Asp | Val | Trp | Ser | Lys | Pro | Gly | His | Glu |
| 610 | 615 | 620 | |||||||||||||
| Glu | Ser | Gly | Ser | Val | Ile | Pro | Asn | Val | Thr | Pro | Leu | Asp | Lys | Arg | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Gl y | Met | Pro | Asn | Trp | Gin | Ile | Ile | His | Ser | Ala | Glu | Glu | Val | Gin | Lys |
| 645 | 650 | 655 | |||||||||||||
| Ala | Leu | Ala | Glu | Gly | Arg | Phe | Ala | Thr | Pro | Asp | Gly | Tyr | Ile | Phe | Asp |
| 660 | 665 | 670 | |||||||||||||
| Pro | Arg | Asp | Val | Leu | Ala | Lys | Glu | Thr | Phe | Val | Trp | Lys | Asp | Gly | Ser |
| 675 | 680 | 685 | |||||||||||||
| Phe | Ser | Ile | Pro | Arg | Ala | Asp | Gly | Ser | Ser | Leu | Arg | Thr | Ile | Asn | Lys |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Leu | Ser | Gin | Ala | Glu | Trp | Gin | Gin | Ala | Gin | Glu | Leu | Leu | Ala |
| 705 | 710 | 715 | 720 | ||||||||||||
| Lys | Lys | Asn | Thr | Gly | Asp | Ala | Thr | Asp | Thr | Asp | Lys | Pro | Lys | Glu | Lys |
| 725 | 730 | 735 | |||||||||||||
| Gin | Gin | Ala | Asp | Lys | Ser | Asn | Glu | Asn | Gin | Gin | Pro | Ser | Glu | Ala | Ser |
| 740 | 745 | 750 | |||||||||||||
| Lys | Glu | Glu | Lys | Glu | Ser | Asp | Asp | Phe | Ile | Asp | Ser | Leu | Pro | Asp | Tyr |
| 755 | 760 | 765 | |||||||||||||
| Gly | Leu | Asp | Arg | Ala | Thr | Leu | Glu | Asp | His | Ile | Asn | Gin | Leu | Ala | Gin |
| 770 | 775 | 780 | |||||||||||||
| Lys | Ala | Asn | Ile | Asp | Pro | Lys | Tyr | Leu | Ile | Phe | Gin | Pro | Glu | Gly | Val |
| 785 | 7 90 | 795 | 800 | ||||||||||||
| Gin | Phe | Tyr | Asn | Lys | Asn | Gly | Glu | Leu | Val | Thr | Tyr | Asp | Ile | Lys | Thr |
| 805 | 810 | 815 | |||||||||||||
| Leu | Gin | Gin | Ile | Asn | Pro | Pro | |||||||||
| 820 |
| <210> | 82 |
| <211> | 2472 párů bází |
| <212> | DNA |
| <213> | mikroorganizmus S.pneumoniae |
| <400> | 82 |
gtgaagaaaa catatggtta tatcggctca gttgctgcca ttttactagc tactcatatt 60 ggaagttacc aacttggtaa gcatcatatg ggtctagcaa caaaggacaa tcagattgcc 120 tatattgatg atagcaaagg taaggcaaaa gcccctaaaa caaacaaaac gatggatcaa 180 atcagtgctg aagaaggcat ctctgctgaa cagatcgtag tcaaaattac tgaccaaggt 240 tatqtgacct cacacggtga ccattatcat ttttacaatg ggaaagttcc ttatgatgcg 300 attattagtg aagagttgtt gatgacggat cctaattacc attttaaaca atcagacgtt 360 atcaatgaaa tcttagacgg ttacgttatt aaagtcaatg gcaactatta tgtttacctc 420 aagccaggta gtaagcgcaa aaacattega accaaacaac aaattgctga gcaagtagcc 480 aaaggaacta aagaagctaa agaaaaaggt ttagctcaag tggcccatct cagtaaagaa 540 gaagttgcgg cagtcaatga agcaaaaaga caaggacgct atactacaga cgatggctat 600 atttttagtc cgacagatat cattgatgat ttaggagacg cttatttagt acctcatggt 660 aatcactatc attatattcc taaaaaagat ttgtctccaa gtgagctagc tgctgcacaa 720 gcttactgga gtcaaaaaca aggtcgaggt gctagaccgt ctgattaccg cccgacacca 780 gccccaggtc gtaggaaagc tccaattcct gatgtgacgc ctaaccctgg acaaggtcat 840 cagccagata acggtggcta tcatccagcg cctcctaggc caaatgatgc gtcacaaaac 900 aaacaccaaa gagatgagtt taaaggaaaa acctttaagg aacttttaga tcaactacac 960 cgtcttgatt tqaaataccg tcatgtggaa gaagatgggt tgatttttga accgactcaa 1020 gtqatcaaat. aaaacgcttt. tgggtatgtg gtgcctcatg gagateatta teatattate 108 0 ccaagaagtc agttatcacc tcttgaaatg gaattagcag atcgatactt agccggtcaa 1140 actgaggaca atgattcagg ttcagatcac tcaaaaccat cagataaaga agtgacacat 1200 acctttcrtg gtcatcgcat caaagcttac ggaaaaggct tagatggtaa accatatgat 1260 acgagtgatg cttatgtttt tagtaaagaa tccattcatt cagtggataa atcaggagtt 1320 acagctaaac aogqagatca tttccactat ataggatttg gagaacttga acaatatgag 1380 ttggatgagg tcgctaacLg ggtgaaagca aaaggtcaag ctgatgagct tgctgctgct 1440 Ltggatcagg aacaaggcaa agaaaaacca ctctttgaca ctaaaaaagt gagtcgcaaa 1500
- 108 C.7 303675 Bó gtaacaaaag atggtaaagt gggctatatt atgccaaaag atggcaagga ctaLttctat 1560 gctcgtgatc aacttgattt gactcagatt qcctttgccg aacaagaact. aaígclt.aaa 1620 gataagaacc attaccgtta tqacattgtt gacacaggta ttgagccacg acttgctgt.a 1680 gatqtqtcaa gtctgccgat gcatgctggt aatgctactt acqatactqg aagttcgttt 1740 gttatccctc atat l.gatca tatccatgtc gttccgtatt catggttgac gcgcgatcag 1800 attgcaacaa tcaagtatgt gatgcaacac cccgaagttc gtccagatgt atggtctaag 1860 ccagggcatg aagagtcagg ttcggtcatt ccaaatgtta cgcctcttga taaacgtgct 1920 qgtatgccaa attggcaaat catccattct gctgaagaag ttcaaaaagc cctagcagaa 1980 ggtcgttttg caacaccaga cggctatatt ttcgatccac gagatgtttt ggccaaagaa 2040 acttttytat ggaaagatgg ctcctttagc atcccaagag cagatggcag ttcattgaga 2100 accattaata aatctgatcl at.cccaagct gagtggcaac aagctcaaga gttatlggca 2160 aagaaaaacg ctggtgatgc tactgatacg gataaaccca aagaaaagca acaggcagat 2220 aagagcaatg aaaaccaaca gccaagtgaa gccagtaaag aagaagaaaa agaatcagat 2280 gactttatag acagtttacc agactatggt ctagatagag caaccctaga agatcatatc 2340 aatcaattag cacaaaaagc taatatcgat cctaagt.at c tcalt tLcca accagaaggt 2400 gtccaattt.t. ataataaaaa tggtgaaLta gtaacttatg atatcaagac gcLtcaacaa 2460 ataaacccttaa 2472 <210> 83 <211> 824 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 83
| Val 1 | Lys | Lys | Thr | Tyr 5 | Gly Tyr | Ile Gly | Ser 10 | Val | Ala | Ala | Ile | Leu 15 | Leu | ||
| Ala | Thr | His | Ile | Gly | Ser | Tyr | Gin | Leu | Gly | Lys | His | His | Met | Gly | Leu |
| 20 | 25 | 30 | |||||||||||||
| Ala | Thr | Lys | Asp | Asn | Gin | Ile | Ala | Tyr | Ile | Asp | Asp | Ser | Lys | Gly | Lys |
| 35 | 40 | 45 | |||||||||||||
| Ala | Lys | Ala | Pro | Lys | Thr | Asn | Lys | Thr | Met | Asp | Gin | Ile | Ser | Ala | Glu |
| 50 | 55 | 60 | |||||||||||||
| Glu | Gly | Ile | Ser | Ala | Glu | Gin | Ile | Val | Val | Lys | Ile | Thr | Asp | Gin | Gly |
| 65 | 70 | 7 5 | 80 | ||||||||||||
| Tyr | Val | Thr | Ser | His | Gly | Asp | His | Tyr | His | Phe | Tyr | Asn | Gly | Lys | Val |
| 85 | 90 | 95 | |||||||||||||
| Pro | Tyr | Asp | Ala | Ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Thr | Asp | Pro | Asn |
| 100 | 105 | 110 | |||||||||||||
| Tyr | His | Phe | Lys | Gin | Ser | Asp | Val | Ile | Asn | Glu | Ile | Leu | Asp | Gly | Tyr |
| 115 | 120 | 125 | |||||||||||||
| Val | Ile | Lys | Val | Asn | Gly | Asn | Tyr | Tyr | Val | Tyr | Leu | Lys | Pro | Gly | Ser |
| 130 | 135 | 140 | |||||||||||||
| Lys | Arg | Lys | Asn | Ile | Arg | Thr | Lys | Gin | Gin | Ile | Ala | Glu | Gin | Val | Ala |
| 145 | 150 | 155 | 160 | ||||||||||||
| Lys | Gly | Thr | Lys | Glu | Ala | Lys | Glu | Lys | Gly | Leu | Ala | Gin | Val | Ala | His |
| 165 | 170 | 175 | |||||||||||||
| Leu | Ser | Lys | Glu | Glu | Val | Ala | Ala | Val | Asn | Glu | Ala | Lys | Arg | Gin | Gly |
| 180 | 185 | 190 | |||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Ser | Pro | Thr | Asp | Ile | Ile |
| 195 | 200 | 205 | |||||||||||||
| Asp | Asp | Leu | Gly | Asp | Al a | Tyr | Leu | Val | Pro | His | Gly | Asn | His | Tyr | His |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Ile | Pro | Lys | Lys | Asp | Leu | Ser | Pro | Ser | Glu | Leu | Ala | Ala | Ala | Gin |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ala | Tyr | Trp | Ser | Gin | Lys | Gin | Gly | Arg | Gly | Ala | Arg | Pro | Ser | Asp | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Arg | Prc | Thr | Pro | Ala | Pro | Gly | Arg | Arg | Lys | Ala | Pro | Ile | Pro | Asp | Val |
| 260 | 2 65 | 270 | |||||||||||||
| Tor | Prc | Asn | Pro | Gl y | Gin | Gly | His | Gin | Pro | Asp | Asn | Cly | Gly | Tyr | His |
TO
| 2 75 | 280 | 285 | |||||||||||||
| Pro | Ala | Pro | Pro | Arg | Pro | Asn | Asp | Ala | Ser | Gin | Asn | Lys | His | Gin | Arg |
| 290 | 295 | 300 | |||||||||||||
| Asp | Glu | Phe | 1 .ys | Gly | Lys | Thr | Phe | Lys | Glu | Leu | Leu | Asp | Gin | Leu | His |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Leu | Asp | Leu | Lys | Tyr | Arg | His | Val | Glu | Glu | Asp | Gly | Leu | Ile | Phe |
| 325 | 330 | 335 | |||||||||||||
| Glu | Pro | Thr | Gin | Val | Ile | Lys | Ser | Asn | Ala | Phe | Gly | Tyr | Val | Val | Pro |
| 340 | 345 | 350 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Ile | Ile | Pro | Arg | Ser | Gin | Leu | Ser | Pro | Leu |
| 355 | 360 | 365 | |||||||||||||
| Glu | Met | Glu | Leu | Ala | Asp | Arg | Tyr | Leu | Ala | Gly | Gin | Thr | Glu | Asp | Asn |
| 370 | 375 | 380 | |||||||||||||
| Asp | Ser | Gly | Ser | Asp | His | Ser | Lys | Pro | Ser | Asp | Lys | Glu | Val | Thr | His |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Phe | Leu | Gly | His | Arg | Ile | Lys | Ala | Tyr | Gly | Lys | Gly | Leu | Asp | Gly |
| 4 05 | 410 | 415 | |||||||||||||
| Tys | Pro | Tyr | Asp | Thr | Ser | Asp | Ala | Tyr | Val | Phe | Ser | Lys | Glu | Ser | Ile |
| 420 | 425 | 430 | |||||||||||||
| His | Ser | Val | Asp | Lys | Ser | Gly | Val | Thr | Ala | Lys | His | Gly | Asp | His | Phe |
| 435 | 440 | 445 | |||||||||||||
| His | Tyr | Ile | Gly | Phe | Gly | Glu | Leu | Glu | Gin | Tyr | Glu | Leu | Asp | Glu | Val |
| 450 | 455 | 460 | |||||||||||||
| Ala | Asn | Trp | Val | Lys | Ala | Lys | Gly | Gin | Ala | Asp | Glu | Leu | Ala | Ala | Ala |
| 465 | 470 | 475 | 480 | ||||||||||||
| Leu | Asp | Gin | Glu | Gin | Gly | Lys | Glu | Lys | Pro | Leu | Phe | Asp | Thr | Lys | Lys |
| 485 | 490 | 495 | |||||||||||||
| Val | Ser | Arg | Lys | Val | Thr | Lys | Asp | Gly | Lys | Val | Gly | Tyr | Ile | Met | Pro |
| 500 | 505 | 510 | |||||||||||||
| Lys | Asp | Gly | Lys | Asp | Tyr | Phe | Tyr | Ala | Arg | Asp | Gin | Leu | Asp | Leu | Thr |
| 515 | 520 | 525 | |||||||||||||
| Gin | Ile | Ala | Phe | Ala | Glu | Gin | Glu | Leu | Met | Leu | Lys | Asp | Lys | Asn | His |
| 530 | 535 | 540 | |||||||||||||
| Tyr | Arg | Tyr | Asp | Ile | Val | Asp | Thr | Gly | Ile | Glu | Pro | Arg | Leu | Ala | Val |
| 545 | 550 | 555 | 560 | ||||||||||||
| Asp | Val | Ser | Ser | Leu | Pro | Met | His | Ala | Gly | Asn | Ala | Thr | Tyr | Asp | Thr |
| 565 | 570 | 575 | |||||||||||||
| Gly | Ser | Ser | Phe | Val | Ile | Pro | His | Ile | Asp | His | Ile | His | Val | Val | Pro |
| 580 | 585 | 590 | |||||||||||||
| Tyr | Ser | Trp | Leu | Thr | Arg | Asp | Gin | Ile | Ala | Thr | Ile | Lys | Tyr | Val | Met |
| 595 | 600 | 605 | |||||||||||||
| Gin | His | Pro | Glu | Val | Arg | Pro | Asp | Val | Trp | Ser | Lys | Pro | Gly | His | Glu |
| 610 | 615 | 620 | |||||||||||||
| Glu | Ser | Gly | Ser | Val | Ile | Pro | Asn | Val | Thr | Pro | Leu | Asp | Lys | Arg | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Gly | Met | Pro | Asn | Trp | Gin | Ile | Ile | His | Ser | Ala | Glu | Glu | Val | Gin | Lys |
| 645 | 650 | 655 | |||||||||||||
| Ala | Leu | Ala | Glu | Gly | Arg | Phe | Ala | Thr | Pro | Asp | Gly | Tyr | Ile | Phe | Asp |
| 660 | 665 | 670 | |||||||||||||
| Pro | Arg | Asp | Val | Leu | Ala | Lys | Glu | Thr | Phe | Val | Trp | Lys | Asp | Gly | Ser |
| 675 | 680 | 685 | |||||||||||||
| Phe | Ser | Ile | Pro | Arg | Ala | Asp | Gly | Ser | Ser | Leu | Arg | Thr | Ile | Asn | Lys |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Leu | Ser | Gin | Ala | Glu | Trp | Gin | Gin | Ala | Gin | Glu | Leu | Leu | Ala |
| 7 05 | 710 | 715 | 720 | ||||||||||||
| Lys | Lys | Asn | Al a | Gly | Asp | Ala | Thr | Asp | Thr | Asp | Lys | Pro | Lys | Glu | Lys |
| 725 | 730 | 735 | |||||||||||||
| CG n | Gl n | Ala | Asp | Lys | Ser | Asn | Glu | Asn | Gin | Gin | Pro | Ser | Glu | AJ a | Ser |
-110CZ 303675 B6
| 740 | 745 | 750 | |||||||||||||
| I,ys | Glu | Glu | Glu | Lys | Glu | Ser | Asp | Asp | Phe | Ile | Asp | Ser | Leu | Pro | Asp |
| 755 | 760 | 765 | |||||||||||||
| Tyr | Gly | Leu | Asp | Arg | Ala | Thr | Leu | Glu | Asp | His | Ile | Asn | Gin | Leu | Ala |
| 770 | 775 | 780 | |||||||||||||
| Gin | Lys | Ala | Asn | Ile | Asp | Pro | Lys | Tyr | Leu | Ile | Phe | Gin | Pro | Glu | Gly |
| 785 | 790 | 795 | 800 | ||||||||||||
| Val | Gin | Phe | Tyr | Asn | Lys | Asn | Gly | Glu | Leu | Val | Thr | Tyr | Asp | Ile | Lys |
| 805 | 810 | 815 | |||||||||||||
| Thr | Leu | Gin | Gin | Ile | Asn | Pro | Pro | ||||||||
| 820 |
<210> 84 <211 > 1019 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 84
| Cys 1 | Ala | Tyr | Ala | Leu Asn Gin His 5 | Arg | Ser 10 | Gin | Glu | Asn | Lys | Asp 15 | Asn | |||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Arg | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Al a | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 2 65 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | .Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Giy | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
i— - -CZ 303675 B6
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 4 30 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val. | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | G.ln | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Giy | Asn | Lys | I le | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 7 80 | |||||||||||||
| Glu | Lvs | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
- 112CZ 303675 B6
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Phe | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 8 30 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met |
| 945 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu |
| 965 | 970 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| Ile | Phe | Asn | Met | Asp | Gly | Thr | Tle | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu |
| 995 | 1000 | 1005 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Leu | Ile | Ala | |||||
| 1010 | 1015 |
<210> 85 <211> 1019 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 85
| Cys Ala 1 | Tyr | A] a | Leu 5 | Asn Gin | His | Arg | Ser Gin Glu Asn Lys Asp | Asn | |||||||
| 10 | 15 | ||||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 7 5 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Tle | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gl y | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ue | Ue | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ue | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ue | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ue | Ala | Arg | Arg | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ue | Phe | Asn | Pro | Lys | Asp | Ue | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ue | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ue | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ue | Asn | Pro | Gly | Ile | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ue | Ue | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Ue | Met | Ser | His | Gly | Asn | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ue | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 4 60 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gl n | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ue | Glu | Glu | Lys | Ile | Ala | Gly | Ue | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ue | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ue | Ue | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gl y | Asp | His | His | His | Ala | Asp | Pro | Ue | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ue | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ue | Asn | Met | Leu | Val | Lys | Leu | Ue |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gl y | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ue | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
-114CZ 303675 B6
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Tle | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Sor | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | lle | Phe | Tyr | Pro | Phe | His | Ala | G ly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | lle | Lys | Leu | Pro | lle | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | lle | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 7 55 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Tle | Val | Glu | Val | Pro | lle | Leu |
| 770 | 775 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | lle | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Sor | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Tle | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 8 75 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | lle | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Cly | Ser | Asp | Pro | Met |
| 945 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu |
| 965 | 97 0 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| Tle | Phe | Asn | Met | Asp | Gly | Thr | Tle | Glu | Leu | Arg | Leu | Pro | Ser | Gl y | Glu |
| 995 | 1000 | 1005 | |||||||||||||
| Val | lle | Lys | Lys | Asn | Leu | Ser | Asp | Leu | lle | Ala | |||||
| 1010 | 1015 |
<210> 86 <211> 1019 aminokyselin <212> protein <213> mikroorganizmus S.pneumomcte <400> 86
| Cys 1 | Ala | Tyr | Ala | Leu 5 | Asn Gin | His | Arg | Ser 10 | Gin Glu | Asn | Lys Asp Asn 15 | ||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | lle | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Al a |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val· | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Al a | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 4 35 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 4 60 | |||||||||||||
| Leu | Glu | Glu | Vči± | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 4 75 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Clu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
-116CZ 303675 B6
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Tle | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 7 90 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Leu | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 625 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Al a | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met |
| 945 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Gl u |
444
| 965 | 970 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu |
| 995 | 1000 | 1005 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Leu | Ile | Ala |
1010 1015
| <210= | ► 87 | ||||||||||||||
| <211> 1019 aminokyselin | |||||||||||||||
| <212> protein | |||||||||||||||
| <213> m | likroorganizmus S.pneumoniae | ||||||||||||||
| <400> 87 | |||||||||||||||
| Cys | Ala | Tyr | Ala | Leu | Asn | Gln | His | Arg | Ser | Gln | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gln | Ser | Ser | Gln | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gln | Val | Ser | Gln | Lys | Glu | Gly | Ile | Gln | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gln | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gln | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gln | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gln | Lys | Gln | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gln | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Giy | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gln | Pro | Ser | Gln | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gln | Ser | Val | Ala | Lys | G1 y | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gln | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gln | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | Hi s | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Al a | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
-118C7. 303675 B6
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Giy | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Giu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | TJ e | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 4 50 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 4 90 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Tle |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Al a | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Va 1 | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val· | Gly | Glu | Ile | Lys | Leu | Pro | Tle | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 7 65 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 77 5 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 7 95 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met |
| 94 5 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu |
| 965 | 970 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu |
| 995 | 1000 | 1005 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |||||
| 1010 | 1015 |
<210> 88 <211> 1019 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 88
| Cys 1 | Ala | Tyr | Ala | Leu Asn Gin 5 | His | Arg | Ser 10 | Gin | Glu | Asn | Lys | Asp 15 | Asn | ||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | As n | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Arg | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Se ι- | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| Ι 95 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
- 120C7 303675 R6
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Tle | Phe | Asn | Pro | Lys | Asp | Tle | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Tle | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | 1 le | Ile | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val· | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 4 35 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 4 60 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 4 65 | 470 | 4 75 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 50 0 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| T.eu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
4-24
| 67 5 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Phe | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met |
| 945 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu |
| 965 | 970 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| I le | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu |
| 995 | 1000 | 1005 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Leu | Ile | Ala | |||||
| 1010 | 1015 |
<210> 89 <211> 1019 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 89
Cys Ala Tyr Ala Leu Asn Gin His Arg Ser Gin Glu Asn Lys Asp Asn 15 10 15
Asn Arg Val Ser Tyr Val Asp Gly Ser Gin Ser Ser Gin Lys Ser Glu 20 25 30
Asn Leu Thr Pro Asp Gin Val Ser Gin Lys Glu Gly Ile Gin Ala Glu 35 40 45
Gin Ile Val Ile Lys Ile Thr Asp Gin Gly Tyr Val Thr Ser His Gly 50 55 60
Asp His Tyr His Tyr Tyr Asn Gly Lys Val Pro Tyr Asp Ala Leu Phe
- 122
C7 303675 R6
| 65 | 70 | 75 | 8 0 | ||||||||||||
| Ser | Glu | G 1 u | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Arg | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Al a | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 24 5 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gl y | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | T.eu | Al a |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 4 60 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 4 90 | 4 9 5 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val· | Val | Asn | Lys | Glu | Lys | Asn | Ala | 1 le | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
Í3?
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | I le | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 7 65 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 7 80 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Phe | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met |
| 945 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu |
| 965 | 970 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| Ile | Phe | Asn | Met | Asp | Gly | Thr | I le | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu |
- 124C7 303675 R6
995 1000
Val Ile Lys Lys Asn Leu Ser Asp Leu Ue Ala
1010 1015
1005 <210> 90 <211 > 819 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 90
| Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | Val | Lys | Lys | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ser | Asn | Arg | Val | Ser | Tyr | Ue | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ue | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ue | Val | Ue | Lys | Ue | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ue |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ue | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ue | Lys | Gly | Gly | Tyr | Val | Ue | Lys | Val | Asp |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ue |
| 1 15 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ue | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Ala | Ala | Ala | Arg | Ala | Gin | Gly |
| 145 | 150 | 155 | 160 | ||||||||||||
| Arq | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ue | Phe | Asn | Ala | Ser | Asp | Ue | Ue |
| 165 | 170 | 175 | |||||||||||||
| Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ue | Val | Pro | His | Gly | Asp | His | Tyr | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | Ue | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Glu |
| 195 | 200 | 205 | |||||||||||||
| Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Asn | Ala | Asn | Pro | Val | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ue | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ue | Phe | Asp | Pro | Ala | Gin | Ue | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ue | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ue | Ala | Arg | Ue | Ue | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Leu | Gin | Pro | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ue | Asp | Glu | Lys | Leu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly |
| 370 | 375 | 380 | |||||||||||||
| Val | Ser | Arg | Tyr | Ue | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Gly | lle | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | lle | His | Gin | Asp | Leu | Leu | Asp | Asn |
| 435 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 460 | |||||||||||||
| Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | lle | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | lle | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 490 | 495 | |||||||||||||
| Ala | Gin | lle | Thr | Tyr | Thr | Asp | Asp | Glu | lle | Gin | Val | Ala | Lys | Leu | Ala |
| 500 | 505 | 510 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | lle | Phe | Asp | Pro | Arg | Asp | lle |
| 515 | 520 | 525 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser |
| 530 | 535 | 540 | |||||||||||||
| His | Trp | lle | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 570 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | lle | Tyr | Asn |
| 580 | 585 | 590 | |||||||||||||
| Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | lle | lle | Pro | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | lle | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val |
| 645 | 650 | 655 | |||||||||||||
| Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly |
| 660 | 665 | 670 | |||||||||||||
| Phe | Giy | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp |
| 67 5 | 680 | 685 | |||||||||||||
| Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | Ser | Glu | Pro | Thr |
| 690 | 695 | 700 | |||||||||||||
| His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser |
| 705 | 710 | 715 | 720 | ||||||||||||
| Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu |
| 725 | 730 | 735 | |||||||||||||
| Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | lle | Pro | Gin | Val | Glu | Asn |
| 740 | 745 | 750 | |||||||||||||
| Ser | Val | lle | Asn | Ala | Lys | lle | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys |
| 755 | 760 | 765 | |||||||||||||
| Val | Thr | Asp | Pro | Ser | lle | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly |
| 77 0 | 775 | 780 | |||||||||||||
| Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | lle | Ser |
| 785 | 790 | 795 | 800 | ||||||||||||
| /Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala |
| 805 | 810 | 815 | |||||||||||||
| Pro | lle | Gin |
- 126C7 303675 R6 <210> 91 <211> 820 aminokyselin <212> protein <213> mikroorganizmus S.pneumomae <400> 91
| Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | Val | Lys | Lys | Glu |
| 5 | 10 | 15 | |||||||||||||
| Ser | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asp |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 17 5 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His | Tyr |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Glu | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | Tyr | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Le u | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala |
| 340 | 345 | 350 | |||||||||||||
| Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val |
| 355 | 360 | 365 | |||||||||||||
| Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn |
| 370 | 375 | 380 | |||||||||||||
| Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys |
| 405 | 410 | 415 |
| Leu | Gly Ala Lys 420 | Lys | Thr Asp Leu Pro Ser Ser Asp 425 | Arg | Glu 430 | Phe | Tyr | ||||||||
| Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | ne | His | Gin | Asp | Leu | Leu | Asp |
| 435 | 440 | 445 | |||||||||||||
| Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu |
| 450 | 455 | 460 | |||||||||||||
| Arg | Leu | Lys | Asp | Val | Pro | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile |
| 465 | 470 | 475 | 480 | ||||||||||||
| Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro |
| 485 | 4 90 | 4 95 | |||||||||||||
| Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu |
| 500 | 505 | 510 | |||||||||||||
| Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp |
| 515 | 520 | 525 | |||||||||||||
| Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His |
| 530 | 535 | 540 | |||||||||||||
| Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp |
| 565 | 570 | 575 | |||||||||||||
| His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr |
| 580 | 585 | 590 | |||||||||||||
| Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr |
| 595 | 600 | 605 | |||||||||||||
| Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro |
| 610 | 615 | 620 | |||||||||||||
| His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr |
| 645 | 650 | 655 | |||||||||||||
| Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn |
| 660 | 665 | 670 | |||||||||||||
| Gl y | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Arg | I.ys | Asn | Lys | Val | Asp | Gin |
| 675 | 680 | 685 | |||||||||||||
| Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | Ser | Glu | Pro |
| 690 | 695 | 700 | |||||||||||||
| Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro |
| 705 | 710 | 715 | 720 | ||||||||||||
| Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu |
| 725 | 730 | 735 | |||||||||||||
| Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu |
| 740 | 745 | 750 | |||||||||||||
| Asn | Ser | Val | Ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu |
| 755 | 760 | 765 | |||||||||||||
| Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr |
| 770 | 775 | 780 | |||||||||||||
| Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile |
| 785 | 790 | 795 | 800 | ||||||||||||
| Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro |
| 805 | 810 | 815 | |||||||||||||
| Ala | Pro | Ile | Gin | ||||||||||||
| 820 | x |
| <210> | 92 |
| <211> | 816 aminokyselin |
| <212> | protein |
| <213> | mikroorganizmus S.pneumoniae |
| <400> | 92 |
- 128
C7. 303675 B6
| Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gln | Ala | Gly | Gln | Asp | Lys | Lys | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ser | Asn | Arg | Val | Ala | Tyr | Ile | Asp | Gly | Asp | Gln | Ala | Gly | Gln | Lys | A.1 a |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gln | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gln | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gln | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | GlU | Ile | Lys | Arg | Gln | Lys | Gln | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gln | Ala | Val | Val | Ala | Ala | Arg | Ala | Gln |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gln | Al a | Tyr | Trp | Asn | Gly | Lys | Gln | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | His | Asn | Ala | Asn | Pro | Ala | Gln | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gln | Asn | Gln | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gln | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gln | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | I le | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gln |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gln | Pro | Ser | Pro | Ser | Pro | Gln | Pro | Ala | Pro | Asn | Pro | Gln |
| 340 | 345 | 350 | |||||||||||||
| Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Giy | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gln | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 4 25 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Ile | His | Gln | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gln | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Clu | Arg | Leu | Lys | Asp |
| 450 | 455 | 460 |
WCZ 303675 B6
| Val 465 | Ser | Ser | Asp | Lys | Val 470 | Lys | Leu | Val | Glu | Asp 475 | Ile | Leu | Ala | Phe | Leu 480 |
| Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | Ile |
| 485 | 490 | 495 | |||||||||||||
| Thr | Tyr | Thr | Asp | Asp | Glu | Tle | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr |
| 500 | 505 | 510 | |||||||||||||
| Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp |
| 515 | 520 | 525 | |||||||||||||
| Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Ile |
| 530 | 535 | 540 | |||||||||||||
| Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Arg | Asp | Ser |
| 565 | 570 | 575 | |||||||||||||
| Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
| 580 | 585 | 590 | |||||||||||||
| Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
| 595 | 600 | 605 | |||||||||||||
| Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
| 645 | 650 | 655 | |||||||||||||
| Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn |
| 660 | 665 | 670 | |||||||||||||
| Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro |
| 675 | 680 | 685 | |||||||||||||
| Asp | Glu | Asp | Lys | Gly | His | Asp | Glu | Val | Ser | Glu | Pro | Thr | His | Pro | Glu |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn |
| 705 | 710 | 715 | 720 | ||||||||||||
| Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu |
| 725 | 730 | 735 | |||||||||||||
| Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | His | Ser | Val | Ile |
| 740 | 745 | 750 | |||||||||||||
| Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp |
| 755 | 760 | 765 | |||||||||||||
| Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Giy | Leu | Lys | Ser |
| 770 | 775 | 780 | |||||||||||||
| Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
| 785 | 790 | 795 | 800 | ||||||||||||
| Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Lys | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
805 810 815 <210> <211>
<212>
<213> <400>
816 aminokyselin protein mikroorganizmus S.pneumoniae 93
| Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Giy | Gin | Asp | Lys | Lys | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ser | Asn | Arg | Val | Ala | Tyr | Ile | Asp | Giy | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Giu | Gin | Ile | Val | TI e | Lys | Ile | Thr | Asp | Glu | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 5 5 | 60 |
- 130 C7 303675 R6
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| Ί 00 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Arg | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | I 60 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Cly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gin | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | His | Asn | Al a | Asn | Pro | Al a | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 | |||||||||||||
| Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 425 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | T.eu | Glu | Arg | Leu | Lys | Asp |
| 450 | 455 | 460 | |||||||||||||
| Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Glu | Asp | Ile | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | Ile |
| 485 | 4 90 | 495 | |||||||||||||
| Thr | Tyr | Thr | Asp | Asp | Glu | I3e | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr |
| 500 | 505 | 510 | |||||||||||||
| Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp |
| 515 | 520 | 525 |
+34
| Glu | Gly 530 | Asp | Ala | Tyr | Val | Thr 535 | Pro | His | Met | Thr | His 540 | Ser | His | Trp | Ile |
| Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
| 565 | 570 | 575 | |||||||||||||
| Gl y | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
| 580 | 585 | 590 | |||||||||||||
| Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
| 595 | 600 | 605 | |||||||||||||
| Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
| 645 | 650 | 655 | |||||||||||||
| Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn |
| 660 | 665 | 670 | |||||||||||||
| Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro |
| 675 | 680 | 685 | |||||||||||||
| Asp | Glu | Asp | Lys | Gly | His | Asp | Glu | Val | Ser | Glu | Pro | Thr | His | Pro | Glu |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn |
| 705 | 710 | 715 | 720 | ||||||||||||
| Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu |
| 725 | 730 | 735 | |||||||||||||
| Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | His | Ser | Val | Ile |
| 740 | 745 | 750 | |||||||||||||
| Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp |
| 755 | 760 | 765 | |||||||||||||
| Pro | Ser | Ile | Arg | Gin | Asn | Aia | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
| 770 | 775 | 780 | |||||||||||||
| Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
| 785 | 790 | 795 | 800 | ||||||||||||
| Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Lys | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
| 805 | 810 | 815 |
<210> <211>
<212>
<213> <400>
816 aminokyselin protein mikroorganizmus S.pneumoniae 94
| Cys 1 | Ser | Tyr Glu | Leu 5 | Gly | Arg | His Gin Ala 10 | Gly Gin Asp Lys | Lys 15 | Glu | ||||||
| Ser | Asn | Arg | Val | Ala | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val· | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 |
- 132 CZ 303675 B6
| Arg | Thr 130 | Lys | Glu | Glu | Ile | Lys 135 | Arg | Gin | Lys | Gin | Glu 140 | His | Ser | His | Asn |
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | cly | Asp | Ala | Tyr | Ile | Val | Pro | Arg | Gly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gin | Ala | Tyr | Trp | Asn | Giy | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | Hi s | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Giy | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | Arg | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 | |||||||||||||
| Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 4 25 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gl n | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp |
| 450 | 455 | 460 | |||||||||||||
| Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Glu | Asp | Ile | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | Ile |
| 485 | 490 | 495 | |||||||||||||
| Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr |
| 500 | 505 | 510 | |||||||||||||
| Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp |
| 515 | 520 | 525 | |||||||||||||
| Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Ile |
| 530 | 535 | 540 | |||||||||||||
| Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Lys | Glu | Lys | Gl y | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
| 565 | 570 | 575 | |||||||||||||
| Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
| 580 | 585 | 590 |
| Ala Ala | Lys 5 95 | Lys | Val | Pro | Leu | Asp Arg Met 600 | Pro | Tyr | Asn 605 | Leu | Gin | Tyr | |||
| Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | dy | Leu | Tyr | Glu | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
| 645 | 650 | 655 | |||||||||||||
| Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn |
| 660 | 665 | 670 | |||||||||||||
| Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro |
| 675 | 680 | 685 | |||||||||||||
| Asp | Glu | Asp | Lys | Gly | His | Asp | Glu | Val | Ser | Glu | Pro | Thr | His | Pro | Glu |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn |
| 705 | 710 | 715 | 720 | ||||||||||||
| Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu |
| 725 | 730 | 735 | |||||||||||||
| Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | His | Ser | Val | Tle |
| 740 | 745 | 750 | |||||||||||||
| Asn | Ala | Lys | Tle | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp |
| 755 | 760 | 765 | |||||||||||||
| Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
| 770 | 775 | 780 | |||||||||||||
| Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
| 785 | 790 | 795 | 800 | ||||||||||||
| Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Lys | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
805 810 815 <210> <211>
<212>
<213> <400>
834 aminokyselin protein mikroorganizmus S.pneumoniae 95
| Cys 1 | Ser | Tyr Glu | Leu Gly 5 | Arg | His | Gin | Ala 10 | Gly | Gin | Val | Lys | Lys 15 | Glu | ||
| Ser | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asp |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | Arg | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Ala | Ala | Ala | Arg | Ala | Gin | Gly |
| 145 | 150 | 155 | 160 | ||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile | Ile |
| 165 | 170 | 175 | |||||||||||||
| Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His | Tyr | Hi s |
180 185 190
- 134CZ 303675 B6
| Tyr | Ile | Pro 195 | Lys | Ser Asp Leu | Ser 200 | Ala | Ser | Glu | Leu | Ala 205 | Ala | Ala | Gin | ||
| Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Asn | Gly | Val | Ala | Val | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Ser | Gin | Leu | Ser | Pro | Leu | Glu | Glu | Lys | Leu | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly |
| 370 | 375 | 380 | |||||||||||||
| Val | Pro | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn |
| 435 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 4 60 | |||||||||||||
| Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 490 | 495 | |||||||||||||
| Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
| 500 | 505 | 510 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile |
| 515 | 520 | 525 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser |
| 530 | 535 | 540 | |||||||||||||
| His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 570 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn |
| 580 | 585 | 590 | |||||||||||||
| Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val |
| 645 | 650 | 655 |
| Lys | Tyr | Tyr | Val 660 | Glu | His | Pro | Asn |
| Phe | Gly | Asn 675 | Ala | Ser | Asp | His | Val 680 |
| Asp | Thr 690 | Asn | Gin | Thr | Glu | Lys 695 | Pro |
| Lys 705 | Pro | Glu | Glu | Asp | Lys 710 | Glu | His |
| Pro | Glu | Ser | Asp | Glu 725 | Lys | Glu | Asn |
| Asp | Asn | Leu | Tyr 740 | Lys | Pro | Ser | Thr |
| Ala | Glu | Asp 755 | Thr | Thr | Asp | Glu | Ala 760 |
| Val | Ile 770 | Asn | Ala | Lys | Ile | Ala 775 | Glu |
| Thr 785 | Asp | Ser | Ser | Ile | Arg 790 | Gin | Asn |
| Lys | Ser | Ser | Leu | Leu 805 | Leu | Gly | Thr |
| Glu Ile | Val Gin | Asp | Ser 820 | Leu | Leu | Ala | Leu |
| Glu | Arg | Pro | His | Ser | Asp | Asn | Gly |
| 665 | 670 | ||||||
| Gin | Arg | Asn | Lys | Asn 685 | Gly | Gin | Ala |
| Asn | Glu | Glu | Lys 700 | Pro | Gin | Thr | Glu |
| Asp | Glu | Val 715 | Ser | Glu | Pro | Thr | His 720 |
| His | Val 730 | Gly | Leu | Asn | Pro | Ser 735 | Ala |
| Asp 745 | Thr | Glu | Glu | Thr | Glu 750 | Glu | Glu |
| Glu | Ile | Pro | Gin | Val 765 | Glu | Tyr | Ser |
| Ala | Glu | Ala | Leu 780 | Leu | Glu | Lys | Val |
| Ala | Val | Glu 795 | Thr | Leu | Thr | Gly | Leu 800 |
| Lys | Asp 810 | Asn | Asn | Thr | Ile | Ser 815 | Ala |
| Leu 825 | Lys | Glu | Ser | Gin | Pro 830 | Ala | Pro |
<210> 96 <211 > 811 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 96
| Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | Asp | Lys | Lys | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ser | Asn | Arg | Val | Ala | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 14 5 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gin | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
210 215 220
- 136CZ 303675 B6
| Ser 225 | His | Asn | Ala | Asn | Pro 230 | Ala | Gin | Pro | Arg | Leu 2 35 | Ser | Glu | Asn | His | Asn 240 |
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 | |||||||||||||
| Pro | Al a | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 425 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp |
| 450 | 455 | 460 | |||||||||||||
| Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Glu | Asp | Ile | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | Ile |
| 485 | 4 90 | 495 | |||||||||||||
| Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr |
| 500 | 505 | 510 | |||||||||||||
| Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp |
| 515 | 520 | 525 | |||||||||||||
| Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Ile |
| 530 | 535 | 540 | |||||||||||||
| Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
| 565 | 570 | 575 | |||||||||||||
| Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
| 580 | 585 | 590 | |||||||||||||
| Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
| 595 | 600 | 605 | |||||||||||||
| Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | His | Asn | Tle | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
| 645 | 650 | 655 | |||||||||||||
| Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn |
| 660 | 665 | 670 | |||||||||||||
| Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro |
| 675 | 680 | 685 |
| Asp Glu 690 | Asp | Lys | dy | His | Asp Glu Val 695 | Ser | Glu Pro Thr 700 | His | Pro | Glu | |||||
| Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn |
| 705 | 710 | i | 715 | 720 | |||||||||||
| Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu |
| 725 | 730 | 735 | |||||||||||||
| Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | His | Ser | Val | Ile |
| 740 | 745 | 750 | |||||||||||||
| Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp |
| 755 | 760 | 765 | |||||||||||||
| Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
| 770 | 775 | 780 | |||||||||||||
| Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
| 785 | 790 | 795 | 800 | ||||||||||||
| Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys | |||||
| 805 | 810 |
<210> 5 <211>
<212>
<213>
<400>
811 aminokyselin protein m i kroorgan izm u s X pneumoniae 97
Cys Ser Tyr Glu Leu Gly Arg His Gin Ala Gly Gin Asp Lys Lys Glu 15 10 15
Ser Asn Arg Val Ala Tyr Ile Asp Gly Asp Gin Ala Gly Gin Lys Ala 20 25 30
Glu Asn Leu Thr Pro Asp Glu Val Ser Lys Arg Glu Gly Ile Asn Ala 35 40 45
Glu Gin Ile Val Ile Lys Ile Thr Asp Gin Gly Tyr Val Thr Ser His
55 60
Gly Asp His Tyr His Tyr Tyr Asn Gly Lys Val Pro Tyr Asp Ala Ile
70 75 80
Ile Ser Glu Glu Leu Leu Met Lys Asp Pro Asn Tyr Gin Leu Lys Asp
90 95
Ser Asp Ile Val Asn Glu Ile Lys Gly Gly Tyr Val Ile Lys Val Asn
100 105 110
Gly Lys Tyr Tyr Gly Tyr Leu Lys Asp Ala Ala His Ala Asp Asn Ile
115 120 125
Arg Thr Lys Glu Glu Ile Lys Arg Gin Lys Gin Glu His Ser His Asn
130 135 140
His Gly Gly Gly Ser Asn Asp Gin Ala Val Val Ala Ala Arg Ala Gin
145 150 155 160
Gly Arg Tyr Thr Thr Asp Asp Gly Tyr Ile Phe Asn Ala Ser Asp Ile
165 170 175
Ile Glu Asp Thr Gly Asp Ala Tyr Ile Val Pro His Gly Asn His Phe
180 185 190
His Tyr Ile Pro Lys Ser Asp Leu Ser Ala Ser Glu Leu Ala Ala Ala
195 200 205
Gin Ala Tyr Trp Asn Gly Lys Gin Gly Ser Arg Pro Ser Ser Ser Ser
210 215 220
Ser His Asn Ala Asn Pro Ala Gin Pro Arg Leu Ser Glu Asn His Asn
225 230 235 240
Leu Thr Val Thr Pro Thr Tyr His Gin Asn Gin Gly Glu Asn Ile Ser
245 250 255
Ser Leu Leu Arg Glu Leu Tyr Ala Lys Pro Leu Ser Glu Arg His Val
260 265 270
Glu Ser Asp Gly Leu Ile Phe Asp Pro Ala Gin Ile Thr Ser Arg Thr
275 280 285
- 138C7 303675 R6
| Ala | Arg 290 | Gly Val | Ala | Val | Pro 295 | His | Gly | Asn His | Tyr 300 | His | Phe | Ile | Pro | ||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 | |||||||||||||
| Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 425 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp |
| 450 | 455 | 460 | |||||||||||||
| Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Glu | Asp | Ile | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | Ile |
| 485 | 4 90 | 495 | |||||||||||||
| Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr |
| 500 | 505 | 510 | |||||||||||||
| Thr | Thr | Glu | Asp | Gly | Tyr | Xle | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp |
| 515 | 520 | 525 | |||||||||||||
| Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Ile |
| 530 | 535 | 540 | |||||||||||||
| Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
| 565 | 570 | 575 | |||||||||||||
| Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
| 580 | 585 | 590 | |||||||||||||
| Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
| 595 | 600 | 605 | |||||||||||||
| Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | lle | Ile | Pro | His | Tyr | Asp | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
| 645 | 650 | 655 | |||||||||||||
| Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn |
| 660 | 665 | 670 | |||||||||||||
| Ala | Ser | Asp | Hi s | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro |
| 675 | 680 | 685 | |||||||||||||
| Asp | Glu | Asp | Lys | Gly | His | Asp | Glu | Val | Ser | Glu | Pro | Thr | His | Pro | Glu |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn |
| 705 | 710 | 715 | 720 | ||||||||||||
| Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu |
| 725 | 730 | 735 | |||||||||||||
| Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | His | Ser | Val | Ile |
| 740 | 745 | 750 |
| Asn | Ala | Lys 755 | Ile | Ala | Asp | Ala | Glu 760 |
| Pro | Ser 770 | Ile | Arg | Gin | Asn | Ala 775 | Met |
| Ser 785 | Leu | Leu | Leu | Gly | Thr 790 | Lys | Asp |
| Asp | Ser | Leu | Leu | Ala 805 | Leu | Leu | Lys |
| Ala | Leu | Leu | Glu | Lys 765 | Val | Thr | Asp |
| Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
| 780 | |||||||
| Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
| 7 95 | 800 | ||||||
| Glu | Ser | Lys |
810 <210> <211>
<212>
<213> <400>
811 aminokyselin protein mikroorganizmus S.pneumoniae 98
| Cys 1 | Ser | Tyr | Glu | Leu 5 | Gly | Arg | His | Gin | Ala 10 | Gly | Gin | Asp | Lys | Lys 15 | Glu |
| Ser | Asn | Arg | Val | Ala | Tyr | Ue | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ue | Val | Ue | Lys | Ue | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ue |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ue | Val | Asn | Glu | Ue | Lys | Gly | Gly | Tyr | Val | Ue | Lys | Val | Asn |
| 100 | 105 | 110 | |||||||||||||
| GJ γ | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ue |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | 1 le | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ue | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ue | Val | PrG | His | Gly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ue | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gin | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ue | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | 1 le | Phe | Asp | Pro | Ala | Gin | Ue | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ue | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Clu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Al a | Arg | Ue | Ue | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 |
- 140C7 303675 R6
| Pro | Ala | Pro 355 | Ser | Asn | Pro | lle Asp 360 | Glu Lys | Leu | Val | Lys 365 | Glu | Ala | Val | ||
| Arg | Lys | Val | Gly | Asp | Gl.y | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | lle | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Al a | Gly | lle | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 425 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Tle | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp |
| 450 | 455 | 4 60 | |||||||||||||
| Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Glu | Asp | lle | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | lle | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | lle |
| 485 | 490 | 495 | |||||||||||||
| Thr | Tyr | Thr | Asp | Asp | Glu | lle | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr |
| 500 | 505 | 510 | |||||||||||||
| Thr | Thr | Glu | Asp | Gly | Tyr | lle | Phe | Asp | Pro | Arg | Asp | lle | Thr | Ser | Asp |
| 515 | 520 | 525 | |||||||||||||
| Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | lle |
| 530 | 535 | 540 | |||||||||||||
| Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
| 565 | 570 | 575 | |||||||||||||
| Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | lle | Tyr | Asn | Arg | Val | Lys |
| 580 | 585 | 590 | |||||||||||||
| Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
| 595 | 600 | 605 | |||||||||||||
| Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | lle | lle | Pro | His | Tyr | Asp | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | His | Asn | lle | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
| 645 | 650 | 655 | |||||||||||||
| Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn |
| 660 | 665 | 670 | |||||||||||||
| Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro |
| 675 | 680 | 685 | |||||||||||||
| Asp | Glu | Asp | Lys | Gly | His | Asp | Glu | Val | Ser | Glu | Pro | Thr | His | Pro | Glu |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn |
| 705 | 710 | 715 | 720 | ||||||||||||
| Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu |
| 725 | 730 | 735 | |||||||||||||
| Asp | Thr | Thr | Asp | Glu | Ala | Glu | lle | Pro | Gin | Val | Glu | His | Ser | Val | lle |
| 740 | 745 | 750 | |||||||||||||
| Asn | Ala | Lys | Tle | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp |
| 755 | 760 | 765 | |||||||||||||
| Pro | Ser | lle | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
| 770 | 775 | 780 | |||||||||||||
| Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Tle | Ser | Ala | Glu | Val |
| 785 | 790 | 795 | 800 | ||||||||||||
| Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys | |||||
| 805 | 810 |
<210> <211> <212> <213>
<400>
811 aminokyselin protein mikroorganizmus S.pneumoniae 99
| Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | Val | Lys | Lys | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ser | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | Hi s | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asp |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | Arg | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Ala | Ala | Ala | Arg | Ala | Gin | Gly |
| 145 | 150 | 155 | 160 | ||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile | Ile |
| 165 | 170 | 175 | |||||||||||||
| Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His | Tyr | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Gin |
| 195 | 200 | 205 | |||||||||||||
| Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 22 5 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Asn | Gly | Val | Ala | Val | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Ser | Gin | Leu | Ser | Pro | Leu | Glu | Glu | Lys | Leu | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly |
| 370 | 375 | 380 | |||||||||||||
| Val | Pro | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| GJ y | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 |
- 142C7 303675 B6
| Gly Ala | Lys | Lys 420 | Thr Asp Leu | Pro | Ser Ser Asp Arg Glu 425 | Phe 430 | Tyr | Asn | |||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | Hi s | Gin | Asp | Leu | Leu | Asp | Asn |
| 435 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 460 | |||||||||||||
| Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu |
| 4 65 | 470 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 4 90 | 495 | |||||||||||||
| Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
| 500 | 505 | 510 | |||||||||||||
| Gly | iys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile |
| 515 | 520 | 525 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser |
| 530 | 535 | 540 | |||||||||||||
| His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 570 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Al a | Ile | Tyr | Asn |
| 580 | 585 | 590 | |||||||||||||
| Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Giy | Ser | Leu | Ile | Ile | Pro | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val |
| 645 | 650 | 655 | |||||||||||||
| Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly |
| 660 | 665 | 670 | |||||||||||||
| Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala |
| 675 | 680 | 685 | |||||||||||||
| Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Asn | Glu | Glu | Lys | Pro | Gin | Thr | Glu |
| 690 | 695 | 700 | |||||||||||||
| Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys |
| 705 | 710 | 715 | 720 | ||||||||||||
| Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu |
| 725 | 730 | 735 | |||||||||||||
| Glu | Ser | Pro | Glu | Glu | Ser | Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val |
| 740 | 745 | 750 | |||||||||||||
| Lys | Glu | Lys | Leu | Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asn |
| 755 | 760 | 765 | |||||||||||||
| Pro | Ile | Ile | Lys | Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn |
| 770 | 775 | 780 | |||||||||||||
| Asn | Leu | Leu | Phe | Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala |
| 785 | 790 | 795 | 800 | ||||||||||||
| Glu | Lys | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys | |||||
| 805 | 810 |
| <210> | 100 |
| <211> | 805 aminokyselin |
| <212> | protein |
| <213> | mikroorganizmus S.pneumoniae |
| <400> | 100 |
| Cys 1 | Ser Tyr | Glu Leu Gly Arg 5 | His | Gin | Ala 10 | Gly | Gin | Asp | Lys | Lys 15 | Glu | ||||
| Ser | Asn | Arg | Val | Ala | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | He | Lys | Arg | Gin | Lys | Gin | Glu | Arg | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Ala | Ala | Ala | Arg | Ala | Gin | Gly |
| 145 | 150 | 155 | 160 | ||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile | Ile |
| 165 | 170 | 175 | |||||||||||||
| Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His | Tyr | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Glu |
| 195 | 200 | 205 | |||||||||||||
| Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Al a |
| 275 | 280 | 285 | |||||||||||||
| Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val |
| 355 | 360 | 365 | |||||||||||||
| Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Al a | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp |
| 405 | 410 | 415 | |||||||||||||
| Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu |
| 420 | 425 | 430 | |||||||||||||
| A.1 a | Arg | Ile | H is | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp |
| 435 | 440 | 445 | |||||||||||||
| Phe | G.l u | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser |
| 4 50 | 455 | 460 | |||||||||||||
| As ρ | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile |
| 465 | 470 | 475 | 480 |
- 144Q7 303675 R6
| Arg | His | Pro | Glu | Arg 485 | Leu | Gly | Lys | Pro Asn Ala 490 | Gin | Ile | Thr | Tyr 495 | Thr | ||
| Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu |
| 500 | 505 | 510 | |||||||||||||
| Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp |
| 515 | 520 | 525 | |||||||||||||
| Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp |
| 530 | 535 | 540 | |||||||||||||
| Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr |
| 565 | 570 | 575 | |||||||||||||
| Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys |
| 580 | 585 | 590 | |||||||||||||
| Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu |
| 595 | 600 | 605 | |||||||||||||
| Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn |
| 610 | 615 | 620 | |||||||||||||
| Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His |
| 64 5 | 650 | 655 | |||||||||||||
| Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp |
| 660 | 665 | 670 | |||||||||||||
| His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala | Asp | Thr | Asn | Gin | Thr | Glu |
| 675 | 680 | 685 | |||||||||||||
| Lys | Pro | Asn | Glu | Glu | Lys | Pro | Gin | Thr | Glu | Lys | Pro | Glu | Glu | Glu | Thr |
| 690 | 695 | 700 | |||||||||||||
| Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys | Pro | Glu | Ser | Pro | Lys | Pro |
| 705 | 710 | 715 | 720 | ||||||||||||
| Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu | Glu | Ser | Pro | Glu | Glu | Ser |
| 725 | 730 | 735 | |||||||||||||
| Glu | Glu | Pro | Gin | Val | Glu | Thr | Gl u | Lys | Val | Lys | Glu | Lys | Leu | Arg | Glu |
| 740 | 745 | 750 | |||||||||||||
| Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asn | Pro | Ile | Ile | Lys | Ser | Asn |
| 7 55 | 760 | 7 65 | |||||||||||||
| Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe | Gly | Thr |
| 770 | 77 5 | 780 | |||||||||||||
| Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu | Ala | Leu |
| 785 | 7 90 | 795 | 800 | ||||||||||||
| Leu | Lys | Glu | Ser | Lys |
805
| <210> | 101 |
| <211> | 807 aminokyselin |
| <212> | protein |
| <213> | mikroorganizmus S.pneumoniae |
| <400 | 101 |
| Cys 1 | Ser | Tyr | Glu | Leu 5 | Gly Arg | His | Gin | Ala 10 | Gly | Gin | Val | Lys | Lys 15 | Glu | |
| Ser | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 |
| Ile | Ser | Glu | Glu | Leu 85 | Leu | Met | Lys | Asp | Pro 90 | Asn | Tyr | Gln | Leu | Lys 95 | Asp |
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asp |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gln | Lys | Gln | Glu | Arg | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Ala | Ala | Ala | Arg | Ala | Gln | Gly |
| 145 | 150 | 155 | 160 | ||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile | Ile |
| 165 | 170 | 175 | |||||||||||||
| Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asn | His | Phe | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Gln |
| 195 | 200 | 205 | |||||||||||||
| Ala | Tyr | Trp | Asn | Gly | Lys | Gln | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| His | Asn | Ala | Asn | Pro | Ala | Gln | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gln | Asn | Gln | Gly | Glu | Asn | Ile | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Le u | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gln | Ile | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Ser | Gln | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gln | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gln | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gln | Ser | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Asn | Pro | Gln | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Val | Val | Arg | Lys | Val | G1 y | Asp | Gly | Tyr | Val | Phe | Glu | Lys | Asn | Gly |
| 370 | 375 | 380 | |||||||||||||
| Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gln | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gln | Asp | Leu | Leu | Asp | Asn |
| 435 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gln | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 4 60 | |||||||||||||
| Leu | Glu | Asp | Val | Pro | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 490 | 495 | |||||||||||||
| Ala | Gln | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gln | Val | Ala | Lys | Leu | Ala |
| 500 | 505 | 510 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile |
| 51 5 | 520 | 525 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser |
| 530 | 535 | 540 |
- 146C7. 303675 B6
| His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 57 0 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn |
| 580 | 585 | 5 90 | |||||||||||||
| Ara | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leví | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | 1 le | Ile | Pro | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val |
| 645 | 650 | 655 | |||||||||||||
| Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | Hi s | Ser | Asp | Asn | Gly |
| 660 | 665 | 670 | |||||||||||||
| Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala |
| 675 | 680 | 685 | |||||||||||||
| Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | Glu |
| 690 | 695 | 700 | |||||||||||||
| Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys |
| 705 | 710 | 715 | 720 | ||||||||||||
| Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu |
| 725 | 730 | 735 | |||||||||||||
| Glu | Ser | Glu | G1 u | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | Leu |
| 740 | 745 | 750 | |||||||||||||
| Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile | Lys |
| 755 | 760 | 765 | |||||||||||||
| Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe |
| 770 | 7 75 | 780 | |||||||||||||
| Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu |
| 785 | 790 | 795 | 800 | ||||||||||||
| Ala | Leu | Leu | Lys | Glu | Ser | Lys | |||||||||
| 805 |
<210> 102 <211> 821 aminokyselin <212> protein <213> mikroorganizmus S.pneumoniae <400> 102
| Cys | Ala | Tyr | Glu | Leu | Gly | Leu | His | Gin | Ala | Gin | Thr | Val | Lys | Glu | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Lys | G.l.n | Ala | Thr | Gin | Lys | Thr | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ser |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Glu | Glu | Tle | Asn | Arg | Gin | Lys | Gin | Glu | His | Ser | Gin | His | Arg |
| 130 | 135 | 140 |
| Glu | Gly | Gly | Thr | Ser | Ala | Asn | Asp | Gly | Ala | Val | Ala | Phe | Ala | Arg | Ser |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gin | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Ile | Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Ala | Glu | Ala | Phe | Leu | Ser | Gly | Arg | Glu | Asn | Leu | Ser | Asn | Leu | Arg | Thr |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Arg | Arg | Gin | Asn | Ser | Asp | Asn | Thr | Pro | Arg | Thr | Asn | Trp | Val | Pro |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ser | Val | Ser | Asn | Pro | Gly | Thr | Thr | Asn | Thr | Asn | Thr | Ser | Asn | Asn | Ser |
| 245 | 250 | 255 | |||||||||||||
| Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp | Ser | Leu | Leu |
| 260 | 265 | 270 | |||||||||||||
| Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin | Arg | His | Val | Glu | Ser | Asp |
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala | Arg | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr | Glu | Gin |
| 305 | 310 | 315 | 320 | ||||||||||||
| Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu | Arg | Tyr |
| 325 | 330 | 335 | |||||||||||||
| Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro | Ser | Pro |
| 340 | 345 | 350 | |||||||||||||
| Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro |
| 355 | 360 | 365 | |||||||||||||
| Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala |
| 370 | 375 | 380 | |||||||||||||
| Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser |
| 385 | 390 | 395 | 400 | ||||||||||||
| Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile |
| 405 | 410 | 415 | |||||||||||||
| Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala |
| 420 | 425 | 430 | |||||||||||||
| Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala |
| 435 | 440 | 445 | |||||||||||||
| Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly |
| 450 | 455 | 460 | |||||||||||||
| Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys |
| 465 | 470 | 475 | 480 | ||||||||||||
| Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe |
| 485 | 490 | 4 95 | |||||||||||||
| Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin |
| 500 | 505 | 510 | |||||||||||||
| Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys |
| 515 | 520 | 525 | |||||||||||||
| Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ue | Thr | Ser |
| 530 | 535 | 540 | |||||||||||||
| Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp |
| 54 5 | 550 | 555 | 560 | ||||||||||||
| Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala |
| 565 | 57 0 | 57 5 | |||||||||||||
| Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp |
| 580 | 585 | 590 | |||||||||||||
| Ser | Gl y | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val |
| 595 | 600 | 605 |
- 148C7 303675 B6
| Lys Ala Ala 610 | Lys | Lys | Val | Pro 615 | Leu | Asp Arg | Met | Pro 620 | Tyr | Asn | Leu | Gin | |||
| Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp |
| 625 | 630 | 635 | 640 | ||||||||||||
| His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu |
| 645 | 650 | 655 | |||||||||||||
| Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr |
| 660 | 665 | 670 | |||||||||||||
| Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly |
| 675 | 680 | 685 | |||||||||||||
| Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala | Asp | Thr |
| 690 | 695 | 700 | |||||||||||||
| Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | Glu | Lys | Pro |
| 705 | 710 | 715 | 720 | ||||||||||||
| Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys | Pro | Glu |
| 725 | 730 | 735 | |||||||||||||
| Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu | Glu | Ser |
| 740 | 745 | 750 | |||||||||||||
| Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | Leu | Arg | Glu |
| 755 | 760 | 765 | |||||||||||||
| Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile | Lys | Ser | Asn |
| 770 | 775 | 780 | |||||||||||||
| Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe | Gly | Thr |
| 785 | 790 | 795 | 800 | ||||||||||||
| Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu | Ala | Leu |
| 805 | 810 | 815 | |||||||||||||
| Leu | Lys | Glu | Ser | Lys | |||||||||||
| 820 |
PATENTOVÉ NÁROKY
Claims (38)
1. Izolovaný polynukleotid kódující polypeptid vybraný z
10 a) polypeptid obsahující aminokyselinovou sekvenci identickou nejméně z 95 % se sekvencí uvedenou v SEQ ID č. 4, 58, 60, 63, 73, 74, nebo 79
b) polypeptid obsahující aminokyselinovou sekvenci identickou nejméně z 99 % se sekvencí uvedenou v SEQ ID č. 4, 14, 58, 60, 63, 73, 74 nebo 79, a
c) polypeptid obsahující aminokyselinovou sekvenci uvedenou v SEQ ID č. 14, 58, 60, 62, 63,
15 67, 68, 73, 74, 77 nebo 79, přičemž kódovaný polypeptid je schopný u jedince vyvolat imunitní odpověď na Streptokoka.
2. Izolovaný polynukleotid podle nároku 1, kde polynukleotid zahrnuje nukleotidovou sekvenci identickou nejméně z 95 % s nukleotidovou sekvencí uvedenou v SEQ ID č. 3, 12 nebo 13.
3. Izolovaný polynukleotid podle nároku 2, zahrnující nukleotidovou sekvenci uvedenou v SEQ ID č. 3, 12 nebo 13.
4. Izolovaný polynukleotid podle kteréhokoliv z předchozích nároků 1 až 3, kde kódovaný 25 polypeptid je schopný generovat protilátky, které se specificky vážou na polypeptid skládající se z aminokyselinové sekvence uvedené v SEQ ID č. 4 nebo SEQ ID č. 14.
5. Izolovaný polynukleotid, který je komplementární k polynukleotidů podle kteréhokoliv z předchozích nároků 1 až 4.
Í4?
6. Izolovaný polynukleotid podle kteréhokoliv z předchozích nároků 1 až 4, kde polynukleotid je DNA.
5
7. Izolovaný polynukleotid podle kteréhokoliv z předchozích nároků 1 až 4, kde polynukleotid je RNA.
8. Vektor zahrnující izolovaný polynukleotid podle kteréhokoliv z předchozích nároků 1 až 4, kde polynukleotid je operativně spojen s oblastí kontrolující expresi.
9. Hostitelská buňka transfektovaná nebo transformovaná vektorem podle nároku 8.
10. Způsob produkce polypeptidů kódovaného polynukleotidem podle kteréhokoliv z předchozích nároků 1 až 4, vyznačující se tím, že se hostitelská buňka podle nároku 9 kulti15 vuje za podmínek vhodných pro expresi polypeptidů.
11. Způsob podle nároku 10, vyznačující se tím, že se polypeptid z hostitelské buněčné kultury dále izoluje.
20
12. Způsob podle nároku 10, vyznačující se tím, že polypeptid je rekombinantní polypeptid.
13. Izolovaný polypeptid vybraný z
a) izolovaný polypeptid zahrnující aminokyselinovou sekvenci identickou nejméně z 95 % 25 s aminokyselinovou sekvencí uvedenou v SEQ ID č, 4, 58, 60, 63, 73, 74 nebo 79,
b) izolovaný polypeptid zahrnující aminokyselinovou sekvenci identickou nejméně z 99 % s aminokyselinovou sekvencí uvedenou v SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 73, 74 nebo 79, nebo
c) izolovaný polypeptid zahrnující aminokyselinovou sekvenci uvedenou v SEQ ID č. 4, 14,
30 58, 60, 62, 63, 67, 68, 73, 74, 77 nebo 79, přičemž izolovaný polypeptid je schopný u jedince vyvolat imunitní odpověď na Streptokoka.
14. Izolovaný polypeptid podle nároku 13, který obsahuje aminokyselinovou sekvenci identickou nejméně z 99% s aminokyselinovou sekvencí uvedenou v SEQ ID č. 14.
15. Izolovaný polypeptid podle nároku 13, který obsahuje aminokyselinovou sekvenci identickou nejméně z 99% s aminokyselinovou sekvencí uvedenou v SEQ ID č. 73.
16. Izolovaný polypeptid podle nároku 13, který obsahuje aminokyselinovou sekvenci uvedenou 40 v SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 nebo 79.
17. Izolovaný polypeptid podle nároku 13, kde N-terminální methioninový zbytek ze SEQ ID č. 4 nebo SEQ ID č. 14 je vynechán.
45
18. Izolovaný polypeptid podle nároku 13, kde sekreční aminokyselinová sekvence ze SEQ ID
č. 4 nebo SEQ ID č. 14 je vynechána.
19. Izolovaný polypeptid podle kteréhokoliv z předchozích nároků 13 až 18, kde izolovaný polypeptid je fúzovaný se sacharidem.
20. Izolovaný polypeptid podle kteréhokoliv z předchozích nároků 13 až 19, kde izolovaný polypeptid je schopný generovat protilátky, které se specificky vážou na polypeptid zahrnující aminokyselinovou sekvenci uvedenou v SEQ ID č. 4 nebo SEQ ID č. 14.
- 150CZ 303675 B6
21. Izolovaný polypeptid podle nároku 13, kde Streptococcus je vybraný ze Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae nebo Streptococcus uberis.
5
22. Izolovaný polypeptid podle nároků 13. kde Streptococcus je Streptococcus pneumoniae.
23. Chimémí polypeptid zahrnující dva nebo více polypeptidů, kde aminokyselinová sekvence každého ze dvou nebo více polypeptidů zahrnuje aminokyselinovou sekvenci vybranou z aminokyselinové sekvence uvedené v SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 nebo 79, kde io dva nebo více polypeptidů jsou spojené za vzniku chimérního polypeptidů, přičemž kódovaný polypeptid je schopný u jedince vyvolat imunitní odpověď na Streptokoka.
24. Chimémí polypeptid podle nároku 23, kde chimémí polypeptid obsahuje dva nebo více polypeptidů, kde aminokyselinová sekvence každého ze dvou nebo více polypeptidů zahrnuje
15 aminokyselinovou sekvenci vybranou z aminokyselinové sekvence uvedené v SEQ ID ě. 58, 60, 62, 67, 68, 74 a 77, kde dva nebo více polypeptidů jsou spojené za vzniku chimérního polypeptidu.
25. Chimémí polypeptid podle nároku 23, obecného vzorce (I):
A—(B)m-(C)n-D (I) kde m je 0 nebo 1,
25 n je 0 nebo 1,
A je vybrán ze SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 a 79;
B je vybrán ze SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 a 79;
C je vybrán ze SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 a 79; a D je vybrán ze SEQ ID č. 4, 14, 58, 60, 62, 63, 67, 68, 73, 74, 77 a 79.
35
26. Chimémí polypeptid podle nároku 23 obecného vzorce (I):
A-(B)m-(C)„-D (I) kde m je 0 nebo 1, n je 0 nebo 1,
A je vybrán ze SEQ ID č. 58, 60, 62, 67, 68, 74 a 77;
45 B je vybrán ze SEQ ID č. 58, 60, 62, 67, 68, 74 a 77;
C je vybrán ze SEQ ID č. 58, 60, 62, 67, 68, 74 a 77; a D je vybrán ze SEQ ID č. 58, 60, 62, 67, 68, 74 a 77.
27. Chimémí polypeptid podle kteréhokoliv z předchozích nároků 23 až 26, kde chimérní polypeptid je fúzovaný se sacharidem.
ŤřF
28. Vakcína, vyznačující se tím, že obsahuje profylakticky nebo terapeuticky účinné množství izolovaného polypeptidu podle kteréhokoliv z předchozích nároků 13 až 22 a farmaceuticky přijatelný nosič nebo rozpouštědlo.
5
29. Vakcína podle nároku 28, vyznačující se tím, že dále obsahuje farmaceuticky přijatelné adjuvans.
30. Vakcína, vyznačující se tím, že obsahuje profylakticky nebo terapeuticky účinné množství chimémího polypeptidu podle kteréhokoliv z předchozích nároků 23 až 27, a farmaio ceuticky přijatelný nosič nebo rozpouštědlo.
31. Vakcína podle nároku 30, vyznačující se tím, že dále obsahuje farmaceuticky přijatelné adjuvans.
15
32. Použití izolovaného polypeptidu podle kteréhokoliv z předchozích nároků 13 až 22 pro výrobu léčiva pro terapeutické nebo profylaktické léčení streptokokové infekce u jedince.
33. Použití chimémího polypeptidu podle kteréhokoliv z předchozích nároků 23 až 27 pro výrobu léčiva pro terapeutické nebo profylaktické léčení streptokokové infekce u jedince.
34. Použití podle nároků 32 nebo 33, kde streptokoková infekce zahrnuje meningitidu, zánět středního ucha, bakteriem» nebo pneumonii.
35. Použití podle nároků 32 a 33, kde jedinec je savec.
36. Použití podle nároků 32 a 33, kde jedinec je člověk.
37. Použití podle nároků 32 a 33, kde streptokoková infekce je způsobená Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae nebo
30 Streptococcus uberis.
38. Použití podle nároků 32 a 33, kde streptokoková infekce je způsobená Streptococcus pneumoniae.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11380098P | 1998-12-23 | 1998-12-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ20012161A3 CZ20012161A3 (cs) | 2001-10-17 |
| CZ303675B6 true CZ303675B6 (cs) | 2013-02-27 |
Family
ID=22351610
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20012161A CZ303675B6 (cs) | 1998-12-23 | 1999-12-20 | Izolovaný polynukleotid, vektor, hostitelská bunka, zpusob produkce, izolovaný polypeptid, chimérový polypeptid, vakcinacní prostredek a pouzití |
| CZ20100674A CZ302790B6 (cs) | 1998-12-23 | 1999-12-20 | Izolovaný polynukleotid, vektor, hostitelská bunka, zpusob produkce, izolovaný polypeptid, chimérní polypeptid, vakcinacní prostredek a použití |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20100674A CZ302790B6 (cs) | 1998-12-23 | 1999-12-20 | Izolovaný polynukleotid, vektor, hostitelská bunka, zpusob produkce, izolovaný polypeptid, chimérní polypeptid, vakcinacní prostredek a použití |
Country Status (29)
| Country | Link |
|---|---|
| EP (2) | EP1141306B1 (cs) |
| JP (2) | JP4761623B2 (cs) |
| KR (4) | KR100802198B1 (cs) |
| CN (3) | CN101134775A (cs) |
| AP (1) | AP2001002199A0 (cs) |
| AR (1) | AR029322A1 (cs) |
| AT (1) | ATE394489T1 (cs) |
| AU (1) | AU1764900A (cs) |
| BR (1) | BR9916477A (cs) |
| CA (1) | CA2356836C (cs) |
| CL (1) | CL2009002037A1 (cs) |
| CY (3) | CY1108223T1 (cs) |
| CZ (2) | CZ303675B6 (cs) |
| DE (1) | DE69938670D1 (cs) |
| DK (3) | DK2261358T3 (cs) |
| EA (1) | EA007409B1 (cs) |
| ES (3) | ES2480417T3 (cs) |
| HU (1) | HU229664B1 (cs) |
| IL (3) | IL143905A0 (cs) |
| MX (1) | MXPA01006427A (cs) |
| NO (1) | NO330800B1 (cs) |
| NZ (1) | NZ512574A (cs) |
| OA (1) | OA11736A (cs) |
| PL (3) | PL205041B1 (cs) |
| PT (3) | PT1950302E (cs) |
| TR (2) | TR200102497T2 (cs) |
| UY (1) | UY25877A1 (cs) |
| WO (1) | WO2000039299A2 (cs) |
| ZA (1) | ZA200105114B (cs) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2321106C (en) | 1998-02-20 | 2013-07-23 | Biochem Pharma Inc. | Group b streptococcus antigens |
| EP1801218A3 (en) * | 1998-07-27 | 2007-10-10 | Sanofi Pasteur Limited | Nucleic acids and proteins from streptococcus pneumoniae |
| US20030134407A1 (en) | 1998-07-27 | 2003-07-17 | Le Page Richard William Falla | Nucleic acids and proteins from Streptococcus pneumoniae |
| EP1140157B1 (en) * | 1998-12-21 | 2009-02-18 | MedImmune, Inc. | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
| KR100802198B1 (ko) * | 1998-12-23 | 2008-02-11 | 샤이어 바이오켐 인코포레이티드 | 신규한 스트렙토코커스 항원 |
| US6866855B2 (en) | 2000-06-12 | 2005-03-15 | University Of Saskatchewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
| DK1294771T3 (da) | 2000-06-12 | 2008-12-15 | Univ Saskatchewan | Kimært GapC-protein fra Streptococcus og anvendelse deraf til vaccinering og diagnosticering |
| US6833134B2 (en) | 2000-06-12 | 2004-12-21 | University Of Saskacthewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
| CA2413450C (en) | 2000-06-20 | 2014-02-18 | Shire Biochem Inc. | Streptococcus antigens |
| US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
| WO2002079475A2 (en) * | 2001-03-30 | 2002-10-10 | Shire Biochem Inc. | Streptococcus pyogenes antigens and corresponding dna fragments |
| BR0210875A (pt) | 2001-07-06 | 2004-06-22 | Shire Biochem Inc | Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes |
| GB0130228D0 (en) * | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
| EP1456231A2 (en) * | 2001-12-20 | 2004-09-15 | Shire Biochem Inc. | Streptococcus antigens |
| EP2287315A1 (en) * | 2003-03-04 | 2011-02-23 | Intercell AG | Streptococcus pyogenes antigens |
| EP2311988A1 (en) * | 2003-04-15 | 2011-04-20 | Intercell AG | S. pneumoniae antigens |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| KR101515078B1 (ko) | 2005-12-22 | 2015-04-24 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| CA2690708A1 (en) | 2007-06-26 | 2008-12-31 | Glaxosmithkline Biologicals S.A. | Vaccine |
| WO2009012588A1 (en) * | 2007-07-23 | 2009-01-29 | Sanofi Pasteur Limited | Immunogenic polypeptides and monoclonal antibodies |
| ES2553113T3 (es) | 2008-04-16 | 2015-12-04 | Glaxosmithkline Biologicals S.A. | Vacuna |
| CN102223876A (zh) | 2008-09-26 | 2011-10-19 | 纳米生物公司 | 纳米乳剂治疗性组合物及其使用方法 |
| US20120052088A1 (en) | 2009-04-30 | 2012-03-01 | Coley Pharmaceutical Group, Inc. | Pneumococcal vaccine and uses thereof |
| WO2010132833A1 (en) | 2009-05-14 | 2010-11-18 | The Regents Of The University Of Michigan | Streptococcus vaccine compositions and methods of using the same |
| WO2011027257A2 (en) | 2009-09-03 | 2011-03-10 | Pfizer Vaccines Llc | Pcsk9 vaccine |
| GB201003920D0 (en) * | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
| MX2013006255A (es) | 2010-12-03 | 2015-08-05 | Sanofi Pasteur Ltd | Composicion para inmunizacion contra streptococcus pneumoniae. |
| WO2012100233A1 (en) * | 2011-01-20 | 2012-07-26 | Genocea Biosciences, Inc. | Vaccines and compositions against streptococcus pneumoniae |
| WO2012131504A1 (en) | 2011-03-02 | 2012-10-04 | Pfizer Inc. | Pcsk9 vaccine |
| CN103533953A (zh) | 2011-05-17 | 2014-01-22 | 葛兰素史密丝克莱恩生物有限公司 | 针对肺炎链球菌的疫苗 |
| ES2642184T3 (es) * | 2012-01-05 | 2017-11-15 | Deutsches Krebsforschungszentrum | Péptidos para su uso en el tratamiento y diagnóstico de cánceres positivos a IDH1 R132H |
| EP2931743A4 (en) * | 2012-12-14 | 2016-08-03 | Sanofi Pasteur Ltd | METHOD FOR ASSESSING IMMUNOGENICITY |
| BR112016015835B1 (pt) | 2014-01-21 | 2023-12-26 | Pfizer Inc | Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae |
| US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| PL3096786T3 (pl) | 2014-01-21 | 2021-11-08 | Pfizer Inc. | Polisacharydy otoczkowe streptococcus pneumoniae i ich koniugaty |
| CN110859957B (zh) | 2014-01-21 | 2024-04-12 | 辉瑞公司 | 包含缀合荚膜糖抗原的免疫原性组合物及其用途 |
| ES2701169T3 (es) | 2014-02-14 | 2019-02-21 | Pfizer | Conjugados glucoproteicos inmunogénicos |
| HUE062499T2 (hu) | 2015-01-15 | 2023-11-28 | Pfizer | Pneumococcus-vakcinákban történõ alkalmazásra szolgáló immunogén készítmények |
| KR102225282B1 (ko) | 2015-07-21 | 2021-03-10 | 화이자 인코포레이티드 | 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도 |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| JP6884145B2 (ja) | 2015-11-20 | 2021-06-09 | ファイザー・インク | 肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物 |
| GB201610599D0 (en) | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
| BR112019014833A2 (pt) | 2017-01-20 | 2020-04-14 | Pfizer | composições imunogênicas para uso em vacinas pneumococais |
| GB201711635D0 (en) | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| US11260119B2 (en) | 2018-08-24 | 2022-03-01 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| CA3120922A1 (en) | 2018-12-12 | 2020-06-18 | Pfizer Inc. | Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof |
| JP7239509B6 (ja) | 2019-02-22 | 2023-03-28 | ファイザー・インク | 細菌多糖類を精製するための方法 |
| WO2020208502A1 (en) | 2019-04-10 | 2020-10-15 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof |
| PH12022550110A1 (en) | 2019-07-31 | 2022-12-12 | Sk Bioscience Co Ltd | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same |
| US20230000966A1 (en) | 2019-11-01 | 2023-01-05 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| CN119371566A (zh) | 2020-02-21 | 2025-01-28 | 辉瑞公司 | 糖类的纯化 |
| BR112022014555A2 (pt) | 2020-02-23 | 2022-09-20 | Pfizer | Composições de escherichia coli e métodos das mesmas. |
| WO2022084852A1 (en) | 2020-10-22 | 2022-04-28 | Pfizer Inc. | Methods for purifying bacterial polysaccharides |
| US12138302B2 (en) | 2020-10-27 | 2024-11-12 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| PE20231934A1 (es) | 2020-10-27 | 2023-12-01 | Pfizer | Composiciones de escherichia coli y metodos de las mismas |
| CA3200602A1 (en) | 2020-11-04 | 2022-05-12 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
| US12357681B2 (en) | 2020-12-23 | 2025-07-15 | Pfizer Inc. | E. coli FimH mutants and uses thereof |
| JP2024517780A (ja) | 2021-05-03 | 2024-04-23 | ファイザー・インク | 細菌およびベータコロナウイルス感染症に対するワクチン接種 |
| WO2022234416A1 (en) | 2021-05-03 | 2022-11-10 | Pfizer Inc. | Vaccination against pneumoccocal and covid-19 infections |
| JP2024521847A (ja) | 2021-05-28 | 2024-06-04 | ファイザー・インク | コンジュゲート化莢膜糖抗原を含む免疫原性組成物およびその使用 |
| MX2023013434A (es) | 2021-05-28 | 2023-12-12 | Pfizer | Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos. |
| CA3247998A1 (en) | 2022-01-13 | 2023-07-20 | Pfizer Inc. | Immunogenic compositions based on conjugated capsular saccharidic antigens and their uses |
| WO2023161817A1 (en) | 2022-02-25 | 2023-08-31 | Pfizer Inc. | Methods for incorporating azido groups in bacterial capsular polysaccharides |
| CA3256617A1 (en) | 2022-05-11 | 2023-11-16 | Pfizer Inc. | PROCESS FOR PRODUCING VACCINE FORMULATIONS WITH PRESERVATIVES |
| WO2024084397A1 (en) | 2022-10-19 | 2024-04-25 | Pfizer Inc. | Vaccination against pneumoccocal and covid-19 infections |
| WO2024110827A1 (en) | 2022-11-21 | 2024-05-30 | Pfizer Inc. | Methods for preparing conjugated capsular saccharide antigens and uses thereof |
| EP4622665A2 (en) | 2022-11-22 | 2025-10-01 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| AU2023403045A1 (en) | 2022-12-01 | 2025-06-12 | Pfizer Inc. | Pneumococcal conjugate vaccine formulations |
| WO2024166008A1 (en) | 2023-02-10 | 2024-08-15 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| PE20252774A1 (es) | 2023-03-30 | 2025-12-22 | Pfizer | Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y usos de estos |
| AU2024255922A1 (en) | 2023-04-14 | 2025-10-30 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| WO2024224266A1 (en) | 2023-04-24 | 2024-10-31 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| KR20260015203A (ko) | 2023-05-19 | 2026-02-02 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 호흡기 세포융합 바이러스 및 스트렙토코쿠스 뉴모니아에 감염에 대한 면역 반응을 유발하는 방법 |
| TW202527906A (zh) | 2023-09-14 | 2025-07-16 | 美商輝瑞股份有限公司 | 包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途 |
| WO2025133971A1 (en) | 2023-12-23 | 2025-06-26 | Pfizer Inc. | Improved methods for producing bacterial capsular saccharide glycoconjugates |
| WO2025186705A2 (en) | 2024-03-06 | 2025-09-12 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| WO2025191415A1 (en) | 2024-03-11 | 2025-09-18 | Pfizer Inc. | Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof |
| WO2025219908A2 (en) | 2024-04-19 | 2025-10-23 | Pfizer Inc. | Media and fermentation methods for polysaccharide production in bacterial cell culture |
| WO2025219904A1 (en) | 2024-04-19 | 2025-10-23 | Pfizer Inc. | Improved methods for producing glycoconjugates by reductive amination in aprotic solvent |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998018930A2 (en) * | 1996-10-31 | 1998-05-07 | Human Genome Sciences, Inc. | Streptococcus pneumoniae antigens and vaccines |
| EP1141306A2 (en) * | 1998-12-23 | 2001-10-10 | ID Biomedical Corporation | Streptococcus antigens |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431739A (en) | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
| US4425437A (en) | 1979-11-05 | 1984-01-10 | Genentech, Inc. | Microbial polypeptide expression vehicle |
| US4338397A (en) | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
| HU217582B (hu) * | 1993-03-19 | 2000-02-28 | Gunnar Lindahl | Streptococcus B csoportba tartozó törzsek elleni immunitást biztosító, Rib fehérjenevű felületi protein, eljárás a protein tisztítására, reagenskészlet és gyógyszerkészítmény |
| EA199800046A1 (ru) * | 1995-06-07 | 1998-06-25 | Байокем Вэксинс Инк. | Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента |
| US5882896A (en) * | 1996-09-24 | 1999-03-16 | Smithkline Beecham Corporation | M protein |
| US5928895A (en) * | 1996-09-24 | 1999-07-27 | Smithkline Beecham Corporation | IgA Fc binding protein |
| AU9510598A (en) * | 1997-09-24 | 1999-04-12 | American Cyanamid Company | Human complement c3-degrading proteinase from (streptococcus pneumoniae) |
| WO1999053940A1 (en) * | 1998-04-23 | 1999-10-28 | Uab Research Foundation | PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR |
| ATE361365T1 (de) * | 1998-07-27 | 2007-05-15 | Sanofi Pasteur Ltd | Streptococcus pneumoniae proteine und nukleinsäuren |
| CN1318103A (zh) * | 1998-07-27 | 2001-10-17 | 微生物技术有限公司 | 肺炎链球菌的核酸和蛋白质 |
| EP1115875A1 (en) * | 1998-09-24 | 2001-07-18 | Regents Of The University Of Minnesota | Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| EP1140157B1 (en) * | 1998-12-21 | 2009-02-18 | MedImmune, Inc. | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
-
1999
- 1999-12-20 KR KR1020017007963A patent/KR100802198B1/ko not_active Expired - Fee Related
- 1999-12-20 CN CNA2007101481600A patent/CN101134775A/zh active Pending
- 1999-12-20 TR TR2001/02497T patent/TR200102497T2/xx unknown
- 1999-12-20 EP EP99960748A patent/EP1141306B1/en not_active Expired - Lifetime
- 1999-12-20 ES ES10180372.4T patent/ES2480417T3/es not_active Expired - Lifetime
- 1999-12-20 IL IL14390599A patent/IL143905A0/xx unknown
- 1999-12-20 EA EA200100565A patent/EA007409B1/ru not_active IP Right Cessation
- 1999-12-20 TR TR2002/00633T patent/TR200200633T2/xx unknown
- 1999-12-20 CN CNB2005100037492A patent/CN100398653C/zh not_active Expired - Fee Related
- 1999-12-20 DK DK10180372.4T patent/DK2261358T3/da active
- 1999-12-20 DE DE69938670T patent/DE69938670D1/de not_active Expired - Lifetime
- 1999-12-20 AP APAP/P/2001/002199A patent/AP2001002199A0/en unknown
- 1999-12-20 AT AT99960748T patent/ATE394489T1/de active
- 1999-12-20 ES ES08155317T patent/ES2400280T3/es not_active Expired - Lifetime
- 1999-12-20 CZ CZ20012161A patent/CZ303675B6/cs not_active IP Right Cessation
- 1999-12-20 EP EP10180372.4A patent/EP2261358B1/en not_active Expired - Lifetime
- 1999-12-20 PL PL382437A patent/PL205041B1/pl unknown
- 1999-12-20 MX MXPA01006427A patent/MXPA01006427A/es not_active IP Right Cessation
- 1999-12-20 PL PL382438A patent/PL204073B1/pl not_active IP Right Cessation
- 1999-12-20 CA CA2356836A patent/CA2356836C/en not_active Expired - Fee Related
- 1999-12-20 KR KR1020087008264A patent/KR101170203B1/ko not_active Expired - Fee Related
- 1999-12-20 JP JP2000591190A patent/JP4761623B2/ja not_active Expired - Fee Related
- 1999-12-20 DK DK99960748T patent/DK1141306T3/da active
- 1999-12-20 CZ CZ20100674A patent/CZ302790B6/cs not_active IP Right Cessation
- 1999-12-20 BR BR9916477-9A patent/BR9916477A/pt active Search and Examination
- 1999-12-20 PL PL349777A patent/PL206576B1/pl unknown
- 1999-12-20 ES ES99960748T patent/ES2306528T3/es not_active Expired - Lifetime
- 1999-12-20 AU AU17649/00A patent/AU1764900A/en not_active Abandoned
- 1999-12-20 OA OA1200100165A patent/OA11736A/en unknown
- 1999-12-20 HU HU0104774A patent/HU229664B1/hu not_active IP Right Cessation
- 1999-12-20 PT PT81553174T patent/PT1950302E/pt unknown
- 1999-12-20 WO PCT/CA1999/001218 patent/WO2000039299A2/en not_active Ceased
- 1999-12-20 PT PT99960748T patent/PT1141306E/pt unknown
- 1999-12-20 KR KR1020067025282A patent/KR100891398B1/ko not_active Expired - Fee Related
- 1999-12-20 CN CNB998149047A patent/CN1191362C/zh not_active Expired - Fee Related
- 1999-12-20 KR KR1020107009285A patent/KR101078919B1/ko not_active Expired - Fee Related
- 1999-12-20 PT PT101803724T patent/PT2261358E/pt unknown
- 1999-12-20 NZ NZ512574A patent/NZ512574A/xx not_active IP Right Cessation
- 1999-12-20 DK DK08155317.4T patent/DK1950302T3/da active
- 1999-12-23 AR ARP990106746A patent/AR029322A1/es not_active Application Discontinuation
- 1999-12-23 UY UY25877A patent/UY25877A1/es unknown
-
2001
- 2001-06-19 NO NO20013045A patent/NO330800B1/no not_active IP Right Cessation
- 2001-06-21 IL IL143905A patent/IL143905A/en not_active IP Right Cessation
- 2001-06-21 ZA ZA200105114A patent/ZA200105114B/en unknown
-
2008
- 2008-07-29 CY CY20081100787T patent/CY1108223T1/el unknown
- 2008-09-21 IL IL194230A patent/IL194230A/en not_active IP Right Cessation
-
2009
- 2009-11-05 CL CL2009002037A patent/CL2009002037A1/es unknown
-
2010
- 2010-02-09 JP JP2010026521A patent/JP5039802B2/ja not_active Expired - Fee Related
-
2012
- 2012-12-27 CY CY20121101268T patent/CY1114722T1/el unknown
-
2014
- 2014-07-16 CY CY20141100536T patent/CY1115340T1/el unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998018930A2 (en) * | 1996-10-31 | 1998-05-07 | Human Genome Sciences, Inc. | Streptococcus pneumoniae antigens and vaccines |
| WO1998018931A2 (en) * | 1996-10-31 | 1998-05-07 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
| EP1141306A2 (en) * | 1998-12-23 | 2001-10-10 | ID Biomedical Corporation | Streptococcus antigens |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ303675B6 (cs) | Izolovaný polynukleotid, vektor, hostitelská bunka, zpusob produkce, izolovaný polypeptid, chimérový polypeptid, vakcinacní prostredek a pouzití | |
| JP5051959B2 (ja) | ストレプトコッカス抗原 | |
| US8211437B2 (en) | Streptococcus antigens | |
| IL137921A (en) | Proteins and polypeptides of group B streptococcus | |
| US7074415B2 (en) | Streptococcus antigens | |
| EP1950302B1 (en) | Streptococcus antigens | |
| AU2008229967B2 (en) | Novel streptococcus antigens | |
| HK1118575B (en) | Streptococcus antigens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20171220 |